Text

Rev 17 to ODCM for Clinton Power Station
	ML20206E628
Person / Time
Site:	Clinton
Issue date:	12/31/1998
From:	; ILLINOIS POWER CO.
To:	;
Shared Package
ML20206E620	List: ML20206E623; ML20206E628; U-603205, Forwards Annual Radioactive Effluent Release Rept for Clinton Power Station for Period Jan-Dec 1998. Rev 17 to ODCM for Clinton Power Station, Also Encl;
References
	PROC-981231, NUDOCS 9905050186
	Download: ML20206E628 (400)
	v • d • e

_ _ - - - _ - _ - _ _ _ - - _ _ _ _ _ - _ _ - _ - - - _ _ _ _ _ - _ _ _ _ _ _ _ - _

I i I

g, 3

l CLINTONPOWER STATION I

l OFFSITE DOSE CALCULATION MANUAL >

I REVISION 17 ;

gi Issued: December 31,1998 I

I I

IL r

3: .

i 9905050186 990427 PDR ADOCK 05000461 R PDP s ~

..r.

CPS-ODCM ILLINOIS POWER COMPANY DOCUMENT CONTROL JAN 1- 99 CONTRO LED COPY CLINTON POWER STATION ILLINOIS POWER COMPANY CLINTON POWER STATION.

UNIT 1 OFFSITE DOSE CALCULATION DOCUMrNT MANUAL o L ILLIN Docket No. 50-461-Y $ 91999 OL T 't 8'. rop weg

LID TH n Y '

I l Sf FRG 'Da f.e i

/)J Manag'er-C$ntoh'Po e#- M r Station i /? 3/-75 Date i

j l

i I

r T.T NTnhT- 1 uno 17-1?/4R I

)

CPS-ODCM Illinois Power Company ILLINOIS POWER COMPANY ,

DOCUMENT CONTROL Clinton Power Station

' ~

OFFSITE DOTiE CALCULATION MANUAL JAN 999 Tab:'.e of Contents CONTR _ ED COPY CLINTON POWER STATION N '

Section Title Page 1.0 PREFACE 1-1 '

1.1 Definitions 1-1 1.2 General Operation Requireinents 1-4 1.3 General Surveillance Requirements 1-4 1.4 Effluent Concentration Limit (ECL) 1-6 i Calculation Requirements . !

l 2.0 LIQUID EFFLUENTS I 2.1 Introduction 2'- 1 2.2 Liquid Radwaste Discharge Process 2-1 Radiation Monitoring (PRM) System 2.3 10CFR20 Release Rate Limits 2-1 2.3.1 Lickuid Effluent Concentration - 2-2 Operation and Surveillance .

Requirements 2.3.2 Liquid Radwaste Discharge PRM 2-6 ,,

Setpoints 2.3.3 Plant Service Water Effluent 2-11 PRM Setpoints 2.3.4 Shutdown Service Water (SX) 2-12

! Effluent PRM Setpoints 2.3.5 Fuel Pool Heat Exchanger Service 2-12 Water Effluent PRM Setpoints .

2.3.6 Component. Cooling Water PRM 2-12 Setpoints m.mTm- 1 i Rev.17-12/90

CPS-ODCH Illinois Power Company -

Clinton Power Station OFFSITE DOSE CALCULATION MANUAL !

Table of Contents Section Title Page 2.0 2.4 10CFR50,' Appendix I Release Rate Limits 2-13 I

2.4.1 10CFR50, Appendix I Release Rate 2-13 i Limits - Operation and Surveillance Requirements 2.4.2 Discussion 2-14 2.5 s Liquid Radwa'te Treatment System 2-24 2.5.1 Liquid Radwaste Treatment ,

System - Operation and 2t-24 g Surveillance Requirements 1 5

2.5.2 Temporary Liquid Radwaste 2r25 Hold-up Tanks 2.6 Doses From Other Significant Liquid Effluent Pathways 2-25 2.7 Radioactive Liquid Effluent Monitoring 2-25 Instrumentation 2.7.1 Radioactive Liquid Effluent 2-25

, Monitoring Instrumentation-Operation and Surveillance Requirements 3.0 GASEOUS EFFLUENTS 3-1 3.1 Introduction 3-1 3.2 Gaseous Effluent Release Point Monitoring 3-2 3.2.1 HVAC Stack Process Radiation 3-2 g Monitoring (PRM) System 5 3.2.2 SGTS Stack Process Radiation 3-2 g Monitoring (PRM) System g Ii I

CLINTON-1 11 Rev.17-12/98 i

~

I CPS-ODCM l Illinois Power Company Clinton Power Station -

l OFFSITE DOSE CALCULATION MANUAL I

Table of Contents Section Title -

Page 3.0 3.3 Main Condenser Off-Gas Monitoring System 3-3 3.3.1 Pre-Treatment Air Ejector 3-3 I Off-Gas Process Radiation Monitor (PRM)

I 3.3.2 Post-Treatment Air Ejecto'r Off-Gas Process Rad.iation Monitor (PRM) 3-4 I 3.4 10CFR20 Release Rate Limits 3- 4 3.4.1 10CFR20 Release Rate Limits - 3i-4

. Operation and Surveillance Requirements >

3.4.2 Dose Rate Due to Noble Gases 3-9 3.4.3 Do'se Rate Due to Radioiodines, 3-9 Pazticulates and Tritium 3.5 10CFR50, Appendix I Release Rate Limits 3-15 l 3.5.1 Noble Gas Dose - Operation and 3-15 i Surveillance Requirements l 3.5.2 Iodine-131, Iodine-133, Tritium, 3-16 l and Radionuclides in Particulate l Form - Operations and l Surveillance Requirements ,

3.5.3 Noble Gas Air Dose Equations 3-17 3.5.4 Radioiodines, Particulates and 3-10 Tritium Dose Equations 3.6 Gaseous Radwaste (Offgas Treatment 3-25 ,

g 3.6.1 Gaseous Radwaste (Offgas 3-25 Treatment) System - Operation 5 and Surveillance Requirements I , . . . . . _ . . . . . - ,.,,,,,n

CPS-ODCM Illinois Power Company Clinton Power Station OFFSITE DOSE CALCUIATION MANUAL ["', {

I I

Table of Contents Section Title Page 3.0 3.7 Ventilation Exhaust Treatment 3-27

- 3.7.1 Ventilation Exhaust Treatment 3-27 System - Operation and '

Surveillance Requirements j i

3.8 Effluent Monitor Setpoint Calculations 3-28 3.8.1 Total Body Dose Rate Setpoint 3-29 J

'3.8.2 Skin Dose Rate Setpoint 3-31 3.9 Radioactive Gaseous Monitoring 3-32 gf Instrumentation g !

(

t 3.9.1 Offgas Radiation Monitoring 3-32 Instrumentation - Operation and Surveillance Requirements 3.9.2 Radioactive Gaseous Effluent 3-39 Monitoring Instrumentation -

Operation and Surveillance Requirements 4.0 COMPLIANCE WITH 40CFR190 4-1 4.1 Total Dose - Operation and Surveillance 4-1 Requirements 4.1.a Remedial Requirement 4-1 5.0 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 5-1 5.1 Monitoring Program - Operation and 5-1 Surveillance Requirements 5.2 Land Use Census - Operation and 5-21 I

Surveillance Requirements I l I

CLINTON-1 iv Rev.17-12/90 I

I CPS-ODCM Illinois Power Company Clinton Power Station I OFFSITE DOSE CALCULATION MANUAL Table,of Contents Section '

Title Page 5.0 5.3 Interlaboratory Comparison Program 5-22 5.3.1 Interlaboratory Comparison 5-23 I ,

Program - Operation and Surveillance Requirements BASES FOR OPERATION AND SURVEILLANCE 61 I 6.0 REQUIREMENTS i

l 6.1 General Operation and Surveillance . . 6-1 Requiremen.ts ,

6.2 Monitoring Instrumentation 6f2 6.3 Radioactive Effluents 6r 3 6.3.1 Liquid Effluents 6-3

/ 6.3.2 Gaseous Effluents 6-5 l 6.3.3 Total Dose 6-9 6.4 Radiological Environmental Monitoring 6-10 7.0 REPORTING REQUIREMENTS 7-1 I ~

7.1 Annual Radiological Environmental Operating Report ,

7-1 7.2 Radioactive Effluent' Release 7-2 I ~

Report

" "" ""' " " " "" " " """ " ~ "~'

I 9.0 ATMOSPHERIC TRANSPORT AND DISPERSION MODEL 9-1 9.1 Introduction 9-1 I

g .

I FF T tver*nt 9 1 ,

n ,,,, 1 *1 19 /OO

CPS-ODCM-Illinois Power Company Clinton Power Station

. . 7M f

OFFSITE DOSE CALCULATION MANUAL Table of Contents Section Title Page Concurrent Meteorological Data Processing 9-1 = !

9.0 9.2 9.2.1 Determination of Pasquill 9-2 g!

Stability Class ,

W 9.2.2 Calculation of Stack IIeight 9--3 Wind Speed 9.2.3 Determination of Release Mode 9-3 and the Entrainment Coefficient 9.2.4 Calculation of Vertical Standard 9i-4 Deviation }

9.2.5 Calculation of the Building Wake 9r5 Correction 9.2.6 Calculation of Momentum Plume 9-5 Rise 9.2.7 Cal'culation of Effective Plume 9-6 Height 9.2.8 Determination of Affected 9-7 Sectors 9.2.9 Calculation of Depletion and 9-8 Deposition Factors Ground' Level X/Q, D2DPXQ, DlXQ, 9-9 9.2.10 D/O Analysis 9.2.11 Elevated X/Q, D2DPXQ, D1XQ, D/O 9-10 Analysis I

I I

I CLINTON-1 vi Rev.17-12/98

7 CPS-OpcH Illinois Power Company Clinton Power. Station 4- OFFSITE DOSE CALCULATION MANUAL Tables Table Title _

Page 1.1-1 Surveillance Frequency Notation 1-6 2.3-1 Radioactive. Liquid Waste Sampling and Analysis 2-3 Program 2.4-1 Adult Ingestion Dose Commitment Factors - Ai3 2-16 2.4-2 Bioaccumulation Factors - BFs 2-18

.2.4-3 Adult Ingestion Dose Factors - DFs 2-19 2.7-1 Radioactive Liquid Effluent Monitoring 2-27 Instrumentation

-2.7-2 Radioactive Liquid Effluent Monitoring 2-30 Instrumentation Surveillance Requirements 3.4-1 Radioactive Gaseous Waste Sampling and Analysis 3-6 Program 3.4-2 Dose Factors for Noble Gases and Daughters 3-11 3.4-3. Inhalation Pathway Dose Rate Factors (Child) - 3-12 Pi3

'3.4 Location of Members of the Public Within the 3-14 CPS Site Boundary and Their Associated Occupancy Factors 3.9.1-1 .Offgas Radiation Monitoring Instrumentation 3-33

/- '3.9.1-2 Offgas Radiation Monitoring Instrumentation 3-37 Surveillance Requirements 3'.9.2-1 ' Radioactive Gaseous' Effluent Monitoring 3-40 Instrumentation 3.9.2-2 Radioactive Gaseous. Effluent Monitoring 3-42

-Instrumentation Surveillance Requirements 3.5-1 Inhalation Dose Factors for Infant-(DFA ).i 3-46

3. 5--2 Inhalation Dose Factors for Child-(DFA ).

i 3-48 3.5-3 Inhalation Dose Factors for Teen-(DFA ).

i 3-50 CLINTON vii Rev.17-12/98

y Illinois Power Company Clinton Power Station OFFSITE DOSE CALCULATION MANUAL

["

Tables Table' Title Page

3. 5--4 Inhalation Dose Factors for Adult-(DFA 1), 3-52 3.5-5 Ground Plane Dose Factors-DFGi 3-54 ,

3.5-6 Ingestion Dose Factors for Infant-(DFL 1). 3-56 3.5 Ingestion Dose Factors for Child-(DFL i). 3-58 i

)

3.5-8 Ingestion Dose Factors for Teen-(DFL 1). ,

3-60 {

3.5-9 Ingestion Dose Factors for Adult-(DFL i). 3-62

, 3.5-10 Input Parameters for Calculating R".i3 3-64 3.5-11 Input Parameters for Calculating R".13 3-65 3.5-12 Input Parameters for Calculating R*.13 3-66 3

3.5-13 Inhalation Pathway Factors - R.33 (INFANT) 3-67 3.5-14 Inhalation Pathway Factors - R*.13 (CHILD) 3-69 3.5-15 Inhalation. Pathway Factors - R*13 (TEEN) 3-71 3.5-16 Inhalation Pathway Factors - R*.13 (ADULT) 3-73 3.5-17 Cow Milk Pathway Factors - R".13 (INFANT) 3-75 3.5-18 Cow Milk Pathway Factors - R".13 (CHILD) 3-77 3.5-19 Cow Milk Pathway Factors - R".13 (TEEN) 3-79 3.5-20 Cow Milk Pathway Factors - R".13 (ADULT) 3-81 3.5-21 Goat Milk Pathway Factors - R.13 (INFANT) 3-83 3.5-22 Goat Milk Pathway Factors - R.13 (CHILD) 3-85 3.5-23 Goat Milk Pathway Factors - R".i3 (TEEN) 3-87 3.5-24' Goat Milk Pathway Factors - R"g3 (ADULT) 3-89

'3.5-25 Meat Pathway Factors - R".13 (CfIILD) 3-91 3.5-26 Meat Pathway Factors - R".33 (TEEN) 3-93 3.5-27 Meat Pathway Factors - R"i3 (ADULT) 3-95 CLINTON-1 viii Rev.17-12/98 I

e CPS-ODCM-Illinois Power Company Clinton Power Station OFFSITE DOSE CALCULATION MANUAL Tables l Tablo Title Page 3.5-28 Vegetation Pathway Factors - R".i3 (CHILD) 3-97 3.5-29. Vegetation Pathway Factors - R".g3 (TEEN) 3-99

. 3.5-30 . Vegetation-Pathway Factors - R*.13 ~ (ADULT) 3-101 3.5-31 Ground Plane Pathway Factors.- R* 3-103, 5.1-1 -Radiological Environmental Monitoring Program 5-4 l 5.1-2 Reporting Levels for Radioactivity 5-17 Concentrations in Environmental Samples I

5.1-3 Detection Capabilities for Environmental Sample 5-18 Analysis Lower Limit of Detection (LLD)

-9.2-1 Gaseous Effluent Release Point Characteristics 9-12 l

l l

l I

l l

CLINTON-1 ix Rev.17-12/98

CPS-ODCH J Illinois Power Company 1 Clinton Power Station OFFSITE DOSE CALCULATION MANUAL Figures Figure Title Page 2.1-1 Unrestricted Area Boundary for Liquid Effluents 2-10 2.5-1 Liquid Radwaste Treatment System 2-21 2.5-2 Shutdown and Fuel Pool Heat Exchanger Service 2-22 Water Effluent Monitors 2.5-3 Solid Radwaste System Simplified Flow Diagram 2-23 3.1-1 CPS Site Boundary For Gaseous Effluents 3-44 3.3-1 Main Condenser Off-Gas Treatment System 3-45 5,0-1 REMP Locations Within 1 Mile of CPS 5-24 5.0-2 REMP Location 1-2 Miles From CPS 5-25 1 5.0-3 REMP Location 2-5 Miles From CPS 5-26 l 5.0-4 REMP Locations Greater than 5 Miles From CPS 5-27 I

I I

II I

I I I

Il CLINTON-1 x Rev.17-12/98 I

FJ ,

m CPS-ODCM

- 1.0- ' GENERAL INFORMATION

. PREFACE 1

The Clinton Power Station OFFSITE DOSE CALCULATION MANUAL

.(CPS-ODCM) provides the methodologies and parameters to be used by Illinois: Power Company (IPC) to assure compliance with the radioactive effluent dose limit'ations stated in 10CFR20,-10CFR50 Appendix A (General Design

. Criteria 60'and 64), 10CFR50 Appendix I, and 40CFR190.

The CPS-ODCM'was prepared based on guidance provided in .

NUREG-0133, PREPARATION OF RADIOLOGICAL EFFLUENT TECHNICAL SPECIFICATIONS FOR NUCLEAR POWER PLANTS (October 1978), and NUREG-0473, RADIOLOGICAL EFFLUENT TECHNICAL SPECIFICATIONS FOR BOILING WATER REACTORS

(Draft 7, to Revision 3). This' manual along with station procedures will be used by CPS personnel to demonstrate compliance with the above referenced Federal Regulations.

Changes to the CPS-ODCM shall be provided in.the RADIOACTIVE EFFLUENT-RELEASE REPORT. .!

11.1 -Definitions .

l TheIfo11owing' terms are defined so that uniform ,

interpretation of requirements of this manual'may be achieved. The defined terms appear in capitalized type and shall be applicable throughout this manual.

CHANNEL CALIBRATION 1.1.1 A CHANNEL CALIBRATION shall be the adjustment, as necessary, of the channel output such that it responds with the necessary range and accuracy to known values of the parameter that the-channel monitors. The CHANNEL

-CALIBRATION shall encompass the entire channel, including the~ required sensor, alarm, display, and trip functions, and shall include the CHANNEL' FUNCTIONAL TEST.

Calibration of instrument channels with resistance temperature detector (RTD) or thermocouple sensors may consist-of an in place qualitative assessment of sensor behavior and normal calibration of the remaining adjustable' devices in-the channel. The CHANNEL

~

CALIBRATION may be performed by means of any series of sequential,1 overlapping or total channel steps so that

'the entire channel is calibrated.

i s

L

-CLINTON-1L 1-1 Rev.17-12/98

p CPS-ODCM CHANNEL CHECK i 1.1.2 A CHANNEL CHECK shall be the qualitative assessment of '

'c'hannel behavior during operating by observation. This determination shall include, where possible, comparison {

of the channel indication and/or status with other indications and/or status derived from independent instrument channels measuring the same parameter.

CHANNEL FUNCTIOIAL TEST 1.1.3 A CHANNEL EUNCTIONAL TEST shall be the injection of a siipulated, or actual, signal into the channel as close to the s.ensor as practicable to verify OPERABILITY, including required alarm, interlock, display, and trip functions, and channel failure trips. The CHANNEL FUNCTIONAL TEST may be performed by means of any series of sequential, overlapping or total channel steps so that; the entire channel is tested. .

FREQUENCY NOTATION I 1.1.4 The FREQUENCY NOTATION specified for the performance of surveillance requirements shall correspond to the intervals defined in Table 1.1-1.

GASEOUS RADWASTE TREATMENT SYSTEM 1.1.5 A GASEOUS RADWASTE TREATMENT SYSTEM is any system designed and installed to reduce radioactive gaseous effluents by collecting primary coolant system offgases from the main condenser evacuation system and providing for delay or holdup for the purpose of reducing the total radioactivity prior to release to the environment.

MEMBER (S) OF THE PUBLIC 1.1.6 An individual in a controlled or unrestricted area.

However, an individual is not a member of the public during any period in which the individual receives an g occupational dose.

, 3 g497 1.1. *7 MODE A MODE shall correspond to any one inclusive combination of mode switch position, average reactor coolant temperature, and reactor vessel head bolt tensioning specified in Technical Specification Table 1.1-1 with fuel in the reactor vessel.

I CLINTON-1 1-2 Rev.17-12/98 o

a i

CPS-ODCM' OPERABLE - OPERABILITY N, 1.1.8 ,A, system,' subsystem, division, component or device shall

.be OPERABLE or have OPERABILITY when it is capable of performing its specified safety function (s) and when all necessary attendant instrumentation, controls, normal or emergency electrical power, cooling or seal water, lubrication.or other auxiliary equipment that are required for the system, subsystem, division, component or device to perform its specified safety function (s) are also capable of performing their related= support

' function (s).

REMEDIAL REQUIREMENT

-_1.1.9 REMEDIAL REQUIREMENT shall be that part of a requirement -

which prescribes remedial measures required under designated conditions. 1

~

SITE BOUNDARY r .1.1.10 The SITE BOUNDARY shall be that line beyond which the

-land is neither owned, nor leased, nor otherwise controlled by the licensee.

SOURCE CHECK-1.1.11 A SOURCE CHECK shall be'the qualitative assessment of channel response when the channel sensor is exposed to a source of increased radioactivity.

UNRESTRICTED AREA .

'1.1.12 An UNRESTRICTED AREA means an area, access to which is neither limited nor controlled by the licensee.

VENTILATION EXHAUST TREATMENT SYSTEM i

1.1.13 A VENTILATION: EXHAUST TREATMENT SYSTEM is any system designed and installed to reduce gaseous radioiodine-or radioactive material in particulate form in effluents by

passing ventilation or vent exhaust gases through~

charcoal adsorbers and/or HEPA filters for the purpose of

! removing; iodines or particulates from the gaseous exhaust L stream prior to the release to the environment. Such a system is not considered to have any effect on noble gas Jeffluents. Engineered Safety Feature (ESP) atmospheric cleanup systems are not considered to be VENTILATION 3 EXHAUST TREATMENT SYSTEM components.

i CLINTON-l' 1-3 Rev.17-12/98 ,

P l

CPS-ODCM Il '

The following systems are designated VENTILATION EXHAUST TREATMENT SYSTEMS: 7

. . k

1) Machine Shop HVAC (VJ) l

2) Laboratory HVAC (VL) i

3) Drywell Purge (VO) .

4) Radwaste Bldg HVAC (VW) 1.2 General Operation Requirements I 1.2.1 Operation Requirements shall be met during the condith ns specified therein; except as provided in Operation Requirement 1.2.2.

1.2.2 Upon discovery of a failure to meet an Operation Requirement, the REMEDIAL REQUIREMENT (s) shall be met, except as provided in 1.2.3. ,

gl g i '

If'the Operation Requirement is met or is no longer i applicable prior to expiration of the REMEDIAL REQUIREMENT (s), completion of the REMEDIAL REQUIREMENT (s) is not required, unless otherwise stated.

1.2.3 Equipment removed from service or declared inoperable to comply with REMEDIAL REQUIREMENT (s) may be returned to service under administr,ative control solely to perform j testing required to demonstrate OPERABILITY or the OPERABILITY of other equipment. This is an exception to Ei B '

OPERATION REQUIREMENT 1.2.2 for the system returned to service under administrative control to perform the testing required to demonstrate OPERABILITY.

1.3 General Surveillance Requirements !

1.3.1 Surveillance Requirements shall be met during the i applicable conditions specified in and for the associated l

Operation Requirement, unless otherwise stated in the l l Surveillance Requirement. Failure to meet a .

i l Surveillance, whether such failure is experienced during j the performance of the surveillance, or between performances of the Surveillance, shall be failure to EI l

Ej meet the Operation Requirement. '

Il I'

I CLINTON-1 1-4 Re y ,1 1- 12 / 98

CPS-ODCM 1.3.2 The specified surveillance interval for each Surveillance Requirement is met if the' Surveillance is performed

, within 1.25 times the specified surveillance interval, as i measured from the previous performance or as measured from the time a specified. condition of the Surveillance Requirement is met.

For surveillance intervals specified as "once", the above interval extension does not apply.

If a REMEDIAL REQUIREMENT requires periodic performance on in "once per ..." basis, the above surveillance interval extension applies to each performance after the initial performance.

Exceptions to this Surveillance Requirement are stated in the individual Surveillance Requirements.

Failure to perform a surveillance within the speci.fied time interval shall be a failure to meet the Operation Requirement except as provided in Surveillance Requirement 1.3.3. Surveillances do not have to be performed on inoperable equipment or variables outside specified limits.

I 1.3.3 If it is discovered that a surveillance was not performed within its specified surveillance interval, then compliance with the requirement to declare the Operational Requirement,not met may be delayed, from the I time of discovery, up to 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months or up to the limit of the specified interval, which ever is less. This delay period is to allow performance of the surveillance.

If the surveillance is not performed within the delay period, the Operational Requirement must immediately be j I declared not met, and the applicable REMEDIAL REQUIREMENTS must be met.

I 1.3.4 Entry into a condition specified in and for an Operation Requirement shall not be made unless the Surveillance, Requirement (s) associated with the Operation Requirement I have been performed within the applicable surveillance interval or as otherwise specified.

This provision shall not prevent entry into conditions I specified for an Operation Requirement that is required to comply with REMEDIAL REQUIREMENT (s) or that are part of a shutdown of the unit.

Surveillance Requirement 1.3.4 is only applicable for entry into a condition specified for an Operation

/ Requirement in MODES 1, 2, and 3.

CLINTON-1 1-5 Rev.17-12/98

e CPS-ODCM 1.4 Effluent Concentration Limit (ECL) Calculation g, Requirements 5 i

~

l 1.4.1 T'en times the values found in 10CFR20 Appendix.B, Table 2, \

\\4 l

b Column 2 shall be used for all ECL calculations in the I ODCM. For dissolved or entrained noble gases, the concentration shall be limited to 2.0 x 10-4 microcuries/ml total activity.

)

TABLE 1.1-1 I'

SURVEILLANCE FREQUENCY NOTATION NOTATION FREQUENCY S At least once per 12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months . .

D At least once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months . I W At least once per 7 days.

M At least once per 31 days.

Q At least once per 5:2 days.

SA At 1, east once per 184 days.

A At least once per 366 days. l R At least once per 18 months (550 days)

P Prior to each release.

S/U Prior to each reactor startup. I NA Not applicable.

Note: A frequency notation for a composite sample describes I\ i the time period over which the sample is to be composited.

l I

I CLINTON-1 1-6 Rev.17-12/98

CPS-ODCM 2.0 LIQUID EFFLUENTS ,

2.1 , Introduction

\g3 63T Liquid radwaste effluent released from CPS will meet ten times the 10CFR20 concentration limits at the point of discharge to the unrestricted area shown in Figure 2.1-1.

This design and operation objective will be achieved at all' times. Actual discharges of liquid radwaste effluent will normally occur on a batch basis and the average concentration at the point of discharge will be only a small percentage of the allowed limits. Refer to Clinton USAR Section 11.5 for a description of radiation i monitoring, sampling and effluent control systems.

Cumulative quarterly dose contributions due to I radioactive effluents released to the unrestricted area will be determined once every 31 days using NUREG-0133 and Regulatory Guide 1.109 methodology and parameters IMfpt during periods when liquid effluent activity exceeds the Lower Limit of Detection (LLD) values.

2.2 Liquid Radwaste Discharge Process Radiation Monitoring 1 (PRM) System ,

This monitoring subsystem measures liquid radwaste I effluent radioactivity prior to the effluent joining plant-service water and circulating water dilution g streams. A high radioactivity signal from this gamma l scintillation detector automatically terminates the liquid radwaste effluent release. The liquid radwaste effluent flow, variable from 10-60 GPM or 50-300 GPM, combines with Plant Service Water flow (minimum flow approximately 2000 GPM during plant shutdown periods depending on system loads) and Plant Circulating Water flow (0-567,000 GPM) in the Seal Well prior to entering the 3.4-mile discharge flume to Lake Clinton (see Figure 2.5-1).

2.3 10CFR20 Release Rate Limits ,

g The Operation and Surveillance Requirements pertaining to l discharge of liquid radwaste effluent to the unrestricted

, area are specified in Section 2.3.1 as follows.

l

~

CLINTON-1 2-1 Rev.17-12/98

CPS-ODCM 2.3.1 Liquid Effluent Concentration - Operation and Surveillance Requirements .

'O'PERATION REQUIREMENT \

The-concentration of radioactive material released in '

I liquid effluent to UNRESTRICTED AREAS (see Figure 2.1-1) shall be limited to ten times the concentrations specified in 10CFR Part 20, Appendix B, Table 2, Column 2 for radionuclides other than dissolved or entrained noble gases. For dissolved or entrained noble the concentration shall be limited to 2 x 10" gases, microcuries/ml total activity. This requirement applies during all releases via this pathway.

REMEDIAL REQUIREMENT:

With the concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS exceeding the above limits, immediately restore the concentration to a within the above limits. ;

i E

SURVEILLANCE REQUIREMENTS t

2.3.1.1 Radioactive liquid wastes shall be sampled and analyzed =

according to the sampling and analysis program of Table 2.3-1.

2.3.1.2 The results of the radi,oactivity analyses shall be used l in accordance with the methodology and parameters of g)

Section 2.3.2 to assure that the concentrations at the 5Ij point of release are maintained within the limits of the above Operation Requirement, gl To comply with the above requirements, setpoints will be E lj M

calculated to assure that Seal Well concentrations do not i

\M exceed the OPERATIONAL REQUIREMENT specified in section )

2.3.1. j

. II I l I. i I

CLINTON-1 2-2 Rev.17-12/98

l l

CPS-ODCM '

TABLE 2.3-1

'R'AD'IOACTIVE LIQUID WASTE SAMPLING AND ANALYSIS PROGRAM LOWER LIMIT LIQUID MINIMUM OF DETECTION RELEASE SAMPLING ANALYSIS TYPE OF ACTIVITY. (LLD)*

TYPE FREQUENCY ANALYSIS FREQUENCY ( Ci/ml)

Batch Waste P P Principal Gamma gSxio_7 Release Each Batch Each Batch Emitters

Tanks b I-131 gixio_6 I P One Batch /M M Dissolved and Entrained Gases *

(Gamma Emitters)

$1x10-5

_{

I k P Q H-3 six10-5 N Each Batch Composite d N Gross Alpha sixio_7 P Q Sr-89, Sr-90 $5x10-8 Each Batch Composite d Fe-55 six10-6

_)

I ll l'

CLINTON-1 2-3 Rev.17-12/98 i

p CPS-ODCM TABLE 2.3-1 (Continued)

' RADIOACTIVE LIQUID WASTE SAMPLING AND ANALYSIS PROGRAM f TABLE NOTATIONS

The LLD is defined, for purposes of these requirements, as the smallest concentration of radioactive material in a sample that g will yield a net count, above system background, that will be g detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal.

For a particular measurements system, which may include radiochemical separation:

LLD e 4.66 s3/[E x V x 2.22 x 10' x Y x exp'- ]

Where:

LLD is the "a priori" lower limit of detection as defined above, as microcuries per unit mass or volume, so is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate,'as E counts per minute. 5 E is the counting efficiency, as counts per disintegration.,

V is the sample size in units of mass or volume, 2.22 x 10' is the number of disintegrations per minute per microcurie, Y is the fractional radiochemical yield, when applicable, 1 is the radioactive decay constant for the particular radionuclide ( s ec-* ) and At for plant effluents is the elapsed time between the midpoint of sample collection and the midpoint of the counting interval (sec).

Typical values of E, V, Y and At should be used in the calculation.

I !

IIJ I

CLINTON-1 2-4 Rev.17-12/98 l

CPS-ODCM TABLE 2.3-1 (Continued)

RADIOACTIVE LIQUID WASTE SAMPLING AND ANALYSIS PROGRAM TABLE NOTATIONS (Continued)

It should be recognized that the LLD is defined as an a priori (before the fact) limit representing the capability of a measurement system and not as an a posteriori (after the. fact) limit for a particular measurement.

"A batch release is the discharge of liquid wastes of a discrete volume. Prior to sampling for analyses, the tank is. isolated from all inputs and recirculated a minimum of two tank volumes at which time a sample is obtained for isotopic analysis.

The principal gamma emitters are: Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, and Ce-141. Ce-144 shall also be measured, but with an LLD of 55 x 10-6 Ci/ml. All identified radionuclides shall be reported in the Radioactive Effluent ,

Release Report pursuant to Technical Specification 5.6.3 in a e fonnat outlined in Regulatory Guide 1.21, Appendix B, Revisionil, '

June 1974.

d A composite sample is one in which the qpantity of liquid sampled is proportional to the quantity of liquid waste discharged and in which the method of sampling employed results in a specimen that is representative of the liquids released.

Dissolved and Entrained gases 'are: Xe-133, Xe-135, Xe-138, Kr-85m, Kr-87, and Kr-88.

CLINTON-1 2-5 Rev.17-12/98

CPS-ODCM 2.3.2 Liquid Radwaste Discharge PRM Setpoints '

To comply with the Operation Requirements of Section

' 2.3.1 and Section 2.7.1, the alarm / trip setpoints for liquid effluent monitors and flow' measurement devices 3 are set to assure that the following equation is satisfied:

g cf/ (F + f) < ECL (1)

ECL =

the Effluent Concentration Limit (Section 2 . 3 '.1 ) implementing 10 times the effluent concentration limit of 10CFR20, Appendix B, Table 2, Column 2 and corresponding.to the specific mix of radionuclides in the effluent stream being considered, in pCi/ml c =

the setpoint, in pCi/ml, of the radioactivity monitor measuring the radioactivity .

concentration in the efflue.nt line prior to dilution and subsequent release; the setpofnt' E is inversely proportional to the volumetrit: 5 flow of the effluent line and proportional to the volumetric flow.of the dilution stream (s) plus the effluent stream.

F =

the dilution water flow setpoints as determined at the Seal Well, in volume per "

unit time .

f =

the liquiri radwaste discharge flow setpoint as determined at the liquid radwaste disch uge PRM loce. tion, in volume per unit time (same units as F)

The available dilution water flow (F) should be {

constant for a given release, and the liquid radwaste EI tank discharge flow (f) and monitor setpoint (c) are set to meet the condition of equation (1) for a given g ll effluent concentration (ECL) . The method by which this is accomplished is illustrated in sections 2.3.2.1 ;

through 2.3.2.5.

2.3.2.1 The isotopic concentration for a liquid radwaste tank to be discharged is obtained from the sum of the measured concentrations as determined by the analyses required in Table 2.3-1:

I I CLINTON-1 2-6 Rev.17-12/98 3!

g1 1

p CPS-ODCM l l b utw=E,C,+E.C.+E.C + C,+ Crei. Ci/ml -

(2) 1 where l

E,C, =

The' sum' of concentrations C, 'of' each measured s

gamma emitter 9 (including I-131) ob'erved by gamma spectroscopy of the waste sample, pCi/ml.

1

=

E.C. The . sum of concentrations C. of alpha emitters (a)'in liquid radwaste as measured in'the most l currentLQUARTERLY composite discharge tank '

sample, pCi/ml.

E.C. = The sum of _ concentrations C, of Sr-89/Sr-90 in l liquid radwaste as' observed in the most current QUARTERLY composite discharge tank sample, '

pCi/ml.

C, = The measured concentration of H-3 in liquid radwaste as determined from analysis of_the most current QUARTERLY composite discharge tank sample, pCi/ml. ,

Cr. = The measured concentration of Fe-55 in liquid radwaste as observed in the most current QUARTERLY composite discharge tank sample, ,

pCi/ml.. j 2.3.2.2 The measured radionuclide concentrations are used to calculate 'a DILUTION FACTOR (DF) which is equivalent to the ratio'of~ total dilution ~ flow. rate to liquid radwaste tank efflueht flow rate required to assure 3 that the limiting concentrations specified in J

. Operational Requirement 2.3.1 are met at the point of

' discharge to the' unrestricted area.

D,.,, , = E Ct i=q ECLt f*R Dr.q,., = E Ct i=nq ECLt f*Rx Dr., = D,.q,, , Dr.q, ., (3)

.k where-Dr.,,, = Required dilution factor for gansna emitters Dm, , = Required dilution factor for non-gamma emitters ECLt = Effluent concentration limit of nuclide i in pCi/ml equal to 10 times the valu3s in 10CFR2O Appendix B, Table 2, Column 2 for radionuclides l other than dissolved or entrained noble gases.

For dissolved or-entrained noble _. gases,_the concentration is -limited to 2 x 10-* pCi/ml.

l l CLINTON-l' 2-7 Rev.17-12/98

CPS-ODCM f = Relecca point safety factor '

, ' R , = The maximum ECL ratio from the release point -

setpoint definition Ci = The concentration of nuclide i in mci /ml SF = The conservative SAFETY FACTOR normally applied g to compensate for statistical fluctuations and 3 measurement errors, dimensionless.

2.3.2.3 The maximum permissible liquid radwaste tank effluent flow rate, Re x, is calculated by the following equation:

R = F.nu'+ (f na,*.F,e.) , volume / time (4)

D,.,

where ,

Re, ,= Maximum waste flow rate F a = Minimum expected dilution water flow rate N (Circulatin'g and/or Service Water systems), volume / time k {'

f.no. = 0.9 = Flow rate correction factor to provide a -

10% margin for variations in flow rates, dimensionless F., t. = Maximum expected liquid radwaste tank effluent flow rate, volume / time Dr., = The-DILUTION FACTOR calculated by equation (3),

dimensionless Equation (4) is valid only for DF>1; for DF<1, the liquid radwaste tank effluent concentration meets the limits of Operational Requirement 2.3.1 without g !

dilution:and therefore Re : may assume any value not to exceed discharge pump capacity.

gl

-2.3.2.4 The liquid radwaste discharge PRM setpoint may'now be l mhfr( l specified based on the values of S tC i (Eq.2) and Re,, , I (Eq.4) which 'fere determined to provide compliance with the concentration limits of Operational Requirement 3 2.3.1. The monitor response is primarily a gamma g!

response and the actual setpoint is therefore based on 1 SqC, (Eq.2). The monitor setpoint, in counts per j minute (cpm), which corresponds to the particular !

yy setpoint concentration, Sox , is determined based on !'

monitor calibration data or operational data which

\ correlates monitor response to sample analyses E associated with the actual liquid radwaste discharged, g The second method is considered valid only if the integrity of laboratory methods of determination are proven more accurate than the monitor data.

CLINTON-1 2-8 Rev.17-12/98

CPS-ODCM The set point concentration, S x, is obtained by the following equation:

Sg = Rc,,_ (5)

F - t.

S., = Sg

I,C, (6) 4here F e. = The actual liquid radwaste effluent flow rate, volume / time If Sg >1, the value obtained for S., is used to determine the monitor setpoint above background, ccpm, from either of the two methods described above. In the case where Sg <1, no release may be made using the existing discharge parameter values (Rc, , Fme.) .

The setpoint concentration is conservative, even if 2 R is attainable, since the calculated flow rate I contains the SAFETY FACTOR, dilution flow rate and liquid radwaste tank effluent flow rate margins.

3.3.2.5 To prevent spurious alarms, revise the Plant Service Water Effluent PRM setpoint to coincide with the setpoint concentration, Sm , calculated by equation (6). This setpoint is valid only during periods of actual liquid radwaste discharges.

CLINTON-1 2-9 Rev.17-12/98

8 M__

. L 9 E Y A /

MS N R

= IN A U 2 _

! EII TO ST I

S E

D U

P M

O C

T L

U C

L S

M_

Y HHD L M 3 R

A D e v

TTN O

C N

L I

I R

G . v M

N

' .Y to g DTC I O A T e U NA E R

D O A T , , ,

N 8 E % SEE DN R E

R E

0 9

G E EI T

(

a YTU OCL UIF W

O P

W O

P W

O P

6 Y M LS ! BRF L TE S S S E

" ES HET TRN I

O N

I O

N I

O N

T A

M

" NUL S E NA L

P L

I L

L I

X O

M E ES I I R T WIF .I P O T I Y YNY P S ) NEY B BOB A T

N P

Y BRD AE D DTD I

S M E (

T EDL KNL E EAE I U E AUO N NTN W WSW E L LOR

.O O G O N F

F E

C N

E D

I E

BT HAORO TECUN NET TNT OIO NPN I

L .

EE RN M-S R S M OI D E NAEOL .LUL HL I R I BLESEPE S U N CCEC C N Q

I s

< "E

)

5 AOL EILTANANA RCRER EO KI M_

L RSINPEPIP AT

' Y AUWAL RDIDED D L LA V

1 R w f N ECTRNSNPNEEE O H HXUAAEAIASHL 1

- F #

T E 'B W L R L P L U T E M 2 Y R

E A . . . . .

R D 1 2 3 4 5 '

U N -

G I

F U

O B

A E

R A

ru L

i f lY 4

1 W

3 E

T O

2 M=

A E

D E

F E

G k 3H N M-T /

R A C I

R 4

R A / f /pN D

E T

T S

E R

Y, o

Tc N

At Lo H

s/ /

/

f ,

M_

C S P J/ 0 I P 1 R C 4 '

M-T Y.

S

W E i H R o -

N 1 l i_

U <

//[

V i

M

/ t r

f /'/

/ '[

D M_

" /

M 1

M M C 2 _

D E 4 c O T T

- O n N S N o I w

P C

L C M M_

CPS-ODCM 2.3.3 Plant Service Water Effluent PRM Setpoints 3 Plant service water effluent continuously releases to the Seal Well where it mixes with circulating water effluent (if present) prior to entering Lake Clinton via the 3.4 mile discharge flume. The plant service water effluent is not considered a radioactive discharge pathway unless liquid radwaste discharges are in progress or any service water cooling load heat exchanger has been detected as failed. To, ensure that Plant Service Water intersystem leakage has not occurred, weekly Service Water effluent grab samples will be obtained (when in service) and analyzed to determine the identity and quantity of principal gamma-emitting radionuclides. In addition, a quarterly composite of positive grab samples will be analyzed to determine the quantity of H-3, Sr-89, Sr-90, Fe-55 and gross alpha species released. The analytical Lower Limit of Detection (LLD) for these analyses are specified in Table 7 3-1.

The Plant Service Water effluent PRM setpoint should be established as close to background as practical to

. prevent spurious alarms, and yet assure an alarm should an inadvertent release occur.

If the weekly grab sample analysis indicates the presence of contanination above background, PRM setpoints will be established following section 2.3.2 methodology as follows: ,

2.3.3.1 Perform section 2.3.2.2, solving equation (3) for DF using the appropriate values in the concentration term from the grab sample analysis. .

2.3.3.2 A modified dilution factor, DF., must be determined so that available dilution flows may be apportioned among ' '

' ~

simultaneous discharge pathways. The modified dilution factor is defined as:

4 DF, =

DF/Fa (7)~

where Fa is an administrative allocation factor which may be assigned any value between 0 and 1 under the condition that M E n ( Fa) n < 1 (8) and.where n = the number of liquid discharge pathways for which DF >l and which are planned for simultaneous release. For simplicity, Fa may be assigned the value 1/n. Calculate R in equat, ion (4) by substituting the value of DF, for Dr.q and perform the calculation specified in section 2.3.2.4 to determine flow rate and PRM setpoints.

CLINTON-1 2-11 Rev.17-12/98

CPS-ODCM 2.3.4 Shutdown Service Water (SX) Effluent PRM Setpoints Shutdown Service Water, when initiated, is a potential ;

continuous radioactive discharge pathway to the ;

Ultimate Heat Sink (UHS) (see Figure 2.5-2). The SX effluent is not considered a radioactive discharge pathway unless any SX cooling load heat exchanger has been detected as failed. SX effluent sampling, g analysis and setpoint establishment will be performed g as discussed for the Plant Service Water system in Section 2.3.3. !

l 2.3.5 Puel Pool Heat Exchanger Service Water Effluent PRM Setpoints The Fuel Pool Heat Exchanger Service Water is normally supplied by the Component Cooling Water (CCW) system (a 3 closed loop system). The Component Cooling Water system rejects heat loads to the Plant Service Water 3 I system where intersystem leakage would be detected as )

described in section 2.3.3. The Fuel Pool Heat J Exchanger Service Water effluent is considered a j potential radioactive discharge pathway when SX l 1 replaces Component Cooling Water as the heat sink for Ej the fuel pool heat exchangers. To account for a 5j g

potential release of Component Cooling Water !

radioactivity to the Ultimate Heat Sink via SX, g Component Cooling Water will be sampled prior to placing the Fuel Fool Heat Exchanger in the SX cooling g

mode and analyzed as discussed in section 2.3.3. The analysis results will then be used to establish Fuel E Pool Heat Exchanger Service Water PRM and flow rate 3 setpoints following Section 2.3.3.1 and 2.3.3.2 methodology.

Any releases of radioactivity to the environment from the Plant Service Water (except during liquid radwaste discharges), Shutdown Service Water or Fuel Pool Heat .

Exchanger Service Water Systems are considered abnormal events. Such events will be accounted for as unplanned releases in the RADIOACTIVE EFFLUENT RELEASE REPORT.

'2.3.6 Component Cooling Water PRM Setpoints The Component Cooling water system is a potential

' continuous radioactive discharge pathway to the Service 3 Water system due to the Component Cooling water system generally operating at a higher pressure. Component 3

Cooling provides cooling to components and heat exchangers that carry radioactive fluids or are in areas'that could result in radioactive contamination if the components are damaged. Except for the sampling requirement described in 2.3.5, sampling on this system g is done on an as needed basis. The PRM setpoints are 3 established using the methodology in Section 2.3.3.

I l

CLINTON-1 2-12 Rev.17-12/98 f l

1

1 CP3-ODCM 2.4 10CFR50, Appendix I Release Rate Limits The Operation and Surveillance Requirements concerning J 10CFR50, Appendix I Release Limits are specified in section 2.4.1. Dose calculations for ensuring compliance with these limits are discussed in section 2.4.2.

)pO3 2.4.1 10CFR50, Appendix I Dose Limits - Operation and Surveillance Requirements OPERATION REQUIREMENT The dose or dose commitment to a MEMBER OF THE PUBLIC from radioactive materials in liquid effluents released to UNRESTRICTED AREAS (see Figure 2.1-1) shall be limited: ,

a. During any calendar quarter to less than or equal to 1.5 mrem to the total body and to less than or equal to 5 mrem to any organ, and

b. During any calendar year to less than or equal to 3 mrem to the total body and to less than or equal to 10 mram to any organ.

This requirement applies at all times.

7 REMEDIAL REQUIREMENT:

With the calculated dose from the release of radioactive materials in liquid effluents exceeding any of the above limits, prepare and submit to the Regional Administrator of the Regional Office of the NRC within 30 days a Special Report that identifies the cause(s) for exceeding the limit (s) and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to~ assure that subsequent releases will be in compliance with the above limits.

. SURVEILLANCE REQUIRD4ENTS 2.4.1.1 Cumulative dose contributions from liquid effluents for the current calendar quarter and the current calendar year shall be determined in accordance with the methodology and parameters described in Section 2.4.2 at least once per 31 days.

CLINTON 2-13 Rev.17-12/98

CPS-ODCM 2.4.2 Discussion ",

2.4.2.1 The dose contribution to the maximum exposed individual from all radionuclices identified in liquid effluents released to the unrestricted area is calculated as

(

follows:

1 D3 =

As3 E [ At.*C 1,

F.r] , , mrem (8) l D3 = The cumulative calendar quarter or yearly dose to any organ j from liquid effluent for the total release period, mrem At. = The length of the time periods over which C._ i EI and F.,are averaged for liquid releases, hours 3J l

= Liquid Radwaste Tank Volume / Liquid Radwaste ]

Discharge Flow Rate j h C,1

= The average concentration of nuclide i in h

N undiluted liquid effluent during release period At. for any liquid ' release, pCi/ml F,,. = The near field average dilution factor for C. t during any liquid effluent release, i dimensionless. Defined as the ratio of the .

average undiluted liquid radwaste flow during the release, to the product of the average flow from the discharge structure (during the reporting period, i.e., quarter or year) to the unrestricted receiving water and Z

= Average Undiluted Liquid Waste Flow (9) g ,

(Average Discharge Structure Flow)Z g Z = The applicable dilution factor for Lake Clinton, dimensionless

= 1.0 1

A 13 = The composite ingestion dose commitment factor i for the total body or critical organ of an ADULT for radionuclide i, mrem /hr per pCi/ml

= Ko [ (U,/Dw) + (UrBF )]DFi t (10)

I i

CLINTON-1 2-14 Rev.17-12/98

)

CPS-ODCM i

where Ko = A units conversion factor,'1.14E+05 pCi-ml-yr/

pCi-liter-hr

= (1.0E+06 pCi/pCi) (1.0E+03 ml/ liter) /8760 hr/yr U, = Annual water consumption by the maximum adult, O liter /yr D, = Dilution factor from the near field area to the nearest potable water intake, 1.0 Ur = Adult fish consumption rate, 21 kg/yr (Table E-5 of Regulatory Guide 1.109)

= Bioaccumulation factor for radionuclide i in BFi fish, pCi/kg.per pCi/ liter (Table 2.4-2 taken from Table A-1 of Regulatory Guide 1.109)

DFi = Adult ingestion dose conversion factor for radionuclide i, total body or critical organ, I mrem /pCi (Table 2.4-3 taken from Table E-11 of Regulatory Guide 1.-109)

Table 2.4-1 contains values for A13 as calculated by equation (10).

') The quarterly limits specified in the OPERATION REQUIREMENT at the beginning of this sect' ion represent one-half of the annual design objective of Section II.A of 10CFR50, Appendix I.

I L

r F

I

- CLINTON-1 2-15 Rev.17-12/98

CPS-ODCM TABLE 2.4-1 I

ADULT INGESTION DOSE COMMITMENT FACTORS - Au (mrem /hr per pCi/ml)

ISOTOPE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 2.26E-01 2.26E-01 2.26E-01 2.26E-01 2.26E-01 2.26E-01 C-14 3.12E+04* 6.24E+03 6.24E+03 6.24E+03 6.24E+03 6.24E+03 6.24E+03 NA-24 4.06E+02 4.06E+02 4.06E+02 4.06E+02 4.06E+02 4.06E+02 4.06E+02 P-32 1.39E+06 8.62E+04 5.36E+04 NO DATA NO DATA NO DATA 1.56E+05 l CR-51 NO DATA NO DATA 1.27E+00 7.60E-01 2.80E-01 1.68E+00 3.20E+02 W HN-54 NO DATA 4.37E+03 8.34E+02 NO DATA 1.30E+03 NO DATA 1.34E+04 NN-56 NO DATA 1.10E+02 1.95E+01 NO DATA 1.40E+02 NO DATA 3.51E+03 FE-55 6.57E+02 4.54E+02 1.06E+02 NO DATA NO DATA 2.53E+02 2.60E+02 FE-59 1.04E+03 2.44E+03 9.34E+02 NO DATA NO DATA 6.81E+02 8.13E+03 )

CO-58 NO DATA 8.90E+01 2.00E+02 NO DATA NO DATA NO DATA 1.80E+03 l CO-60 NO DATA 2.56E+02 5.64E+02 NO DATA NO DATA NO DATA 4.80E+03 I NI-63 3.11E+04 2.15E+03 1.04E+03 NO DATA NO DATA NO DATA 4.49E+02 NI-65 1.26E+02 1.64E+01 7.48E+00 NO DATA NO DATA NO DATA 4.16E+02 CU-64 NO DATA 9.97E+00 4.67E+00 NO DATA 2.51E+01 NO DATA 8.48E+02 ZN-65 2.31E+04 7.36E+04 3.33E+04 NO DATA 4.92E+04 NO DATA 4.64E+04 ZN-69 4.92E+01 9.42E+01 6.55E+00 No DATA 6.12E+01 NO DATA 1.41E+01 BR-83 NO DATA NO DATA 4.03E+01 NO DATA NO DATA NO DATA 5.81EF01 BR-84 NO DATA NO DATA 5.23E+01 NO DATA NO DATA NO DATA 4.10E-04 BR-85 NO DATA NO DATA 2.15E+00 NO DATA NO DATA NO DATA LT E-15**

RB-86 NO DATA 1.01E+05 4.70E+04 NO DATA NO DATA NO DATA 1.99E+04 :

RB-88 NO DATA 2.89E+02 1.53E+02 NO DATA NO DATA NO DATA 4.00E-09 RB-89 NO DATA 1.92E+02 1.35E+02 NO DATA NO DATA NO DATA 1.11E-11 SR-89

2.21E+04 NO DATA 6.34E+02 NO DATA NO DATA NO DATA 3.54E+03 SR-90 5.43E+05 NO DATA 1.33E+05 NO DATA NO DATA NO DATA 1.57E+04 SR-91 4.06E+02 NO DATA 1.64E+01 NO DATA NO DATA NO DATA 1.94E+03 SR-92 1.54E+02 NO DATA 6.67E+00 NO DATA NO DATA NO DATA 3.05E+03 Y-90 5.75E-01 NO DATA 1.54E-02 NO DATA NO DATA NO DATA 6.10E+03 Y-91m 5.43E-03 NO DATA 2.10E-04 NO DATA NO DATA NO DATA 1.60E-02 Y-91 8.42E+00 NO DATA 2.25E-01 NO DATA NO DATA NO DATA 4.64E+03 Y-92 5.05E-02 NO DATA 1.48E-03 NO DATA NO DATA NO DATA 8.84E+02 Y-93 1.60E-01 NO DATA 4.42E-03 NO DATA NO DATA NO DATA 5.08E+03 ZR-95 2.40E-01 7.69E-02 5.20E-02 NO DATA 1.21E-01 NO DATA 2.44E+02 ZR-97 1.32E-02 2.67E-03 1.22E-03 NO DATA 4.04E-03 NO DATA 8.28E+02 NB-95 4.46E+02 2.48E+02 1.33E+02 NO DATA 2.45E+02 NO DATA 1.51E+06 l MO-99 NO DATA 1.03E+02 1.96E+01 NO DATA 2.33E+02 NO DATA 2.39E+02 E TC-99m 8.86E-03 2.50E-02 3.19E-01 NO DATA 3.80E-01 1.23E-02 1.48E+01 TC-101 9. ? 1.E-03 1.31E-02 1.29E-01 NO DATA 2.36E-01 6.70E-03 3.94E-14 RU-103 4.4 E+00 NO DATA 1.90E+00 NO DATA 1.69E+01 NO DATA 5.16E+02 RU-105 3.68E-01 NO DATA 1.45E-01 NO DATA 4.76E+00 NO DATA 2.25E+02 RU-106 6.57E+01 NO DATA 8.32E+00 NO DATA 1.27E+02 NO DATA 4.25E+03 AG-110m NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA TE-125m 2.57E+03 9.28E+02 3.43E+02 7.70E+02 1.04E+04 NO DATA 1.02E+04 TE-127m 6.47E+03 2.31E+03 7.89E+02 1.65E+03 2.63E+04 NO DATA 2.17E+04 TE-127 1.05E+02 3.77E+01 2.20E+01 7.79E+01 4.28E+02 NO DATA 8.30E+03 TE-129m 1.10E+04 4.10E+03 1.74E+03 3.78E+03 4.59E+04 NO DATA 5.54E+04 TE-129 3.00E+01 1.13E+01 7.31E+00 2.30E+01 1.26E+02 NO DATA 2.26E+01 l

5 TE-131m 1.65E+03 8.09E+02 6.74E+02 1.28E+03 8.19E+03 NO DATA B.03E+04 TE-131 1.88E+01 7.87E+00 5.95E+00 1.55E+01 8.25E+01 NO DATA 2.67E+00 1

CLINTON-1 2-16 Rev.17-12/98 I

i

CPS-ODCM TABLE 2.4-1 (cont'd)

ADULT INGESTION DOSE COMMITMENT FACTORS - Au (mrem /hr per pCi/ml)

ISOTOPE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI TE-132 2.41E+03 1.56E+03 1.46E+03 1.72E+03 1.50E+04 NO DATA 7.37E+04 I-130 2.71E+01 7.99E+01 3.15E+01 6.7CE+03 1.25E+02 NO DATA 6.88E+01

-I-131 1.49E+02 2.13E+02 1.22E+02 6.99E+04 3.66E+02 NO DATp 5.63E+01 I-132 7.28E+00 1.95E+01 6.81E+00 6.81E+02 3.10E+01 NO DATA 3.66E+00 I-133 5.09E+01 8.85E+01 2.70E+01 1.30E+04 1.54E+02 NO DATA 7.96E+01 I 1-134 I-135

'3.80E+00 1.59E+01 1.03E+01 4.16E+01 3.69E+00 1.53E+01 1.79E+02 2.74E+03 1.64E+01 NO DATA 6.67Et01 NO DATA 9.00E-03 4.70E+01 CS-134 2.97E+05 7.07E+05 5.78E+05 NO DATA 2.29E+05 7.60E+04 1.24E+04 CS-136 3.11E+04 1.23E+05 8.84E+04 NO DATA 6.84E+04 9.37E+03 1.40E+04 I CS-137 CS-138 3.81E+05 2.64E+02 5.21E+05 5.21E+02 3.41E+05 NO DATA 2.58E+02 NO DATA 1.77E+05 3.83E+02 5.88E+04 3.78E+01 1.01E+04 2.22E-03 BA-139 9.29E-01 6.60E-04 2.72E-02 NO DATA 6.18E-04 3.75E-04 1.65E+00 l BA-140 1.94E+02 2.44E-01 1.27E+01 NO DATA 8.29E-02 1.40E-01 4.00E+02 5 BA-141 4.50E-01 3.40E-04 1.52E-02 NO DATA 3.16E-04 1.93E-04 2.12E-10 BA-142 2.04E-01 2.09E-04 1.28E-02 NO DATA 1.77E-04 1.18E-04 2.89E-19 IA-140 1.49E-01 7.53E-02 1.99E-02 NO DATA NO DATA NO DATA' 5.53E+03 IA-142 7.65E-03 3.48E-03 8.66E-04 NO DATA NO DATA NO DATA 2.54E+01 CE-141 2.24E-02 1.51E-02 1.72E-03 NO DATA 7.03E-03 NO DATA 5.78E+01 CE-143 3.94E-03 2.92E+00 3.23E-04 NO DATA 1.2BE-03 NO DATA 1.09E+02 l CE-144 1.17E+00 4.88E-01 6.26E-02 NO DATA 2.89E-01 NO DATA 3.94E+02 g PR-143 5.50E-01 2.20E-01 2.72E-02 NO DATA 1.27E-01 NO DATA 2.41E+03 PR-144 1.80E-03 7.47E-04 9.14E-05 NO DATA 4.21E-04 NO DATA 2.59E-10 ND-147 3.76E-01 4.34E-01 2.60E-02 NO DATA 2.54E-01 NO DATA 2.08E+03 W-187 2.95E+02 2.47E+02 8.63E+01 NO DATA NO DATA NO DATA 8.09E+04 I..: ,

NP-239 2.84E-02 2.80E-03 1.54E-03 NO DATA 8.72E-03 NO DATA 5.74E+02

3.12 x 10'

*Less than 10-15 -

1 I

I i

l l

I l'

CLINTON-1 2-17 Rev.17-12/98

)

TABLE 2.4-2 BIOACCUMULATION FACTORS -BFs l (pCi/kg per pCi/ liter) [ly FRESHWATER ELEMENT FISH H 9.0E-01 C 4.6E+03 Na 1.0E+02 P 1.0E+05 Cr 2.0E+02 Mn 4.0E+02 Fe 1.0E+02 ,

Co . 5.0E+01 Ni 1.0E+02 g

Cu 5.0E+01 Zn 2.0E+03 3 Br 4.2E+02 Rb 2.0E+03 Sr 3.0E+01 Y 2.5E+01 Zr 3.3E+00 Nb 3.0E+04 Mo 1.0E+01 Tc 1.5E+01 Ru 1.0E+01 lI Rh 1.0E+01 W Te 4.0E+02 I 1.5E+01 Cs 2.0E+03 Ba 4.0E+00 La 2.5E+01 Ce 1.0E+00 Pr 2.5E+01 Nd 2.5E+01 W 1.2E+03 Np 1.0E+01 I

I I

I CLINTON-1 2-18 Rev.17-12/98

CPS-ODCM TABLE 2.4-3 ADULT INGESTION DOSE FACTORS -DFi -

(mrem /pci ingested)

I!tOTOPE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 C-14 2.84E-06* 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 NA-24 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 P-32 1.93E-04 1.20E-05 7.46E-06 NO DATA NO DATA No DATA 2.17E-05 CR-51 NO DATA NO DATA- 2.66E-09 1.59E-09 5 86E-10 3.53E-09 6.69E-07 MN NO MTA 4.57E-06 8.72E-07 NO DATA 1.36E-06 NO DATA 1.40E-05 MM-56 NO DATA 1.158 2.04E-08 NO DATA 1.46E-07 No DATA 3.67E-06 FE-55 2.75E-06 1.90E-06 4.43E-07 HO DATA NO DATA 1.06E-06 1.09E-06 FE-59 4.34E-06 1.02E 3.91E-06 NO DATA NO DATA 2.85E-06 3.40E-05 00-58 NO DATA 7.45E-07 1.67E-06 NO DATA NO DATA NO DATA 1.51E-05 C0 NO DATA 2.14E-06 4.72E-06 NO DATA NO DATA NO DATA 4.025-05 NI-63 1.30E-04 '9.01E-06 4.36E-06 NO DATA NO DATA' NO DATA 1.88E-06 NI-65 5.28E-07 6.86E-08 3.13E-08 ~NO DATA NO DATA NO DATA 1.74E-06 CU-64 NO DATA 8.33E-08 3.91E-08 NO DATA 2.10E-07 NO DATA 7.10E-06 EN-65 4.84E-06 1.54E-05 6.96E-06 NO DATA 1.03E-05 NO DATA 9.70E-06 EN-69 1.03E-08 1.97E-08 1.37E-09 NO DATA 1.28E-08 NO DATA 2.96E-09 GR-83 NO DATA NO DATA 4.02E-08 NO DATA NO DATA NO DATA 5.79E-08 BR-84 NO DATA NO DATA 5.21E-08 NO DATA NO DATA NO DATA 4.09E-13 BR-85 NO DATA NO DATA 2.145-09 NO DATA NO DATA NO DATA LT E-24**

RB-86 NO DATA 2.11E-05 9.83E-06 NO DATA NO DATA NO DATA 4.16E-06

- RB-88 NO DATA '

6.05E-08 3.21E-08 NO DATA NO DATA NO DATA 8.36E-19 RB-89 NO DATA 4.01E-08 2.82E-08 NO DATA NO DATA NO DATA 2.33E-21 SR-89 3.08E-04 NO DATA 8.84E-06 NO DATA NO DATA NO DATA 4.94E-05 SR-90 7.58E-03 NO DATA 1.86E-03 NO DATA NO DATA NO DATA 2.19E-04 SR-91 5.67E-06 NO DATA 2.29E-07 NO DATA NO DATA NO DATA 2.70E-05 SR-92 2.15E-06 NO DATA 9.30E-08 NO DATA NO DATA NO DATA 4.26E-05 Y-90 9.62E-09 NO DATA 2.58E-10 NO DATA NO DATA NO DATA 1.02E-04 Y-91m 9.09E-11 NO DATA 3.52E-12 No DATA NO DATA NO DATA 2.67E-10 Y-91 1.41E-07 NO DATA 3.77E-09 NO DATA NO DATA NO DATA 7.76E-05 Y-92 8.45E-10 NO DATA 2.47E-11 NO DATA NO DATA NO DATA 1.48E-05 Y-93 2.68E-09 NO DATA 7.40E-11 NO DATA NO DATA NO DATA 8.50E-05 ZR-95 3.04E-08 9.75E-09 6.60E-09 NO DATA 1.53E-08 NO DATA 3.09E-05 ER-97 1.68E-09 3.39E-10 1.55E-10 NO DATA 5.12E-10 NO DATA 1.05E-04 NS-95 6.22E-09 3.46E-09 1.86E-09 NO DATA 3.42E-09 NO DATA 2.10E-05 MO-99 NO DATA 4.31E-06 8.20E-07 NO DATA 9.76E-06 NO DATA '9.99E-06 TC-99m 2.47E-10 6.98E-10 8.89E-09 NO DATA' 1.06E-08 3.42E-10 4.13E-07 TC-101 2.54E-10 3.66E-10 3.59E-09 NO DATA 6.59E-09 1.87E-10 1.10E-21 RU-103 1.85E-07 NO DATA 7.97E-08 NO DATA 7.06E-07 NO DATA 2.16E-05 RU-105 1.54E-08 NO DATA 6.08E-09 NO DATA 1.99E-07 NO DATA 9.42E-06 l-RU-106- 2.75E-06 NO DATA 3.4LE-07 NO DATA 5.31E-06 NO DATA 1.78E-04 y AG-110m 1.60E-07 1.48E-07 8.79E-08 NO DATA 2.91E-07 NO DATA 6.04E-05

\ TE-125m 2.68E-06 9.71E-07 3.59E-07 8.06E-07 1.09E-05 NO DATA 1.07E-05 TE-127m- 6.77E 2.42E-06 8.25E-07 1.73E-06 2.75E-05 NO DATA 2.27E-05 TU-127 1.10E-07 3.95E-08 2.38E-08 8.15E-08 4.48E-07 NO DATA 8.68E-06 TE-129m 1.15E-05 4.29E-06 1. 82 E-06 3.95E-06 4.80E-05 NO DATA 5.79E-05

.TE-129 3.14E-08 1.18E-08 7.65E-09 2.41E-08 1.32E-07 NO DATA 2.37E-08 TE-131m 1.73E-06 8.46E-07 ~7.05E-07 1.34E-06 8.57E-06 NO DATA 8.40E-05 l TE-131 1.97E-08 8.23E-09 6.22E-09 1.62E-08 8.63E-08 NO DATA 2.79E-09 W

i I

L CLINTON-l' 2-19 Rev.17-12/98 4

i CPS-ODCM TABLE 2.4-3 (cont'd) Ill ADULT INGESTION DOSE FACTORS - DFs #

(mrem /pCi ingested)

ISCfrOPE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI TE-132 2.52E-06 1.63E-06 1.53E-06 1.80E-06 1.57E-05 NO DATA 7.71E-05 I-130 7.56E-07 2.23E-06 8.80E-07 1.89E-04 3.48E-06 NO DATA 1.92E-06 I-131 4.16E-06 5.95E-06 3.41E-06 1.95E-03 1.02E-05 NO DATA 1.57E-06 I-132 2.03E-07 1.42E-0G 5.43E-07 1.90E-07 7.53E-07 1.90E-05 8.65E-07 NO DATA 4.31E-06 NO DATA 1.02E-07 ll l I-133 2.47E-06 3.63E-04 2.22E-06 5 I-134 1.06E-07 2.88E-07 1.03E-07 4.99E-06 4.58E-07 NO DATA 2.51E-10 I-135 4.43E-07 1.16E-06 4.28E-07 7.65E-05 1.86E-06 NO DATA 1.31E-06 CS-134 6.22E-05 1.48E-04 1.21E-04 NO DATA 4.79E-05 1.59E-05 2.59E-06 CS-136 6.51E-06 2.57E-05 1.85E-05 NO DATA 1.43E-05 1.96E-06 2.92E-06 CS-137 7.97E-05 1.09E-04 7.14E-05 NO DATA 3.70E-05 1.23E-05 2.11E-06 CS-158 5.52E-08 1.09E-07 5.40E NO DATA 8.01E-08 7.91E-09 4.65E-13 BA-139 9.70E-08 6.91E-11 2.84E-09 NO DATA 6.46E-11 3.92E-11 1.72E-07 BA-140 2.03E-05 2.55E-08 1.33E-06 NO DATA 8.67E-09 1.46E-08 4.18E-05 BA-141 4.71E-08 3.56E-11 1.59E-09 NO DATA 3.31E-11 2.02E-11 2.22E-17 BA-142 2.13E-08 2.19E-11 1.34E-09 NO DATA 1.85E-11 1.24E-11 3.00E-26 LA-140 2.50E-09 1.26E-09 3. ME-10 NO DATA NO DATA NO DATA' 9.25E-05 LA-142 1.28E'10 5.82E-11 1.')E-11 NO DATA NO DATA NO DATA 4.25E-07 CE-141 9.36E-09 6.33E-09 7.18E-10 NO DATA 2.94E-09 NO DATA 2.42E-05 /

CE-143 1.65E-09 1.22E-06 1.35E-10 NO DATA 5.37E-10 NO DATA 4.56E-05 l CE-144 4.88E-07 2.04E-07 2.62E-08 NO DATA 1.21E-07 NO DATA 1.65E-04 W PR-143 9. 20E-09 3.69E-09 4.'56E-10 NO DATA 2.13E-09 NO DATA 4.03E-05 PR-144 3.01E-11 1.25E-11 1.53E-12 NO DATA 7.05E-12 NO DATA 4.33E-18 ND-147 6.29E-09 7.27E-09 4.35E-10 'No DATA 4.25E-09 NO DATA 3.49E-05 W-187 1.03E-07 8.61E-08 3.01E-08 NO DATA NO DATA NO DATA 2.82E-05 NP-239 1.19E-09 1.17E-10 6.45E-11 NO DATA 3.65E-10 NO DATA 2.40E-05

/

2.84 x 10"

*Less than 10-**

I i

I I

a l 1 CLINTON-1 2-20 Rev.17-12/98 I

r I CPS-ODCM FIGURE 2.5-1 LIQUID RADWASTE TREATMENT SYSTEM w

_e - =_

=- h

$ " h h

l

~...I u

e_

CW@U"A w _=q e __

I- -

=

m-p_

I . _.

h __

j _

UUU We y's a misr,xusma4 ucumu

% g 1' -E

._L __

Monitors required by Section 2.7 WF01S Floor Drain OWZO1P Chem. Wat. 2WF04T Floor Drain OWE 02PA,B, and C Evaporator Evap. Tank Pump Evaporator Tank Waste Samp. Tk i Pumps l WF01S Floor Drain OWE 01FA,B, and C OWZO1T Chem. Waste 0WE01TA and B Evaporator Waste Filters Evaporator Tank Excess Water Tanks OWZOIS Chemical OWE 01DA,B, and C IWF04P Fir. Drn. 0WE01PA and B Waste Demins Evap. Tank Pump Excess Water Tank i

Waste Evaporator Pumps WF04T Floor Drain OWE 02TA,B, and C 2WF04P Fir. Drn. IPR 036 Service Evaporator Tank Waste Sample Tks. Evap. Tank Pump Water PRM i -

OPR040 Liquid RW Discharge PRM t !

l

/

I CLINTON-1 2-21 Rev.17-12/98 l

r FIGURE 2.5-2 SHUTDOWN AND FUEL POOL HEAT EXCHANGER SERVICE WATER l EFFLUENT MONITORS T A

SHUTDOHN SHUTDOWN j SERVICE SERW CE l RHR HEAT WATER l EXCHANGER "A" H FUEL POOL HEAT SHUTDOWN SINK EXCHANGER SERVICE SERVICE HATER SHUTDOWN s NATER PRM aa i

140P "A" CfrHER SYSTEM SERVICE WATER 1RIX-PROO4*

W DS EFFLUENT "A" 1RIX-PR038* j 7 COOLING HEAT i EXCHANGER "A" C04PONENT CCHPCHENT COOLING \ \ COOLING MATER / / WATER E1JEL POOL COOLING HEAT I EXCHANGER "B" SHUTDOWN VI WATER

E

_ g.UEL POO H T SERVICE HATER ErrLUENT "B" ** ""

SINK EXCHANGER SERVICE LOOP "B" 1RIX-PR039' WATER PRM 1RIX-PR005* *

/\ N/

SHuTo0wN SHUTrowN ,

RHR HEAT SERVICE SERVICE j EXCHANGER "B" WATER W ER .

NORMAL COOLING SUPPLY - COMPONENT COOLING WATER I EMERGENCY COOLING SUPPLY - SHUTDOWN SERVICE WATER V

Monitors required by Section 2.7 1RIX-PR038 Shutdown Service 1RIX-PR005 Fuel Pool Heat '

Water Effluent "A" Exchanger Service Water PRM 1RIX-PR039 Shutdown Service 1RIX-PR004 Fuel Pool Heat Water Effluent "B" Exchanger Service Water PRM i

i CLINTON-1 2-22 Rev.17-12/98 I

i

8 9

T /

NG 2 EN E 1 MI G PR = A -

IO R 7 NT O

, SI 1

- N T .

S EO RM v P e R

T N NG N EN O E IO MI E G

I MT PR T t UC IO = A A L

O U V D NT SI

- N R

O T

CS TE RIC E S R EO ODI RM DIV P NLR O EOE

VSS _

E TL M IA SI G MA TR N ER FU OB I

T TG R SA O S

3 YI

- SD _

5

. EW ,

2 TO ;

SL E AF 3 n W 2 u DD -

u AE 2 I RI F F .

DI _

IL E LP V I

OM .

C T

SI A S I O

D A

R E

A T

R A O R TN NI K T A E g T

N ES N PE A ER DG E EE SRT SA FDK T K CTK AP /UN N NSN HE PLA A OAA PS FST T CWT R 1 E -

Z N I IR AO R

O N

L A RT L T O R CAS A AS T E RM C RM N EN ROO IEOO TI OPT MTPT I SM OAT ESAT L AE LVO HAVO WD FEB CWEB C

CPS-ODCM 2.5 Liquid Radwaste Treatment System 2.5.1 Liquid Radwaste Treatment System - Operation and Surveillance Requirements OPERATION REQUIREMENT The liquid radwaste treatment system shall be OPERABLE.

The' appropriate portions of the system (Figure 2.5-1) shall be used to reduce the radioactive materials in liquid wastes prior to their discharge when the projected doses due to the liquid _ effluent to UNRESTRICTED AREAS (see Figure 2.1-1) would exceed 0.06 mrem to the total l body or 0.2 mrem to any organ in a 31-day period. This y requirement applies at all times.

REMEDIAL REQUIREMENT:

With radioactive liquid waste being discharged without 3 treatment and in excess of the above limits and any E -

portion of the liquid radwaste treatment system not in operation prepare and submit to the Regional Administrator of the Regional Office of the NRC within 30 days a Special Report that includes the following information:

1. Explanation of why liquid radwaste was being j discharged without treatment, identification of any inoperable equipment or subsystems, and the reason h, for the inoperability. 3, 1

! 2. Action (s) taken to restore the inoperable equipment l to OPERABLE status, and j 3. Summary description of action (s) taken to prevent a l recurrence.

SURVEILLANCE REQUIREMENTS 2.5.1.1 Doses due to ' liquid releases to UNRESTRICTED AREAS shall be projected at least once per 31 days in accordance with the methodology and parameters described in Section l 2.4.2.

1 2.5.1.2 The liquid radwaste treatment shall be demonstrated OPERABLE by meeting the Operation Requirements of Section 2.3.1 and 2.4.1.

i I

CLINTON-1 2-24 Rev.17-12/98 I

I

CPS-ODCM 2.5.2 Temporary Liquid Radwaste Hold-Up Tanks The use of temporary liquid radwaste hold-up tanks may occur.at CPS. To comply with Operational Requirements i Manual (ORM) 2.4.4, the curie limit for liquid radwaste l stored in such tanks may be calculated using the l methodology presented in Appendix B of NUREG-0133 (BWR-l RATAFR code), but limited to less than or equal to 10 curies, excluding tritium and dissolved or entrained noble gases. 4 t i 2.6 Doses From Other Significant Liquid Effluent Pathways Section 2.4 of this manual is based upon the aquatic food {

and potable water exposure pathways only. Other exposure pathways, namely shoreline deposits and irrigated crops, l

)

may arise at Clinton Power Station and will be included in the section 2.4 dose contribution if they are likely to provide a significant contribution to the total dose. 4 A pathway is considered significant if a conservative evaluation yields an additional dose increment greater than or equal to 10 percent of the total from all other existing pathways. Methods for calculating doses from other potentially significant liquid effluent pathways are presented in Appendix A to Regulatory Guide 1.109.

When it_is determined that other liquid effluent pathways

do exist, the Regulatory Guide 1.109 Appendix A equations and parameters will be used in lieu of site-specific data ;

to determine a pathway's significance. l 2.7 Radioactive Liquid Effluent Monitoring Instrumentation 2.7.1 Radioactive Liquid Effluent Monitoring Iastrumentation -

Operation and Surveillance Requirements OPERATION REQUIREMENT The radioactive liquid effluent monitoring instrumentation channels shown in Table 2.7-1 shall be OPERABLE with their alarm / trip setpoints set to ensure that the limits of Section 2.3.1 are not exceeded. The.

alarm / trip setpoints of these channels shall be I determined and adjusted in accordance with the ;

methodology and parameters described in Sections 2.3.2 through 2.3.5. This requirement applies during releases via the associated pathway, f

CLINTON-1 2-25 Rev.17-12/98

CPS-ODCM REMEDIAL REQUIREMENT:

a. With a radioactive liquid effluent monitoring l instrumentation channel alarm / trip setpoint less ry conservative than required by the above requirement, s ;

without delay suspend the. release of radioactive liquid effluents monitored by the affected channel, or declare the channel inoperable, or change the ,

setpoint so it is acceptably conservative.

b. With less than the minimum numb.er of radioactive liquid effluent monitoring instrumentation channels OPERABLE, comply with the REMEDIAL REQUIREMENT shown )

in Table 2.7-1. Restore the inoperable instruments to OPERABLE status within 30 days and, if unsuccessful, explain in the next Radioactive j Effluent Release Report why the inoperability was 4 not corrected in a timely manner.

SURVEILLANCE REQUIREMENTS 2.7.1.1 Each radioactive liquid effluent monitoring instrumentation control shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION and CIUuTNEL FUNCTIONAL TEST at the frequencies shown in Table 2.7-2.

t I

i i

I-1 I

i a

CLINTON-1 2-26 Rev.17-12/98 i

.I!Il !lI lIi)l lIil l1 lll Il1 r 8 T 9 L EN e /

k 2 A

I M a 1 DE e -

E IR 1 22 2 2 333 44 r 7 b 1 M

E U p .

R EQ v m e R u p R W

C

)

a e

( h t

M SE U LL n

N EB ) ) o ) ) n M NA a ai a a o O I s 111 11 p I

T N NR I AE

(

1

(

1i

(

1

(

1 u A M HP v d .

T CO i e N D

/ s te E 1 aa M br U

R s w T i o S r l N o ef I t c r G i iv t G o N n N t I on r e e s I i D Moi n o de R n I o t r O o V nt i i t 1 T C M O oa t n n p I I R i i a o e a 7 N T n P td i M m O A o aa d e 2 M M i T i R a n r s e O t O d R o ui a 7 E T T N as i sf 2 L N U i Rs r t e ~a i E A e e a g ec -

y B A U L D d

R a

T U

B sc so t

a i

d a

r me 2

T F F

N er W a o e p s n A s M cP R e t t m

E s R o e n S at u M e A rt c s i r a D R c L Pn i s g z I A o A e v e e L** n wt h U L r tu r c nte i o Q A P GEnl e o inn l l l I NSef S r Lei o f a g L E

G N

e g IAuf DELE r e

P Stl uL S

eo gC )

n g

I r ILf r Enfr Ea .W V D a VEfr g e Cefe Crn yCs i I I h OREe n t I uEt Ioo l(

T V c R t a a Vl a Vti n or go

- C A

O I

O(-

. F i

l s PFra S

RNae OeW t

h E

c x

W g

n EfrW Dfe T

Etn ao ESt D

Gto el a

It I a e l a

ru D SAe OOWc NeWi Nas n n wa i

A ret TI i t l Et t I sI m R OLs ITev a o Msea Tn on n e tea NAcr e o Eacl Aee isio a IRw ONie H C Rwiu Cdr e N d MI vS Udvc I no ivat d OFa Mr l t Sarr doc n MOR YRen o n ARei NC il TESwrore E SC I r Du a ENd Mditt dr c n IT ooPon do VOi V tdt to Let II u ICntilip Eunn El c ni o i TTq TI aunenm Tqaa Vca act m

y CAi ANL OI IM DR AE RTa CTlhouoo AAPSMFMC OM IO DT AU RAab C

d Aill RLPP W

O L

Fabc Eye LCR K

N A .

Tab It nap ol i p s

ie n o i

s 1

N O

T vh N i T I u

. . . . L 1 2 3 4 D"

C p

l ,

g

i TABLE 2.7-1 (Continued)

RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION r

TABLE NOTATION (a)Cha'nnel OPERARILITY shall include the capability of the Main Control Room Central Control Terminal (MCR-CCT) to provide the alarm status of the applicable radiation monitor channel (s) .

g g

REMEDIAL REQUIREMENT REMEDIAL With the number of channels OPERABLE less than '

REQUIREMENT required by the Minimum Channels OPERABLE 1 requirement, effluent releases may continue via )

this pathway provided that prior to initiating a release:

a. At least two independent samples are analyzed in accordance with Section 2.3.1.1, and ll I l

b. At least two technically qualified members independently verify the release rate calculations and discharge line valving:

Otherwise, suspend release of radioactive effluents via this pathway. -

i REMEDIAL a. With the communication link or the MCR-CCT .. I REQUIREMENT inoperable perform CHANNEL CHECK using local 2 monitor indication within 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months and at least once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months thereafter.

I With the monitor otherwise inoperable, II b.

effluent releases via this pathway may continue provided that at least once per 12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months , grab samples are collected and analyzed for radioactivity at a Lower Limit of.

Detection of s5.0 x 10" Ci/ml for the l Principal Gamma Emitters. The Principal Gamma Emitters are: Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, and Ce-141.

Ce-144 shall be measured with an LLD of s5.0 x 10-' Ci/s. Dissolved and Entrained Gases (gamma emitters only) shall be measured with an LLD of $1.0 x 104 pCi/ml. These Dissolved and Entrained Gases are: Xe-133, Xe-l 135, Xe-138, Kr-85m, Kr-87, and Kr-88.

I CLINTON-1 2-28 Rev.17-12/98 i

I

CPS-ODCM

.,, TABLE 2.7-1 (Continued)

RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION TABLE NOTATION REMEDIAL With the number of channels OPERABLE less than REQUIREMENT required by the Minimum Channels OPERABLE 3 requirement, effluent releases via this pathway may continue provided the flow rate is estimated at I. least once per 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months during actual releases.

Pump performance curves generated in place may be lj used to estimate flow. CW flow may also be F estimated from the number of CW pumps in operation.

All flows diverted from Plant Service Water must be I taken into account when estimating dilution flow F when Plant Service Water is the only dilution source.

REMEDIAL With the number of channels OPERABLE less than REQUIREMENT required by the Minimum Channels OPERABLE 4 requirement, liquid additions to this tank may continue provided the tank liquid level is estimated during all liquid additions to the tank.

J I .

I I

I w

[

i

?

CLINTON-1 2-29 Rev.17-12/98

8 M

L 9 L A /

E N OT ) ) ) ) )

2

_ N IS 1 2 2 2 2 N TE ( ( ( ( (

A H CT

_ Q Q Q Q Q ]

C N S

T U v N

F e M R

_ E M

E R N I

U Q

LI ET O

) ) ) ) )

W E NA 3 3 3 3 3 R NR ( ( ( ( (

AB R R R R R E

C N

HI CL A

M A C .

L L

I E

- V -

R -

U E K S

N C

RC P M M M M M-O UE I OH C T S A

T M N

E 2 M

- U R

7 T M 2 S N

L EK

E I NC

NE L

B A

G N

AH HC D 'D 'D 'D 'D 2 M

T I C R

O T

N I M

. O F M O C

_ t n

G GI n

_ T N

NN IO er NT IA e

ur o r

r o

M DM

- E DI go lo i U IT rt IO ft t en rt L VA ai VT fi ra go ei F ON hn OU En ei ni tn F

E RI PM co sM RA P rM o td aa at ha ao WM M R i G e WR ci gn D SE Dn SNE tn xd I RT o RIS ao es Ea no U O ei ODA Wi cs R ii Q

I TC II tt sae TIE IVL ea t i e vc t

ar lt oa M NT ro ee L ain NOE ci oi OA wdi ORR id er Ht Cd E MM daL MP F va SP a a

- V O aR rR l M tR I

T C

YT TU R

sn t

' ,C

O e Ss nt wnr o

oer n

es M IA dse INN s oeo Pco ns A V ieu V O te dut it oe O ID ucl ITI nc tli l vi pc I

D TN qof TUT ao uf n ern mo or M A CAES irf CBA l r hfo ueo P

A LPE A N PP SEM FSM CP T OMA CMI N IRE IRM 1 E DAL DAR M ALE .

ALE . . . .

M U RAR a RAT a b c d C R T T N S I N . . L I 1 2 C M M'

_ L 8 9

LA N /

E OT 2 N IS A A A 1 N TE Q Q N N N -

A CT 7

- H N 1 S CU v T F e N R E

M E

R .N .

I O U LI _

Q ET E NA R NR R R R R R E

AB HI C CL N A A C L

L I

E V

R U

S E C K R C A ^

A A A A N

U E N N N N N O O H S C

)

I d T .

A e

u T n N i E _

tt M U _

L i

R L

(

T S

'L -

N EK 1 _

NC 2 I ' ' 3 3

- NE " D D -

7 G AH 'D D D 2 2

N I

HC C _

R E O L T I

B N A O e .

T M n t 'e i n n .

T L e i k N u L e n -

E S t l S g a U E n f r E a t_ -

L C e f e C r n .

F I u E t I o o e -

F V l a V t i h E E D

f f

r e

W E D

S t a

t D E t n e l o I T a o G t o t U N e W i N a s Q E t t I s I s I M s e a T n n L E a c l A e e o R w i u C d r i E U d v c I n o t V S a r r D o C i I A R e i N C rg d

- T E S C I d C M d -

d on a A i t t L e ti O E u ne n E l cl d I T q an a V c ao i D A i li l E y eo u q

A R L PL P L C RC R T i N W K l 1 E O N -

M L . . .

A . . g N U F a b c T a b n O T

R i

N T r S u I L

N . D

- I 3 4

C

CPS-ODCM TABLE 2.7-2 (Continued)

RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REQUIREMENTS T TABLE NOTATIONS (1) The CHANNEL FUNCTIONAL TEST shall also demonstrate that automatic isolation of this pathway occurs and that the MCR-CCT provides annunciation and event display in response to l each of the following conditions:

1. Instrument indicates measured levels above the alarm / trip (HIGH) setpoint. '

2. Detector failure (LOW FAIL, HI FAIL) .

3. Sample flow failure (EXTERNAL FAIL).

4. Instrument not set in normal operate mode (UNINITIALIZED, CALIBRATE, MAINTENANCE, or STANDBY. ) *

(2) The CHANNEL FUNCTIONAL TEST shall also demonstrate that the '

MCR-CCT responds with annunciation and event display to each of the following conditions:

1. Instrument indicates measured levels above the alarm (HIGH) setpoint.

2. Detector failure (LOW FAIL, HI FAIL) .

3. Sample flow failure (EXTERNAL FAIL).

4. Instrument not set in normal operate mode (UNINITIALIZED, CALIBRATE, MAINTENANCE, or STANDBY.)*

8 l

I i

A demonstration of automatic isolation of the release pathway is not applicable to this condition.

1 CLINTON-1 2-32 Rev.17-12/98 I'

i

CPS-ODCM

. . , TABLE 2.7-2 (Continued)

RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REQUIh"MENTS TABLE NOTATIONS (3) .The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST.

These standards shall permit calibrating the system over its intended. range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration shall be used.

~

(4) CHANNEL CHECK shall consist of verifying indication of flow during periods of release. CHANNEL CHECK shall be made at least once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months on days which continuous, periodic, j or batch releases are made.

(5) Determine that channel communication is established to the MCR-CCT.

-I t

G l

[

t l CLINTON-1 2-33 Rev.17-12/98

CPS-ODCM ,

l 3.0 GASEOUS EFFLUENTS I 3.1 Introduction Gaseous effluents from CPS are released on both a batch and continuous'l$ asis. Gaseous effluents are normally 3 discharged on a long term basis. High volume j '

Continuous Containment Purge and mechanical vacuum pump discharge may be considered short term releases.

There are two gaseous effluent release points to the environment: the Common Station HVAC Stack and the

~

Standby Gas Treatment System (SGTS) Stack. The height l of these stacks is such that all gaseous effluents are P treated as mixed-mode releases (reference Table 9.2-1).

The SGTS is an Engineered Safety Feature filter system ,

utilized following an accident to reduce. iodine and )

particulate activity in gases leaking from the primary l containment and which are potentially present in the g secondary containment. The Common Station HVAC Stack g<

("HVAC Stack") receives proc'ess and ventilation exhaust from the following inputs:

1) Continuous Containment Purge .(CCP)

2) Containment Building Ventilation

3) Turbine Building Ventilation

4) Radwaste Building Ventilation

5) Auxiliary Building Ventilation

6) Fuel Building Ventilation

7) Auxiliary Building Refrigerant Purge

8) Laboratory Ventilation System

9) Counting / Equipment Decon Rooms Ventilation

10) Steam Packing Exhauster

11) Mechanical Vacuum Pump

12) Drywell Purge The effluent exiting the SGTS stack is monitored at the

! SGTS stack and the combined inputs to the HVAC stack l are monitored at the HVAC stack. All inputs to the l HVAC Stack, with the excep, tion of input numbers 7 through 10, can be monitored prior to entering the stack.

Figure 3.1-1 delineates the CPS site boundary for implementation of gaseous effluent 10CFR20 and 10CFR50, Appendix I Release Rate Limits. .

1 l

l I' Il

(

l CLINTON-1 3-1 Rev.17-12/98 l

l I, l

._-.-______-a

CPS-ODCM 3.2 Gaseous Effluent Release Point Monitoring 3.2.1- HVAC Stack Process Radiation Monitoring (PRM) System The HVAC Stack inputs are monitored for radioactivity prior to discharge to the environment by the HVAC Stack PRM. The PRM detector configuration provides effluent monitoring using nine (9) channels as follows:

1) Beta scintillator for particulates

2) Alpha surface barrier detector to account for the radon / thoron contribution to the beta particulate measurement

3) Gamms scintillator for iodine

4) Iodine background subtraction

5) Beta scintillator for low range noble gas

6) Energy-compensated Geiger-Mueller (G-M) detector for high range noble gas

7) Energy-compensated G-M detector for gamma area subtraction

8) Sample pres *,ure indication at the HVAC PRM

9) Sample flov rate indication at the HVAC PRM

'rhie monitor he.s no control function but annunciates in the Main Cer.tiol Room where proper response actions will be initiated in accordance with CPS procedures.

3.1,2, SGTS Stack Process Radiation Monitoring (PRM) System As discussed in section 3.1, the SGTS is used to reduce post-accident concentrations of radioactivity in the primary and secondary containment via filter trains.

The SGTS' Stack PRM monitors the gaseous effluent of the filter trains at the SGTS Stack prior to release to the environment. The PRM detector configuration utilizes nine (9) channels as follows:

1) Beta scintillator for particulates

2) Gamma scintillator for iodine CLINTON-1 3-2 Re/.17-12/98

3) Iodine background subtraction

4) Beta scintillator for low range noble gas

5) Energy-compensated G-M detector for intermediate range noble gas

6) Energy-compensated G-M detector for gamma area subtraction

7) Alpha surface barrier detector to account for the radon / thoron contribution to the beta particulate measurement

8) Sample pressure indication at the SGTS PRM

9) Sample flow-rate indication at the SGTS PRM This monitor has no control function but annunciates in 5 the Main Control Room where proper response actions W will be initiated in accordance with CPS procedures.

3.3 Main Condenser Off-Gas. Monitoring System 3.3.1 Pre-Treatment Air Ejector Off-Gas Process Radiation Monitor (PRM)

The Pre-Treatment Off-Gas PRM monitors hydrogen recombiner effluent for gross noble gas radioactivity. ,

This effluent is then routed to the charcoal adsorbers for eventual release to the environment via the station HVAC Stack-(see Figure 3.3-1). The PRM detector configuration consists of a single energy-compensated .

G-M detector mounted in a gas volume.

The monitor has no control function but annunciates in the Main Control Room where proper response actions will be initiated in accordance with CPS procedures.

I I

I Il CLINTON-1 .3-3 Rev.17-12/98 Il! .

I CPS-ODCM

.s 3.3.2 Post-Treatment Air Ejector Off-Gas Process Radiation Monitor (PRM)

The Post-Treatment Off-Gas PRM monitors the gaseous radioactivity at upstream, intermediate or downstream sections of the charcoal adsorber beds prior to the effluent entering the station HVAC Stack for release to the environment (see Figure 3.3-1) . The PRM detector configuration is as described for the HVAC Stack PRM (Section 3.2.1).

The monitor has two control functions. Upon detection of noble gas activity in excess of the ALERT setpoint, the charcoal adsorber bypass valves shut (if in the charcoal bypass mode) and the off-gas is routed through the adsorbers.

Should noble gas activity exceed the HIGH setpoint, or upon PRM failure,.the off-gas system is automati~cally isolated from the HVAC Stack and a reactor scram may occur if loss of condenser vacuum occurs.

The Main Condenser Off-Gas Treatment System is shown in Figure 3.3-1.

3.4 10CFR20 Release Rate Limits The Operation and Surveillance Requiremen,ts concerning 10CFR20 Release Rate Limits are specified in Section 3.4.1. Dose Rate calculations for ensuring compliance with these limits are discussed in Sections 3.4.2 and 3.4.3.

Revision 17 of the ODCM initiates the use of new software for the determination of dose and dose rate values for gaseous effluents. In order to allow the transition from Revision 16 to Revision 17, dose and

@[ dose rate values for the year 1998 will be calculated using Revision 16 methodology. Doses and dose rates l for 1999 and on shall be calculated using Revision 17 P methodology.

3.4.1 10CFR20 Release Rate Limits - Operation and I Surveillance Requirements l

OPERATION REQUIREMENT _

l The dose rate due to radioactive materials released in gaseous effluents from the site to areas at and beyond s the SITE BOUNDARY (see Figure 3.1-1) shall be limited to the following:

a. For noble gases: Less than or equal to 500 mrem /yr to the total body and less than or equal to 3000 s mrem /yr to_the nkin,__and

- CLINTON-1 3-4 Rev.17-12/98

b. For iodine-131, for iodine-133, for tritium, and for all radionuclides in particulate form with j half lives greater than 8 days: Less than or equal ,. l to 1500 mrem /yr to any organ. l 1

This requirement applies at all times.

l REMEDIAL REQUIREMENT:

With the dose rate (s) exceeding the above limits, immediately restore the release rate to within the l above limit (s). I SURVEILLANCE REQUIREMENTS 3.4.1.1 The dose rate due to noble ga.ses in gaseous effluents shall be determined to be within the above limits in accordance with the methodology and parameters in Section 3.4.2 by obtaining representative samples and .

performing analyses in accordance with the sampling and analysis program specified in Table 3.4-1.

3.4.1.2 -The dose rate due to iodine-131, iodine-133, tritium, and all radionuclides in particulate form with half lives greater than 8 days in gaseous effluents shall be determined'to be within the above limits in accordance with the methodology and parameters in Section 3.4.3 by obtaining representative samples and performing analyses in accordance with the sampling and analysis program specified in Table.3.4-1.

D :

I I

I CLINTON-1 3-5 Rev.17-12/98 I

I

I lt l

CPS-ODCM TABLE 3.4-1 is j RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM Lower Limit I of Detection Sampling Analysis Type of LLD Gaseous Release Type Frequency Frequency Activity Analysis ( Ci/cc)

A. Station HVAC Exhaust

1. Noble Gas and W' W3 Principal Gamma $1.0 x 10

I Tritium Release

2. Iodines Release Grab Continuous 8 W'

Emitters

H-3 si,o x 10-es I-131 s1.0 x 10-l*

I-133 s1.0 x 10~1'

3. Particulates Release Continuous' W' Principal Gama gl ,o x 10-11 Emitters t M Gross Alpha si ,o x 10-11 Composite Activity Q Sr-89, Sr-90 s i ,o x 1 0-11 Composite Activity l

B. Standby Gas Treatment System Exhaust, when flow exists

! . Noble Gas and W W Principal Gamma si,o x 10-04

, Tritium Release Grab Emitters

i H-3 s1.0 x 10

8 8

2. Iodines Release Continuous W I-131 si,0 x 10-12 l I-133 sl.0 x 10~2'

3. Particulates Release Continuous' W d Principal Gamma , si, o x 10-11 I M Composite Emitters

Gross Alpha Activity si,o x 10-11 Q Sr-89, Sr-90 s1.0 x 10'2*

Composite Activity 1

i I

r CLINTON-1 3-6 Rev.17-12/98

CPS-ODCM TABLE 3.4-1 (Continutd) ,

RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM TABLE NOTATIONS

The LLD is defined, for purposes of these specifications, as the smallest concentration of radioactive material in a sample that will yield a net count, above system background, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "rr.al" signal.

For a particular measurement system, which may include g radiochemical separation: 3 LLD = 4.66 sb/ [E x V x 2.22 x 10' x Y x exp '- )

Where:

E y

LLD is the "a priori" lower limit of detection as defined above, as microcuries per unit mass or volume, su is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate, as counts per minute,s =

where Rex, = background counts A t=the background count time

'E is the counting efficiency,~as counts per disintegration, V is the sample size in units of mass or volume, 2.22. x 10' is the number of disintegrations per minute per microcurie, Y is the fractional radiochemical yield, when applicable, A is the radioactive decay constant for the particular E

radionuclide (s ec-* ) and At for plant effluents is the elapsed time between the midpoint of sample collection and the midpoint of the i

counting interval (sec).

Typical values of E, V, Y, and At should be used in the calculation.

I CLINTON-1 3-7 Rev.17-12/98 I

I

CPS-ODCM TABLE 3.4-1 (Continued)

RADIOACTIVE GASEOUS WASTE SAMP, LING AND ANALYSIS PROGRAM TABLE NOTATIONS (Continued)

It should'be recognized that the LLD is defined as an a priori (before the fact) limit representing the capability of a msasurement system and not as an a posteriori (after the fact) ,

limit for a particular measurement.

2 The principal gamma emitters are: Kr-87, Kr-88, Xe-133, Xe-133m, Xc-135, and Xe-138 in noble gas releases and Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, I-131, Cs-134, Cs-137, Ce-141 and Ce-144 in iodine and particulate releases. Other gamma peaks that are identifiable, together with those of the above nuclides, shall be cnalyzed and reported in the Radioactive Effluent Release Report pursuant to Technical Specification 5.6.3 in-the format outlined in Regulatory Guide 1.21, Appendix B, Revision 1, June 1974.

Sampling and analysis shall also be performed following shutdown, star' tup, or a THERMAL POWER change exceeding 15% of RATED THERMAL POWER within a 1-hour period.

'The ratio of the sample flow. rate to the sampled stream flow rate shall be known for the time period covered by each dose or dose rate calculation made in accordance with Sections 3.4.1, 3.5.1 and 3.5.2.

' Samples shall be changed at least once per 7 days and analysis shall_be completed within 48 hours5.555556e-4 days 0.0133 hours 7.936508e-5 weeks 1.8264e-5 months after changing, or after-removal from sampler. Sampling shall also be performed at least once per 24. hours for at least 7 days following each shutdown, startup,-or THERMAL POWER change exceeding 15% of RATED THERMAL

. POWER in 1-hour period and analyses shall be completed within 48 hours5.555556e-4 days 0.0133 hours 7.936508e-5 weeks 1.8264e-5 months of changing. When samples collected for 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months or less

.are analyzed, the corresponding LLDs may be increased by a factor of 10. Twenty-four (24) hour sampling requirements do apply if:

(1) analysis shows that the DOSE EQUIVALENT I-131 concentration in the primary coolant has increased more than a factor of 3, and (2) the noble gas monitor on the applicable PRM (HVAC or SGTS) shows that effluent activity has increased more than a factor of 3.

CLINTON-1 3-8 Rev.17-12/98

CPS-ODCM 3.4.2 Dc;e Rate Due to Noble Gases g

W In order to comply with Section 3.4.1. (a), the dose rate at or beyond the site boundary due to noble gases shall be calculated as follows:

=

De EKi i

shf

E,[ (X/Q) =*Qi,] (1) p = total body dose rate at time of release,

\

y mrem / year D, = Ei shf * (Li + 1.1M )

E, * [ (X/Q) n* Qi,] (2 ) ,

i

= skin-dose rate at time of release, mrem / year The terms in the above equations are E defined in section;3.4.3. 5 3.4.3 Dose Rate Due to Radioiodines, Particulates and Tritium In order to comply with Section 3.4.1(b), organ dose rates due to radioiodines (I-131, I-133), particulates with half-lives > 8 days and tritium shall be calculated as follows:

gij Do = E(Pi3

Qi, * %,] (3)

= organ dose rate at time of release, v mrem /yr The terms used 'in equations (1) through (3) are defined 5 as follows:

Ki = The total body dose factor due to gamma emissions for- each identified noble gas !

radionuclide i, mrem /yr per pCi/m' from 3 59 Table 3.4-2 g Li = The skin dose factor due'to beta emissions for each. identified noble gas radionuclide i, mrem /yr per pCi/m from gA U Table 3.4-2 Mi = The air dose factor due to gamma emissions for each identified noble gas radionuclide i, mrad /yr per pCi/m' (1.1 0g. mrem / mrad converts air dose to skin dose) p\3 from Table 3.4-2 I

Il CLINTON-1 3-9 Rev.17-12/98 I'

I

CPS-ODCM Pn = The dose factor for non-noble gas radionuclide i and organ j which includes pathway transport parameters, receptor usage factors and the dosimetry of the exposure. The dose factors for the inhalation, mrem /yr per pCi/m', pathway are listed in Table 3.4-3 (CHILD). Dose factors are based on NUREG-0133, Section 5.2.1.1 assumptions unless otherwise stated.

Qiv = The release rate of noble gas radionuclide i in gaseous effluent from mixed-mode release points, pCi/sec Qi. = The release rate of non-noble gas g

radionuclide.i.in. gaseous effluent from mixed-mode release points, pCi/sec (X/Q),e= The highest value of the annual atmospheric dispersion factor at the site boundary, for all sectors.

p4 WL, = The highest calculated average relative 49 concentration (X/Q) for any area at or beyond the site boundary from mixed-mode releases, sec/m3.

Do is calculated for each of six organs and the total body; the maximum Do value is then used to determine compliance with Section 3.4.1(b) . ,

The factors K i , L i , and Mi relate the radionuclide airborne concentrations to various dose rates assuming a semi-infinite cloud. These factors are listed in Table 3.4-2 and were obtained from Table B-1 of Regulatory Guide 1.109 after multiplying the values by the conversion 10' pCi/pCi.

10CFR20 organ dose rate calculations are limited'to the inhalation pathway only. Section 3.4.l(a) is applicable to the unrestricted area location

\'d characterized by the WL, value which results in the

$N maximum total body or skin dose commitment. Should the total body and skin locations differ, the selected location shall be that which minimizes allowable release rates.

There are unrestricted areas within the CPS site boundary which are utilized by members of the public for residences, farming, recreation and camping. These areas are identified in Table 3.4-4. Table 3.4-4 will be revised to remain consistent with the most recent land use census.

CLINTON-1 3-10 Rev.17-12/98

_ m

)

u n

8

'm 9

/

r i C

/

2 m ro i tc p33434333323433 0

1 u

_ Aa r+0000000000000

+++++++++++++

eEEEEEEEEEEEEEE ".

i a F N p7 5 3 3 6 318 5 9 6 7 5 8 .

v m m

e t 99090814034272 s a e e r.... ......... t R

_ B so y11121711172143 n

/ e D d

(

a r

m u

l f

f e

y o

s u m

)

'm o

e -

a S / s R a E r i C g n a

T ro H

G it Aca p31344422233333 000 r+++00000000000

+++++++++++ i n a U eEEEEEEEEEEEEEE A EF t

m M m D p32723367362110 d 2 e u D

me as r.7157652539523 y11611113331199

. t c n N Go / e .

A D S

d a

r t

d e s u

2 E 4

- S A

(

m e .

a

. G b 3 y E )

a E

L B

O t r

o /

i m

t m e A N c C T

R a p33334322223433 h a e O F 0 r+0000000000000

+++++++++++++

t 1

m i

F ei eEEEEEEEEEEEEEE s 1 S sL p6 4 3 719 6 4 616 2 3 9 e -

o R

O D 4

r.3730279018216 d

i 3

n T

C n /

y11921749371142 l c a A i m e u F k n S r o s E m i u S

O

(

d a s D )

r

'm

/

r o

e y r i

C f m dot p31344412233333 e

o 0 r s B c a r+0000000000000

+++++++++++++ a -

l a

FK t

eEEEEEEEEEEEEEE p712 7 6 6 514 212 3 4 s r

a 16946515918488 o t e r.

o os .............

y11511192231188 t s T D /

m c

a u s

e f r

m e

( s d

e d

d o

e i

e s M l mm m t

s 1

u C

D c

u m

55789033333331 1335578 i l C a

O n 88888911111114 T

- o - e N r S i rrrrrreeeeeeer P

C d

a KKKKKKXXXXXXXA h T

I L

C u

s R

a m

u

CPS-ODCM TABLE 3.4-3

) INHALATION PATHWAY DOSE RATE FACTORS (CHILD) - Po (mrem /yr per pCi/m')

ORGAN BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISCfrOPE H-3 NO DATA 1.12E+03* 1.12E+03 1.12E+03 1.12E+03 1.12E+03 1.12E+03 C-14 3.59E+04 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 NA-24 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 P-32 2.60E+06 1.14E+05 9.88E+04 NO DATA NO DATA - NO DATA 4.22E+04 -

CR-51 NO DATA NO DATA 1.54E+02 8.55E+01 2.43+01 1.70E+04 1.08E+03 MN-54 NO DATA 4.29E+04 9.51E+03 NO DATA 1.00E+04 1.58E+06 2.29E+04 MN-36 NO DATA 1.66E+00 3.12E-01 NO DATA 1.67E+00 1.31E+04 1.23E+05 FE-55 4.74E+04 2.52E+04 7.77E+03 NO DATA NO DATA 1.11E+05 2.87E+03 FE-59 2.07E+04 3.34E+04 1.67E+04 NO DATA NO DATA 1.27E+06 7.07E+04 CO-58 NO DATA 1.77E+03 3.16E+03 NO. DATA NO DATA 1.11E+06 3.44E+04 -

CO-60 NO DATA 1.31E+04 2.26E+04 NO DATA NO DATA 7.07E+06 9.62E+04 NI-63 8.21E+05 4.63E+04 2.80E+04 NO' DATA NO DATA 2.75E+05 6.33E+03 NI-65 2.99E+00 2.96E-01 1.64E-01 NO DATA NO DATA 8.18E+03' 8.40E+04 CU-64 NO DATA 1.99E+00 1.07E+00 NO DATA 6.93E+00 9.58E+03 3.67E+04 EN-65 4.26E+04 1.13E+05 7.03E+04 NO DATA 7.14E+04 9.95E+05 1.63E+04 ZN-69 6.70E-02 9.66E-02 8.92E-03 NO DATA 5.85E-02 1.42E+03 1.02E+04 BR-83 NO DATA NO DATA 4.74E+02 NO DATA NO DATA NO DATA LT 3.70E-15**

BR-84 NO DATA NO DATA 5.48E+02 NO DATA NO DATA NO DATA LT 3.70E-15 BR-85 NO DATA NO DATA 2.53E+01 NO DATA NO DATA NO DATA LT 3.70E-15 RB-86 NO DATA 1.98E+05 1.14E+05 NO DATA NO DATA NO DATA 7.99E+03 M-88 NO DATA 5.62E+02 3.66E+02 NO DATA NO DATA NO DATA 1.72E+01

,- 8 9 NO DATA 3.45E+02 2.90E+02 NO DATA NO DATA NO DATA 1.89E+00 sR-89 5.99E+05 NO DATA 1.72E+04 NO DATA NO DATA 2.16E+06 1.67E+05 JSR-90 1.01E+08 NO DATA 6.49E+06 NO DATA NO DATA 1.48E+07 3.43E+05 SR-91 1.21E+02 NO DATA 4.59E+00 NO DATA NO DATA 5.33E+04 1.74E+05 SR-92 1.31E+01 NO DATA 5.25E-01 NO DATA NO DATA 2.40E+04 2.42E+05 Y-90 4.11E+03 NO DATA 1.11E+02 NO DATA NO DATA 2.62E+05 2.68E+05 Y-91m 5.07E-01 NO DATA 1.84E-02 NO DATA NO DATA 2.81E+03 1.72+03 Y 9.14E+05 NO DATA 2.44E+04 NO DATA NO DATA 2.63+06 1.84E+05 Y-92 2.04E+01 NO DATA 5.81E-01 NO DATA NO DATA 2.39E+04 2.39E+05 Y-93 1.87E+02 NO DATA 5.11E+00 NO DATA NO DATA 7.44E+04 3.8.9E+05 ZR-95 1.90E+05 4.18E+04 3.70E+04 NO DATA 5.96E+04 2.23E+06 6.11E+04 F.R- 97 1.88E+02 2.72E+01 1.60E+01 NO DATA 3.89E+01 1.13E+05 3.51E+05 NB-95 2.35E+04 9.18E+03 6.55E+03 NO DATA 8.62E+03 6.14E+05 3.70E+04 MO-99 NO DATA 1.72E+02 4.26E+01 NO DATA 3.92E+02 1.35E+05 1.27E+05 TC-99m 1.78E-03 3.48E-03 5.77E-02 NO DATA 5.07E-02 9.51E+02 4.81E+03 TC-101 8.10E-05 0.51E-05 1.08E-03 NO DATA 1.45E-03 5.82E+02 1.63E+01 RU-103 2.79E+03 .NO DATA 1.07E+03 NO DATA 7.03E+03 6.62E+05 4.48E+04 RU-105 1.53E+00 NO DATA 5.55E-01 NO DATA 1.34E+00 1.59E+04 9.95E+04 RU-106 1.36E+05 NO DATA 1.69E+04 NO DATA 1.84E+05 1.43E+07 4.29E+05 AG-110m 1.69E+04 1.14E+04 9.14E+03 NO DATA 2.12E+04 5.40E+06 1.00E+05 iTE-125m 6.73E+04 2.33E+03 9.14E+02 1.92E+03 NO DATA 4.77E+05 3.38E+04 l TE-127m 2.49E+04 8.56E+03 3.03E+03 6.07E+03 6.36E+04 1.48E+06 7.14E+04 TE-127 2.77E+00 9.51E-01 6.11E-01 1.96E+00 7.07E+00 1.00E+04 5.62E+04 TE-129m 1.92E+04 6.85E+03 3.04E+03 6.33E+03 5.03E+04 1.76E+06 1.82E+05

[TE-129 9.77E-02 3.50E-02 2.38E-02 7.14E-02 2.57E-01 2.93E+03 2.55E+04 1TE-131m 1.34E+02 5.92E+01 5.07E+01 9.77E+01 4.00E+02 2.06E+05 3.08E+05

[ TE-131 2.17E-02 8.44E-03 6.59E-03 1.33E+03 1.70E-02 5.88E-02 2.05E+03 liMif k

CLINTON-1 3-12 Rev.17-12/98

CPS-ODCM TABLE 3.4-3 (cont'd) '

INilALATION PATl!WAY DOSE RATE FACTORS (CIIILD) - Py (mrem /yr per pCi/m')

l ORGAN BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI !

ISOTOPE TE-132 4.81E+02 2.72E+02 2.63E+02 3.18E+02 1.77E+03 3.77E+05 1.38E+05 I-130 8.18E+03 1.64E+04 8.44E+03 1.85E+06 2.45E+04 NO DATA 5.11E+03 g I-131 4.81E+04 2.12E+03 4.81E+04 4.07E+03 2.73E+04 1.88E+03 1.62E+07 1.94E+05 7.88E+04 6.25E+03 NO DATA NO DATA 2.84E+03 3.20E+03 g

I-132 I-133 1.66E+04 2.03E+04 7.70E+03 3.85E+06 3.38E+04 NO DATA 5.48E+03 I-134 1.17E+03 2.16E+03 9.95E+02 5.07E+04 3.30E+03 NO DATA 9.55E+02 l I-135 4.92E+03 8.73E+03 4.14E+03 7.92E+05 1534E+04 NO DATA 4.44E+03 g CS-134 6.51E+05 1.01E+06 2.25E+05 NO DATA 3.30E+05 1.21E+05 3.84E+03 CS-136 6.51E+04 1.71E+05 1.16E+05 NO DATA 9.55E+04 1.45E+04 4418E+03 CS-137 9.07E+05 8.25E+05 8.40E+02 1.28E+05 NO DATA 2.82E+05 6.21E+02 1.04E+05 6.81E+01 3.62E+03 E CS-138 6.33E+02 5.55E+02 NO DATA 2.70E+02 LIE BA-139 1.84E+00 9.84E-04 5.37E-02 NO DATA 8.62E-04 5.77E+03 5.77E+04 BA-140 7.40E+04 6.48E+01 4.33E+03 NO DATA 2.11E+01 1.74E+06 1.02E+05 BA-141 1.96E-01 1.09E-04 6.36E-03 NO. DATA 9.47E-05 2.92E+03 2.75E+02 BA-142 5.00E-02 3.60E-05 2.79E-03 NO DATA 2.91E-05 1.64E+03 2.74E+00 LA-140 6.44E+02 2.25E+02 7.55E+01 NO DATA NO DATA 1.83E+05 2.26E+05 LA-142 1.30E+00 4.11E-01 1.29E-01 NO DATA NO DATA 8.70E+03 7.59E+04 E 3.92E+04 1.95E+04 2.90E+03 8.55E+03 5.44E+05 CE-141 CE-143 3.66E+02 1.99E+02 2.88E+01 NO DATA NO DATA 8.36E+01 1.15E+05 5.66E+04

1. 2"a E+05 5

CE-144 6.77E+06 2.12E+06 3.62E+05 NO DATA 1.17E+06 1.20E+07 3.89E+05 PR-143 1.85E+04 5.55E+03 9.14E+02 NO DATA 3.00E+03 4.33E+05 9.73E+04 l FR-144 5.96E-02 1.85E-02 3.00E-03 NO DATA 9.77E-03 1.57E+03 1.97E+02 N ND.147 1.08E+04 8.73E+03 6.81E+02 NO DATA 4.81E+03 3.28E+05 8.21E+04 W-187 1.63E+01 9.66E+00 4.33E+00 NO DATA NO DATA 4.11E+04 9.10E+04 NP-239 4.66E+02 3.35E+01 2.35E+01 NO DATA 9.73E+01 5.81E+04 6.40E+04 3

1.12 x 10 1

- Less than 3.70 x 10*

I E

I I

I' CLINTON-1 3-13 Rev.17-12/98

1..

CPS-ODCM TABLE 3.4-4 LOCATION OF MEMBERS OF THE PUBLIC WITHIN THE CPS SITE BOUNDARY AND THEIR ASSOCIATED OCCUPANCY FACTORS

Distance Occupancy Location (mile / meter) Sector (hrs /yr)

Road 0.3/495 SE 243(1)

Agricultural'-

Acreage (2) 0.9/1372 SSW 966(3)

Clinton Lake 0.2/335 NW 2208(4)

Department of 0.8/1287 ESE 2208(S)

Conservation Recreation Area Residence 0.8/1219 SW 8760 Residence 1.5/2414 WSW 8760 Residence 1.7/2736 SSE 8760 1

(1) Assumes travel on road for forty minutes per day.

(2) Maximum farm acreage (276) within site boundary.

(3) Assumes 3.5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months in field.per acre farmed.

(4) Assumes continuous occupation on Clinton Lake for the months of June, July, and August.

(5) Assumes continuous occupation on Department of Conservation camping areas for the months of June, July, and August.

ODoses for such MEMBERS OF THE PUBLIC are provided in the Radioactive Effluent Release Report as given in Section 6.3.2.

CLINTON-1 3-14 Rev.17-12/98

CPS-ODCM 3.5 10CFR50, APPENDIX I RELEASE RATE LIMITS The Operation and Surveillance Requirements concerning jW 10CFR50 (Appendix I) Release Rate Limits,are specified in Sections 3.5.1 and 3.5.2. Dose calculations for ensuring compliance with these limits are discussed in E Sections 3.5.3 and 3.5.4. 5 Revision 17 of the ODCM initiates the use of new software for the determination of dose and dose rate values for gaseous effluents. In order to allow the transition from Revision 16 to Revision 17, dose and

( dose rate values for the year 1998 will be calculated

\ using Revision 16 methodology. Doses and dose rates for 1999 and on shall be calculated using Revision 17 methodology. .

3.5.1 Noble Gas Dose - Operation and Surveillance Requirements OPERATION REQUIREMENT The air dose due to noble gases released in gaseous effluents, from each reactor unit, to areas at and beyond the SITE BOUNDARY (see Fig'ure 3.1-1) shall be limited to the following:

a. During any calendar quarter: Less than or equal to 5 mrad for gamma radiation and less than or equal to 10 mrad for beta radiation, and

b. During any calendar year: Less than or equal to 10 ~g mrad for gamma radiation and less than or equal to 5 20 mrad for beta radiation.

This requirement applies at all times.

REMEDIAL REQUIREMENT:

a. With the calculated air dose from radioactive I nobles gases in gaseous effluents exceeding any of the above limits, in lieu of a Licensee Event Report, prepare and submit to the Regional Administrator of the Regional Office of the NRC within 30 days a Special Report that identifies E' the cause(s) for exceeding the limit (s) and 3l defines the corrective actions that have been taken,to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits.

! CLINTON-1 3-15 Rev.17-12/98 I

I

CPS-ODCM

. SURVEILLANCE REQUIREMENTS 3.5.1.1 Cumulative dose contributions for the current calendar

'} quarter and current calendar year for noble gases shall be determined in accordance with the methodology and parameters described in Section 3.5.3 at least once per 31 days.

3.5.2 Iodine-131, Iodine-133, Tritium, and Radionuclides in Particulate Form - Operation and Surveillance Requirements ODERATION REQUIREMENT The dose to a MEMBER OF THE PUBLIC from iodine-131, iodine-133, tritium, and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents released to areas at and.beyond the SITE BOUNDARY (see Figure 3.1-1) shall be limited to the following:

a. During any calendar quarter: Less than or equal to 7.5 mrem to any organ, and

b. During.any calendar year: Less than or equal to 15 mrem to any organ.

This requirement applies at all times.

REMEDIAL REQUIREMENT:

a. With the calculate'd dose from the release of iodine-131, iodine-133, tritium, and radionuclides in particulate form with half lives greater than 8 days, in gaseous effluents exceeding any of the above limits prepare and submit to the Regional Administrator of the Regional Office of the NRC within 30 days a Special Report that. identifies the cause(s) for exceeding the limit and defines the corrective actions that have been taken to re. duce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits.

l L i 1

r CLINTON-1 3-16 Rev.17-12/98 l

CPS-ODCM SURVEILLANCE REQUIREMENTS 3.5.2.1 Cumulative dose contributions for the current calendar .

quarter and current calendar year for icdine-131, iodine-133, tritium, and radionuclides in particulate form with half-lives greater than 8 days shall be E determined in a'ccordance with the methodology and 5 parameters described in Section 3.5.4 at least once per 31 days. -

3.5.3 Noble Gas Air Dose Equations The air dose at or beyond the site boundary due to noble gases released in gaseous effluent will be determined using the following equations.

3.5.3.1 During any calendar quarter or calendar year, for gamma radiation:

Dy = 3.17 x 10

E [ M * (X/Q),

Qiy]

i i (4)

Iph 3.5.3.2 During any calendar quarter or calendar year, for beta radiation:

8 Dp = 3.17 x 17

E [N i .1 (X/Q),

Qiy] (5) where Mi = The gamma air dose factor for each identified noble gas radionuclide i, mrad / year per pCi/m' (Mi values are E 3

listed in Table 3.4-2).

Ni = The beta air dose factor for each identified noble gas radionuclide i, mrad / year per pCi/m' (Ni values are g listed in Table 3.4-2). E (X/Q), = The highest calculated. average relative t'tASW {

concentration from mixed-mode release points for areas at or beyond the site boundary, sec/m*.

gyS))@ Q1, = The total release of noble gas E B

~

radionuclide i for long-term releases-from mixed-mode release points, Ci.

Releases shall be cumulative over the E calendar quarter or year, as 5 appropriate. I I

CLINTolt-1 3-17 Rev.17-12/98 I

{

o

-CPS-ODCM 3.17 x 10~' = The inverse of the number of seconds in a year.

Section 3.5.1 noble gas dose calculations are evaluated at the site boundary location where maximum air doses prevail. Should the beta and gamma locations differ, the selected location shall be that which minimizes allowable release rates due to the gamma component.

3.5.4 Radioiodines, Particulates and Tritium Dose Equations 1

The dose to an individual at or beyond the site boundary due to radioiodines (I-131, I-133), tritium and particulates with half-lives > 8 days, will be fd determined using the follow equation:

for any calendar quarter or calendar year, i

f De = 3.17 x 10~'* fo

E [Ript. *Wyp

Qiv) i (6) l where

[l Oi, = The releases of radionuclide.1 (I-131, I-133, tritium and particulates) for releases from mixed-mode release points, pCi. Releases shall be cumulative over the calendar quarter or year, as appropriate.

I Wv p = The dispersion parameter for estimating the

@f( dose to an individual at a controlling location for mixed-mode releases. l

= (X/Q)p, sec/m', for the inhalation pathway at the location of the critical receptor.

(D/0)p, m', for the food and ground plane

~

=

pathways at the location of the critical receptor.

3.17 x 10-8 = The inverse of the number of seconds in a year.

CLINTON-1 3-18 Rev.17-12/98

F . 1 CPS-ODCM j i

gd Rin3 = The dose factor for each identified radionuclide i, pathway (p), organ (T) , and age group (a), m*-mrem / year per pCi/sec or - {

mrem / year per pCi/m'.

pAM( fo = Occupancy factor which is set to 1 ;

Section 3.5.2 is applicable to the location at or beyond the site boundary where the combination of existing pathways and receptor age groups indicates the maximum potential exposure. The inhalation and ground plane exposure pathways exist at all locations; other pathways exist as determined by the most current land use census.

3.5.4.1 Dose Factor For Radionuclide i (Rip.)

The R.13 values used to calculate Dp in equation (6) are g determined separately for each of the potential 3' exposure pathways, namely:

- Inhalation (I)

- Ground Plane Contamination (G)

- Grass-Cow / Goat-Milk (C)

- Grass-Cow-Meat (M)

- Vegetation (V) '

The R.13 parameter is independent of the duration of E gaseous releases and is calculated using the 5 methodology discussed in the remainder of this section.

3.5.4.1.1 Calculation of the Inhalation Pathway Factor, R*in R*iu = K' (BR),(DFAti )., mrem / year per pCi/m' (7)

_ K' = A units conversion constant, 10' pCi/pCi 6

(BR). = The breathing rate of the receptor age group g (a), m'/ year g

=

1400 (infant)

=

3700 (child)

=

8000 (teen and adult)

Values for (BR), are obtained from NUREG-0133, pg. 32 I

CLINTON-1 3-19 Rev.17-12/98 I

8

CPS-ODCM (DEAa) . = The organ inhalation dose factor for receptor of age group'(a) for radionuclide i, mrem /pCi. - Values for (DEAi ). were obtained from Tables E-7 through E-10 of Regulatory Guide 1.109 and are presented in Tables 3.5-1

.through 3.5-4 of this manual. 1 1

3.5.4.1.2 Calculation of the Ground Plane Pathway Factor, R"su R"in =

K' K" - (SF) (DFGa) [ (1-e- **) /l i) , (8) m*-mrem / year per pCi/sec where K' = A units conversion constant, 10' pCi/pCi

'K" = A units conversion constant, 8760 hour0.101 days 2.433 hours 0.0145 weeks 0.00333 months / year SF = The shielding factor, dimensionless

= 0.7 as suggested in Table E-15 of Regulatory Guide 1.109

= The ground plane dose conversion factor for DEGa radionuclide i, mrem / hour per pCi/m'. Values for DFGi were obtained from Table E-6 of Regulatory Guide 1.109 and are presented in Table 3.5-5 of this manual.

Ai = The decay constant for radionuclide i, sec* -

t = The exposure time, sec

= 6.31E+08 sec (20 years) 3.5.4.1.3 Calculation of the' Grass-Cow / Goat-Milk Pathway. Factor, R"is.

R"su = K' (Or(U.p) / ( Ai + ()] F.(r) (DFL ,) .

i (9)

[f pf /Y p+ (1-f f.)p e i*h/Y.] e i'f, m*-mrem /yr per Ci/sec 4

where K' = A units conversion constant, 10' pCi/pCi i

l 1

CLINTON-1 3-20 Rev.17-12/98

CPS-ODCM Or = The cow / goat feed consumption rate,

kg(wet)/ day U., = The receptor's milk consumption rate for age ,7

. group (a) , liters / year Yp = The agricultural productivity by unit area of pasture feed grass, kg/m*

Y. = The agricultural roductivity by unit area of stored feed, kg/m Fi = The stable element transfer coefficient for

\gd{ nuclide i in milk, days / liter. These values are from Tables E-1 and E-2 of Regulatory Guide 1.109.

r = Fraction of deposited activity retained on feed grass, dimensionless (DFLi ,) . = The organ ingestion dose factor for radionuclide i and the receptor in age group g (a),. mrem /pC1. Values for (DFL i s), were g obtained from Tables E-11 through E-14 of Regulatory Guide 1.109 and are presented in Table 3.5-6 through 3.5-9 of this manual.

11 = The decay constant for radionuclide i, sec* -

A,, = The decay constant for removal of activity on leaf and plant surfaces by weathering, sec -2 I

= 5. 73 x 10-' sec-* (corresponding to a 14-day i half-life) tr = The transport time from pasture to animal, to milk, to receptor, see tn = The transport time from pasture to harvest, to animal, sec fp = Fraction of the year that the cow / goat is on pasture, dimensionless I

f. = Fraction of the cow / goat feed that is pasture 7

grass while the cow / goat is on pasture, dimensionless l The input parameters for calculating R"is, are listed in Table 3.5-10.

, I j CLINTON-1 3-21 Rev.17-12/98 I

I

CFJ-ODCM

. Tritium

I~ l The concentration of tritium in milk is based on its l airborne concentration rather than the' deposition.

Rr =

K ' K" F OrU., ( DFLi ,) .

I. 'where 0 . 7 5 ( 0 . 5 / 11) ,

mrem /yr per pCi/m' (10)

K" = A units conversion constant, 10 gm/kg

= The absolute atmospheric humidity I

11

= 8 gm/m3 (NUREG-0133, p. 34)

I .

0.75 = The fraction of total feed that is water, dimensionless I

0.5 = The ratio of the specific activity of the !

feed grass water to the atmospheric water, dimensionless i The other parameters are as defined in the es1culation

~

of R* 13 l l

Carbon - 14 Following the development of equation C-8 on page I 1.109-26 of Regulatory Guide 1.109, carbon-14 is assumed to be released as an oxide, either C**O or C**02 . The concentration of. carbon-14 in milk is i

I therefore based upon its airhorne concentration assuming that the vegetation C**/C ratio is the same as the local atmospheric C**/C ratio.

R. 2

= K' K"F.QgU,p (DFL s) p (0.11/0.16) ,

i mrem /yr per pCi/m' (11) where ,

p = Fractional equilibrium ratio, dim 1sionless I = Ratio of the, total annual C-14 atmospheric l

' release time to the total annual I photosynthesis time (4400 hours0.0509 days 1.222 hours 0.00728 weeks 0.00167 months ) not to exceed unity

= 1.0 t -

CLINTON-1 3-22 Rev.17-12/98

0.11 = Natural carbon' fraction of total plant mass, dimensionless 0.16 = Atmospheric natural carbon concentration, gm/in' The other parameters are as defined in the calculation 4 of R r 3.5.4.1.4 Calculation of the Grass-Cow-Meat Pathway Factor,'R"to R"su = [K'Or(U p) / (At + L) ] Fr (r) (DFL ,)

i .

[f pf /Y p+ [ (1-f f.) /Y ]e i*h] e p l's, m*-mrem /yr per pCi/sec (12) where I' K' = A. units conversion constant, 10' pCi/ Ci U.p = The receptor's meat consumption rate for age {

group (a), kg/ year i I

Fr = The stable element transfer coefficient, days /kg

t. = The transport time from pasture to animal to slaughter of meat animal to receptor, seconds 4 th = The transport time from crop field to harvest to animal, seconds 1 (DFLi s) . = The organ ingestion dose factor for radionuclide i and the receptor in age group (a), mrem per pCi. Values are tabulated in Table 3.5 ,6 through 3.5-9 of this manual.

. The input parameters necessary for calculating R".13 are g listed in Table 3.5-11. All other terms are as defined 3 for equations (9) and (10).

Tritium ,

The concentration of tritium in meat is based on its airborne concentration rather than the deposition.

R*r = K' K"F 0rU p (DFL ,) . [0.75(O.S/H)],

1 i mrem /yr per pCi/m' (13)

I I

CLINTON-1 3-23 Rev.17-12/98 I

~

l I i CPS-ODCM I The terms in equation (13) are as defined in equations (10) and (12).

Carbon - 14 Following the development of egaation C-8 on page 1.109-26 of Regulatory Guide 1.109, carbon-14 is !

5 assumed to be released as an oxide, either C**O or )

C*'O2 . The concentration of carbon-14 in meat is therefore based upon its airborne concentration assuming that the vegetation C**/C ratio is the same as the local atmospheric C**/C ratio.

R*te = K'K"FrQrU p(DFL1 ,) p (0.11/0.16) ,

mrem /yr per Ci/m' -

(14)

I The terms in equation (14) are as defined in equations (11) and (13).

3.5.4.1.5 Calculation of the Vegetation Pathway Factor, R*.13 R*.13 = K' [ (r) / [Y,( A t + L) ] ] (DFL ,) .

i

[U'.f .e t 1*L + U .fge" i*h) ,

S m*-mrem /yr per pCi/sec (15) where j

) = A units conversion constant, 10' pCi/pCi i I

K' U'. = The consumption rate of fresh leafy l vegetation by the receptor in age group (a),

kg/ year U*. = The consumption rate of stored vegetation by the receptor in age group (a), kg/yr fr. = The fraction of the annual intake of fresh leafy vegetation grown locally, dimensionless f, = The fraction of the annual intake of stored vegetation grown locally, dimensionless tt = The average time between harvest of leafy vegetation and its consumption, seconds I tn = The average time between harvest of stored vegetation and its consumption, seconds l'

CLINTON-1 3-24 Rev.17-12/98

CPS-ODCM Y, = the vegetation aroc density, kg/m* *

(DFLii ) . = The organ ingestion dose factor for l radionuclide i and the receptor '.n age group M (a), mrem per pCi. Values are tabulated in Table 3.5-6 through 3.5-9 of this manual.

The input parameters necessary for calculating R*.13 are !

31sted in Table 3.5-12. All other terms are as defined for equations (9) and (14).

Tritium ,

The concentration of tritium in vegetation is based on Ii '

its airborne concentration rather than the deposition.

R*r = K' K" (U*'.f , + U".f,) (DFL i 1 ,) . [0.75(0.5/H)],

mrem /yr per pCi/m' (16)

The terms in equation (16) are as defined in equations (10) and (15) .

Carbon - 14 Following the development of equation C-8 on page g 1.109-26 of Regulatory Guide 1.109, carbon-14 is assumed to be released as an oxide, either C*'O or g

C**02 . The concentration of carbon-14 in vegetation is therefore based upon its airborne concentration assuming that the vegetation C**/C ratio is the same as

. the local atmospheric C**/C ratio.

R*i4 = K' K" (UI " f , + U8 .f g) (DFL ,) . p (0.11/0.16) ,

i i mrem /yr per pCi/m' (17)

The terms in equation (17) are as defined in equations (11) and (15) .

The pathway dose rate factors (R*io, R*3 u , R# i s., R"in, R"i) , by age group are listed in Table 3.5-13 through 3.5-31. ,

3.6 Geseous Radwaste (Offgas Treatment) 3.6.1 Gaseous Radwaste (Offgas Treatment) System - Operation j and Surveillance Requirements j l

l B, l l l

l I 1 Il CLINTON-1 3-25 Rev.17-12/98 ,

II_a

h I.' '

l JCPS-ODCM OPERATION REQUIREMENT-(. ~The GASEOUS RADWASTE (OFFGAS) TREATMENT SYSTEM shall be

['

l

. in operation. .-This requirement applies'whenever the main.condens'er steam jet air ejector system is in L operation.

l L REMEDIAL REQUIREMENT:

a. Wi'th gaseous radwaste from the main condenser air !

ejector system being-discharged without treatment

'for more than 7' days, prepare and submit to the Regional Administrator'of the Regional Office of 1

.the NRC within 30 days a Special Report that includes the following int.unation: -

1. Identification of.any inoperable. equipment or subsystems, and the reason for the inoperability.

l2. Action (s) taken to restore the inoperable equipment to-OPERABLE status,-and

3. Summary description of action (s) taken to prevent'a recurrence.

i SURVEILLANCE REQUIREMENT k 3. 6.1.1. The GASEOUS RADWASTE (OFFGAS) TREATMENT-SYSTEM shall be verified to be in operation once every 12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months when the main condenser air ejector is in use to ensure that i the-main condenser offgas treatment system is

. functioning.

NOTE When' placing the Offgas Treatment System in the ;

charcoal bypass mode, the alarm setpoints-for the 1 Station'HVAC Exhaust and the Post-Treatment Offgas radiation monitors may be calculated to account for the increasedofractions of short-lived noble gases.

The_ noble gas release fractions shall be based either on actual measured values or'on design basis noble' gas concentration fractions (30-minute delay) in the primary coolant offges.

l.

CLINTON-1 3-26 Rev.17-12/98

CPS-ODCM 3.7 Ventilation Exhaust Treatment 3.7.1 Ventilation Exhaust Treatment System - Operation and ,

Surveillance Requirements OPERATION REQUIREMENT The VENTILATION EXHAUST TREATMENT SYSTEM (VETS) shall :

be used to reduce radioactive materials in gaseous El waste prior to their discharge when the projected doses 3 1 due to gaseous effluent releases to areas at and beyond !

the SITE BOUNDARY (see Figure 3.1-1) would exceed 0.3 gl mrem to any organ in a 31-day period. This requirement E! '

applies at all times other than when the VETS is undergoing routine maintenance. l REMEDIAL REQUIREMENT:

a. With gaseous waste being discharged without treatment and in excess of the above limit, prepare and submit to the Regional Administrator of the Regional Office of the NRC within 30 days a g Special Report that includes the following 5 information:

1. Explanation'of why gaseous radwaste was being

' discharged without treatment, identification of any inoperable equipment or subsystems, and the reason for the inoperability,

2. Action (s) taken to restore the inoperable equipment-to OPERABLE status, and

3. Summary description of action (s) taken to .

prevent a recurrence.

SURVEILLANCE REQUIREMENTS 3.7.1.1 Doses due to gaseous releases from the site shall be projected at least once per 31 days in accordance with this manual when the ventilation exhaust treatment system is not in use.*

The projected doses resulting from such releases will be pA3d l calculated using Section 3.7.2 methodology. If the dose impact resulting from the projected 31-day release exceeds 0.3 mrem and the VETS is capable of reducing the projected impact to less than 0.3 mrem, the VETS shall be used.

I I

CLINTON-1 3-27 Rev.17-12/98 8

CPS-ODCM.

3.7.1.2 The installed VENTILATION EXHAUST TREATMENT SYSTEM shall be considered OPERABLE by meeting the Operation J

Requirements of Sections 3.4, 3.5.1, and 3.5.2.

).

3.7.2 Gaseous Effluent Dose Projection Calculations The 31 day projected dose shall be calculated using the I following equation Dg, = (D,

p) + D., (18) where: j Dp = the 31 day projected dose by organ t. I

\g 3, a sum of dose for all valid release points in

n. rem / day by organ t.

p = the projection factor.which*is the results of 31 divided by the number of days from the start of 1 the quarter to the end of the release.

l D., = additional anticipated dose for gaseous release by organ t and quarter of release.

3.8 Effluent Monitor Setpoint Calculations Gaseous effluent Process Radiation Monitor (PRM) alarm setpoints shall be calculated to ensure that the l f instantaneous dose rate in unrestricted areas due to noble gases released do not exceed 500 mrem / year to the total body and 3000 mrem / year to the skin. The initial i

setpoints were calculated using the BWR/ GALE code radionuclide mix obtained for CPS; when the actual l radionuclide mix can be determined, it will be used for ;

setpoint calculations. The PRM setpoints are based on the instantaneous noble gas dose rates and are applied at the point of which the effluent enters an unrestricted area.

Due to PRM limitations, non-noble gas setpoints will not be implemented to demonstrate compliance with Section 3.4.l(b) . Compliance with the organ dose rate limitation is demonstrated.during performance of sampling and analysis activities required by Table 3.4-1.

Both total body and skin dose setpoints will be calculated and the more restrictive limit applied to the respective PRM. The actual setpoint used may be lower than the restrictive limit since the two release points will be partitioned such that their sum does not exceed 100 percent of the restrictive limit. The percentages used to partition the release points could

? vary'at plant discretion to accommodate plant operational conditions. In no case will the combined CLINTON-1 3-28 Rev.17-12/98

. l

' CPS-OCCM

^

releases due to variations in the PRM isetpoints result .

in effluent limits being exceeded.

3.8.1 Total Body Dose Rate Setpoint The fraction of the total gaseous radioactivity in each g gaseous effluent release path j for aach noble gas 3 radionuclide.i shall be determined using the following relationship: :

1 fi3 = Ci3/(EC13 ) , dimensionless S (19)

I' I

I I

E i

I I

I I'

I CLINTON-1 - 3-29 Rev.17-12/98 I

I

CPS-ODCM where C33 = The measured concentration of identified noble gas radionuclide i in gaseous effluent release path j,- Ci/cc The maximum acceptable release rate of all noble gases in release path j-to comply with Section 3.4.1 is calculated by using the equation:

s9M l Or3 = 500 F 3/ [ (X/Q) 3Ei (K fi i3) ], pCi/sec (20) where

The maximum acceptable release rate of all Ch3 noble gases in release path j, pCi/sec F3

Total dose rate allocation factor assigned to release path j (varying between 0.0 and 1.0),

dimensionless 500 = Total body dose rate limit specified in Section 3.4.1(a), mrem / year

=

(X/Q)3 The highest. calculated average relative concentration of release path j at the site boundary Ki = The total body dose factor due to gamma emissions of noble gas radionuclide i as listed in Table B-1 of Regulatory Guide 1.109 and Table 3.4-2 of this manual, mrem /yr per pCi/m' f i3 = The fraction as defined by equation (18),

dimensionless The total maximum acceptable concentration setpoint of noble gas radionuclides in release path j is calculated using the following equation:

C73 = Or3 /R , pCi/cc 3 (21) where

= The total maximum acceptable concentration Cr3 setpoint of all noble gases in release path 3, pCi/cc i.

g CLINTON-1 3-30 Rev.17-12/98

CPS-ODCM Or3

= The maximum acceptable release rate of all noble gases in release path j determined from- i equation (19), pCi/sec R3

= The efflitent release rate of release point j, '

cc/sec 3.8.2 Skin Dose Rate Setpoint i

~

To ensure compliance with the section 3.4.1(a) skin dose rate limit, PRM setpoints shall be calculated {

using the methodology presented in Section 3.8.1 and by ai substituting the following equation for equation (19): g Os3 = 3000F3 /[(X/Q)3 Et (L +1.1Mi a13) ], pCi/sec i (22)

Os3

= The maximum acceptable release rate of all noble gases in release path j, pCi/sec F3

= Total dose rate allocation factor assigned to release path j (varying between 0.0 and 1.0),

dim'ensionless 3000 = Skin dose rate limit specified in'Section 3.4.1(a), mrem / year (X/0)3 = The highest calculated average relative concentration of release path j at the site boundary Li = The skin dose factor due to gamma emissions for each identified noble gas radionuclide i, mrem /yr per.pCi/m', as listed in Table 3.4-2 of this manual.

1.1 = An air dose to skin dose equivalent conversion factor, mrem / mrad Mi = The air dose factor due to gamma emissions E for each identified noble gas radionuclide i, 5 mrad /yr per pCi/m , as listed in Tab.le 3.4-2 of this manual f i3 = The fraction defincd by equation (18)

I I

CLINTON-1 3-31 Rev.17-12/98 I

I

CPS-ODCM The calculated total body and skin maximum acceptable s concentration setpoints are compared and the more i restrictive setpoint used. A safety factor may also be applied to the concentration setpoint calculated by equat' ion (20) to compensate for statistical f-) fluctuations and measurement errors.

3.9 Radioactive Gaseous Monitoring Instrumentation

)

3.9.1 Offgas~ Radiation Monitoring Instrumentation - Operation and Surveillance Requirements OPERATION REQUIREMENT f- .The offgas radiation monitoring instrumentation channels shown in Table 3.9.1-1.shall be OPERABLE, with their alarm / trip setpoints.within the specified. limits.-

This requirement applies during operati.on of the main f- condenser air ejector (s).

REMEDIAL REQUIREMENT:

a. With'a radiation monitoring instrumentation channel alarm / trip setpoint exceeding the value shown in Table 3.9.1-1, adjust the setpoint to within the limit within 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months or declare the '

channel inoperable.

b. With one or more radiation monitoring channels inoperable, comply with the REMEDIAL REQUIREMENT specified by Table 3.9.1-1.

SURVEILLANCE REQUIREMENTS 3.9.1.1 Each of the above required radiation monitoring instrumentation channels shall be demonstrated OPERABLE j by the performance of the CHANNEL CHECK, SOURCE CHECK, I

CHANNEL FUNCTIONAL TEST and CHANNEL CALIBRATION.at the -

frequencies shown in Table 3.9.1-2.

r I

l' f

CLINTON-1 3-32 Rev.17-12/98

8 9

M_-

/ -

2 -

1 T

M--

L N E v

_ AM I e D

E R E

I 5 6 7 7 R M-MU EQ R

E R

M M

N

_ O I

T A

T N

P IT RN c

'cc d

/

i c

c M E

M U

TI

/O MP

/

i C

p C

p A N

A N

M-R RT 6 T AE 0 M

S 0 .

IS 5

_ N I

A 7 1 <- <-

_ - G N

1 9

. I R

M

. O ' ;

3 T I

E N L

B O

M 3

M A S T N L O E ND I

T NE M A AL I

D HB *

A CA 1 1 R 1 1

_ R ME U P M

S A MO I

G N F

F O

I M 8-g M

s -

e n e ee a f l i m c tc N fG f r O b d f e i ai O

I f

Oeo lt t o

Nyv i o t s

vRv e e M

- T to n y D wD A tbi non e n eir o S o T gvPdci eg l g N eNo m E

M m

t -

M ta y e ni atratae nai Rco nit ttnFn ans err ul er u i M-U a Atmmia u R eMt rM h irome lws ps 1 M T rRi tR gsnatrl foa ma '-

C S tPv P D N -

est ss i t iaol uee fl e ae HGMAATR EFM SM M O I rac oa . . .

T PgA Pg a b c N S I P . . L C 1 2 C M lllI ,l ifl l1ll I M

CPS-ODCM TABLE 3.9.1-1 (Continued)

OFFGAS RADIATION MONITORING INSTRUMENTATION TABLE NOTATIONS a . Alarm only.

b A channel may be placed in an inoperable status for up to I hour for the purpose of performing surveillances.

c Radioactivity concentration expected at the monitor location is a noble gas mix with a 2.9-minute decay.

d Radioactivity concentration expected at the monitor location is a noble gas mix released from the off-gas treatment system.

e Channel OPERABILITY shall include the capability of the Main Control Room Central Control Terminal (MCR-CCT) to provide the alarm status of the applicable radiation monitor channel (s) .

REMEDIAL REQUIREMENT REMEDIAL REQUIREMENT a. With the MCR-CCT inoperable, 5

1. Perform a CHANNEL CHECK using local monitor indication within 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months and at least once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months thereafter, and

2. Restore the MCR-CCT to OPERABLE status for the applicable channel (s) within the next 30 days, and if unsuccessful, .

prepare and submit to the Regional Administrator of the Regional Office of the NRC within the next 10 days a Special Report outlining the cause of the CCT failure or malfunction and the action taken to restore the inoperable equipment to OPERABLE status.

CLINTON-1 3-34 Rev.17-12/98 L

I l

CPS-ODCM i TABLE L 9.1-1'(Continued)

OFFGAS RADIATION MONITORING INSTRUMENTATION

\ ,

TABLE NOTATIONS l

b. With the Pre-treatment Off-gas PRM - Noble Gas Activity Monitor otherwise inoperable, gases from the main condenser off-gas treatment system may be released to the environment provided:

1. The off-gas treatment system is not E bypassed, and 5'

2. The post-treatment air ejector off-gas 3 i PRM high range noble gas activity 'g monitor is OPERABLE,.or the provisions of REMEDIAL REQUIREMENT 6-b are in effect.

REMEDIAL REQUIREMENT a. With the MCR-CCT inoperable, 6

1. Perform a CHANNEL CHECK using local g; monitor indication within 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months and at 3 least once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months thereafter, and

2. Restore the MCR-CCT to OPERABLE status !

for the applicable channel (s) within the next 30 days, and if unsuccessful, i prepare and submit to the Regional Administrator of the Regional Office of the NRC within the next 10 days a l Special Report outlining the cause of the CCT failure or malfunction and the action taken to restore the inoperable equipment to OPERABLE status.

I Il l

i l

I; Il l CLINTON-1 3-35 Rev.17-12/98 I-8

CPS-ODCM TABLE 3.9.1-1 (Continued)

'N OFFGAS RADIATION MONITORING INSTRUMENTATION

) TABLE NOTATIONS I

b. With the Post-treatment Off-gas PRM High Range Noble Gas Activity Monitor otherwise inoperable, effluent releases via this pathway may continue provided grab samples are taken at least once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months , and a noble gas gamma I isotopic analysis performed within 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months .

REMEDIAL REQUIREMENT 7 With the number of channels OPERABLE less than required by the minimum channels OPERABLE I requirement, effluent releases via-this pathway may continue provided the flow rate is estimated at least once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months .

I IJ l

i I

I O

i

8 9

/

W-2 1

M_

v e

R S

T E-N Es E

t M_ .

R N I O U

Q LI ET )

E E NA )

R NR 2( 2

(

R R AB R HI R E__

E L C C. A N C A

L L

I E

V E-R L U L A S N E

N O

N N

A OT IS TE

)

1

(

)

1

( Q Q E_

2 I H CT Q Q

- T N 1 A C U 9

3 T

N E

M F

E-U E

L R

T E C K 7

3 E_

B S R C A A -

A N U E M D N N 3 T I OH C S

G N E I

R O

T I

N L E O EK M NC NE U D D N AH 'D 'D O

I HC C

E T

A I

D c g E A s i n R a gt i g ee e na r S

A f

- f f l im mu es tc ai b dof G

F f

O r O o o N yv u ito ta se Rv

- e E

F t t yM wD O tsi n toAn N nan e eir o S o O ego m gvPdi e lg Fn I

T m te M t a

ni atraae na nt tt i E A aly e Rco ns eRe er T ebt rM Atmia ucl u irme l wi ps 1 N roi TR h gsnarl fov ma M E TNv P C

D M

U - - i t iaol ee fl e ae HGMATR EFD SM E O R eMt ss T

- T rRc oa PPA Pg a b

c N -

S I S L P N . .

C C I 1 2 E-E

F 1 1

CPS-ODCM TABLE 3.9.1-2 (Continued)

OFFGAS RADIATION MONITORING INSTRUMENTATION SURVEILLANCE REQUIREMENTS lf; TABLE NOTATION

a Automatic isolation of valve IN66-F060 shall be demonstrated during the CHANNEL CALIBRATIOM.

(1) The CHANNEL FUNCTIONAL TEST shall also demonstrate that the MCR-CCT responds with annunciation and event display to each of the following conditions:

1. Instrument indicates measured levels above the alarm / trip (HIGH) setpoint.

2. Detector failure (LOW FAIL, HI FAIL).

3. Sample flow failure (EXTERNAL FAIL) .

4. Instrument not set in normal operate mode (UNINITIALIZED, CALIBRATE, MAINTENANCE, or STANDBY).

(2) The initial CHANNEL CALIBRATION shall be performed'using one or more of the reference standards certified by the National I

Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that l ..) participate in measurement assurance activities with NIST. I I These standards shall permit calibrating the system over its intended energy range and measurement range. Subsequent CHANNEL CALIBRATION shall be performed using the initial

(

l radioactive standards or other standards of equivalent I quality or radioactive s,ources that have been related to the initial calibration.

(3) The CHANNEL CHECK shall also determine that channel I communication is established to the MCR-CCT.

I

.I

I I.

F CLINTON-1 3-38 Rev.17-12/98

CPS-ODCM l 3.9.2 Radioactive Gaseous Effluent Monitoring Instrumentation

- Operation and Surveillance Requirements OPERATION REQUIREMENT The radioactive gaseous effluent monitoring instrumentation channels shown in Table 3.9.2-1 shall be OPERABLE with their alarm / trip setpoints set to 1 ensure that the limits of Section 3.4.1 and Technical l Specification 3.7.5 are not exceeded. The alarm / trip ]

setpoints of these channels shall be determined and i adjusted in accordance with the methodology and parameters in this manual. This requirement applies as

)

l I

shown in Table 3.9.2-1.

REMEDIAL REQUIREMENT:

a. With a radioactive gaseous effluent monitoring instrumentation channel alarm / trip setpoint less conservative than required by the above requirement, immediately suspend the release of radioactive gaseous effluents monitored by the affected channel, or declare the channel E inoperable. E

b. With less than the minimum number of radioactive 3 gaseous effluent monitoring instrumentation 5 channels OPERABLE, comply with the' REMEDIAL REQUIREMENT specified in Table 3.9.2-1. Restore the inoperable instrumentation to OPERABLE status within 30 days and, if unsuccessful, explain in the next Radioactive Effluent Release Report pursuant to Technical Specification 5.6.3 why this inoperability was not corrected in a timely manner.

SURVEILLANCE REQUIREMENTS 3.9.2.1 Each radioactive gaseous effluent monitoring g instrumentation channel shall be demonstrated OPERABLE E by performance of the CHANNEL CHECK, SOURCE CHECK, l CHANNEL CALIBRATION and CHANNEL FUNCTIONAL TEST l operations at the frequencies shown in Table 3.9.2-2. l i

I I

Il l CLINTON-1 3-39 Rev.17-12/98 I

M -

8 W 9

/

2 1

T -

M, L N A

I M D E E .

7 1

v E IR MU 8 8 9 9 0 1 8 8 9 9 0' 1

0 1

0 1 R e

E M R Q E

R -

N O ~

MT I A

T Y T _

N I E _

MU M L -

I R B T A a a a a a b b b b b a b S C N I MI G N

L P

P A

I Md R c

E b L _

B M A .

R _

ME N _

UP 0

M I O d d d d 4 l l 1 1 1 l 1 1 1 1 1 1 _

W NS 3 F I L E ME N

S N WO U E

S A

H C

A G

WE V I

t i

y v

t i

y g

t i

y v

t i

y g

e t ,

a) i v n m i v n m T t i e t i i e R1 WA C i t te - -

c t r s c t r sc w1 O M A c u y A c u yi o5 I R s A '

' s a S s A s a Sv l0 D P a s 'r e a s r e e FR A G a t a tD P4 WR T N

E t

s u le a b G

e l

e M p e mt n

e m

t G

l e

G e

l e M p e mt n

eg un li m00 e11 t( G s V M h l 'r a a a b l r a a fr yeI U x o b e S R e o b e S R fu ScF R E N o l - N o l -

W T S

C g N A e

N e

p e w mt o a al r

T e g

N e

p e w mt o a a l Es Ce a tv ner i0 I n g S l F sM n g S l F AM) eDo V ar nr u aR ar nr u V 6 u H Ro ao e c ee GP Ro ao e c ee He- l g ,

W n hi t Rt nilc o i i t pi gn wn d r mvbs gn du yt wn t Rt nil c dhir mv i i t pi oR0 iEr0R t1 fn4 na5 fi0 1

" i i o oo o a ae io oo o a ae uG N t

HM LM I P SD na HM LM I P SD twP SsV O a ah ao0 tai T t . . . . . tx . . . . . tl1 GeF N s S a b c d e SE a b cd e SF( SM0 I p . . . . L 1 2 3 4 C S

CPS-ODCM TABLE 3.9.2-1 (Continued) )

RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION j TABLE NOTATIONS l a At all times. i b During standby gas treatment system operation.

c A channel may be placed in an inoperable status for up to 1 i hour for the purpose o'f performing surveillance's. {

d Channel OPERABILITY shall include the capability of the Main Control Room Central Control Terminal (MCR-CCT) to provide 3 the alarm status of the applicable radiation monitor 5 channel (s).

e Filter, media (particulate collection patch.for particulates and charcoal cartridge for iodines) in place with an operating sample pump constitutes an iodine / particulate

, , sampler.

REMEDIAL REQUIREMENT REMEDIAL REQUIREMENT a. With the communication link OR the MCR-CCT inoperable, perform a CHANNEL CHECK 8 using local monitor indication'within 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months 3 and at least once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months thereafter. E

b. With the noble gas activity monitor channel (s) otherwise inoperable, effluent releases via this pathway may continue provided grab samples are taken at least once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months and analyzed for gross noble gas activity within 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months .

REMEDIAL With the number of channels OPERABLE less than REQUIREMENT required by the minimum channels OPERABLE 9 requirement, effluent releases via this pathway may continue provided that, within 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months after g the channel has been declared inoperable,' samples E required by Table 3.4-1 are continuously collected with auxiliary samplin.g equipment.

REMEDIAL With the number of channels OPERABLE less than REQUIREMENT required by the minimum channels OPERABLE 10 requirement, effluent releases via this pathway may continue provided the flow rate is estimated at least once per 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months .

I I l B

CLINTON'1 3-41 Rev.17-12/98 I

1

jjl l {ll1ilII i i

!]

8 9

/

2 1

Y 7 T 1 _

I S L T I v N B d e E A a a a a a a b b b b b b ,

R M C c -

E I R L I P U P Q A E

R E

C L N A L N A E OT L N IS ) ) ) )

L N

1 1 AA Q Q 1 1 A A Q G A I

A TE N N N

( ( ( (

N N E CT H N Q Q Q Q .

V C U R

U F S

N O

I N T O A LI T ET N NA ) ) ) )

E NR 2 2 A A R 2 2 A NA R 2 M

- U AB

(

R

(

R N N 'R (

R

(

R N R A 2 R HI T

CL 2 S A C

. N 3 I E G L N E K 2 B I C C 4 A R R E A A A A A A A A -

T O T

U H O C M M A AN N 'N N N M N N N N N 3 I S N

O M

T L N EK E NC '

" 3' "

U NE '

WWD D WWD D A L AH 'D 'D 'D 'D N MF F E

HC C

MU S

O E

M R

P s wc e

s wc e

n od sa n

S a s r oi a s r oi n E A t G a e lv t G a e l v t E G s er G l Fe ne G l Fe otn ises u lo r p ee D er r p ee D tumM E a eo r mtc meg tR mM l o eo mtc a aimeg aatR

- V T h bt lt a e S Rvtnai aP bt lt r N oi bi E Ex Nn on oi bi e S Rvtn rhaP MC I T

A O

M U C eM R A g T

o ny gy No e

p M mt l

e wD yr a a log S l Fn t a e si Su s

e rt Ts Nn on u eM sa ny gyeg o No M

l ma p e wD yr iErt t o a l 3 e si Su s

bxe l

aC Casa Ts u

I V S l Fh ta Vah S

N H Ri ai at nt e u i ne ah Gx at nt u c

l ne eHGx A n c er eM Ri ai R I n hi - vRv i i i lu u y E - vRv e n i lpo eaueM c iny E

o gt wt d t ps ft l e b m hi i i t. sa ft l e vobm 1 WD r ma gt wt d -

i o de ride N t ic oc I a ae fa nt ic oc o P SM ae f a etnt

a. HA LA P SM ER as HA LA I ER saas O t . . . . . . ty . . . . . . ntty T S a b cd e f SS a b cd e f ISSS N I

. . . L 5*

1 2 3 C L

lll

CPS-ODCM TABLE 3.9.2-2 (Continued) W RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION g I SURVEILLANCE REQUIREMENTS -g l

a At all times.

b During operation of the standby gas treatment system.

(1) The CHANNEL FUNCTIONAL TEST shall also demonstrate that the ,

MCR-CCT responds with annunciation and event display to {

each of the following conditions: {

i

1. Instrument indicates measured levels above the alarm (HIGH) setpoint. !

2. Detector failure (LOW FAIL, HI FAIL) .

3. Sample flow failure (EXTERNAL FAIL).

I

4. Instrument not set in normal operate mode (UNINITIALIZED, CALIBRATE, MAINTENANCE, or STANDBY).

I)l \

(2) The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that g participate in measurement assurance activities with NIST. g ,

These standards shall permit calibrating the system over its intended range of energy and measurement range. Subsequent CHANNEL CALIBRATION shall be performed using the initial radioactive standards or other standards of equivalent quality or radioactive sources that have been related to the initial calibration.

(3) The CHANNEL CHECK shall also determine that channel

. communication is established to the MCR-CCT.

c Per Regulatory Guide 1.21, compare the PRM readings with grab sample results for the noble gas and particulate / iodine EJ channels. Modify the channel calibrations as necessary to 3 ensure monitor readings are related to the concentration or release rates of nuclides in the monitored path.

d Not applicable if the activity in the sample stream is not high enough to provide a statistically relevant comparison.

I, '

I I'

CLINTON-1 3-43 Rev.17-12/98 I

li l IllI l 9

v . l 9 a e y a /

^

o ms n r 2

" in a p

u 1

u to s t

*o i e m l -

M

st d o u L 7 Y '

" eii u c c S 1 R

A D

I #c 1

hhd ttn o

l c

n i l

ir M g . v N

U L"* ! dtc i na o a f

t R

e

/

- D NO a t , , ,

E S dn r r r 0 see e e e M"NT.

O 9 GE T ytu w w w 6 o

EI LS W ocl uif brf P P o

P o

l y

e

te s s s es i i i t het o o o a trn n n n m

" S E nul na i i i i l l l x T e p l l l o O es I I r N wif .I p t y yny p

)

P ey i a Y brd b b o i b.

T ae d dtd s S

( edl e eae i E, knl n ntn T

C auo w wsw o

e N N lor.o g o n E E e bt net i

U D

- tnt l ,

L I haoro oio npn ee F S tecun r s rn E Y m oi F R R naeol . lul hl E A i blesepe n ccec c s

n 8 DN aol rcrer eo S 4 N

eiltanana ki U U r s i n p e pi p at O

Y OM auwa d l 1 E W S

EN l

ectrnsnpneee rdided .lav S N

- 1 A

G K

A L

hxuaaeaiashl T e B w L r L pL u T e 3 R 1 2 3 4 5 O

mR E U

G F

Y A 4 3 4 I R f

1 E M" E 4 F D A R A

U L

/ y T -

P ) , O 3 N

- U O

D E

T E

G N

l N

C R B

E T

I R

T S

E 4

s v

A T Cf /

NS l

/

N I o AI R L D S N S

S P

P /

/ o t

P C l .

C v 1

w i N r

' n

- lv Yr i .

i A, &

e

~ // - /

1

\ - N 4 O T

M N

" o I N L C

l

CPS-ODCM FIGURE 3.3-1 =

MAIN CONDENSER OFF-GAS TREATMENT SYSTEM

,. l

1RDCfROM I IN66Z001A f

=i e I

- f ng a e 0l03 M

-a

, 4 3 rusaamB 3CA0lAA 3CA0 LAB IN6@0MB WNDOW ll mHD012 IHi@00

- :Ho e j a *0RIXfneel g -

J. db OCA0lPA OCAeln g OCA01PB E ICD 01A MANCX2CDSER -R- ,

PRIMARY /SECONhutY 5.

coura m orrExHAust SOTS EXHAUST STACK

Monitors required by Sections 3.9.1 and 3.9.2 1CD01A Main OCA01TA CV IN66B010B 1N66D013 1RIX-PR035 condenser Separator Tank Cooler Charcoal Off-Gas Post A Condenser B Adsorber Treatment PRM 1CA01AA Steam 0CA01TB CV IN66 ZOO 3A IN66D016 HEPA 1RIX-PR041-Jat Air Separator Tank Dessicant Filter Off-Gas Post Ejector A B Dryer A Treatment PRM 1CA01AB Steam IN66D005A IN66 ZOO 3B ORIX-PR001 ORIX-PR003 Jet Air Recombiner A Dessicant HVAC Stack PRM Standby Gas Ejector B Dryer B #1 Treatment PRM OCA01PA IN66D005B IN66B011 Gas ORIX-PR002 ORIX-PR004 Condenser Recombiner B Cooler HVAC Stack PRM Standby Gas Vacuum (CV) #2 Treatment PRM l Pump A OCA01PB CV IN66B010A IN66D012 1RIX-PR034 3 Pump B Cooler Charcoal Off-Gas Condenser A Adsorber Pretreatment CLINTON-1 3-45 Rev.17-12/98 I

I

CPS-ODCM TABLE 3.5-1 INHALATION DOSE FACTORS FOR INFANT - (DFA ) . i V (mrem per pCi inhaled)

)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA- 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 C-14 1.89E-05* 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 NA-24 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 P-32 1.45E-03 8.03E-05 5.53E-05 NO DATA NO DATA NO DATA 1.15E-05 CR-51 NO. DATA NO DATA 6.39E-08 4.11E-08 9.45E-09 9.17E-06 2.55E-07 MN-54 NO DATA 1.81E-05 3.56E-06 NO DATA 3.56E-06 7.14E-04 5.04E-06 MN-56 NO DATA 1.10E-09 1.58E-10 NO DATA 7.86E-10 8.95E-06 5.12E-05 FE-55 1.41E-05 8.39E-06 2.38E-06 NO DATA NO DATA 6.21E-05 7.82E-07 FE-59 9.69E-06 1.68E-05 6.77E-06 NO DATA NO DATA 7.25E-04 1.77E-05 lCO-58 NO DATA 8.71E-07 1.30E-06 NO DATA NO DATA 5.55E-04 7.95E-06 CO-60 No DATA 5.73E-06 8.41E-06 NO DATA NO DATA 3.22E-03 2.28E-05 NI-63 2.42E-04 1.46E-05 8.29E-06 NO DATA NO DATA 1.49E-04 1.73E-06 NI-65 1.71E-09 2.03E-10 8.79E-11 NO DATA NO DATA 5.80E-06 3.58E-05 CU-64 NO DATA 1.34E-09 5.53E-10 *NO DATA 2.84E-09 6.64E-06 1.07E-05 EN-65 1.38E-05 4.47E-05 2.22E-05 NO DATA 2.32E-05 4.62E-04 3.67E-05 ZN-69 3.85E-11 6.91E-11 5.13E-12 NO DATA 2.87E-11 1.05E-06 9.44E-06 ER-83 NO DATA NO DATA 2.72E-07 NO DATA NO DATA NO DATA LT E-24**

BR-84 NO DATA NO DATA 2.86E-07 NO DATA NO DATA NO DATA LT E-24 BR-85 NO DATA NO DATA 1.46E-08 NO DATA NO DATA NO DATA LT E-24 RB-86 NO DATA 1.36E-04 6.30E-05 NO DATA NO DATA NO DATA 2.17E-06 RB-88 NO DATA 3.98E-07 2.05E-07 NO DATA NO DATA NO DATA 2.42E-07 RB-89 NO DATA 2.29E-07 1.47E-07 NO DATA NO DATA NO DATA 4.87E-08 SR-89 2.84E-04 NO DATA 8.15E-06 NO DATA NO DATA 1.45E-03 4.57E-05 T-90 2.92E-02 NO DATA 1.85E-03 NO DATA NO DATA 8.03E-03 9.36E-05

.-91 6.83E-08 NO DATA 2.47E-09 NO DATA NO DATA 3.76E-05 5.24E-05 JSR-92 7.50E-09 NO DATA 2.79E-10 NO DATA- NO DATA 1.70E-05 1.00E-04 Y-90 2.35E-06 NO DATA 6.30E-08 NO DATA NO DATA 1.92E-04 7.43E-05 Y-91u 2.91E-10 NO DATA 9.90E-12 NO DATA NO DATA 1.99E-06 1.68E-06 Y-91 4.20E-04 NO DATA 1.12E-05 NO DATA NO DATA 1.75E-03 5.02E-05 Y-92 1.17E-08 NO DATA 3.29E-10 NO DATA NO DATA 1.75E-05 9.04E-05 Y-93 1.077.-07 NO DATA 2.91E-09 NO DATA NO DATA 5.46E-05 1.19E-04 ZR-95 8.24'-05 1.99E-05 1.45E-05 NO DATA 2.22E-05 1.25E-03 1.55E-05 ZR-97 1.07E-07 1.83E-08 8.36E-09 NO DATA 1.85E-08 7.88E-05 1.00E-04 NB-95 1.12E-05 4.59E-06 2.70E-06 NO DATA 3.37E-06 3.42E-04 9.05E-06 MO-99 NO DATA 1.18E-07 2.31E-08 NO DATA 1.89E-07 9.63E-05 3.48E-05

'TC-99m 9.98E-13 2.06E-12 2.66E-11 NO DATA' 2.22E-11 5.79E-07 1.45E-06 TC-101 4.65E-14 5.88E-14 5.80E-13 NO DATA 6.99E-13 4.17E-07 6.03E-07 RU-103 1.44E-06 NO DATA 4.85E-07 NO DATA 3.03E-06 3.94E-04 1.15E-05 RU-105 8.74E-10 NO DATA 2.93E-10 NO DATA 6.42E-10 1.12E-05 3.46E-05 RU-106 6.20E-05 NO DATA 7.7E-06 NO DATA 7.61E-05 8.26E-03 1.17E-04 AG-110m 7.13E-06 5.16E-06 3.57E-06 NO DATA 7.80E-06 2.62E-03 2.36E-05 TE-125m 3.40E-06 1.42E-06 4.70E-07 1.16E-06 NO DATA 3.19E,01 9.22E-0G TE-127m 1.19E-05 4.93E-06 1.4BE-06 3.48E-06 2.68E-05 9.37E-04 1.95E-05 TE-127 1.59E-09 6.81E-10 3.49E-10 1.32E-09 3.47E-09 7.39E-06 1.74E-05 j

TE-129m 1.01E-05 4.35E-06 1.59E-06 3.91E-06 2.27E-05 1.20E-03 4.93E-05 TE-129 5.63E-11 2.48E-11 1.34E-11 4.82E-11 1.25E-10 2.14E-06 1.88E-05 TE-131m 7.62E-08 3.93E-08 2.59E-08 6.38E-08 1.89E-07 1.42E-04 8.51E-05 ITE-131 1.24E-11 5.87E-12 3.57E-12 1.13E-11 2.85E-11 1.47E-06 5.87E-06 l

l CLINTON-1 3-46 Rev.17-12/98

CPS-ODCM TABLE 3.5-1 (continued)

INHALATION DOSE FACTORS FOR INFANT - (DFAt ) .

(mrem per pCi inhaled) .

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI TE-132 2.66E-07 1.69E-07 1.26E-07 1.99E-07 7.39E-07 2.43E-04 3.15E-05 I-130 4.54E-06 9.91E-06 3.98F.-06 1.14E-03 1.09E-05' NO DATA 1.42E-06 '

I-131 2.71E-05 3.17E-05 1.40E-05 1.06E-02 3.70E-05 NO DATA 7.56E-07 I-132 1.21E-06 2.53E-06 8.99E-07 1.21E-04 2.82E-06 NO DATA 1.3.6E-06 I-133 9.46E-06 1.37E-05 4.00E-06 2.54E-03 1.60E-05 NO DATA 1.54E-06

'I-134 6.58E-07 1.34E-06 4.75E-07 3.18E-05 1.49E-06 NO DATA 9.21E-07 I-135 2.76E-06 5.43E-06 1.98E-06 4.97E-04 6.05E-06 NO DATA 1.31E-06 CS-134 2.83E-04 5.02E-04 5.32E-05 NO DATA 1.36E-04 5.69E-05 9.53E-07 CS-136 3.45E-05 9.61E-05 3.78E-05 NO DATA 4.03E-05 8.40E-06 1.02E-06 CS-137 3.92E-04 4.37E-04 3.255-05 NO DATA 1.23E-04 5.09E-05 9.53E-07 CS-138 3.61E-07 5.5BE-07 2.84E-07 NO DATA 2.93E-07 4.67E-08 6.26E-07 )

.BA-139 1.06E-09 7.03E-13 3.07E-11 NO DATA 4.23E-13 4.25E-06 3.64E-05 EI BA-140 4.00E-05 4.00E-08 2.07E-06 NO. DATA : 9.59E 1.14E-03 2.74E-05 g BA-141 1.12E-10 7.70E-14 3.55E-12 NO DATA '4.64E-14 2.12E-06 3.39E-06 BA-142 2.84E-11 2.36E-14 1.40E-12 NO DATA 1.36E-14 1.11E-06 4.95E-07 l I

LA-140 3.61E-07 1.43E-07 3.68E-08 NO DATA NO DATA 1.20E-04 6.06E-05 LA-142 7.36E-10 2.69E-10 6.46E-11 NO DATA NO DATA 5.87E-06 4.25E-05 CE-141 1.98E-05 1.19E-05 1.42E-06 NO DATA 3.75E-06 3.69E-04 1.54E-05 CE-143 2.09E-07 1.38E-07 1.58E-08 NO DATA 4.03E-08 8.30E-05 3.55E-05 CE-144 2.28E-03 8.65E-04 1.26E-04 NO DATA 3.84E-04 7.03E-03 1.06E-04 PR-143 1.00E-05 3.74E-06 4.99E-07 NO DATA 1.41E-06 3. 09E-04 2.66E-05 PR-144 3.42E-11 1.32E-11 1.72E-12 NO DATA 4.80E-12 1.15E-06 3.06E-06 ND-147 5.67E-06 5.81E-06 3.57E-07 NO DATA 2.25E-06 2.30E-04 2.23E-05 W-187 9.26E-09 6.44E-09 2.23E-09 NO DATA NO DATA 2. 83E-05 2.54E-05 NP-239 2.65E-07 2.37E-08 1.34E-08 NO DATA 4.73E-08 4.25E-05 1.78E-05 ,

\

1.89 x 10

- Less than 10~8' I

I I

CLINTON-1 3-47 Rev.17-12/98 I

CPS-ODCM TABLE 3.5-2 INHALATION DOSE FACTORS FOR CHILD - (DFA ) . i

/ (mrem per pCi inhaled)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 C-14 9.07E-066 1.02E-06 1.82E-06 1.82E-06 1.02E-06 1.82E-06 1.82E-06 NA-24 4.35E-06 4.35E-06 '4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 P-32 7.04E-04 3.09E-05 2. 67 E-05 NO DATA NO DATA NO DATA 1.14E-05 CR-51 NO DATA NO DATA 4.17E-08 2.31E-08 6.57E-09 4.59E-06 2.93E-07 HN-54 NO DATA 1.16E-05 2.57E-06 NO DATA 2.71E-06 4.26E-04 6.19E-06 MN-56 NO DATA 4.48E-10 8.43E-11 NO DATA 4.52E-10 3.55E-06 3.33E-05 FE-55 1.28E-05 6.80E-06 2.10E-06 NO DATA NO DATA 3.00E-05 7.75E-07 FE-59 5.59E-06 9.04E-06 4.51E 06 NO DATA NO DATA 3.43E-04 1.91E-05 iCO-58 NO DATA 4.79E-07 8.55E-07 NO DATA NO DATA 2.99E-04 9.29E-06 CO-60 NO DATA 3.55E-06 6.12E NO DATA NO DATA 1.91E-03 2.60E-05 NI-63 2.22E-04 1.25E-05 7.56E-06 NO DATA NO DATA 7.43E-05 1.71E-06 NI-65 8.08E-10 7.99E-11 4.44E-11 NO DATA - NO DATA 2.21E-06 2.27E-05 CU-64 NO DATA 5'.39E-10 2.90E-10 NO DATA 1.63E-09 2.59E-06 9.92E-06 EN-65 1.15E-05 3.06E-05 1.90E-05 NO DATA 1.93E-05 2.69E-04 4.41E-06 ZN-69 1.81E-11 2.61E-11 2.41E-12 NO DATA 1.58E-11 3.84E-07 2.75E-06 IR-83 NO DATA No DATA 1.28E-07 NO DATA NO DATA NO DATA LT E-24**

TR-84 NO DATA NO DATA 1.48E-07 NO DATA NO DATA NO DATA LT E-24 BR-85 NO DATA NO DATA 6.84E-09 HO DATA NO DATA NO DATA LT E-24 RB-86 NO DATA 5.36E-05 3.09E-05 NO DATA NO DATA NO DATA 2.16E-06 RB-88 NO DATA 1.52E-07 9.90E-08 NO DATA NO DATA NO DATA 4.66E-09 RB-89 NO DATA 9.33E-08 7.83E-08 NO DATA NO DATA NO DATA 5.11E-10 SR-89 1.62E-04 NO DATA 4.66E-06 NO DATA NO DATA 5.83E-04 4.52E-05

't-9 0 2.73E-02 NO DATA 1.74E-03 NO DATA NO DATA 3.99E-03 9.28E-05 t-91 3.28E-08 NO DATA 1.24E-09 NO DATA NO DATA 1.44E-05 4.70E-05 R-92 3.54E-09 NO DATA 1.42E-10 NO DATA NO DATA 6.49E-06 6.55E-05

[Y-90 1.11E-06 NO DATA 2.99E-08 NO DATA NO DATA 7.07E-05 7.24E-05 Y-91m 1.37E-10 NO DATA 4.98E-12 NO DATA NO DATA 7.60E-07 4.64E-07 Y-91 2.47E-04 NO DATA 6.59E-06 NO DATA NO DATA 7.10E-04 4.97E-05 Y-92 5.50E-09 NO DATA 1.57E-10 NO DATA NO DATA 6.46E-06 6.46E-05 Y-93 5.04E-08 NO DATA 1.38E-09 NO DATA N0 DATA 2.01E-05 1.05E-04 ZR-95 5.13E-05 1.13E-05 1.00E-05 NO DATA 1.61E-05 6.03E-04 1.65E-05 ZR-97 5.07E-08 7.34E-09 4.32E-09 NO DATA 1.05E-08 3.06E-05 9.49E-05 NB-95 6.35E-06 2.48E-06 1.77E-06 NO DATA 2.33E-06 1.66E-04 1.00E-05 HO-99 NO DATA 4.66E-08 1.15E-08 NO DATA 1.06E-07 3.66E-05 3.42E-05 1

TC-99m 4.81E-13 9.41E-13 1.56E-11 NO DATA 1.37E-11 2.57E-07 1.30E-06 TC-101 2.19E-14 2.30E-14 2.91E-13 NO DATA 3.92E-13 1.58E-07 4.41E-09 RU-103 7.55E-07 NO DATA 2.90E-07 NO DATA 1.90E-06 1.79E-04 1.21E-05 RU-105 4.13E-10 NO DATA 1.50E-10 NO DATA 3.63E-10 4.30E-06 2.69E-05 RU-106 3.68E-05 NO DATA 4.57E-06 NO DATA 4.97E-05 3.87E-03 1.16E-04 AG-110m 4.56E-06 3.08E-06 2.47E-06 NO DATA 5.74E-06 1.48E-03 2.71E-05 TE-125m 1.82E-06 6.29E-07 2.47E-07 5.20E-07 NO DATA 1.29E-04 9.13E-06 TE-127m 6.72E-06 2.31E-06 8.18E-07 1.64E-06 1.72E-05 4.00E-04 1.93E-05 TE-127 7.49E-10 2.57E-10 1.65E-10 5.30E-10 1.91E-09 2.71E-06 1.52E-05 TE-129m 5.19E-06 1.85E-06 8.22E-07 1.71E-06 1.36E-05 4.76E-04 4.91E-05 TE-129 2.64E-11 9.45E-12 6.44E-12 1.93E-11 6.94E-11 7.93E-07 6.89E-06 TE-131m 3.63E-08 1.60E-08 1.37E-08 2.64E-08 1.08E-07 5.56E-05 8. 32 E-05 TE-131 5.87E-12 2.28E-12 1.78E-12 4.59E-12 1.59E-11 5.55E-07 3.60E-07 l

{

l l J

CLINTON-1 3-48 Rev.17-12/98 '

CPS-ODCM TABLE 3.5-2 (continued) "N INHALATION DOSE FACTORS FOR CHILD - (DFAi ) . l (mrem per pCi inhaled) E

~~

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI TE-132 1.30E-07 7.36E-00 7.12E-08 8.58E-08 4.79E-07 1.02E-04 3.72E-05 I-130 2.21E-06 4.43E-06 2.28E-06' 4.99E-04 6.61E-06 NO DATA 1.38E-06 I-131 1.30E-05 1.30E-05 7.37E-06 4.39E-03 2.13E-05 NO DATA' 7.68E-07 I-132 5.72E-07 1.10E-06 5.07E-07 5.23E-05 1.69E-06 NO DATA 8.65E-07 E I-133 4.48E-06 5.49E-06' 2.08E-06 1.04E-03 9.13E-06 NO DATA 1.48E-06 g I-134 3.17E-07 5.84E-Ja 2.69E-07 1.37E-05 8.92E-07 NO DATA 2.58E-07 I-135 1.33E-06 2.36E-06 1.12E-06 2.14E-04 3.62E-06 NO DATA 1.20E-06 CS-134 1.76E-04 2.74E-04 6.07E-05 NO DATA 8.93E-05 3.27E-05 1.04E-06 CS-136 1.76E-05 4.62E-05 3.14E-05 NO DATA 2.58E-05 3.93E-06 1.13E-06 CS-137 2.45E-04 2.23E-04 3.47E-05 NO DATA 7.63E-05 2.81E-05 9.78E-07 ;

CS-138 1.71E-07 2.27E-07 1.50E NO DATA 1.68E-07 1.84E-08 7.29E-08 !

BA-139 4.98E-10 2.66E-13 1.45E-11 NO DATA 2.33E-13 1.56E-06 1.56E-05 BA-140 2.00E-05 1.75E-08 1.17E-06 NO DATA 5.71E-09 4.71E-04 2.75E-05 BA-141 5.29E.11 2.95E-14 1.72E-12 NO DATA 2.56E-14 7.89E-07 7.44E-08 )

BA-142 1.35E-11 9.73E-15 7.54E-13 NO DATA 7.87E-15 4.44E-07 7.41E-10 LA-140 1.74E-07 6.08E-08 2.04E-08 NO DATA NO DATA 4.94E-05 6.10E-05

)

i LA-142 3.50E-10 1.11E-10 3.49E-11 NO DATA NO DATA 2.35E-06 2.05E-05 l CE-141 1.06E-05 5.28E-06 7.83E-07 NO DATA 2.31E-06 1.47E-04 1.53E-05 CE-143 9.89E-08 1.83E-03 5.37E-08 7.77E-09 NO DATA 2.26E-08 3.12E-05 3.44E-05 g CE-144 5.72E-04 9.77E-05 NO DATA 3.17E-04 3.23E-03 1.05E-04 g PR-143 4.99E-06 1.50E-06 2.47E-07 NO DATA 8.11E-07 1.17E-04 2.63E-05 PR-144 1.61E-11 4.99E-12 8.10E-13 NO DATA 2.64E-12 4.23E-07 5.32E-08 ND-147 2.92E-06 2.36E-06 1.84E-07 NO DATA 1.30E-06 8.87E-05 2.22E-05 l Wr187 4.41E-09 2.61E-09 1.17E-09 NO DATA NO DATA 1.11E-05 2.46E-05 E NP-239 1.26E-07 9.04E-09 6.35E-09 NO DATA 2.63E-08 1.57E-05 1.73E-05 9

0 9. 7 0 x 10" -

00Less than 10-24

-I I

l Il Il l l

Il Il I'

CLINTON-1 3-49 Rev.17-12/98 I

1 l

ICPS-ODCM J I

TABLE 3.5-3 INHALATION DOSE FACTORS FOR TEEN - (DFA ) . i (mrem per pCi inhaled)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 C-14 3.25E-06* 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 RA-24 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 2 2.36E-04 1.37E-05' 8.95E-06 NO DATA NO DATA- NO DATA 1.16E-05 CR-51 NO DATA NO DATA 1.69E-08 9.37E-09 3.84E-09 2.62E-06 3.75E-07 EMN-54 NO DATA $39E-06 1.05E-06 NO DATA 1.59E-06 2.48E-04 8.35E-06 EMN-56 NO DATA 2.12E-10 3.15E-11 NO DATA 2.24E-10 1.90E-06 7.18E-06 FE-55 4.18E-06 2.98E-06 6.93E-07 NO DATA NO DATA 1.55E-05 7.99E-07

_FE-59 1.99E-06 4.62E-06 1.79E-06 NO DATA NO DATA 1.91E-04 2.23E-05 NO DATA 2.59E-07 3.47E-07 HO DATA NO DATA 1.68E-04 1.19E-05 BCO-58 CO-60 NO DATA 1.89E-06 2.48E-06 NO DATA NO DATA 1.09E-03 3.24E-05 NI-63 7.25E-05 5.43E-06 2.47E-06 NO DATA NO DATA 3.84E-05 1.77E-06

NI-65 2.73E-10 3.66E-11 1.59E-11 NO DATA NO DATA 1.17E-06 4.59E-06 NO DATA 2.54E-10 1.06E-10 NO DATA 7.68E-06 ICU-64 ZN-65 4.82E-06 1.67E-05 7.80E-06 NO DATA 8.01E-10 1.08E-05 1.39E-06 1.55E-04 5.83E-06 ZN-69 6.04E-12 1.15E-11 0.07E-13 NO DATA 7.53E-12 1.98E-07 3.56E-08 NO DATA NO DATA 4.30E-08 NO DATA NO DATA NO DATA LT E-24**

IBR-83 BR-84 NO DATA NO DATA 5.41E-08 NO DATA NO DATA. NO DATA LT E-24 BR-85 NO DATA NO DATA 2.29E-09 NO DATA NO DATA NO' DATA LT E-24 RB-86 NO DATA 2.38E-05 1.05E-05 NO DATA NO DATA NO DATA 2.21E-06 ERB-88 NO DATA 6.82E-08 3.40E-08 NO DATA NO DATA NO DATA 3.65E-15 ERB-89 NO DATA 4.40E-08 2.91E-08 NO DATA NO DATA NO DATA 4.22E-17 SR-89 5.43E-05 NO DATA 1.56E-06 NO DATA NO DATA 3.02E-04 4.64E-05

~ ~ ~'- 9 0 1.35E-02 NO DATA 8.35E-04 NO DATA NO DATA 2.06E-03 9.56E-05 91 1.10E-0C NO DATA 4.39E-10 NO DATA NO DATA 7.59E-06 3.24E-05 d-92 1.19E-09 NO DATA 5.08E-11 NO DATA NO DATA 3.43E-06 1.49E-05

-90 3.73E-07 NO DATA 1.00E-08 NO DATA NO DATA 3.66E-05 6.99E-05 Y-91m 4.63E-11 NO DATA 1.77E-12 NO DATA NO DATA 4.00E-07 3.77E-09 8.26E-05 NO DATA 2.21E-06 NO DATA 3.67E-04 IY-91Y-92 1.84E-09 NO DATA 5.36E-11 NO DATA NO DATA NO DATA 3.35E-06 5.11E-05 2.06E-05 Y-93 1.69E-08 NO DATA 4.65E-10 NO DATA NO DATA 1.04E-05 7.24E-05 ZR-95 1.82E-05 5.73E-06 3.94E-06 NO DATA 8.42E-06 3.36E-04 1.86E-05 ZR-97 1.72E-08 3.40E-09 1.57E-09 NO DATA 5.15E-09 1.62E-05 7.88E-05 NB-95' 2.32E-06 1.29E-06 7.08E-07 NO DATA 1.25E-06 9.39E-05 1.21E-05 MO-99 NO DATA 2.11E-08 4 . 03 E-09 NO DATA 5.14E-08 1.92E-05 3.36E-05 TC-99m 1.73E-13 4.83E-13 6.24E-12 NO DATA 7.20E-12 1.44E-07 7.66E-07 TC-101 7.40E-15 1.05E-14 1.03E-13 NO DATA 1.90E-13 8.34E-08 1.09E-16 RU-103 2.63E-07 NO DATA 1.12E-07 NO DATA 9.29E-07 9.79E-05 1.36E-05

_ RU-105 1.40E-10 NO DATA 5.42E-11 NO DATA 1.76E-10 2.27E-06 1.13E-05 RU-106 1.23E-05 NO DATA 1.55E-06 NO DATA 2.38E-05 2.01E-03 1.20E-04 EAG-110m1.73E-06 1.64E-06 9.99E-07 NO DATA 3.13E-06 8.44E-04 3.41E-05 fTE-125m 6.10E-07 2.80E-07 8.34E-08 1.75E-07 NO DATA 6.70E-05 9.38E-06 TE-127m 2.25E-06 1.02E-06 2.73E-07 5.48E-07 8.17E-06 2.07E-04 1.99E-05 E-127 2.51E-10 1.14E-10 5.52E-11 1.77E-10 9.10E-10 1.40E-06 1.01E-05

E-129m 1.74E-06 8.23E-07 2.81E-07 5.72E-07 6.49E-06 2.47E-04 5.06E-05

! TE-129 8.87E-12 4.22E-12 2.20E-12 6.48E-12 3.32E-11 4.12E-07 2.02E-07 E-131m- 1.23E-08 '7.51E-09 5.03E-09 9.06E-09 5.49E-00 2.97E-05 7.76E-05 E-131 1.97E-12 1.04E-12 6.30E-13 1.55E-12 7.72E-12 2.92E-07 1.89E-09 I~

LINTON-1 3-50 Rev.17-12/98

~

. CPS-ODCM TABLE 3.5-3 (continued)

INHALATION DOSE FACTORS FOR TEEN - ( DF7.i ) ,

(mrem per pCi inhaled)

BONE LIVER T. BODY ' THYROID KIDNEY LUNG GI-LLI NUCLIDE

-TE-132 4.50E-08 3.63E-08 2.74E-08 3.07E-00 2.44E-07 5.61E-05 5.79E-05 I-130 7.80E-07 2.24E-06 8.96E-07 1.86E-04 3.44E-06 NO DATA 1.14E-06 I-131 4.43E-06 6.14E-06 3.30E-06 1.83E-03 1.05E-05 NO DATA 8.11E-07 I-132 1.99E-07 5.47E-07 1.97E-07 1.89E-05 8.65E-07 NO DATA 1.59E-07 I-133 1.52E-06 2.56E-06 7.78E-07 3.65E-04 4.49E-06 NO DATA 1.29E-06 I-134 1.11E-07 2.90E-07 1.05E-07 4.94E-06 4.58E-07 NO DATA 2.55E-09 I-135 4.62E-07 1.18E-06 4.36E-07 7.76E-05 1.86E-06 NO DATA 8.69E-07 CS-134- 6. 2 8 E-05 1.41E-04 6.85E-05 NO DATA 4.69E-05 1.83E-05 1.22E-06 CS-136 6.44E-06 2.42E-05 1.71E-05 NO DATA 1.38E-05 2.22E-06 1.36E-06 CS-137 8.3SE-05 1.06E-04 3.89E-05 NO DATA 3.80E-05 1.51E-05 1.06E-06 CS-138 5.82E-08 1.07E-07 5.58E-08 NO DATA 8.28E-08 9.84E-09 3.38E-11 BA-139 1.67E-10 1.18E-13 4.87E-12 NO DATA 1.11E-13 8.08E-07 8.06E-07 i BA-140 6.84E-06 8.38E-09 4.40E-07 NO DATA ,2.85E-09 2.54E-04 2.86E-05 BA-141 1.78E-11 1.32E-14 5.93E-13 NO DATA 1.23E-14 4.11E-07 9.33E-14 BA-142 4.62E-12 4.63E-15 2.84E-13 NO DATA 3.92E-15 2.39E-07 5.99E-20 LA-140 5.99E-08 2.95E-08 7.825-09 NO DATA NO DATA 2.68E-05 6.09E-05 l LA-142 1.20E-10 5.31E-11 1.32E-11 NO DATA NO DATA 1.27E-06 1.50E-06 CE-141 3.55E-06 2.37E-06 2.71E-07 NO DATA 1.11E-06 7.67E-05 1.58E-05 CE-143 3.32E-08 2.42E-08 2.70E-09 NO DATA 1.08E-08 1.63E-05 3.19E-05 CE-144 6.11E-04 2.53E-04 3.28E-05 NO DATA 1.51E-04 1.67E-03 1.00E-04 PR-143 1.67E-06 6.64E-07 8.28E-08 NO DATA 3.86E-07 6.04E-05 2.67E-05 PR-144 5.37E-12 2.20E-12 2.72E-13 NO DATA 1.26E-12 2.19E-07 2.94E-14 ND-147 9.83E-07 1.07E-06 6.41E-08 NO DATA 6. 28 E-07 4.65E-05 .2. 2 8 E-05 W-187 1.50E-09 1.22E-09 4.29E-10 NO DATA NO DATA 5.92E-06 2.21E-05 NP-239 4.23E-08 3.99E-09 2.21E-09 NO DATA 1.25E-08 8.11E-06 1.65E-05

3. 52 x 10~'~

~**Less than 10~**

I I

I CLINTON-1 3-51 Rev.17-12/98 I

CPS-ODCM TABLE 3.5-4 INHALATION DOSE FACTORS FOR ADULT - (DFA ) . t (mrem per pCi inhaled)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 C-14 2.27E-06* 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 NA-24 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 P-32 1.65E-04 9.64E-06 6.26E-06 NO DATA NO DATA NO DATA 1.08E-05 CR-51 NO DATA NO DATA 1.25E-08 7.44E-09 2.85E-09 1.80E-06 4.15E-07 MN-54 NO DATA 4.95E-06 7.87E-07 NO DATA 1.23E-06 1.75E-04 9.67E-06 MN-56 NO DATA 1.55E-10 2.29E-11 NO DATA 1.63E-10 1.18E-06 2.53E-06 FE-55 3.07E-06 2.12E-06 4.93E-07 NO DATA NO DATA 9.01E-06 7.54E-07' l FE-59 ~ 1.47E-06 3.47E-06 1.32E-06 NO DATA NO DATA 1.27E-04 2.35E-05 l CO-58 NO DATA 1. 98 E--07 2.59E-07 NO DATA NO DATA 1.16E-04 1.33E-05 '

CO-60. NO DATA 1.44E-06 1.85E-06 NO DATA NO DATA 7.46E-04 3.56E-05 NI-63 5.40E-05 3.93E-06 1.81E-06 NO DATA NO DATA 2.23E-05 1.67E-06 NI-65 1.92E-10 2.62E-11 1.14E-11 NO DATA NO DATA 7.00E-07 1.54E-06 CU-64 NO DATA 1.83E-10 7.69E-11 NO DATA 5.78E-10 8.48E-07 6.12E-06 ZN-65 4.05E-06 1.29E-05 5.82E-06 NO DATA 8.62E-06 1.08E-04 6.68E-06 ZN-69 4.23E-12 8.14E-12 5.65E-13 NO DATA 5.27E-12 1.15E-07 2.04E09 )

IR-83~ NO DATA NO DATA 3.01E-08 NO DATA NO DATA NO DATA 2.90E-08 -

BR-84 NO DATA NO DATA 3.91E-08 NO DATA NO DATA NO DATA 2.05E-13 ZR-85 NO DATA NO DATA 1.60E-09 NO DATA NO DATA NO DATA LT E-24**

RB-86 NO DATA 1.69E-05 7.37E-06 NO DATA' NO DATA NO DATA 2.00E-06 RB-88 NO DATA 4.84E-08 2.41E-08 NO DATA NO DATA NO DATA 4.18E-19 RB NO DATA 3.20E-08 2.12E-08 NO DATA NO DATA NO DATA 1.16E-21 SR-89 3.80E-05 NO DATA 1.09E-06 NO DATA NO DATA 1.75E-04 4.37E-05 9R-90 1.24E-02 NO DATA 7.62E-04 NO DATA NO DATA 1.20E-03 9.02E-05

-91 7.74E-09 NO DATA 3.13E-10 NO DATA NO DATA 4.56E-06 2.39E-05 A-92 8.43E-10 NO DATA 3.64E-11 NO DATA NO DATA 2.06E-06 5.38E-06 k-90 2.61E-07 NO DATA 7.01E-09 NO DATA -NO DATA 2.12E-05 6.32E-05 Y-91::n 3.26E-11 NO DATA 1.27E-12 NO DATA NO DATA 2.40E-07 1.66E-10 Y-91 5.78E-05 NO DATA 1.55E-06 NO DATA NO DATA 2.13E-04 4.81E-05 Y-92 1.29E-09 NO DATA 3.77E-11 NO DATA NO DATA 1.96E-06 9.19E-06 Y-93 1.18 E- 08 NO DATA 3.26E-10 NO DATA NO DATA 6.06E-06 5.27E-05 i ZR 1.34E-05 .4.30E-06 2.91E-06 NO DATA 6.77E-06 2.21E-04 1.88E-05 l ZR-97 1.21E-08 2.45E-09 1.13E-09 NO DATA 3.71E-09 9.84E-06 6.54E-05 l NB-95 1.76E-06 9.77E-07 5.26E-07 NO DATA 9.67E-07 6.31E-05 1.30E-05 MO-99. NO DATA 1.51E-08 2.87E-09 NO DATA 3.64E-08 1.14E-05 3.10E-05 TC-99m 1.29E-13 3.64E-13 4.63E-12 NO DATA 5.52E-12 9.55E-08 5.20E-07 TC-101 5.22E-15 7.52E-15 7.38E-14 NO DATA 1.35E-13 4.99E-08 1.36E-21 RU-103- 1.91E-07 NO DATA 8.23E-08 NO DATA 7.29E-07 6.31E-05 1.38E-05 RU-105 9.88E-11 NO DATA 3.89E-11 NO DATA 1.27E-10 1.37E-06 6.02E-06 RU-106 8.64E-06 NO DATA 1.09E-06 NO DATA 1.67E-05 1.17E-03 1.14E-04 AG-110m 1.35E-06 1.25E-06 7.43E-07 NO DATA 2.46E-06 5.79E-04 3.78E-05 TE-125m 4.27E-07 1.98E-07 5.84E 1.31E-07 1.55E-06 3.92E-05 8.83E-06 TE-127m 1.58E-06 7.21E-07 1.96E-07 4.11E-07 5. 72 E- 06 1.20E-04 1.87E-05 TE-127 1.75E-10 8.03E-11 3.87E-11 1.32E-10 6.37E-10 8.14E-07 7.17E-06 TE-129m 1.22E-06 5.84E-07 1.98E-07 4.30E-07 4.57E-06 1.45E-04 4.79E-05 TE-129 6.22E-12 2.99E-12 1.55E-12 4.87E-12 2.34E-11 2.42E-07 1.96E-08 TE-131m 8.74E-09 5.45E-09 3.63E-09 6.88E-09 3.86E-08 1.82E-05 6.95E-05 TE-131 1.39E-12 7.44E-13 4.49E-13 1.17E-12 5.46E-12 1.74E-07 2.30E-09 CLINTON-1 3-52 Rev.17-12/98

r CPS-ODCM-TADLE 3.5-4 (continued)

INHALATION DOSE FACTORS FOR ADULT - (DFA ), i (mrem per pCi inhaled)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI TE-132 3.2SE-08 2.69E-08 2.02E-08 2.37E-08 1.82E-07 3.60E-05 6.37E-05 g I-130 5.72E-07 1.68E-06 6.60E-07 1.42E-04 2.61E-06 NO DATA 9.61E-07 g I-131 3.15E-06 4.47E-06 2.56E-06 1.49E-03 7.56E-06 NO DATA 7.85E-07 I-132 1. 45E-07 4.07E-07 1.45E-07 1.43E-05 6. 4 8 E-07 NO DATA 5.08E-08 I-133 1.08E-06 1.85E-06 5.65E-07 2.69E-04 3.23E-06 NO DATA 1.11E-06 l I-134 8.05E-08 2.16E-07 7.69E-08 3.73E-06 3. 4 4 E-07 NO DATA 1.26E-10 W I-135 3.35E-07 8.73E-07 3.21E-07 5.60E-05 1.39E-06 NO DATA 6.56E-07 CS-134 4.66E-05 1.06E-04 9.10E-05 NO DATA 3.59E-05 1.22E-05 1.30E-06 CS-136 4.88E-06 1.83E-05 1.38E-05 NO DATA 1.07E-05 1.50E-06 1.46E-06 CS-137 5.98E-05 7.76E-05 5.35E-05 NO DATA 2.78E-05 9.40E-06 1.05E-06 )

CS-138 4.14E-08 7.76E-08 4.05E-08 NO DATA 6.00E-08 6.07E-09 2.33E-13 J BA-139 1.17E-10 8.32E-14 3.42E-12 NO DATA 7.78E-14 4.70E-07 1.12E-07 g l BA-140 4.88E-06 .6.13E-09 3.21E-07 NO DATA 2.095-09 1.59E-04 2.42E-07 2.73E-05 1.45E-17 gI BA-141 1.25E-11 9.41E-15 4.20E-13 NO DATA 8.75E-15 BA-142 3.29E-12 3.38E-15 2.07E-13 NO DATA 2.86E-15 1.49E-07 1.96E-26 LA-140 4.30E-08 2.17E-08 5.73E-09 NO DATA NO DATA 1.70E-05 5.73E-05 g IA-142 8.54E-11 3.88E-11 9.65E-12 NO DATA NO DATA 7.91E-07 2.64E-07 E CE-141 2.49E-06 1.69E-06 1.91E-07 NO DATA 7.83E-07 4.52E-05 1.50E-05 CE-143 2.33E-08 1.72E-08 1.91E-09 NO DATA 7.60E-09 9.97E,06 2.835-05 CE-144 4.29E-04 1.79E-04 2.30E-05 NO DATA 1.06E-04 9.72E-04 1.02E-04 l PR-143 1.17E-06 4.69E-07 5.80E-08 NO DATA 2.70E-07 3.51E-05 2.50E-05 5 PR-144 3.76E-12 1.56E-12 1.91E-13 NO DATA 8.81E-13 1.27E-07 2.69E-18 ND-147 6.59E-07 7.62E-07 4.56E-08 NO DATA 4.45E-07 2.76E-05 2.16E-05 C-187 1.06E-09 8.85E-10 3.10E-10 NO DATA NO DATA 3.63E-06 1.94E-05 NP-239 2.87E-08 2.82E-09 1.55E-09 NO DATA 8.75E-09 4.70E-06 1.49E-05

2.27 x 10*

- Less than 10-**

I g,

l I

I CLINTON-1 3-53 Rev.17-12/98 Il !

Il, L J

PS-ODCM TABLE 3.5-5 GROUND PLANE DOSE FACTORS - DFG i (mrem /hr per pCi/m*)

LEMENT TOTAL BODY SKIN

-3 0.0 0.0

-14 0.0 0.0

'a-24 2.50E-08* 2.90E-08

'-32 0.0 0.0

r-51 2.20E-10 2.60E-10 in-54 5.80E-09 6.80E-09 h-56 1.10E-08 1.30E-08

'e-55 0.0 0.0

'e-59 8.00E-09 9.40E-09 .

o-58 7.00E-09 8.20E-09

o-60 1.70E-08 2.00E-08 fi-63 0.0 0.0 li-65 3.70E-09 4.30E-09 lu-64 1.50E-09 1.70E-09

,n-65 4.00E-09 4.60E-09 n-69 0.0 0.0 r-83 6.40E-11 9.30E-11

r-84 1.20E-08 1.40E-08

'r-85 0.0 0.0 5-86 6.30E-10 7.20E-10 o-88 3.50E-09 4.00E-09 b-89 1.50E-08 1.80E-08 r-89 5.60E-13 6.50E-13 r-91 7.10E-09 8.30E-09 r-92 9.00E-09 1.00E-08 90 2.20E-12 2.60E-12 91m 3.80E-09 4.40E-09

-91 2.40E-11 2.70E-11

-92 1.60E-09 1.90E-09 93 5.70E-10 7.80E-10 r-95 5.00E-09 5.80E-09 r-97 5.50E-09 6.40E-09 b-95 5.10E-09 6.00E-09

@-99 1.90E-09 2.20E-09 c-99m 9.60E-10 1.10E-09 c-101 2.70E-09 3.00E-09 u-103 3.60E-09 4.20E-09 u-105 4.50E-09 5.10E-09 u-106 1.50E-09 1.80E-09 g-110m 1.80E-08 2.10E-08 l

l LINTON-1 3-54 Rev.17-12/98

CPS-OL 24 g

TABLE 3.5-5 (Continued) E GROUND PLANE DOSE FACTORS - DFGi '

(mrem /hr per pCi/m*) -

ELEMENT TOTAL BODY SKIN -

Ta-125m 3.50E-11 4.80E-11 Ta-127m 1.10E-12 1.30E-12 Ts-127 1.00E-11 1.10E-11 g Ts-129m 7.70E-10 9.00E-10 m Tc-129 7.10E-10 8.40E-10 Ts-131m 8.40E-09 9.90E-09 Tc-131 2.20E-09 2.60E-06 '

Ta-132 1.70E-09 2.00E-09 I-130 1.40E-08 1.70E-08 I-131 2.80E-09 3.40E-09 I-132 1.70E-08 2.00E-08 I-133 . 3.70E-09 4.50E-09 I-134 1.60E-08 1.90E-08 I-135 1.20E-08 1.40E-08 Cs-134 1.20E-08 1.40E-08 Cs-136 1.50E-08 1.70E-08 Cs-137 4.20E-09 4.90E-09 Cs-138 2.10E-08 2.40E-08 Ba"139 2.40E-09 2.70E-09 g Ba-140 2.10E-09 2.40E-09 3

Ba-141 4.30E-09 4.90E-09 Ba-142 7.90E-09 9.00E-09 Ln-140- ,1.50E-08 1.70E-08 La-142 1.50E-08 1.80E-08 Co-141 5.50E-10 6.20E-10 Ce-143 2.20E-09 2.50E-09 Ce-144 3.20E-10 3.70E-10 Pr-143 0.0 0.0 Pr-144 2.00E-10 2.30E-10 Nd-147 1.00E-09 1.20E-09 W-187 3.10E-09 3.60E-09 Np-239 9.50E-10 1.10E-09

2.50 X 10 "

I I

I CLINTON-1 3-55 Rev.17-12/98 I.

PS-ODCl4 TABLE 3.5-6 INGESTION DOSE FACTORS FOR INFANT - (DFL ) . i .

(mrem per pCi ingested)

WCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI i-3 NO DATA 3.08E-07 3.08E-07 3.00E-07 3.08E-07 3.08E-07 3.08E-07 C-14 2.37E-05* 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 m-24 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 P-32 1.70E-03 1.00E-04 6.59E-05 NO DATA NO DATA NO DATA 2.30E-05 CR-51 NO DATA NO DATA 1.41E-08 9.20E-09 2.01E-09 1.79E-08 4.11E-07 KN-54 NO DATA 1.99E-05 4.51E-06 NO DATA 4.41E-06 NO DATA 7.31E-06 HN-56 NO DATA 8.18E-07 1.41E-07 NO DATA 7.03-07 NO DATA 7.43E-05 FE-55 1.39E-05 8.98E-06 2.40E-06 NO DATA NO DATA 4.39E-06 1.14E-06 FE-59 3.08E-05 5.38E-05 2.12E-05 NO DATA NO DATA 1.59E-05 2.57E-05 CO-58 NO DATA 3.60E-06 8.98E-06 NO DATA NO DATA NO DATA 8.97E-06 CO-60 NO DATA 1.08E-05 2.55E-05 NO DATA NO DATA NO DATA 2.57E-05 NI-63 6.34E-04 3.92E-05 2.20E-05 NO DATA NO DATA NO DATA 1.95E-06 MI-65 4.70E-06 5.32E-07 2.42E-07 NO DATA NO DATA NO DATA 4.05E-05 CU-64 NO DATA 6.09E-07 2.82E-07 NO DATA 1.03E-06 NO-DATA 1.25E-05 ZN-65 1.84E-05 6.31E-05 2.91E-05 NO DATA 3.06E-05 NO DATA 5.33E-05 ZN-69 9.33E-08 1.68E-07 1.25E-08 NO DATA 6.98E-08 NO DATA 1.37E-05 BR-83 NO DATA NO DATA 3.63E-07 NO DATA NO DATA NO DATA LT E-24**

BR-84 NO DATA NO DATA 3.82E-07 NO DATA NO DATA NO DATA LT E-24 BR-85 NO DATA NO DATA 1.94E-08 NO DATA NO DATA NO DATA LT E-24 RB-86 NO DATA 1.70E-04 8.40E-05 NO DATA NO DATA NO DATA 4.34E-06 RB-88 NO DATA 4.98E-07 2.73E-07 NO DATA NO DATA NO DATA 4.85E-07 RB-89 NO DATA 2.86E-07 1.97E-07 NO DATA NO DATA NO DATA 9.74E-08 SR-89 2.51E-03 NO DATA 7.20E-05 NO DATA NO DATA NO DATA 5.16E-05 9R-90 1.85E-02 NO DATA 4.71E-03 NO DATA NO DATA NO DATA 2.31E-04 1-91 5.00E-05 NO DATA 1.81E-06 NO DATA NO DATA NO DATA 5.92E-05 aR-92 1.92E-05 NO DATA 7.13E-07 NO DATA NO DATA NO DATA 2.07E-04 Y-90 8.69E-08 NO DATA 2.33E-09 NO DATA NO DATA NO DATA 1.20E-04 . .

Y-91m 8.10E-10 NO DATA 2.76E-11 NO DATA NO DATA NO DATA 2.70E-06 Y-91 1.13E-06 NO DATA 3.01E-08 NO DATA NO DATA NO DATA 8.10E-05 Y-92 7.65E-09 NO DATA 2.15E-10 NO DATA NO DATA NO DATA 1.46E-04 Y-93 2.43E-08 NO DATA 6.62E-10 NO DATA NO DATA NO DATA 1.92E-04 ZR-95 2.06E-07 5.02E-08 3.56E-08 NO DATA 5.41E-08 NO DATA 2.50E-05 ZR-97 1.48E-08 2.54E-09 1.16E-09 NO DATA 2.56E-09 NO DATA 1.62E-04 NB-95 4.20E-08 1.73E-08 1.00E-08 NO DATA 1.24E-08 NO DATA 1.46E-05 KO-99 NO DATA 3.40E-05 6.63E-06 NO DATA 5.08E-05 NO DATA 1.12E-05 ,

TC-99m 1.92E-09 3.96E-09 5.10E-08 NO DATA 4.26E-08 2.07E-09 1.15E-06 TC-101 2.27E-09 2.86E-09 2.83E-08 H0 DATA 3.40E-08 1.56E-09 4.86E-07 RU-103 1.48E-06 NO DATA 4.95E-07 NO DATA 3.08E-06 NO DATA 1.80E-05 RU-105 1.36E-07 NO DATA 4.58E-08 NO DATA 1.00E-06 NO DATA 5.41E-05 RU-106 2.41E-05 NO DATA 3.01E-06 NO DATA 2.85E-05 NO DATA 1.83E-04 9.96E-07 NG-110m 7.27E-07 4.81E-07 NO DATA 1.04E-06 NO DATA 3.77E-05 TE-125m 2.33E-05 7.79E-06 3.15E-06 7.84E-06 NO DATA NO DATA 1.11E-05 TE-127m 5. 85 E- 05 1. 94 E-05 7.08E-06 1.69E-05 1.44E-04 NO DATA 2.36E-05 kE-127 1.00E-06 3.35E-07 2.15E-07 8.14E-07 2.44E-06 NO DATA 2.10E-05

$E-129m 1.00E-04 3.43E-05 1.54E-05 3.84E-05 2.50E-04 NO DATA 5.97E-05 fE-129 2.84E-07 9.79E-08 6.63E-08 2.38E-07 7.07E-07 NO DATA 2.27E-05 s RE-131m 1.52E-05 6.12E-06 5.05E-06 1.24E-05 4.21E-05 NO DATA 1.03E-04 IE-131 1.76E-07 6.50E-08 4.94E-08 1.57E-07 4.50E-07 NO DATA 7.11E-06

! 4 .

i

$LINTON-1 3-56 Rev.17-12/98

CPS-ODCM f'

TABLE 3.5~6 (continued _),

INGESTION DOSE FACTORS FOR INFANT - (DFL1 ) .

(mrem per pCi ingested)

NUCLIDE BONE LIVER T.DODY THYROID KIDNEY LUNG GI-LLI TE-132 2.08E-05 1.03E-05 9.61E-06 1.52E-05 6.44E-05 NO DATA 3.81E-05 I-130 6.00E-06 1.32E-05 5.30E-06 1.48E-03 1.45E-05 NO DATA 2.83E-06 I-131 3.59E-05 4.23E-05 1.86E-05 1.39E-02 4.94E-05 NO DATA 1.51E-06 I-132 1.66E-06 3.37E-06 1.20E-06 1.58E-04 3.76E-06 NO DATA 2.73E'06 I-133 1.25E-05 1.82E-05 5.33E-06 3.31E-03 2.14E-05 NO DATA 3.08E-06 I-134 8.69E-07 1.78E-06 6.33E-07 4.15E-05 1.99E-06 NO DATA 1.84E-06 I-135 3.64E-06 7.24E-06 2.64E-06 6.49E-04 8.07E-06 NO DATA 2.62E-06 CS-134 3.77E-04 7.03E-04 7.10E-05 NO DATA 1.81E-04 7.42E-05 1.91E-06 CS-136 4.59E-05 '1.35E-04 5.04E-05 NO DATA 5.38E-05 1.10E-05 2.05E-06 CS-137 5.22E-04 6.11E-04 4.33E-05 NO DATA 1.64E-04 6.64E-05 1.91E-06 CS-138 4.81E-07 7.82E-07 3.79E-07 NO DATA 3.90E-07 6.09E-08 1.25E-06 BA-139 8.81E-07 5.84E-10 2.55E-08 NO DATA 3.51E-10 3.54E-10 5.58E-05 BA-140 1.71E-04 1.71E-07 8.81E-06 NO DATA- 4.06E-08 1.05E-07 4.20E-05 BA-141 4.25E-07 2.91E-10 1.34E-08 NO DATA 1.75E-10 1.77E-10 5.19E-06 BA-142- 1.84E-07 1.53E-10 9.06E-09 NO DATA 8.81E-11 9.26E-11 7.59E-07 IA-140 2.11E 8.32E-09 2.14E-09 NO DATA NO DATA NO DATA 9.77E-05 IA-142 1.10E-09 4.04E-10 9.67E-11 NO DATA NO DATA NO DATA 6.86E-05 CE-141 7.87E-08 4.80E-08 5.65E-09 NO DATA 1.48E-08 NO DATA 2.48E-05 CE-143 1.48E-08 9.82E-06 1.12E-09 NO DATA 2.86E-09 NO DATA 5.73E-05 i CE-144 2.98E-06 1.22E-06 1.67E-07 NO DATA 4.93E-07 NO DATA 1.71E-04 l, '

PR-143 8.13E-08 3.04E-08 4.03E-09 NO DATA 1.13E-08 NO DATA 4.29E-05 3 PR-144 2.74E-10 1.06E-10 1.38E-11 NO DATA 3.84E-11 NO DATA 4.93E-06 ND .147 5.53E-08 5.68E-08 3.48E-09 NO DATA 2.19E-08 NO DATA 3.60E-05 W-187 9.03E-07 6.28E-07 2.17E-07 NO DATA NO DATA NO DATA 3.69E-05 NP-239 1.1',E- 0 8 9.93E-10 5.61E-10 NO DATA 1.90E-09 NO DATA 2.87E-05 ,

2.37 x 10*

*Less than 10-24 I

I I. t l

I CLINTON-1 3-57 Rev.17-12/98 I

PS-ODCM TABLE 3.5-7 1 INGESTION DOSE FACTORS FOR CHILD - (DFLt ) .

(mrem per pCi ingested)

UCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI

-3 NO DATA 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07

-14 1.21E-05* 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 A-24 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06

-32 8.25E-04 3.86E-05 3.18E-05 NO DATA NO DATA NO DATA 2.28E-05 R-51 NO DATA NO DATA. 8.90E-09 4.94E-09 1.35E-09 9.02E-09 4.72E-07 N-54 NO DATA 1.07E-05 2.85E-06 NO DATA 3.00E-06 NO DATA 8.98E-06 N-56 NO DATA 3.34E-07 7.54E-08 NO DATA 4.04E-07 NO DATA 4.84E-05 E-55 1.15E-05 6.10E-06 1.89E-06 NO DATA NO DATA 3.45E-06 1.13E-06 E-59 1.65E-05 2.67E-05 1.33E-05 NO DATA NO DATA 7.74E-06 2.78E-05 O-58 NO DATA 1.80E-06 5.51E-06 NO DATA NO DATA NO DATA 1.05E-05 0-60 NO DATA 5.29E-06 1.56E-05 NO DATA NO DATA NO DATA 2.93E-05

'I-63 5.38E-04 2.88E-05 1.83E-05 NO DATA NO DATA NO DATA 1.94E-06 I-65 2.22E-06 2.09E-07 1.22E-07 NO DATA NO DATA NO DATA -2.56E-05 U-64 NO DATA 2.45E-07 1.48E-07 NO DATA 5.92E-07 -NO DATA 1.15E-05~

N 1.37E-05 3.65E-05 2.27E-05 NO DATA 2.30E-05 NO DATA 6.41E-06 N-69 4.38E-08 6.33E-08 5.85E-09 NO DATA 3.84E-08 NO DATA 3.99E LR-83 NO DATA NO DATA 1.71E-07 NO DATA NO DATA NO DATA LT E-24**

iR-84 NO DATA NO DATA 1.98E-07 NO DATA NO DATA NO DATA LT E-24 iR-85 NO DATA NO DATA 9.12E-09 NO DATA NO DATA NO DATA LT E-24 LB-86 NO DATA 6.70E-05 4.12E-05 NO DATA NO DATA NO DATA 4.31E-06 LB-88 NO DATA 1.90E-07 1.32E-07 NO DATA NO DATA NO DATA 9.32E-09 LB-89 NO DATA 1.17E-07 1.04E-07 NO DATA NO DATA NO DATA 1.02E-09 iR-89 1.32E-03 NO DATA 3.77E-05 NO DATA NO DATA NO DATA 5.11E-05 R-90 l'. 7 0 E- 02 NO DATA 4.31E-03 NO DATA NO DATA NO DATA 2.29E-04 A-91 2.40E-05 NO DATA 9.06E-07 NO DATA NO DATA NO DATA 5.30E-05 lR-92 9.03E-06 NO DATA 3.62E-07 NO DATA NO DATA NO DATA 1.71E-04

'- 90 4.11E-08 NO DATA 1.10E-09 NO DATA NO DATA NO DATA 1.17E-04

'91m-3.82E-10 NO DATA 1.39E-11 NO DATA NO DATA NO DATA 7.48E-07

' 91 6.02E-07 NO DATA 1.61E-08 NO DATA NO DATA. NO DATA 8.02E-05

'- 92 3.60E-09 NO DATA 1.03E-10 NO DATA NO DATA NO DATA 1.04E-04

'- 93 1.14E-08 NO DATA 3.13E-10 NO DATA NO DATA I:0 DATA 1.70E-04

R-95 1.16E-07 2.55E-00 2.27E-08 NO DATA 3.65E-08 NO DATA 2.66E-05

R-97 6.99E-09 1.01E-09 5.96E-10 NO DATA 1.45E-09 NO DATA 1.53E-04 IB-95 2.25E-08 8.76E-09 6.26E-09 NO DATA 8.23E-09 NO DATA 1.62E-05 10 - 9 9 NO DATA 1.33E-05 3.29E-06 NO DATA 2.84E-05 NO DATA 1.10E-05

'C-99m 9.23E-10 1.81E-09 3.00E-08 NO DATA 2. 63E-0 8 9.19E-10 1.03E-06

'C-101 1.07E-09 1.12E-09 1.42E-08 NO DATA 1.91E-08 5.92E-10 3.56E-09 tU-103 7.31E-07 NO DATA 2.01E-07 NO DATA 1.84E-06 NO DATA 1.89E-05 tU-105 6.45E-08 NO DATA 2.34E-08 NO DATA 5.67E-07 NO DATA 4.21E-05 ~

LU-106 1.17E-05 NO DATA 1.46E-06 NO DATA 1.58E-05 NO DATA 1.82E-04 6G-110m 5.39E-07 3.64E-07 2.91E-07 NO DATA 6.78E-07 NO DATA 4.33E-05

'E- 125m 1.14E-05 3.09E-06 1.52E-06 3.20E-06 NO DATA NO DATA 1.10E-05

'E-127m 2.89E-05 7.78E-06 3.43E-06 6.91E-06 8.24E-05 NO DATA 2.34E-05

'E-127 4.71E-07 1.27E-07 1.01E-07 3.26E-07 1.34E-06 NO DATA 1.84E-05

'E-129m 4.87E-05 1.36E-05 7.56E-06 1.57E-05 1.43E-04 NO DATA 5.94E-05

'E-129 1.34E-07 3.74E-08 3.18E-08 9.56E-08 3.92E-07 NO DATA 8.34E-06

'E-133m 7.20E-06 2.49E-06 2.65E-06 5.12E-06 2.41E-05 NO DATA 1.01E-04

'E-131 0.30E-08 2.53E-08 2.47E-08 6.35E-08 2.51E-07 NO DATA 4.36E-07 fLINTON-1 3-58 Rev.17-12/98

CPS-ODCM TABLE 3.5-7 (Continued)

INGESTION DOSE FACTORS FOR CHILD - ( DFLi ) . 3 (mrem per pCi ingested) 'E NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI TE-132 1.01E-05 4.47E-06 5.40E-06 6.51E-06 4.15E-05 NO DATA 4.50E-05 I-130 2.92E-06 5.90E-06 3.04E-06 6.50E-04 8.82E-06 NO DATA 2.76E-06 1-131 1.72E-05 1.73E-05 9.83E-06 5.72E-03 2.84E-05 NO DATA 1.54E-06 I-132 0.00E-07 1.47E-06 6.76E-07 6.82E-05 2.25S-06 NO DATA 1.73E-06 I-133 '5.92E-06 7.32E-06 2.77E-06 1.36E-03 1.22E-05 NO DATA 2.95E-06 I-134 4.19E-07 7.78E-07 3.58E-07 1.79E-05 1.19E-06 NO DATA 5.16E-07 I-135 1.75E-06 .3.15E-06 1.49E-06 2.79E-04 4.83E-06 NO DATA 2.40E-06 CS-134 2.34E-04 3.84E-04 8.10E-05 NO DATA 1.19E-04 4.27E-05 2.07E-06 CS-136 2.35E-05 6.46E-05 4.18E-05 NO DATA 3.44E-05 5.13E-06 2.27E-06 CS-137 3.27E-04 3.13E-04 4.62E-05 NO DATA 1.02E-04 3.67E-05 1.96E-06 CS-138 2.28E-07 3.17E-07 2.01E-07 NO DATA 2.23E-07 -2.40E-08 1.46E-07 BA-139 4.14E-07 2.21E-10 1.20E-08 NO DATA 1.93E-10 1.30E-10 2.39E-05 BA-140 8.31E-05 7.28E-08 4.85E-06 NO DATA 2.37E-08 4.34E-08 4.21E-05 BA-141 2.00E-07 1.12E-10 6.51E-09 NO DATA 9.69E-11 6.58E-10 1.14E-07 BA-142 8.74E-08 6.29E-11 4.88E-09 NO DATA 5.09E-11 3.70E-11 1.14E-09 LA-140 1.01E-08 3.53E-09 1.10E-09 NO DATA NO DATA NO DATA 9.84E-05 LA-142 5.24E-10 1.67E-10 5.23E-11 NO DATA NO DATA NO DATA 3.31E-05 CE-141 8.97E-08 1.98E-08 2.94E-09 NO DATA 8.68E-09 NO DATA 2.47E-05

.CE-143 6.99E-09 3.79E-06 5.49E-10 NO DATA 1.59E-09 NO DATA 5.55E-05 CF-144 2.08E-06 6.52E-07 1.11E-07 NO DATA 3.61E-07 NO DATA 1.70E-04 PK-143 3.93E-08 1.18E-08 1.95E-09 NO DATA 6.39E-09 NO DATA 4.24E-05 PR-144 1.29E-10 3.99E-11 6.49E-12 NO DATA 2.11E-11 NO DATA 8.59E-08 ND-147 2.79E-08 2.26E-08 1.75E-09 NO DATA 1.24E-08 NO DATA 3.58E-05 l C-187 4.29E-07 2.54E-07 1.14E-07 NO DATA NO DATA NO DATA 3.57E-05 g N P-239 5.25E-09 3.77E-10 2.65E-10 NO DATA 1.09E-09 NO DATA 2.79E-05

1.21 x 10"

- Less than 10-**

I I

I CLINTON-1 3-59 Rev.17-12/98 I

i

CPS-ODCM TABLE 3.5-8 INGESTION DOSE FACTORS FOR TEEN - (DFLi ),

(mrem per pCi ingested) i NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 C-14 4.06E-06* 8.12E-07 8.12E-07 8.12E-07 8.12E-07 8.12E-07 8.12E'-07 NA-24 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 P-32 2.76E-04 1.71E-05 1.07E-05 NO DATA NO DATA CR-51 NO DATA -2.32E-05 NO DATA NO DATA 3.60E-09 2.00E-09 7.89E-10 5.14E-09 6.05E-07 MN-54 NO DATA 5.90E-06 1.17E-06 NO DATA 1.76E-06 NO DATA 1.21E-05 MN-56 NO DATA 1.58E-07 2.81E-08 NO DATA 2.00E-07 NO DATA 1.04E-05 FE-55 3.78E-06 2.68E-06 6.25E-07 NO DATA NO DATA 1.70E-06 1.16E-06 FE-59 5.87E-06 1.37E-05 5.29E-06 NO DATA NO DATA 4.32E-06 3.24E-05 CO-58 NO DATA 9.72E-07 2.24E-06 NO DATA NO DATA CO-60 NO DATA 1.34E-05 NO DATA 2.81E-06 6.33E-06 NO DATA NO DATA NO DATA 3.66E-05 NI-63 '1.77E-04 1.25E-05 6.00E-06 NO DATA NO DATA NO DATA 1.99E-06 NI-65 7.49E-07 9.57E-08 4.36E-08 NO DATA NO DATA NO DATA 5.19E-06 CU-64 NO DATA 1.15E-07 5. 41E- 08 NO DATA 2.91E-07 ZN-65 5.76E-06 NO DATA 8.92E-06 2.00E-05 9.33E-06 NO DATA 1.28E-05 NO DATA 8.47E-06 ZN-69 1.47E-08 2.80E-08 1.96E-09 NO DATA 1.03E-08 BR-83 NO DATA 5.16E-08 NO DATA NO DATA 5.74E-08 NO DATA NO DATA NO DATA LT E-24**

BR-84 NO DATA NO DATA 7.22E-08 NO DATA NO DATA NO DATA LT E-24 BR-85 NO DATA NO DATA 3.05E-09 NO DATA NO DATA NO DATA LT E-24 RB-86 NO DATA 2.98E-05 1.40E-05 NO DATA NO DATA RB-88 NO DATA 4.41E-06 NO DATA 8.52E-08 4.54E-08 NO DATA NO DATA NO DATA 7.30E-15 RB-89 NO DATA 5.50E-08 3.89E-06 NO DATA NO DATA SR-89 4.40E-04 NO DATA 8.43E-17 NO DATA 1.26E-05 NO DATA NO DATA NO DATA 5.24E-05 s SR-90 8.30E-03 NO DATA 2.05E-03 NO DATA NO DATA NO DATA 2.33E-04

-91 8.07E-06 NO DATA 3.21E-07 NO DATA NO DATA

.-92 3.05E-06 NO DATA 3.66E-05 NO DATA 1.30E-07 NO DATA NO DATA NO DATA 7.77E-05

'Y-90 1.37E-08 NO DATA 3.69E-10 NO DATA NO DATA Y-91m NO DATA 1.13E-04 1.29E-10 NO DATA 4.93E-12 NO DATA NO DATA NO DATA 6.09E-09 Y-91 2.01E-07 NO DATA 5.39E-09 NO DATA NO DATA Y-92 1.21E-09 NO DATA 8.24E-05 NO DATA 3.50E-11 NO DATA NO DATA NO DATA 3.32E-05 Y-93 3.83E-09 NO DATA 1.05E-10 NO DATA NO DATA NO DATA 1.17E-04 1R-95 4.12E-08 1.30E-08 8.94E-09 NO DATA ZR-97 1. 91E NO DATA 3.00E-05 2.37E-09 4.69E-10 2.16E-10 NO DATA 7.11E-10 NO DATA 1.27E-04 NB-95 8.22E-09 4.56E-09 2.51E-09 MO-99 NO DATA 4.42E-09 NO DATA 1.95E-05 NO DATA 6.03E-06 1.15E-06 NO DATA 1.38E-05 NO DATA 1.08E-05 TC-99m 3.32E_10 9.26E-10 1.20E-08 1.38E-08 NO DATA 5.14E-10 6.08E-07 TC-101 3.60E-10 5.12E-10 5.03E-09 NO DATA 9.26E-09 RU-103 3.12E-10 8.75E-17 2.55E-07 NO DATA 1.09E-07 NO DATA 8.99E-07 NO DATA 2.13E-05 RU-105 2.18E-08 NO DATA 8.46E-09 NO DATA 2.75E-07 RU-106 NO DATA 1.76E-05 3.92E-06 No DATA 4.94E-07 NO DATA 7.56E-06 NO DATA 1.88E-04 AG-110m 2.05E-07 1.94E-07 1.18E-07 NO DATA 3.70E-07 NO DATA 5.45E-05 ITE-125m 3.83E-06 1.38E-06 5.12E-07 1.07E-06 NO DATA TE-127m NO DATA 1.13E-05 9.67E-06 3.43E-06 1.15E-06 2.30E-06 3.92E-05 NO DATA 2.41E-05 TE-127 1.58E-07 5.60E-08 3.40E-08 1.09E-07 6.40E-07 TE-129m 1.63E-05 NO DATA 1.22E-05 6.05E-06 2.58E-06 5.26E-06 6.82E-05 NO DATA 6.12E-05

"#E-129 4.48E-08 1.67E-08 1.09E-08 3.20E-08 1.88E-07 NO DATA 2.45E-07 EE-131m 2.44E-06 1.17E-06 9.76E-07 1.76E-06 1.22E-05 NO DATA 9.39E-05 iiE-131 2.79E-08 1.15E-08 8.72E-09 2.15E-08 1.22E-07 NO DATA 2.29E-09 l

! I CLINTON-1 3-60 Rev.17-12/98

CPS-ODCM TABLE 3.5-8 (continued)

INGESTION DOSE FACTORS FOR TEEN - (DFLi ) .

(mrem per pCi ingested) .

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI NUCLIDE TE-132 3.49E-06 2.21E-06 2.08E-06 2.33E-06 2.12E-05 NO DA A 7.00E-05 I-130 1.03E-06 2.98E-06 1.19E-06 2.43E-04 4.59E-06 NO DATA 2.29E-06 I-131 5.85E-06 8.19E-06 4.40E-06 2.39E-03 1.41E-05 NO DATA 1.62E-06 I-132 2.79E-07 7.30E-07 2.62E-07 2.465-05 1.15E-06 NO DATA 3.18E-07 I-133 2.01E-06 3.41E-06 1.04E-06 4.76E-04 5.98E-06 NO DATA 2.58E-06 I-134 1.46E-07 3.87E-07 1.39E-07 6.45E-06 6.10E-07 NO DATA 5.10E-09 I -135 6.10E-07 1. 57E-06 5.82E-07 1.01E-04 2.48E-06 NO DATA 1.74E-06 CS-134 8.37E-05 1.97E-04 9.14E-05 NO DATA 6.26E-05 2.39E-05 2.45E-06 CS-136 8.59E-06 3.38E-05 2.27E-05 NO DATA 1.84E-05' 2.90E-06 2.72E-06 CS-137 1.12E-04 1.49E-04 5.19E-05 NO DATA 5.07E-05 1.97E-05 2.12E-06 CS-138 7.76E-08 1.49E-07 -7.45E-08 NO DATA 1.10E-07 1.28E-08 6.76E-11 BA-139 1.39E-07 9.78E-11 4.05E-09 NO DATA 9.22E-11 6.74 E-11 1.24E-06 BA-140 2.84E-05 3.48E-08 1.83E-06 NO DATA 1.18E-08 '2.34E-08 4.38E-05 '

BA-141 6.71E-08 5.01E-11 2.24E-03 NO DATA 4.65E-11 3.43E-11 1.43E-13 BA-142 2.99E-08 2.99E-11 1.84E-09 NO DATA 2.53E-11 1.99E-11 9.18E-20 LA-140 3.48E-09 1.71E-09 4.55E-10 NO DATA NO DATA NO DATA 9.82E-05 LA-142 1.79E-10 7.95E-11 1.98E-11 MO DATA NO DATA NO DATA 2.42E-06 CE-141 1.33E-08 8.88E-09 1.02E-09 NO DATA 4.18E-09 NO DATA 2.54E-05 CE-143 2.35E-09 1.71E-06 1.91E-10 NO DATA 7.67E-10 NO DATA 5.14E-05 CE-144 6.96E-07 2.88E-07 3.74E-08 NO DATA 1.72E-07 NO DATA 1.75E-04 PR-143 1.31E-08 5.23E-09 6.52E-10 NO DATA 3.04E-09 NO DATA 4.31E-05 PR-144 4.30E-11 1.76E-11 2.18E-12 NO DATA 1.01E-11 NO DATA 4.74E-14 ND-147 9.38E-09 1.02E-00 6.11E-10 NO DATA 5.99E-09 NO DATA 3.60E-05 W-187 1.46E-07 1.19E-07 4.17E-08 NO DATA NO DATA NO DATA 3.22E-05 NP-239 1.76E-09 1.66E-10 9.22E-11 NO DATA 5.21E-10 NO DATA 2.67E-05

4.06 x 10 " l W

- Less than 10~*

I I

CLINTON-1 3-61 Rev.17-12/98 I

CPS-ODCM TABLE 3.5-9 INGESTION DOSE FACTORS FOR ADULT - (DFLi ) .

, (mrem per pCi ingested)

)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 C-14 2.84E-06* 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 NA-24 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 P-32 1.93E-04 1.20E-05 7.46E-06 NO DATA NO DATA NO DATA 2.17E-05 CR-51 NO, DATA NO DATA 2.66E-09 1.59E-09 5.86E-10 3.53E-09 6.69E-07 MN-54 NO DATA 4.57E-06 8.72E-07 NO DATA 1.36E-06 NO DATA 1.40E-05 MN-56 NO DATA 1.15E-07 2.045-08 NO DATA 1.46E-07 NO DATA 3.67E-06 FE-55 2.75E-06 1.90E-06 4 .'4 3 E-07 NO DATA NO DATA 1.06E-06 1.09E-06 FE-59 4.34E-06 1.02E-05 3.91E-06 NO DATA No DATA 2.85E-06 3.40E-05 ICO-58 CO-60 NO DATA

'NO DATA 7.45E-07 2.14 E-06 1.67E-06 4.72E-06 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 1.51E-05 4.02E-05 NI-63 1.30E-04 9.01E-06 4.36E-06 NO DATA NO DATA NO DATA 1.88E-06 NI-65 5.28E-07 6.86E-08 3.13E-08 NO DATA NO DATA 1.74E-06 i CU-64 ZN-65 NO DATA 4.84E-06 8.33E-08 1.54E-05 3.91E-08 6.96M-06 NO DATA NO DATA 2.10E-07 1.03E-05 NO DATA NO DATA NO DATA 7.10E-06 9.70E-06 ZN-69 1.03E-08 1.97E-08 1.37E-09 NO DATA 1.28E-08 NO DATA 2.96E-09 BR-83 NO DATA 4.02E-08 i BR-84 BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA 5.21E-08 7.14E-09 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 5.79E-08 4.09E-13 LT E-24**

RB-86 NO DATA 2.11E-05 9.83E-06 NO DATA NO DATA NO DATA 4.16E-06 RB-88 i RB-89 SR-89 NO DATA NO DATA 6.05E-08 4.01E-08 3.21E-08 2.82E-08 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 8.36E-19 2.33E-21 3.08E-04 NO DATA 8.84E-06 NO DATA NO DATA NO DATA 4.94E-05 "R-90 7.58E-03 NO DATA 1.86E-03 NO DATA NO DATA NO DATA 2.19E-04

.-91 5.67E-06 NO DATA 2.29E-07 NO DATA NO DATA NO DATA 2.70E-05 y R-92 2.15E-06 NO DATA 9.30E-08 NO DATA NO DATA NO DATA 4.26E-05 J Y-90 9.62E-09 NO DATA 2.58E-10 NO DATA NO DATA NO DATA 1.02E-04 Y-91m 9.09E-11 NO DATA 3.52E-12 NO DATA NO DATA NO DATA 2.67E-10 Y-91 1.41E-07 NO DATA 3.77E-09 NO DATA NO DATA NO DATA 7.76E-05 Y-92 8.45E-10 NO DATA 2.47E-11 NO DATA NO DATA NO DATA 1.48E-05 Y-93 2.68E-09 NO DATA 7.40E-11 NO DATA NO DATA NO DATA 8.50E-05 3.04E-08 9.75E-09 6.60E-09 NO DATA 1.53E-08 NO DATA 3.09E-05 IZP.-95 ZR-97 NB-95 1.68E-09 3.39E-10 1.55E-10 NO DATA 5.12E-10 NO DATA 1.05E-04 6.22E-09 3.46E-09 1.86E-09 NO DATA 3.42E-09 NO DATA 2.10E-05 NO DATA 4.31E-06 8.20E-07 NO DATA 9.76E-06 NO DATA 9.99E-06 TC-99m 2.47E-10 6.98E-10 lMO-99 TC-101 2.54E-10 3.66E-10 8.89E-09 3.59E-09 NO DATA NO DATA 1.06E-08 6.59E-09 3.42E-10 1.87E-10 4.13E-07 1.10E-21 RU-103 1.85E-07 NO DATA 7.97E-08 NO DATA 7.06E-07 NO DATA 2.16E-05 RU-105 1.54E-08 NO DATA 6.08E-09 NO DATA 1.99E-07 NO DATA 9.42E-06 RU-106 2.75E-06 NO DATA 3.48E-07 NO DATA 5.31E-06 NO DATA 1.78E-04 AG-110m 1.60E-07 1.48E-07 8.79E-08 NO DATA 2.91E-07 NO DATA 6.04E-05 TE-125m 2.68E-06 9.71E-07 3.59E-07 8.06E-07 1.09E-05 NO DATA 1.07E-05 6.77E-06 2.42E-06 8.25E-07 1.73E-06 2.75E-05 NO DATA 2.27E-05 ITE-127m TE-127 TE-129m 1.10E-07 3.95E-08 2.38E-08 8.15 E-0 8 4.48E-07 NO DATA 8.68E-06 1.15E-05 4.29F-06 1.82E-06 3.95E-06 4.80E-05 NO DATA 5.79E-05 TE-129 3.14E-08 1.18E-08 7.65E-09 2.41E-08 1.32E-07 NO DATA 2.37E-08 TE-131m 1.73E-06 8.46E-07 7.05E-07 1.34E-06 8.57E-06 NO DATA 8.40E-05 TE-131 1.97E-08 8.23E-09 6.22E-09 1.62E-08 8.63E-08 NO DATA 2.79E-09

)

CLINTON-1 3-62 Rev.17-12/98

n ,

CPS-ODCM TABLE 3.5-9 (continued)

. INGESTION DOSE FACTORS FOR ADULT - (DFLi ) . 3 (mrem per pCi ingested) -g NUCLIDE BONE LIVER T. BODY THYROID KIDNEY " LUNG GI-LLI TE-132 2.52E-06 1.63E-06 1.53E-06 1.80E-06 1.57E-05 NO DATA 7.71E-05 I-130 7.56E-07 2.23E-06 8.80E-07 1.89E-04 3.48E-06 NO DATA 1.92E-06 I-131 4.16E-06 5.95E-06 3.41E-06 1.95E-03 1.02E-05 NO DATA 1.57E-06 I-132 2. 03E- 07 5.43E-07 1.90E-07 1.90E-05 8.65E-07 NO DATA 1.02E-07 I-133 1.42E-06 2.47E-06 7.53E-07 3.63E-04 4.31E-06 NO DATA 2.22E-06 I-134 1.06E-07 2.88E-07 1.03E-07 4.99E-06 4.58E-07 NO DATA 2.51E-10 I-135 4.43E-07 1.16E-06. 4.28E-07 7.65E-05 1.86E-06 NO DATA 1.31E-06 CS-134 6.22E-05 1.48E-04 1.21E-04 NO DATA 4.79E-05 1.59E-05 2.59E-06 CS-136 6.51E-06 2.57E-05 1.85E-05 NO DATA 1.43E-05 1.96E-06 2.92E-06 CS-137 7.97E-05 1.09E-04 7.14E-05 NO DATA 3.70E-05 1.23E-05 2.11E-06 CS-138 5.52E-08 1.09E-07 5.40E-08 NO DATA 8.01E-08 7.91E-09 4.65E-13 BA-139 9.70E-08 6.91E-11 2.84E-09 NO DATA 6.46E-11 3.92E-11 1.72E-07 BA-140 2.03E-05 2.55E-08 1.33E-06 NO. DATA 8.67E-09 1. 4 6E-08 4.18E-05 BA-141 4.71E-08 3.56E-11 1.59E-09 NO DATA 3.31E-11 '2.02E-11 2.22E-17 BA-142 2.13E-08 2.19E-11 1.34E-09 NO DATA 1.85E-11 1.24E-11 3.00E-26 IA-140 2.50E-09 1.26E-09 3.33E-10 NO DATA NO DATA NO DATA 9.25E-05 LA-142 1.28E-10 5.82E-11 l'. 45E-11 NO DATA NO DATA NO DATA' 4.25E-07 CE-141 9.36E-09 6.33E-09 7.18E-10 NO DATA 2.94E-09 NO DATA 2.42E-05 CE-143 1.65E-09 1.22E-06 1.35E-10 NO DATA 5.37E-10 NO DATA 4.56E-05 CE-144 4.88E-07 2.04E-07 2.62E-08 NO DATA 1.21E-07 NO DATA 1.65E-04 PR-143 9.20E-09 3.69E-09 4.56E-10 NO DATA 2.13E-09 NO DATA 4.03E-05 PR-144 3.01E-11 1.25E-11 1.53E-12 NO DATA 7.05E-12 NO DATA 4.33E-18 ND-147 6.29E-09 7.27E-09 4.35E-10 NO DATA 4.25E-09 NO DATA 3.49E-05 C-187 1.03E-07 0.61E-08 3.01E-08 NO DATA NO DATA NO DATA 2.82E-05 NP-239 1.19E-09 1.17E-10 6.45E-11 NO DATA 3.65E-10 NO DATA 2.40E-05

2.84 x 10 "

*Less than 10-**

I I

I II l l,

I CLINTON-1 3-63 Rev.17-i2/98 I ,

CPS-ODCM TABLE 3.5-10 INPUT PARAMETERS FOR CALCULATING R".y Parameter Value Table

Or(kg/ day) 50 for cow E-3 6 for goat Uip(liters /yr) -

Infant 330 E-5 330 Child E-5 Teen 400 E-5 Adult 310 -

E-5 Yp (kg/m*) 0.7 E-15 Y (kg/m*) 2.0 E-15 F3 (dsys/ liter) Each stable element for cow E-l' Each stable element for goat E-2 r(dimensionless) 1.0 for radioiodine E-15 0.2 for particulates E-15 5

tr(seconds) 1.73 x 10 (2 days) E-15 tn(seconds) 7.78 x 10'(90 days) E-15 f, (dimensionless) 1.0 for cow NUREG -

1.0 for goat 0133 Section 5.3.1.3 p(dimensionless) 1.0 for cow NUREG -

1.0 for goat 0133 Section 5.3.1.3 i *of Regulatory Guide 1.109 unlesu otherwise stated i

I l CLINTON-1 3-64 Rev.17-12/98

CPS-ODCM' l TABLE 3.5-11 E I INPUT PARAMETERS FOR CALCULATING R".y Parameter Value Table * ,

U,p(liters /yr) - Infant 0 E-5 g Child 41 E-5 5 Teen 65 E-5 1

- Adult 110 E-5 Fr (days /kg) Each stable element E-1 t (seconds) 1.73E+06 (20 days) E-15 tn(seconds) 7.78E+06 (90 days) E--15 Yp(kg/m*) 0.7 E-15 Y (kg/m*) 2.0 E-15 r(dimensionless) 1.0 for radioiodine E-15 0.2 for particulates E-15 Or(kg/ day) 50 ,,

E-3

of Regulatory Guide 1.109 l

1 I

I I

t I

i I

I CLINTON-1 3-65 Rev.17-12/98 I

I

l PS-ODCM TABLE 3.5-12 INPUT PARAMETERS FOR CALCUIATING R* t3

'aramster Value Table

t'. (kg/yr) - Infant O E-5

- Child 26 E-5

- Teen 42 E-5

- Adult 64 E-5 8

I. (kg/yr) - Infant 0 E-5

- Child 520 E-5

- Teen 630 E-5

- Adult 520 E-5 t (din nsionless) 1.0 E-15 f, (dintnsionless) 0.76 E- 15

t, (seconds) 8.6 x 10' (1 day) E-15

.n (seconds) 5.18 x 10' (60 days) E-15 "v (kg/m') 2.0 E-15 of Regulatory Guide 1.109 INTON-1 3-66 Rev.17-12/98

r CPS-ODCM TABLE 3.5-13 INHAIATION PATHWAY FACTORS - Rh (INFANT)

(mrem /yr per pCi/m') ,

ORGAN: DONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE q NO DATA 6.47E+02* 6.47E+02* 6.47E+02* 6.47E+02* 6.47E+02* 6.47E+02* W H-3 a C-14 2.65E+04 5.31E+03 5.32E+03 5.31E+03 5.31E+03 5.31E+03 5.31E+03 NA-24 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 P-32 2.03E+06 1.12E+05 7.74E+04 NO DATA NO DATA NO DATA 1.61E+04 ;

CR-51 NO DATA NO DATA 8.95E+01 5.75E+01 1.32E+01 1.28E+04 3.57E+02 HN-54 NO DATA 2.53E+04 4.98E+03 NO DATA 4.98E+03 1.00E+06 7.06E+03 MN-56 NO DATA 1.54E+00 2.21E-01 NO DATA 1.10E+00 1.25E+04 7.17E+04 i FE-55 1.97E+04 1.17E+04 3.33E+03 NO DATA NO DATA 8.69E+04 1.09E+03 FE-59 1.36E+04 2.35E+04 9.48E+03 NO DATA NO DATA 1.02E+06 2.48E+04 CO-58 NO DATA 1.22E+03 1.82E+03 NO DATA NO DATA 7.77E+05 1.11E+04 ,I CO-60 NO DATA 8.02E+03 1.18E+04 NO DATA NO DATA 4.51E+06 3.19E+04 NI-63 3.39E+05 2.04E+04 1.16E+04 NO. DATA NO DATA 2.09E+05 2.42E+03 NI-65 2.39E+00 2.84E-01 1.23E-01 NO DATA NO DATA 8.12E+03 5.01E+04 CU-64 NO DATA 1.88E+00 7.74E-01 NO DrfrA 3.98E+00 9.30E+03 1.50E+04 ZN-65 1.93E+04 6.26E+04 3.11E+04 NO DATA 3.25E+04 6.47E+05 5.14E+04 ,

ZN-69 5.39E-02 9.67E-02 7.18E-03 NO DATA 4.02E-02 1.47E+03 1.32E+04 BR-83 NO DATA NO DATA 3.81E+02 NO DATA NO DATA NO DATA LT1.4E-15** '

BR--8 4 NO DATA NO DATA 4.00E+02 NO DATA NO DATA NO DATA LT1.4E-15 BR-85 NO DATA NO DATA 2.04E+01 NO DATA NO DATA NO DATA LT1.4E-15 RB-86 NO DATA 1.90E+05 8.82E+04 NO DATA NO DATA NO DATA 3.04E+03 RB-88 NO DATA 5.57E+02 2.87E+02 NO DATA NO DATA NO DATA 3.39E+02 RB-89 NO DATA 3.21E+02 2.06E+02 NO DATA NO DATA NO DATA 6.82E+01 SR-89 3.98E+05 NO DATA 1.14E+04 NO DATA NO DATA 2.03E+06 6.40E+04 SR-90 4.09E+07 NO DATA 2.59E+06 NO DATA NO DATA 1.12E+07 1.31E+05 SR-91 9.56E+01 NO DATA 3.46E+00 NO DATA NO DATA 5.26E+04 7.34E+04 SR-92 1.05E+01 NO DATA 3.91E-01 NO DATA NO DATA 2.38E+04 1.40E+05 l Y-90 3.29E+03 NO DATA 8.82E+01 NO DATA NO DATA 2.69E+05 1.04E+05 g Y-91m 4,07E-01 NO DATA 1.39E-02 NO DATA NO DATA- 2.79E+03 2.35E+03 Y-91 5.88E+05 NO DATA 1.57E+04 NO DATA NO DATA 2.45E+06 7.03E+04 Y-92 1.64E+01 NO DATA 4.61E-01 NO DATA NO DATA 2.45E+04 1.27El05 Y-93 1.50E+02 NO DATA 4.07E+00 NO DATA NO DATA 7.64E+04 1.67E+05 um ZR-95 1.15E+05 2.79E+04 2.03E+04 NO DATA 3.11E+04 1.75E+06 2.17E+04 ZR-97 1.50E+02 2.56E+01 1.17E+01 NO DATA 2.59E+01 1.10E+05 1.40E+05 g NB-95 1.57E+04 6.43E+03 3.78E+03 NO DATA 4.72E+03 2.65E+02 4.79E+05 1.35E+05 1.27E+04 4.87E+04 g

MO-99 NO DATA 1.65E+02 3.23E+01 NO DATA m TC-99m 1.40E-03 2. 8 8 E-0 3 3.72E-02 NO DATA 3.11E-02 8.11E+02 2.03E+03 TC-101 6.51E-05 8.23E-05 8.12E-04 NO DATA 9.79E-04 5.84E+02 8.44E+02 RU-103 2.02E+03 NO DATA 6.79E+02 NO DATA 4.24E+03 5.52E+05 1.61E+04 RU-105 1.22E+00 NO LATA 4.10E-01 NO DATA 8.99E-01 1.57E+04 4.84E+04 RU-106 8.68E+04 NO D4TA 1.09E+04 NO DATA 1.07E+05 1.16E+07 1.64E+05 AG-110m 9.98E+03 7.22E+03 5.00E+03 NO DATA 1.09E+04 3.67E+06 3.30E+04 l TE-125m 4.76E+03 1.99E+03 6.58E+02 1.62E+03 NO DATA 4.47E+05 1.29E+04 5 TE-127m 1.67E+04 6.90E+03 2.07E+03 4.87E+03 3.75E+04 1.31E+06 2.73E+04 TE-127 2.23E+00 9.53E-01 4.89E-01 1.85E+00 4.86E+00 1.03E+04 2.44E+04 TE-129m 1.41E+04 6.09E+03 2.23E+03 5.47E+03 3.18E+04 1.68E+06 6.90E+04 ~~~

TE-129 7.88E-02 3.47E+02 1.88E-02 6.75E-02 1.75E-01 3.00E+03 2.63E+04 TE-131m 1.07E+02 5.50E+01 3.63E+01 8.93E+01 2.65E+02 1.99E+05 1.19E+05 TE-131 1.74E-02 8.22E-03 5.00E-03 1.58E-02 3.99E-02 2.06E+03 8.22E+03 l

(

1 3-67 Rev.17-12/98 1

CLINTON-1 L

CPS-ODCM TABLE 3.5-13 (continued)

INHALATION PATHWAY FACTORS - R' y (INFANT)

, (mrem /yr per pCi/m )

ORGAN BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE TE-132 3.72E+02 2.37E+02 1.76E+02 2.79E+02 1.03E+03 3.40E+05 4.41E+04

'I-130 6.39E+03 1.39E+04 5.57E+03 1.60E+06 1.53E+04 NO DATA 1.99E+03 >

I-131 3.79E+04 4.44E+04 1.96E+04 1.48E+07 5.18E+04 NO DATA 1.06E+03 I-132 1.69E+03 3.54E+03 1.26E+03 1.69E+05 3.95E+03 NO DATA 1.90E+03 I-133 '1.32E+04 1.92E+04 5.60E+03 3.56E+06 2.24E+04 NO DATA 2.16E+03

>I-134 9.21E+02 1.88E+03- 6.65E+02 4.45E+04 2.09E+03 NO DATA 1.29E+03 I-135 3.86E+03 7.60E+03 2.77E+03 6.96E+05 8.47E+03 NO DATA 1.83E+03 3.96E+05 7.03E+05 7.45E+04 NO DATA 1.90E+05 7.97E+04 1.33E+03

]CS-134 4.83E+04 1.35E+05 5.29E+04 5.64E+04 1.18E+04

cS-136 NO DATA 1.43E+03

' CS-1;17 5.49E+05 6.12E+05 4.55E+04 NO DATA 1.72E+05 7.13E+04 1.33E+03 ,

CS-130 5.05E+02 7.81E+02 3.98E+02 NO DATA. 4.10E+02 6.54E+01 8.76E+02 BA-139 1.48E+00 9.84E-04 4.30E-02 NO DATA 5.92E-04 5.95E+03 5.10E+04 BA-140 5.60Et04 5.60E+01 2.90E+03 NO DATA 1.34E+01 1.60E+06 3. 84 E+04-BA-141 1.57E-01 1.08E-04 4.97E-03 NO DATA 6.50E-05 2 97E+03 4.75E+03 BA-142 3.98E-02 3.30E-05 1.96E-03 NO DATA 1.90E-05 1.55E+03 6.93E+02 LA-140 5.05E+02 2.00E+02 5.15E+01 NO DATA NO DATA 1.68E+05 8.48E+04 LA-142 1.03E+00 3.77E-01 9.04E-02 NO DATA NO DATA 8.22E+03 5.95E+04 CE-141 2.77E+04 1.67E+04 1.99E+03 NO DATA 5.25E+03 5.17E+05 2.16E+04 CE-143 2.93E+02 1.93E+02 2.21E+01 NO DATA 5.64E+01 1.16E+05 4.97E+04 CE 144 3.19E+06 1.21E+06 1.76E+05 NO DATA 5.30E+05 9.84E+06 1.48E+05 PR-143 1.40E+04 5.24E+03 6.99E+02 NO DATA 1.97E+03 4.33E+05 3.72E+04 PR-141 4.79E-02 1.85E-02 2.41E-03 NO DATA 6.72E-03 1.61E+03 4.288+03

'-147 7.94E+03 8.13E+03 5.00E+02 NO DATA 3.15E+03 3.22E+05 3.12E+04 187 1.30E+01 .9.02E+00 3.12E+00 NO DATA NO DATA 3.96E+04 3.56E+04 JNP-239 3.71E+02 3.32E+01 1.88E+01 NO DATA 6.62E+01 5.95E+04 2.49E+04

6.47 x 10'

- Less than 1.40 x 10*

i j

l l

t t

CLINTON-1 3-68 Rev.17-12/98

CPS-ODCM TABLE 3.5-14 INHALATION PATHWAY FACTORS - R*au (CHILD)

(mrem /yr per pC1/m3)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOfrOPE NO DATA 1.12E+03* 1.12E+03 1.12E+03 1.12E+03 1.12E+03 1.12E+03 5 H-3 C-14 3.58E+04 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 l NA-24 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 l P-32 2.60E+06 1.14E+05 9.87E+04 NO DATA NO DATA NO DATA 4.21E+04 CR-51 NO DATA NO DATA 1.54E+02 8.54E+01 2.43E+01 1.70E+04 1.08E+03 HN-54 NO DATA 4.29E+04 9.51E+03 NO DATA 1.00E+04 1.58E+06 2.29E+04 HN-56 NO DATA 1.66E+00 3.12E-01 NO DATA 1.67E+00 1.31E+04 1.23E+05 FE-55 4.74E+04 2.52E+04 7.77E+03 NO DATA NO DATA 1.11E+05 2.87E+03 FE-59 2.07E+04 3.34E+04 1.67E+04 NO DATA NO DATA 1.27E+06 7.07E+04 -

CO-58 NO DATA 1.77E+03 3.16E+03 NO DATA NO DATA 1.11E+06 3.44E+04 CO-60

NO DATA 1.31E+04.

4.63E+04 2.26E+04 2.80E+04 NO DATA NO DATA NO DATA NO DATA 7.07E+06 2.75E+05 9.62E+04 6.33E+03 h

g NI-63 8.21E+05 NI-65 2.99E+00 2.96E-01 1.64E-01 NO DATA NO DATA 8.18E+03 8.40E+04 CU-64 NO DATA 1.99E+00 1.07E+00 NO DATA 6.03E+00 9.58E+03 3.67E+04 ZN-65 4.26E+04 1.13E+05 7.03E+04 NO DATA 7.14E+04 9.95E+05 1.63E+04 ZN-69 6.70E-02 9.66E-02 8.92E-03 NO DATA 5.85E-02. 1.42E+03 1.02E+04 W BR-83 NO DATA NO DATA 4.74E+02 NO DATA NO DATA NO DATA ,LT3.70E-15**

BR-84 NO DATA NO DATA 5.48E+02 NO DATA NO DATA NO DATA LT3.70E-15 BR-85 NO DATA NO DATA 2.53E+01 NO DATA NO DATA NO DATA LT3.70E-15 RB-86 NO DATA 1.98E+05 1.14E+05 NO DATA NO DATA NO DATA 7.99E+03 RB-88 NO DATA 5.62E+02 3.66E+02 NO DATA NO DATA NO DATA 1.72E+01 RD-89 NO DATA 3.45Et02 2.89E+02 NO DATA NO DATA NO DATA 1.89E+00 SR-89 5.99E+05' NO DATA 1.72E+04 NO DATA NO DATA 2.16E+06 1.67E+05 SR-90 1.01E+08 NO DATA 6.44E+06 NO DATA NO DATA 1.48E+07 3.43E+05 5.33E+04 1.74E+05 \

SR-91 1.21E+02 NO DATA 4.59E+00 NO DATA NO DATA SR-92 1.31E+01 NO DATA 5.25E-01 NO DATA NO DATA 2.40E+04 2.62E+05 2.42E+05 2.66E+05 h

g Y-90. 4.11E+03 NO DATA 1.11E+02 NO DATA NO DATA Y-91m 5.07E-01 NO DATA 1.84E-02 NO DATA NO DATA 2.81E+03 1.72E+03 Y-91 9.14E+05 NO DATA 2.44E+04 NO DATA NO DATA 2.63E+06 1.84E+05 Y-92 2.04E+01 NO DATA 5.81E-01 NO DA'l A NO DATA 2.39E+04 2.39E+05 l Y-93 1.86E+02 NO DATA 5.11E+00 NO DATA NO DATA 7.44E+04 3.89E+05 N ZR-95 1.90E+05. 4.18E+04 3.70E+04 NO DATA 5.96E+04 2.23E+06 6.11E+04 ZR-97 1.88E+02 2.72E+01 1.60E+01 NO DATA 3.89E+01 1.13E+05 3.51E+05 NB-95 2.35E+04 9.18E+03 6.55E+03 NO DATA 8.62E+03 6.14E+05 3.70E+04 HO-99 NO DATA 1.72E+02 4.26E+01 NO DATA 3.92E+02 1.35E+05 1.27E+05 TC-99m 1.78E-03 3.48E-03 5.77E-02 NO DATA 5.07E-02 9.51E+02 4.81E+03 TC-101 8.10E-05 8.51E-05 1.08E-03 NO DATA 1.45E-03 5.84E+02 1.63E+01 RU-103 2.79E+03 NO DATA 1.07E+03 NO DATA 7.03E+03 6.62E+05 4.48E+04 RU-105 1.53E+00 NO DATA 5.55E-01 NO DATA 1.34E+00 1.59E+04 9.95E+04 RU-106 1.36E+05 NO DATA 1. 69 E+ 0 4 NO DATA 1.04E+05 1.43E+07 4.29E+05 AG-110m 1.69E+04 1.14E+04 9.14E+03 NO DATA 2.12E+04 5.48E+06 1.00E+05 l TE-125m. 6.73E+03 2.33E+03 9.14E+02 1.92E+03 NO DATA 4.77E+05 3.38E+04 3 TE-127m 2.49E+04 0.55E+03 3.02E+03 6.07E+03 6.36E+04 1.48E+06 7.14E+04 TE-127 2.77E+00 9.51E-01 6.11E-01 1.96E+00 7.07E+00 1.00E+04 5.62E+04 TE-129m 1.92E+04 6.85E+03 3.04E+03 6.33E+03 5.03Ev04 1.76E+06 1.82E+05 l TE-129 9.77E-02 3.50E-02 2.38E-02 7.14E-02 2.57E-01 2.93E+03 2.55E+04 W TE-131m 1.34E+02 5.92E+01 5.07E+01 9.77E+01 4.00E+02 2.06E+05 3.08E+05 TE-131 2.17E-02 8.44E-03 6.59E-03 1.70E-02 5.88E-02 2.05E+03 1.33E+03 I

CLI,NTON-1 3-69 Rev.17-12/98 I

I CPS.-ODCM TABLE 3.5-14 (continued)

INHALATION PATHWAY FACTORS - R*.y (CHILD)

(mrem /yr per pCi/m')

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI e ISOTOPE 4.81E+02 2.72E+02 2.63E+02 3.17ht02 1.77E+03 3.77E+05 1.38E+05 5TE-132 I-130' 8.1,8E+03 1.64E+04 8.44E+03 1.85E+06 2.45E+04 NO DATA 5.11E+03 I-131 4.81E+04 4.81E+04 2.73E+04 .1.62E+07 7.88E+04 NO DATA 2.84E+03 I-132 2.12E+03 4.07E+03 1.88E+03 1.94E+05 6.25E+03 NO DATA 3.20E+03 II-133 I-134 1.66E+04 1.17E+03 2.03E+04 2.16E+03 7.70E+03 9.95E+02 3.85E+06 5.07E+04 3.38E+04 3.30E+03 NO DATA 5.48E+03 NO DATA 9.54E+02 I-135 4.92E+03 8.73E+03 4.14E+03 7.92E+05 1.34E+04 NO DATA 4.44E+03 6.51E+05 1.01E+06 2.25E+05 NO DATA 3.30E+05 1.21E+05 3.85E+03 ICS-134 CS-136 6.51E+04 1.71E+05 1.16E+05 NO DATA 9.55E+04 1.45E+08 4.18E+03 CS-137 9.70E+05 8.25E+05 1.28E+05 NO DATA 2.82E+05 1.04E+05 3.62E+03 CO-138 6.33E+02 8.40E+02 5.55E+02 NO DATA 6.22E+02 6.81E+01 2.70E+02 hBA-139 1.84E+00 9.84E-04 5.37E-02 UO' DATA '8.62E-04 5.77E+03 5.77E+04 IW BA-140 7.40E+04 6.48E+01 4.33E+03 NO DATA 2.11E+01 1.74E+06 1.02E+05 BA-141 1.96E-01 1.09E-04 6.36E-03 NO DATA 9.47E-05 2.92E+03 2.75E+02 m BA-142 5.00E-02 3.60E-05 2.79E-03 NO DATA 2.91E-05 1.64E+03 2.74E+00 6.44E+02 2.2SE+02 7.55E+01 NO DATA NO DATA 1.83E+05 2.26E+05 5LA-140 LA-142 1.30E+00 4.11E-01 1.29E-01 NO DATA NO DATA 8.70E+03 7.59E+04 CE-141 3.92E+04 1.95E+05 2.90E+03 NO DATA 8.55E+03 5.44E+05 5.66E+04 CE-143 3.66E+02 1.99E+02 2.87E+01 NO DATA 8.36E+01 1.15E+05 1.27E+05 ICE-144 PR-143 6.77E+06 1.85E+04 2.12E+06 5.55E+03 3.61E+05 9.14E+02 NO DATA 1.17E+06 3.00E+03 1.20E+07 3.89E+05 NO DATA 4.33E+05 9.73E+04 5.96E-02 1.85E-02 3.00E-03 NO DATA 9.77E-03 1.57E+03 1.97E+02

-147 1.08E+04 8.73E+03 6.81E+02 NO DATA 4.81E+03 3.28E+05 8.21E+04 iDR-144 j -187 1.63E+01 9.66E+00 4.33E+00 NO DATA NO DATA 4.11E+04 9.10E+04

, f P-239 4.66E+02 3.34E+01 2.35E+01 NO DATA 9.73E+01 5.81E+04 6.40E+04 I***1.12x10' Less than 3.70 x 10-"

I 1

I I

t' l

'ICLINTON-1 3-70 Rev.17-12/98

CPS-ODCM TABLE 3.5-15 3

INHALATION PATHWAY FACTORS - R.g (TEEN)

(mrem /yr per pCi/m') [Eg ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISCrrOPE ,

H-3 NO DATA 1.27E+03* 1.27E+03 1.27E+03 1.27E+03 1.27E+03 1.27E+03 C-14 2.60E+04 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 NA-24 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 E P-32 1.89E+06 1.10E+05 7.16E+04 NO DATA NO DATA NO DATA 9.20E+04 g CR-51 NO DATA NO DATA 1.35E+02 7.50E+01 3.07E401 2.10E+04 3.00E+03 HN-54 NO DATA 5.11E+04 8.40E+03 NO DATA 1.27E+04 1.98E+06 6.68E+04 MN-56 NO DATA 1.70E+00 2.52E-01 NO DATA 1.79E+00 1.52E+04 5.74E+04 h FE 3.34Et04 2.38E+04 5.54E+03 NO DATA NO DATA 1.24E+05 6.39E+03 5 FE-59 1.59E+04 3.70E+04 1.43E+04 NO DATA NO DATA 1.53E+06 1.78E+05 CO-58 NO DATA 2.07E+03 2.78E+03 NO DATA NO DATA 1.34E+06 9.52E+04 CO-60 NO DATA 1.51E+04 1.98E+04 NO DATA NO DATA 8.72E+06 2.59E+05 NI-63 5.80E+05 4.34E+04 1.98E+04 NO DATA NO DATA 3.07E+05 1.42E+04 m NI-65 2.18E+00 2.93E-01 1.27E-01 NO DATA NO DATA 9.36E+03 3.67E+04 CU-64 NO DATA 2.03E+00 8.48E-01 NO DATA 6.41E+00 ^1.11E+04 6.14E+04 3 ZN-65 3.86E+04 1.34E+05 6.24E+04 NO DATA 8.64E+04 1.24E+06 1.58E+03 4.66E+04 2.85E+02 g

ZN-69 4.83E-02 9. 20E-02 6.46E NO DATA 6.02E-02 BR-83 NO DATA NO DATA 3.44E+02 NO DATA NO DATA NO DATA LT8E-15**

BR-84 NO DATA NO DATA 4.33E+02 NO DATA- NO DATA NO DATA LT8E-15 BR-85 NO DATA NO DATA 1.83E+01 NO DATA NO DATA NO DATA LT8E-15 RB-86 NO DATA 1.90E+05 8.40E+04 NO DATA NO DATA NO DATA 1.77E+04 RB-88 NO DATA 3.46E+02 2.72E+02 NO DATA NO DATA NO DATA 2.92E-05 RB-89 NO DATA 3.52E+02 2.33E+02 1.25E+04 NO DATA NO DATA NO DATA NO DATA NO DATA 2.42E+06 3.38E-07 3.71E+05 l

m SR-89 4.34E+05 NO DATA SR-90 1.08E+08 NO DATA 6.68E+06 NO DATA NO DATA 1.65E+07 7.65E+05 SR-91 8.80E+01 NO DATA 3.51E+00 NO DATA NO DATA 6.07E+04 2.59E+05 SR-02 9.52E+00 NO DATA 4.06E-01 NO DATA NO DATA 2.74E+04 1.19E+05 Y-90 2.98E+03 NO DATA 8.00E+01 NO DATA NO DATA 2.93E+05 5.59E+05 Y-91m 3.70E-01 NO DATA 1.42E-02 NO DATA NO DATA 3.20E+03 3.02E+01 Y-91 6.61E+05 NO DATA 1.77E+04 NO DATA NO DATA 2.94E+06 4.09E+05 Y-92 1.47E+01 NO DATA 4.29E-01 NO DATA NO DATA 2.68E+04 1.65E+05 Y-93 1.35E+02 NO DATA 3.72E+00 NO DATA NO DATA 8.32E+04 5.79E+05 ZR-95 1.46E+05 4.58E+04 3.15E404 NO DATA 6.74E+04 2.69E+06 1.49E+05 ZR-97 1.38E+02 2.72E+01 1.26E+01 NO DATA 4.12E+01 1.30E+05 6.30E+05 NB-95 1.86E+04 1.03E+04 5.66E+03 NO DATA 1.00E+04 7.51E+05 9.68E+04 HO-99 NO DATA 1.69E+02 3.22E+01 NO DATA 4.11E+02 1:54E+05 2.69E+05 TC-99m 1.38E-03 3.86E-03 4.99E-02 NO DATA 5.76E-02 1.15E+03 6.13E+03 TC-101 RU-103 5.92E-05 2.10E+03 8.40E-05 8.24E-04 8.96E+02 NO DATA NO DATA 1.52E-03 7.43E+03 6.67E+02 7.83E+05 8.72E-07 1.09E+05 h

g NO DATA RU-105 1.12E+00 NO DATA 4.34E-01 NO DATA 1.41E+00 1.82E+04 9.04E+04 RU-106 9.84E+04 NO DATA 1.24E+04 NO DATA 1.90E+05 1.61E+07 9.60E+05 AG-110m 1.38E+04 1.31E+04 7.99E+03 NO DATA 2.50E+04 6.75E+06 2.73E+05 TE-125m 4.88Et03 2.24E+03 6.67E+02 1.40E+03 NO DATA 5.36E+05 7.50E+04 TE-127m 1.80E+04 8.16E+03 2.18E+03 4.38E+03 6.54E+04 1.66E+06 1.59E+05 TE-127 2.01E+00 9.12E-01 4.42E-01 1.42E+00 7.20E+00 1.12E+04 8.00E+04 g TE-129m 1.39E+04 6.58E+03 2.25E+03 4.58E+03 5.19E+04 1.98E+06 4.05E+05 g TE-129 7.10E-02 3.38E-02 1.76E-02 5.18E-02 2.66E-01 3.30E+03 1. 62 E4 03 -

TE-131m 9.84E+01 6.01E+01 4.02E+01 7.25E+01 4.39E+02 2.38E+05 6.21E+05 TE-131 1. 58 E- 02 8.32E-03 5.04E-03 1.24E-02 6.18E-02 2.34E+03 1.51E+01 I

CLINTON-1 3-71 Rev.17-12/98 I

I

1 CPS-ODCM TABLE 3.5-15 (continued)

INHALATION PATHWAY FACTORS - R*.y (TEEN)

{ (mrem /yr per pCi/m')

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE TE-132 3.60E+02 2.90E+02 2.19E+02 2.46E+02 1.95E+03 4.49E+05 4.63E+05

'I-130 6.24E+03 1.78E+04 7.17E+03 1.49E+06 2.75E+04 NO DATA 9.12E+03 I-131 3.54E+04 4.91E+04 2.64E+04 1.46E+07 8.40E+04 NO DATA 6.49E+03 I-132 1.59E+03 4.38E+03 1.58E+03 1.51E+05 6.92E+03 NO DATA 1.27E+03 I-133 1.22E+04 2.05E+04 6.22E+03 2.92E+06 3.59E+04 NO DATA 1.03E+04 I-134 8.88E+02 2.32E+03 8.40E+02 3.95E+04 3.66E+03 NO DATA 2.04E+01 I-135 3.70E+03 9.44E+03 3.49E+03 6.21E+05 1.49E+04 NO DATA 6.95E+03 CS-134 5.02E+05 1.12E+06 5.49E+05 NO DATA 3.75E+05 1.46E+05 9.76E+03 (CS-136 5.15E+04- 1.94E+05 1.37E+05 NO DATA 1.10E+05 1.78E+04 1.09E+04 CS-137 6.70E+05 8.48E+05 3.11E+05 NO DATA 3.04E+05 1.21E+05 8.48E+03 CS-138 4'66E+02

. 8.56E+02 4.46E+02 NO DATA '6.62E+02 7.87E+01 2.70E-01 BA-139 1.34E+00 9.44E-04 3.90E-02 NO DATA 8.88E-04 6.46E+03 6.45E+03 BA-140 5.47E+04 6.70E+01 3.52E+03 NO DATA 2.28E+01 2.03E+06 2.29E+05

' BA-141 1.42E-01 1.06E-04 4.74E-03 NO DATA 9.84E-05 3.29E+03 7.46E-04 BA-142 3.70E-02 3.70E-05 2.27E-03 NO DATA 3.14E-05 1.91E+03 4.79E-10 LA-140 4.79E+02 2.36E+02 6.26E+01 NO DATA NO DATA 2.14E+05 4.87E+05 IA-142 9.60E-01 4.25E-01 1.06E-01 NO DATA NO DATA 1.02E+04 1.20E+04 CE-141 2.84E+04 1.90E+04 2.17E+03 NO DATA 8.88E+03 6.14E+05 1.26E+05 CE-143 2.66E+02 1.94E+02 2.16E+01 NO DATA 8.64E+01 1.30E+05 2.55E+C5 CE-144 4.89E+06 2.02E+06 2.62E+05 NO DATA 1.21E+06 1.34E+07 8.64E+05 PR-143 1.34E+04 5.31E+03 6.62E+02 NO DATA 3.09E+03 4.83E+05 2.14E+05 "R-144 '4.30E-02 1.76E-02 2.18E-03 NO DATA 1.01E-02 1.75E+03 2.35E-04

-147 7.86E+03 8.56E+03 5.13E+02 NO DATA 5.02E+03 3.72E+05 1.82E+05

,.-187 1.20E+01 9.76E+00 .3.43E+00 NO DATA NO DATA 4.74E+04 1.77E+05 jNP-239 3.38E+02 3.19E+01 1.77E+01 NO DATA 1.00E+02 6.49E+04 1.32E+05

1.27 x 10"

- Less than 8.00 x 10-"

h CLINTON-1 3-72 Rev.17-12/98

CPS-ODCM g

TABLE 3.5-16 as INHALATION PATHWAY FACTORS - Rh (ADULT)

(mrem /yr per pCi/m')

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 1.26E+03* 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 l C-14 1.82E+04 3.41E+03 3.41E+03 3.41E+03 3.41E+03 3.41E+03 3.41E+03 {

NA-24 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 I P-32 1.32E+06 7.71E+04 5.01E+04 NO DATA NO DATA NO DATA 8.64E+04 CR-51 NO DATA NO DATA 1.00E+02 5.95E+01 2.28E+01 1.44E+04 3.'32E+03 MN-54 NO DATA 3.96E+04 6.30E+03 NO DATA 9.84E+03 1.40E+06 7.74E+04 MN-56 NO DATA 1.24E+00 1.83E-01 NO DATA 1.30E+00 9.44E+03 2.02E+04 FE-55 2.46E+04 1.70E+04 3.94E+03 .NO DATA NO DATA 7.21E+04 6.03E+03 ,

FE-59 1.18E+04 2.78E+04- 1.06E+04 NO DATA NO DATA 1.02E+06 1.88E+05' CO-58 NO DATA 1.58Et03 2.07E+03 NO DATA NO DATA 9.28E+05 1.06E+05 -

CO-60 NO DATA 1.15E+04 1.48E+04 NO DATA NO DATA 5.97E+06 2.85E+05 '

NI-63 4.32E+05 3.14E+04 1.45E+04 NO DATA NO DATA 1.78E+05 1.34E+04 NI-65 1.54E+00 2.10E-01 9.12E-02 NO DATA NO DATA 5.60E+03 1.23E+04 CU-64 NO DATA 1.46E+00 6.15E-01 'NO DATA 4.62E+00 6.78E+03 4.90E+04 ZN-65 3.24E+04 1.03E+05 4.66E+04 NO DATA 6.90E+04 8.64E+05 5.34E+04 i

ZN-69 3.38E-02 6.51E-02 4.52E-03 NO DATA 4.22E-02 9.20E+02 1.63E+01 BR-83 NO DATA NO DATA 2.41E+02 NO DATA NO DATA NO DATA 2.32E+02 ra-84 NO DATA NO DATA 3.13E+02 NO DATA NO DATA NO DATA 1.64E-03 BR-85 NO DATA NO DATA- 1.28E+01 NO DATA NO DATA NO DATA LT8E-15**

RB-86 NO DATA 1.35E+05 5,,90E+04 NO DATA NO DATA NO DATA 1.66E+04 RB-88 NO DATA 3.87E+02 1.93E+02 NO DATA NO DATA NO DATA 3.34E-09 RB-89 NO DATA 2 56E+02 1.70E+02 NO DATA NO DATA NO DATA 9.20E-12 l SR-89 3.04E+05 NO DATA 8.72E+03 NO DATA NO DATA 1.40E+06 3.50E+05 SR-90 9.92E+07 NO DATA 6.10E+06 NO DATA NO DATA 9.60E+06 7.22E+05 SR-91 6.19E+01 NO DATA 2.50E+00 NO DATA NO DATA 3.65E+04 1.91E+05 g. N ,

SR-92 6.74E+00 NO DATA 2.91E-01 NO DATA NO DATA 1.65E+04 4.30E+04 Y-90 2.09E+03 NO DATA 5.61E+01 NO DATA NO DATA 1.70E+05 5.06E+05 Y-91m 2.61E-01 NO DATA 1.02E-02 NO. DATA NO DATA 1.92E+03 1.33E+00 Y-91' 4.62E+05 NO DATA 1.24E+04 NO DATA NO DATA 1.70E+06 3.85E+05 Y-92 1.03E+01 NO DATA 3.02E-01 NO DATA NO DATA 1.57E+04 7.35E+04 j Y-93 9.44E+01 NO DATA 2.61E+00 NO DATA NO DATA 4.85E+04 4.22E+05 ZR-95 1.07E+05 3.44E+04 2.33E+04 NO DATA 5.42E+04 1.77E+06 1.50E+05 ZR-97 9.68E+01 1.96E+01 9.04E+00 NO DATA 2.97E+01 7.87E+04 $.23E+05 NB-95 1.41E+04 7.82Et03 4.21E+03 NO DATA 7.74E+03 5.05E+05 1.04E+05 $

MO-99 NO DATA 1.21E+02 2.30E+01 NO DATA 2.91E+02 9.12E+04 2.48E+05 TC-99m 1.03E-03 2.91E-03 3.70E-02 NO DATA 4.42E-02 7.64E+02 4.16E+03 _

TC-101 4.18E-05 6.02E-05 5.90E-04 NO DATA 1.08E-03 3.99E+02 1.09E-11 RU-103 1.53E+03 NO DATA 6.58E+02 No DATA 5.83E+03 5.05E+05 1.10E+05 RU-105 7.90E-01 NO DATA 3.11E-01 NO DATA 1.02E+00 1.10E+04 4.82E+04 RU-106 6.91E+04 No DATA 8.72E+03 NO DATA 1.34E+05 9.36E+06 9.12E+05 -

AG-110m 1.0EE+04 1.00E+04 5.94E+03 NO DATA 1.97E+04 4.63E+06 3.02E+05 g TE-125m 3.42E+03 1.58E+03 4.67E+02 1.05E+03 1.24E+04 3.14E+05 7.06E+04 g TE-127m 1.26E404 5.77E+03 1.57E+03 3.29E+03 4.58E+04 9.60E+05 1.50E+05 TE-127 1.40E+00 6.42E-01 3.10E-01 1.06E+00 5.10E+00 6.51E+03 5.74E+04 q TE-129m 9.76E+03 4.67E+03 1.58E+03 3.44E+03 3.66E+04 1.16E+06 3.83E+05 TE-129 4.9BE-02 2.39E-02 1.24E-02 3.90E-02 1.87E-01 1.94E+03 1.57E+02 TE-131m 6.99E+01 4.36E+01 2.90E+01 5.50E+01 3.09E+02 1.46E+05 5.56E+05 TE-131 1.11E-02 5.95E-03 3.59E-03 9.36E-03 4.37E-02 1.39E+03 1.84E+01 CLINTON-1 3-73 Rev.17-12/98 1

CPS-ODCM TABLE 3.5-16 (continued) l INHALATION PATHWAY FACTORS - R*,y (ADULT)

) (mrem /yr per pCi/m')

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE 2.60E+02 2.15E+02 1.62E+02 1.90E+02 1.46E+03 2.88E+05 5.10E+05 ITE-132 I-130 4.58E+03 1.34E+04 5.28E+03 1.14E+06 2.09E+04 NO DATA 7.69E+03 I-131 2.52E+04 3.58E+04 2.05E+04 1.19E+07 6.13E+04 NO DATA 6.28E+03 I-132 1.16E+03 3.26E+03 1.16E+03 1.14E+05 5.18E+03 NO DATA 4.06E+02 II-133 I-134 8.64E+03 6.44E+02 1.48E+04 1.73E+03 4.52E+03 6.15E+02 2.15E+06 2.98E+04 2.58E+04 2.75E+03 NO DATA NO DATA 8.88E+03 1.01E+00 I-135 2.68E+03 6.98E+03 2.57E+03 4.48E+05 1.11E+04 NO DATA 5.25E+03 lCS-134. 3.73E+05 8.48E+05 7.28E+05 NO DATA 2.87E+05 9.76E+04 1.04E+04 y CS-136 3.90E+04 1.4GE+05 1.10E+05 NO DATA 8.56E+04 1.20E+04 1.17E+04 CS-131 4.78E+05 6.21E+05 4.28E+05 NO DATA 2.22E+05 7.52E+04 8.40E+03 CS-138. 3.31E+02 6.21E+02 3.24E+02 NO DATA 4.80E+02. 4.86E+01 1.86E-03 BA-139 9.36E-01 6.66E-04 2.74E-02 NO DATA 6.22E-04 3.76E+03 8.96E+02 IBA-140 3.90E+04 4.90E+01 2.57E+03 NO DATA 1.67E+01 1.27E+06 2.18E+05 BA-141 1.00E-01 7.53E-05 3.36E-03 .NO DATA 7.00E-05 1.94E+03 1.16E-07 BA-142 2.63E-02 2.70E-05 1.66E-03 NO DATA 2.29E-05 1.19E+03 1.57E-16 LA-140 3.44E+02 1.74E+02 4.58E+01 NO DATA NO DATA 3.36E+05 4.5BE+05 LA-142 6.83E-01 3.10E-01 7.72E-02 NO DATA NO DATA 6.33E+03 2.11E+03 CE-141 1.99E+04 1.35E+04 1.53E+03 NO DATA 6.26E+03 3.62E+05 1.20E+05 CE-143 1.86E+02 1.38E+02 1.53E+01 NO DATA 6.08E+01 7.98E+04 2.26E+05 ICE-144 PR-143 3.43E+06 9.36E+03 1.43E+06 3.75E+03 1.84E+05 4.64E+02 NO DATA NO DATA 8.48E+05 2.16E+03 7.78E+06 2.81E+05 8.16E+05 2.00E+05 PR-144 3.01E-02 1.25E-02 1.53E-03 NO DATA 7.05E-03 1.02E+03 2.15E-08 bl47 5.27E+Q3 6.10E+03 3.65E+02 NO DATA 3.56E+03 2.21E+05 1.73E+05

,,-187 8.48E+00 7.08E+00 2.48E+00 NO DATA NO DATA 2.90E+04 1.55E+05 2NP-239 2.30E+02 2.26E+01 1.24E+01 NO DATA 7.00E+01 3.76E+04 1.19E+05 3

1.26 x 10

- Less than 8.00 x 10~"

i l

I I

I J

s

, CLINTON-1 3-74 Rev.17-12/98

Ces-oocM TABLE 3.5-17 'l COW MILK PATHWAY FACTORS - Rh (INFANT)

(m* rem /yr per Ci/sec) l ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 2.38E+03* 2.38E+03* 2.38E+03* 2.38E+03* 2.38E+03* 2.38E+03*

C-14 3.23E+06* 6.89E+05* 6.89E+05* 6.89E+05* 6.89E+05* 6.89E+05* 6.89E+05*

NA-24 1.55E+07** 1.55E+07 1.55E+07 1.55E+07 1.55E+07 1.55E&O7 1.55E+07 P-32 1.60E+11 9.41E+09 6.20E+09 NO DATA NO DATA NO DATA 2.16E+09 l CR-51 NO DATA NO DATA- 1.61E+05 1.05E+05 2.29E+04 2.04E+05 4.69E+06 I bel-54 NO DATA 3.90E+07 8.84E+06 NO DATA 8.64E+06 NO DATA 1.43E+07 MN-56 NO DATA 3.12E-02 5.39E-03 NO DATA 2.69E-02 NO DATA 2.84E+00 TE-55 1.35E+08 8.72E+07 2.33E+07 NO DATA NO DATA 4.26E+07 1.11E+07 FE-59 2.25E+08 3.92E+08 1.55E+08 NO DATA NO DATA 1.16E+08 1.87E+08 Co-58 NO DATA 2.43E+07 6.06E+07 NO DATA NO DATA NO DATA 6.05E+07 .

CO-60 NO DATA 8.82E+07 2.08E+08 NO DATA NO DATA NO DATA 2.10E+08 NI-63 3.50E+10 2.16E+09 1.21E+09 NO DATA NO DATA NO DATA 1.08E+08 .

NI-65 3.52E+00 3.98E-01 1.81E-01 .NO DATA NO DATA NO DATA 3.03E+01 CU-64 NO DATA 1.84E+05 8.52E+04 NO DATA 3.11E+05 NO DATA 3.78E+06 )

EN-65 5.55E+09 1.91E+10 8.78E+09 NO DATA 9.23E+09 NO DATA 1.61E+10 '

ZN-69 1.94E-11 3.49E-11 2.60E-12 NO DATA 1.45E-11 No DATA 2.85E-09 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA !

BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA ER-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA l RB-86 NO DATA 2.23E+10 1.10E+10 NO DATA NO DATA NO DATA 5.70E+08 i '

RB-88 NO DATA 1.88E-44 1.03E-44 NO DATA NO DATA NO DATA 1.83E-44 RB-89 HO DATA 3.43E-52 2.36E-52 NO DATA NO DATA NO DATA 1.17E-52 l SR-89 1.26E+10 NO DATA 3.61E+08 NO DATA NO DATA NO DATA 2.59E+08 y ,

SR-90 1.22E+11 NO DATA 3.10E+10 NO DATA NO DATA NO DATA 1.52E+09-3R-91 2.71E+05 NO DATA 9.76E+03 NO DATA NO DATA NO DATA 4 20E+05 SR-92' 4.68E+00 NO DATA 1.74E-01 NO DATA NO DATA NO DATA 5.05E+01 )

Y-90 6.83E+02 NO DATA 1.83E+01 NO DATA NO DATA NO DATA 9.43E+05 Y-91m 6.09E-19 NO DATA 2.08E-20 NO DATA NO DATA NO DATA 2.03E-15 Y-91 7.33E+04 NO DATA 1.95E+03 NO DATA NO DATA NO DATA 5.26E+06 )

Y-92 5.35E-04 NO DATA 1.50E-05 NO DATA NO DATA NO DATA 1.02E+01 l Y-93 2.14E+00 NO DATA 5.83E-02 NO DATA NO DATA NO DATA 1.69E+04 !

ZR-95 6.82E+03 1.66E+03 1.18E+03 NO DATA 1.79E+03 NO DATA 8.283+05 f ZR-97 4.03C+00 6.96E-01 3.16E-01 NO DATA 7.01E-01 NO DATA 4.41E+04 I NB-95 5.93E+05 2.44E+05 1.41E+05 NO DATA 1.75E+05 NO DATA 2.06E+08 )

MO-99 NO DATA 2.07E+08 4.04E+07 NO DATA 3.10E+08 NO DATA 6.83E+07 l TC-99m 2.75E+01 5.66E+01 7.29E+02 NO DATA 6.09E+02 2.96E+01 1.64E+04 l TC-101 2.72E-59 3.42E-59 3.39E-58 NO DATA 4.07E-58 1.87E-59 5.81E-57 I RU-103 8.67E+03 NO DATA 2.92E+03 NO DATA 1.81E+04 NO DATA 1.06E+05 l RU-105 8.00E-03 NO DATA 2.70E-03 NO DATA 5.88E-02 NO DATA 3.18E+00 l RU-106 1.91E+05 NO DATA 2.38E+04 NO DATA 2.26E+05 NO DATA 1.45E+06 -

AG-110m 3.85E+08 2.81E+08 1.86E+08 NO DATA 4.02E+08 NO DATA 1.46E+10 TE-125m 1.51E+08 5.05E+07 2.04E+07 5.08E+07 NO DATA NO DATA 7.19E+07 TE-127m 4.22E+08 1.40E+08 5.10E+07 1.22E+08 1.04E+09 NO DATA 1.70Et08 TE-127 6.31E+03 2.11E+03 1.39E+03 5.13E+03 1.58E+04 NO DATA 1.36E+05 TE-129m 5.56E+08 1.91E+08 8.56E+07 2.14E+08 1.39E+09 NO DATA 3.32E+08 TE-129 2.71E-09 9.34E-10 6.33E-10 2.27E-09 6.75E-09 NO DATA 2.17E-07 TE-131m 3.37E+06 1.36E+06 1.12E+06 2. 75 E+ 06 9.35E+06 NO DATA 2.29E+07 TE-131 3.48E-32 1.29E-32 9.78E-33 3.11E-32 8.91E-32 NO DATA 1.41E-30 Ii l CLINTON-1 3-75 Rev.17-12/98 I

I

CPS-ODCM TABLE 3.5-17 (continued)

COW MILK PATHWAY FACTORS - R" g (INFANT)

(m* mrem /yr per pCi/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE TE-132 2.12E+07 1.05E+07 9.80E+06 1.55E+07 6.57E+07 NO DATA 3.89E+07 I-130 3.53E+06 7.76E+06 3.12E+06 8.70E+08 8.53E+06 NO DATA 1.66E+06 I-131 2.71Et09 3.19E+09 1.40E+09 1.05E+12 3.73E+09 NO DATA 1.1'4 E+ 08 I-132 1.43E+00 2.90E+00 1.03E+00 1.36E+02 3.24E+00 NO DATA 2.35E+00 I-133 3.63E+07 5.28E+07 1.55E+07 9.60E+09 6.21E+07 NO DATA 8.93E+06 I-134 1.64E-11 3.36E-11 1.20E-11 7.86E-10 3.76E-11 NO DATA 3.48E-11 I-135 1.13E+05 2.24E+05 0.18E+04 2. ole +07 2.50E+05 NO DATA 8.12E+04 !

Csa134 3.65E+10 6.81E+10 6.88E+09 NO DATA 1.75E+10 7.19E+09 1.85E+08 CS-136 1.97E+09 5.81E+09 2.17E+09 NO DATA 2.31E+09 4.73E+08 8.82E+07 l CS-137 5.15E+10 6.03E+10 4.27E+09 NO DATA 1.62E+10 6.44E+09 1.89E+08 ;

CS-138, 8.06E-23 1.31E-22 6.35E-23 NO DATA 6.53E-23 1.02E-22 2.09E-22 BA-139 4.29E-07 2.84E-10 1.24E-08 NO DATA' 1.71E-10 1.72E-10 2.72E-05 BA-140 2.45E+08 2.45E+05 1.26E+07 NO DATA 5.72E+04 1.50E+05 5.92E+07 BA-141 4.16E-45 2.85E-48 1.31E-46 NO DATA 1.71E-48 1.73E-48 5.08E-44 BA-142 2.32E-79 1.93E-82 1.14E-80 NO DATA 1.11E-82 1.17E-82 9.56E-79 !

IA-140 4.05E+01 1.60E+01 4.11E+00 NO DATA NO DATA NO DATA 1.88E+05 LA-142 1.73E-10 6.34E-11 1.52E-11 NO DATA NO DATA NO DATA 1.08E-05 CE-141 4.34E+04 2.65E+04 3.12E+03 NO DATA 8.17E+03 NO DATA 1.37E+07 CE-143 3.98E+02 2.64E+05 3.01E+01 NO DATA 7.69E+01 NO DATA 1.54E+06 CE-144 2.34E+06 9.56E+05 1.31E+05 NO DATA 3.87E+05 NO DATA 1.34E+08 PR-143 1.49E+03 .5.56E+02 7.37E+01 NO DATA 2.07E+02 NO DATA 7.85E+05 LR-144 6.27E-53 2.43E-53 3.16E-54 NO DATA 8.79E-54 NO DATA 1.13E-48

-147 8.79E+02 9.03E+02 5.53E+01 NO DATA 3.48E+02 NO DATA 5.72E+05 187 6.10E+04 4.24E+04 1.46E+04 NO DATA NO DATA NO DATA 2.49E+06 PNP-239 3.64E+01 3.26E+00 1.84E+00 NO DATA 6.49E+00 NO DATA 9.41E+04

mrem /yr per pCi/m

- 1.55 x 10' l I

1 i

}

l t

I CLINTON-1 3-76 Rev.17-12/98

CPS-ODCM TABLE 3.S'10 I CCW MILK PATHWAY FACTORS - Rh (CHILD)

(m* mrem /yr per pCi/sec) :

LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ORGAN: BONE ISOTOPE 1.57E403*

NO DATA 1.57E+03* 1.57E+03* 1.5?Ef03* 1.57E+03* 1.57E+03* l H-3 3.29E+05* 3.29E+05* 3.29E+05*

C-14 1.65E+06* 3.29E+05* 3.29E+05* 3.29E+05*

8.93E+06** 8.93E+06 8.93E+06 8.93E+06 8.93E+06 8.93E+06 8.93E+06 NA-24 2.15E+09 7.79E+10 3'.64E+09 3.00E+09 NO DATA NO DATA NO DATA P-32 1.03E+05 5.38E+06 CR-51 NO DATA NO DATA 1.01E+05 5.63E+04 1.54E+04 NO DATA 2.10E+07 5.59E+06 NO DATA 5.88E+06 NO DATA 1.76E+07 MN-54 NO DATA 1.285-02 2.88E-03 NO DATA 1.54E-02 NO DATA 1.85E+00 l MN-56 1.10E+07 FE-55 1.12E+0B 5.94E+07 1.84E+07 NO DATA NO DATA 3.36E+07 3 1.20E+08 1.95E+08 9.71E+07 NO. DATA NO DATA 5.65E+07 2.03E+08 FE-59 7.08E+07 CO-58 CO-60 NO DATA NO DATA 1.21E+07-4.32E+07 3.'71E+07 1.27E+08 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 2.39E+08 l ;f NI-63 2.97E+10 1.59E+09* 1.01E+09 NO DATA NO DATA' NO DATA 1.07E+08 W l 1.65E+00 1.56E-01 9.10E-02 NO DATA NO DATA NO DATA 1.91E+01 !

NI-65 '

CU-64 NO DATA 7.40E+04 4.47E+04 NO DATA 1.79E+05 NO DATA 3.47E+06 4.13E+09 1.10E+10 6.83E+09 NO DATA 6.92E+09 NO DATA 1.93E+09 ZN-65 ZN-69 9.11E-12 1.32E-11 1.22E-12 NO DATA 7.99E-12 NO DATA 8.30E-10 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA GR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-85 NO DATA RB-86 NO DATA 8.78E+09 5.40E+09 NO DATA NO DATA NO DATA 5.65E+08 NO DATA 7.16E-45 4.98E-45 NO DATA NO DATA NO DATA 3.51E-46 RB-88 RB-89 NO DATA 1.40E-52 1.25E-52 NO DATA NO DATA NO DATA 1.22E-54 SR-89 '6.63E+09 NO DATA 1.89E+08 NO DATA NO DATA NO DATA 2.57E+08 SR-90 1.12E+11 NO DATA 2.84E+10 NO DATA NO DATA NO DATA 1.51E+09 SR-91 1.30E+05 NO DATA 4.89E+03 NO DATA NO DATA NO DATA 2.86E+05 s SR-92~ 2.20E+00 NO DATA 8.83E-02 NO DATA NO DATA NO DATA 4.17E+01 l Y-90 3.23E+02 NO DATA 8.65E+00 NO DATA NO DATA NO DATA 9.20E+05 N.

Y-91m 2.88E-19 NO DATA 1.05E-20 NO DATA NO DATA NO DATA 5.63E-16 Y-91 3.90E+04 NO DATA 1.04E+03 NO DATA NO DATA NO DATA 5.20E+06 Y-92 2.53E-04 NO DATA 7.23E-06 NO DATA NO DATA NO DATA 7.30E+00 Y-93 1.01E+00 NO DATA 2.76E-02 NO DATA NO DATA NO DATA 1.50E+04 ZR-95 3.84E+03 8.44E+02 7.51E+02 NO DATA 1.21E+03 NO DATA 8.80E+05 ~

ZR-97 1.92E+00 2.78E-01 1.64E-01 NO DATA 3.99E-01 NO DATA 4.21E+04 NB-95 3.18E+05 1.24E+05 8.84E+04 NO DATA 1.16E+05 NO DATA 2.29E+08 MO-99 NO DATA 8.15E+07 2.02E+07 NO DATA 1.74E+08 NO DATA 6.74E+07 TC-99m 1.32E+01 2.58E+'J1 4.28E+02 NO DATA 3.75E+02 1.31E+01 1.47E+04 TC-101 1.28E-59 1.34F-59 1.70E-58 NO DATA 2.29E-50 7.08E-60 4.26E-59 RU-103 4.29E+03 NO PATA 1.65E+03 NO DATA 1.0BE+04 NO DATA 1.11E+05 g RU-105 3.80E-03 NO DATA 1.38E-03 NO DATA 3.34E-02 NO DATA 2.48E+00 RU-106 9.25E+04 NO DATA 1.15E+04 NO DATA 1.25E+05 NO DATA 1.44E+06 AG-110m TE-125m 2.09E+08 7.39E+07 1.41E+08 2.00E+07 1.13E+08 9.85E+07 NO DATA 2.07E+07 2.63E+08 NO DATA NO DATA NO DATA 1.68E+10 7.13E+07 l'N TE-127m 2.08E+08 5.61E+07 2.47E+07 4.98E+07 5.94E+0B NO DATA 1.69E+08 TE-127 2.97E+03 8.01E+02 6.37E+02 2.06E+03 8.45E+03 NO DATA 1.16E+05 TE-129m 2.71E+08 7.58E+07 4.21E+07 8.74E+07 7.97E+08 NO DATA 3.31E+08 TE-129 1.28E-09 3.57E-10 3.04E-10 9.12E-10 3.74E-09 NO DATA 7.96E-08 TE-131m 1.60E+06 5.53E+05 5.88E+05 1.14E+06 5.35E+06 NO DATA 2.24E+07 TE-131 1.64E-32 5.01E-33 4.89E-33 1.26E-32 4.97E-32 NO DATA 8.63E-32 I

CLINTON-1 3-77 Rev.17-12/98 I

i

S-ODCM TABLE 3.5-18 (continued) '

COW MILK PATHWAY FACTORS - R" y (CHILD)

(m* mrem /yr per pCi/sec) j

AN BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI YTOPE

-132 1.03E+07 4.56E+06 5.51E+06 6.64E+06 4.23E+07 NO DATA 4.59E+07 L30 1.72E+06 3.47E+06 1.79E+06 3.82E+08 5.19E+06 NO DATA 1.62E+06 L31 1.30E+09 1.31E+09 7.44E+08 4.33E+11 2.15E+09 NO DATA 1.17E+08 ,

L32 6.91E-01 1.27E+00 5. 8 4 E--01 5.89E+01 1.94E+00 NO DATA 1.49E+00 L33 1.72E+07 2.12E+07 8.03E+06 3.94E+09 3.54E+07 NO DATA 8.56E+06 L34 7.92E-12 1.47E-11 6.77E-12 3.38E-10 2.25E-11 NO DATA 9.75E-12 L35 5.43E+04 9.77E+04 4.62E+04 8.56E+06 1.50E+05 NO DATA 7.44E+04

-134 2.27E+10 3.72E+10 7.85E+09 NO DATA 1.15E+10 4.14E+09 2.01E+08 -

-136 1.01E+09 2.78E+09 1.80E+09 NO DATA 1.48E+09 2.21E+08 9.76E+07

-137 3.23E+10 3.09E+10 4.56E+09_ NO DATA 1.01E+10 3.63E+09 1.94E+08

-138 3.82E-23 5.31E-23 3.37E-23 NO DATA 3.74E-23 4.02E-24 2.45E-23

-139 2.01E-07 1.08E-10 5.84E-09 NO DATA 9.39E-11 6.33E-11 1.16E-05 '

-140 1.18E+08 1.03E+05 6.84E+06 NO DATA 3.37E+04 6.12E+04 5.94E+07

-141 1.96E-45 1.10E-48 6.38E-47 NO DATA 9.50E-49 6.45E-48 1.12E-45

-142 1.10E-79 7.93E-83 6.15E-81 NO DATA 6.41E-83 4.66E-83 1.44E-81

-140 1.94E+01 6.78E+00 2.11E+00 NO DATA NO DATA NO DATA 1.89E+05

-142 8.23E-11 2.62E-11 8.21E-12 NO DATA NO DATA NO DATA 5.20E-06

-141 2.19E+04 1.09E+04 1.62E+03 NO DATA 4.78E+03 NO DATA 1.36E+07

-143 1.87E+02 1.02E+05 1.47E+01 NO DATA 4.26E+01 NO DATA 1.49E+06

-144 1.63E+06 5.10E+05 8.68E+04 NO DATA 2.82E+05 NO DATA 1.33E+08

-143 7.19E+02 2.16E+02 3.57E+01 NO DATA 1.17E+02 NO DATA 7.76E+05

-144 2.94E-53 9.10E-54 1.48E-54 NO DATA 4.81E-54 NO DATA 1.96E-50

-147 4.44E+02 3.59E+02 2.78E+01 NO DATA 1.97E+02 NO DATA 5.69E+05 L87 2.88E+04 1.71E+04 7.66E+03 NO DATA NO DATA NO DATA 2.40E+06

-239 1.72E+01 1.24E+00 8.69E-01 NO DATA 3.58E+00 NO DATA 9.15E+04 rem /yr per 8.93 x'10' pCi/m -

$NTON-1 3-78 Rev.17-12/98

CPS-ODCM E !

TABLE 3.5-19 Ei

-]

I COW MILK PATHWAY FACTORS - R h (TEEN) g>

=

(m* mrem /yr per pCi)

ORGAN: DONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 9.92E+02* 9.92E+02* 9.92E+02* 9.92E+02* 9.92E+02* 9.92E+02*

C-14 6.70E+05* 1.34E+05* 1.34E+05* 1.34E+05* 1.34E+05* 1.34E+05* 1.34E+05*

NA-24 4.29E+06* 4.29E+06 4.29E+06 4.29E+06 4.29E+06 4.29E+06 4.29E+06 l

~~

&-32 3.15E+10 1.95E+09 1.22Et09 NO DATA NO DATA NO DATA 2.64E+09 5 CR-51 NO DATA NO DATA 5.00E+04 2.78E+04 1.10E+04 7.14E+04 8.41E+06 MN-54 NO DATA 1.40E+07 2.78E+06 NO DATA 4.19E+06 NO DATA 2.88E+07 MN-56 NO DATA 7.32E-03 1.30E-03 NO DATA 9.26E-03 NO DATA 4.82E-01 FE-55 4.46E+07 3.16E+07 7.MEM6 NO DATA NO DATA 2.01E+07 1.37E+07 FE-59 5.18E+07 1.21E+08 4.67(+67 3.0 DATA NO DATA 3.81E+07 2.68E408 CO-58 NO DATA 7.98E+06 1 J O5 f I ~30 DATA NO' DATA NO DATA 1.10E+08 g CO-60 NO DATA 2.78E+07 6.a6r+V7 NO DATA NO DATA NO DATA 3.62E+08 g NI-63 1.18E+10 8.34E+08 4.0 % 08 NO DATA NO DATA NO DATA 1.33E+08 NI-65 6.79E-01 8.67E-02 3.95E-02 .NO DATA NO DATA NO DATA 4.70E+00 CU-64 NO DATA 4.20E+04 1.97E+04 3.41E+09 NO DATA 1.06E+05 4.68E+09 NO' DATA NO DATA 3.26E+06 3.10E+09 5

g ZN-65 2.11E+09 7.32E+09 NO DATA ZN-69 3.70E-12 7.06E-12 4.94E-13 NO DATA 4.61E-12 NO DATA 1.30E-11 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA l BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 5 RB-86 NO DATA 4.74E+09 2.23E+09 NO DATA NO DATA NO DATA 7.01E+08 RB-88 NO DATA 3.90E-45 2.08E-45 NO DATA NO DATA NO DATA 3.3 4 E -52 RB-89 NO DATA 7.98E-53 5.64E-53 NO DATA NO DATA NO DATA 1.22E-61 SR-89 2.68E+09 NO DATA 7.67E+07 NO DATA NO DATA NO DATA 3.19E+08 WW SR-90 6.62E+10 NO DATA 1.64E+10 NO DATA NO DATA NO DATA 1.86E+09 i SR-91 5.27E+04 NO DATA 2.10E+03 NO DATA NO DATA NO DATA 2.39E+05 SR-92 9.03E-01 NO DATA '3.85E-02 NO DATA NO DATA NO DATA 2.30E+01 Y-90 1.31E+02 NO DATA 3.53E+00 NO DATA NO DATA NO DATA 1.08E+06 Y-91m 1.10E-19 NO DATA 4.49E-21 NO DATA NO DATA NO DATA 5.55E-18 Y-91 1.58E+04 NO DATA 4.24E+02 NO DATA NO DATA NO DATA 6.48E+06 E Y-92 1.03E-04 NO DATA 2.97E-06 NO DATA NO DATA NO DATA 2.82E+00 g Y-93 4.10E-01 NO D1:A 1.12E-02 NO DATA NO DATA NO DATA 1.25E+04 ZR-95 1.65E+03 5.20 % '2 3.58E+02 NO DATA 7.65E+02 NO DATA 1.20E+06 ZR-97 7.87E-01 1.561.-01 7.17E-02 NO DATA 2.36E-01 NO DATA 4.22E+04 l NB-95 1.41E+05 7.81E+04 4.30E+04 NO DATA 7.57E+04 NO DATA 3.34E+08 3 MO-99 NO DATA 4.46E+07 8.50E+06 NO DATA 1.02E+08 NO DATA 7.98E+07 TC-99m 5.74E+00 1.60E+01 2.08E+02 NO DATA 2.39E+02 8.89E+00 1.05E+04 TC-101 5.22E-60 7.42E-60 7.29E-59 NO DATA 1.34E-58 4.52E-60 1.27E 56 RU-103 1.81E+03 NO DATA 7.73E+02 NO DATA 6.37E+03 No DATA 1.51E+05 E RU-105 1.56E-03 NO DATA 6.06E-04 NO DATA 1.97E-02 NO DATA 1.26E+00 RU-106 3.75E+04 NO DATA 4.73E+03 NO DATA 7.23E+04 NO DATA 1.80E+06 g AG-110m 9. 64 E+ 07 9.12E+07 5.55E+07 NO DATA 1.74E+08 NO DATA 2.56E+10 8.88E+07 g

TE-125m 3.01E+07 1.0BE+07 4.02E+06 8.41E+06 NO DATA NO DATA TE-127m 8.43E+07 2.99E+07 1.00E+07 2.01E+07 3.42E+08 NO DATA 2.10E+08 TE-127 1.21E+03 4.28E+02 2.60E+02 8.33E+02 4.89E+03 NO DATA 9.33E+04 TE-129m 1.10E+08 4.09E+07 1.74E+07 3.56E+07 4.61E+08 NO DATA 4.14E+08 TE-129 5.18E-10 1.93E-10 1.26E-10 3.70E-10 2.17E-09 NO DATA 2.83E-09 TE-131m 6.56E+05 3.15E+05 2.63E+05 4.73E+05 3.28E+06 NO DATA 2.53E+07 TE-131 6.70E-33 2.76E-33 2.09E-33 5.16E-33 2.92E-32 NO DATA 5.50E-34 I

CLINTON-1 3-79 Rev.17-12/98 I

I

PS-ODCM TABLE 3.5-19 (continued)

COW MILK PATHWAY FACTORS R".y (TEEN)

(m* mrem /yr per pCi/sec)

RGAN BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI SOFOPE E-132 4.29E+06 2.72E+06 2.56E+06 2.87E+06 2.61E+07 NO DATA 8.61E+07

-130 7.33E+05 2.12E+06- 8.47E+05 1.73E+08 3.27E+06 NO DATA 1.63E+06

-131 5.36E+08 7.50E+08 4.03E+08 2.19E+11 1.29E+09 NO DATA 1.48E+08

-132- 2.90E-01 7.59E-01 2.72E-01 2.56E+01 1. 2 0E+00 NO DATA 3.31E-01

-133 7.06E+06 '1.20E+07 3.65E+06 1.67E+09 2.104+07 NO DATA 9.06E+06

-134- 3.34E-12 8.86E-12 3.18E-12 1.48E-10 1.40E-11 NO DATA 1.17E-13

-135- 2.29E+04 5.90E+04 2.19E+04 3.80E+06 9.32E+04 NO DATA 6.54E+04 s-134 9.79E+09. 2.30E+10 1.07E+10 NO DATA ' 7.32E+09 2.80E+09 2.87E+08 S-136- 4.48E+08 1.76E+09 1.18E+09 NO DATA 9.59E+08 1.51E+08 1.42E+08 S-137 1.33E+10- 1.77E+10 6.18E+09 NO DATA 6.03E+09 2.34E+09 2.52E+08 s-138.<. I'58E-23

. 3.03E-23 1.51E-23 NO DATA 2.23E-23 '2.60E-24 1.37E-26 '

A-139 8'.20E-08 5.77E-11 2.39E-09 NO DATA 5.44E-11 3.98E-11 7.31E-07 l A-140. 4.85E+07- 5.95E+04 3.13E+06 NO DATA 2.02E+04 4.00E+04 7.49E+07 A-141 7.98E-46. 5.96E-49 2.67E-47 NO DATA ~ 5.53E-49 4.00E-49 1.70E-51 A-142 4.54E-80 4.54E-83 2.80E-81 NO DATA 3.85E-83 3.02E-83 1.40E-91 {

A-140 8.11E+00 3.98E+00- 1.06E+00 NO DATA NO DATA NO DATA 2.29E+05 )

A-142 3.42E-11 1.52E-11 3.78E-12 NO DATA NO DATA NO DATA 4.62E-07 E-141 8.88E+03 5.93E+03 6.81E+02 NO DATA 2.79E+03 NO DATA 1.70E+07 E-143 5.55E+04 6.21E+00 NO DATA 2.49E+01 NO DATA 1.67E+06 E-144 7.64E+01 6.61E+05 ~ 2.73E+05 3.55E+04 NO DATA 1.63E+05 NO DATA 1.66E+08 l

'R-143 2.91E+02 1.16E+02 1.45E+01 NO DATA 6.75E+01 NO DATA 9.57E+05

'R-144 1.19E-53 4.88E-54 6.04E-55 NO DATA 2.80E-54 NO DATA 1.31E-56

-147 1.81E+02 1.97E+02 1.18E+01 NO DATA 1.16E+02 NO DATA 7.10E+05

-187 1.19E+04 9.72E+03 3.41E+03 NO DATA NO DATA NO DATA 2.63E+06 P-239 6.99E+00 6.59E-01 3.66E-01 NO DATA 2.07E+00 NO DATA 1.06E+05 mrem /yr per pCi/m

4.29 x 10' .

LINTON-1 3-80 Rev.17-12/98

CPS-ODCM g

TABLE 3.5-20 W COW MILK PATHWAY FACTORS - Rh (ADULT) g (m* mrem /yr per Ci/sec) m ORGAN: BONE LIVER T. B0i Y THYROID KIDNEY LUNG GI-LLI l l

ISOTOPE H-3 NO DATA 7.62E+02* 7.62E+02* 7.62E+02* 7.62E+02* 7.62E+02* 7.62E+02*

C-14 3.63E+05* 7.26E+04* 7.26E+04* 7.26E+04* 7.26E+04* 7.26E+04* 7.26E+04*

NA-24 2.46E+06** 2.46E+06 2.46E+06 2.46E+06 2.46E+06 2.46E+06 2.46E+06 P-32 1.71E+10 1.06E+09 6.61E+08 NO DATA NO DATA NO DATA 1.92E+09 CR-51 NO DATA NO DATA 2.85E+04 1.70E+04 6.27E+03 3.78E+04 7.16E+06 HN-54 NO DATA 8.41E+06 1.60E+06 NO DATA 2.50E+06 NO DATA 2.58E+07 MN-56 NO DATA 2.51E+07 4.14E-03 1.73E+07 7.34E-04 4.04E+06 NO DATA NO DATA 5.26E-03 NO DATA NO DATA 9.68E+06 1.32E-01 9.95E+06 l! l FE-55 3 !

FE-59 2.97E+07 6.99E+07- 2.68E+07 NO DATA NO DATA 1.95E+07 2.33E+08 {

CO-58 NO DATA 4.72E+06 1.06E+07 NO DATA NO DATA NO DATA 9.57E+07 !

Co-60 NO DATA- 1.64E+07 3.62E+07 NO DATA NO DATA NO DATA 3.08E+08 )

NI-63 6.73E+09 4.67E+08 2.26E+08 NO DATA NO DATA NO DATA 9.74E+07 l NI-65 3.70E-01 4.81E-02 2.19E-03 NO DATA NO DATA NO DATA 1.22E+00 '

CU-64 NO DATA '2.36E+04 1.11E+04 NO DATA 5.94E+04 .NO DATA 2.01E+06 3 ZN-65 1.37E+09 4.37E+09 1.98E+09 NO DATA 2.93E+09 NO DATA NO DATA 2.75E+09 5.77E-13 g

ZN-69 2.01E-12 3.84E-12 2.67E-13 NO DATA 2.50E-12 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA No DATA NO DATA NO DATA NO DATA NO DATA !

BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA RB-86 No DATA 2.60E+09 1.21E+09 NO DATA NO DATA NO DATA 5.12E+08 '

RB-88 NO DATA 2.15E-45 1.14E-45 NO DATA NO DATA NO DATA 2.97E-56 RB-89 NO DATA 4.49E-53 3.16E-53 NO DATA NO DATA NO DATA 2.61E-66 SR-89 1.45E+09 NO DATA 4.16E+07 NO DATA NO DATA NO DATA 2.33E+08 W SR-90 4.68E+10 NO DATA 1.15E+10 NO DATA NO DATA NO DATA 1.35E+09 S R-91. 2.87E+04 NO DATA 1.16E+03 NO DATA NO DATA NO DATA 1.37E+05 SR-92 4.92E-01 NO DATA 2.13E-02 NO DATA NO DATA NO DATA 9.76E+00 Y-90 7.10E+01 NO DATA 1.90E+00 NO DATA NO DATA NO DATA 7.53E+05 Y-91m 6.42E-20 NO DATA 2.49E-21 NO DATA NO DATA NO DATA 1.89E-19 Y-91 8.60E+03 NO DATA 2.30E+02 NO DATA NO DATA NO DATA 4.73E+06 g Y-92 Y-93 5.57E-05 2.22E-01 NO DATA NO DATA 1.63E-06 6.12E-03 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 9.75E-01 7.03E+03 gi ZR-95 9.45E+02 3.03E+02 2.05E+02 NO DATA 4.76E+02 NO DATA 9.61E+05 ZR-97 4.32E-01 8.71E-02 3.98E-02 NO DATA 1.32E-01 NO DATA 2.70E+04 ,

NB-95 8.25E+04 4.59E+04 2.47E+04 NO DATA 4.54E+04 NO DATA 2.79E+08 {

MO-99 NO DATA 2.48E+07 4.72E+06 .NO DATA 5.61E+07 NO DATA 5.74E+07 j TC-99m 3.31E+00 9.35E+00 1.19E+02 NO DATA 1.42E+02 4.58E+00 5.53E+03 TC-101 RU-103 2.85E-60 1.02E+03 4.11E-60 NO DATA 4.03E-59 4.39E+02 NO DATA NO DATA 7.41E-59 3.89E+03 2.10E-60 NO DATA 1.24E-71 1.19E+05 hl E

RU-105 8.52E-04 NO DATA 3.36E-04 NO DATA 1.10E-02 NO DATA 5.21E-01 RU-106 2.04E+04 NO DATA 2.58E+03 NO DATA 3.94E+04 NO DATA 1.32E+06 AG-110m 5.82E+07 5.39E+07 3.20E+07 NO DATA 1.06E+08 NO DATA 2.20E+10 TE-125m 1.63E+07 5.91E+06 2.19E+06 4.91E+06 6.64E+07 NO DATA 6.52E+07 TE-127m 4.58E+07 1.64E+07 5.58E+06 1.17E+07 1.86E+08 NO DATA 1.53E+08 TE-127 6.52E+02 2.34E+02 1.41E+02 4.83E+02 2.65E+03 NO DATA 5.14E+04 g TE-129m 6.01E+07 2.24E+07 9.52E+06 2.07E+07 2.51E+08 NO DATA 3.03E+08 TE-129 2.82E-10 1.06E-10 6.86E-11 2.16E-10 1.18E-09 NO DATA 2.12E-10 E TE-131m 3.60E+05 1.76E+05 1.47E+05 2.79E+05 1.78E+06 NO DATA 1.75E+07 TE-131 3.68E-33 1.54E-33 1.16E-33 3.03E-33 1.61E-32 NO DATA 5.22E-34 I

l CLINTON-1 3-81 Rev.17-12/98 Ill I;

I CPS-ODCM TABLE 3.5-20 (continued)

COW MILK PATIlWAY FACTORS - R".y (ADULT)

(m' mrem /yr per pCi/sec)

ORGAN: BONE LIVER T.BCDY THYROID KIDNEY LUNG GI-LLI e ISOTOPE 2.41E+06 1.56E+06 1.46E+06 1.72E+06 1.50E+07 NO DATA 7.36E+07 E.TE-132 I-130 4.16E+05 1.23E+06 4.84E+05 1.04E+08 1.91E+06 NO DATA 1.06E406 I-131 2.97E+08 ~4.24E+08 2.43E+08 1.39E+11 7.27E+08 NO DATA 1.12E+08 1.65E-01 4.40E-01 1.54E-01 1.54E+01 7.02E-01 NO DATA 8.27E-02 II-132 I-133 I-134 3.86E+06 1.89E-12 6.72E+06 5.13E-12 2.05E+06 1.83E-12 9.87E+08 8.88E-11 1.17E+07 NO DATA 8.15E-12 NO DATA 6.04E+06 4.47E-15 I-135 1.29E+04 3.39E+04 1.25E+04 2.23E+06 5.43E+04 NO DATA 3.83E+04 5.67E+09 1.35E+10 1.10E+10 NO DATA 4.37E+09 1.45E+09 2.36Et08 ICS-134.

CS-136 2.64E+08 1.04E+09 7.49E+08 NO DATA 5.79E+08 7.94E+07 1.18E+08 CS-137 7.39E+09 1.01E+10 6.62E+09 HO DATA 3.43E+09 1.14E+09 1.96E+08 CS-138 '.69E-24.

8 1.72Z-23 8.50E-24 NO DATA 1.26E-23 1.24E-24 7.32E-29

$BA-139 4.43E-08 3.16E-11 1.30E-09 NO DATA 2.95E-11 1.79E-11 7.86E-08 W BA-140, 2.72E+07 3.42E+04 1.78E-06 NO DATA 1.16E+04 1.96E+04 5.60E+07 BA-141 4.33E-46 3.27E-49 1.46E-47 NO DATA 3.04E-49 1.86E-49 2.04E-55 g BA-142 2.51E-80 2.58E-83 1.58E-81 NO DATA 2.18E-83 1.46E-83 3.54E-98 gLA-140- 4.53E+00 2.28E+00 6.03E-01 NO DATA NO DATA NO DATA 1.67E+05 LA-142 1.89E-11' 8.61E-12 2.15E-12 NO DATA NO DATA NO DATA 6.29E-08 1 CE-141 4.84E+03 3.27E+03 3.71E+02 NO DATA 1.52E+03 NO DATA 1.25E+07 CE 143 4.16E+01 S.07E+04 3.40E+00 NO DATA 1.35E+01 NO DATA 1.15E+06 ICE-144 PR-143 3.58E+05 1.58E+02 1.50E+05 6.35E+01 1.92E+04 7.84E+00 NO DATA NO DATA 8.87E+04 NO DATA 3.66E+01 NO DATA 1.21E+08 6.93E+05 6.47E-54 2.69E-54 3.29E-55 NO DATA 1.52E-54 NO DATA 9.31E-61

-147 9.44E+01 1.09E+02 6.53E+00 NO DATA 6.38E+01 NO DATA 5.24E+05 IR-144187 6.50E403 3.67E+00 5.43E+03 1.90E+03 NO DATA NO DATA NO DATA 1.78E+06 i

l

}NP-239 3.60E-01 1.99E-01 NO DATA 1.12E+00 NO DATA 7.39E+04

mrem /yr per pCi/m'

- 2.46'x 10' I

I 1

I E

I I

E CLINTON-1 3-82 Rev.17-12/98

I CPS-ODCM *

)

TABLE 3.5-21

j GOAT MILK PATHWAY FACTORS - Rh (INFANT)

(m* rem /yr per 'li/seC)

'EE ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE '

H-3 NO DATA 4.86E+03* 4.86E+03* .4.86E+03* 4.86E+03* 4.86E+03* 4.86E+03*

C-14 3.23E+06* 6.89E+05* 6.89E+05* 6.89E+05* 6.89E+05* 6.89E+05* 6.89E+05*

} NA-24 1.87E+06** 1.87E+06 1.87E+06 1.87E+06 1.87E+06 1.87E+06 1.87E+06 g P-32 1.90E+11 1.12E+10 7.46E+09 NO DATA NO DATA NO DATA 2.58E+09 3 CR-51 NO DATA NO DATA 1.93E+04 1.26E+04 2.75E+03 2.45E+04 5.63E+05 HN-54 NO DATA 4.68E+06 1.06E+06 NO DATA 1.04E+06 NO DATA 1.72E+06 MN-56 NO DATA 3.75E-03 6.46E-04 NO DATA 3.22E-03 NO DATA 3.40E-01 l W

FE-55 1.75E+06 1.13E+06 3.02E+05 NO DATA NO DATA 5.53E+05 1.44E+05 FE-59 2.91E+06 5.08E+06 2.00E+06 NO' DATA NO DATA 1.50E+06 2.43E+06 CO-58 NO DATA 2.90E+06 7.24E+06 NO DATA NO DATA NO DATA 7.23E+06 CO-60 NO DATA 1.06E+07 3 49E+07 NO DATA NO DATA NO DATA 2.51E+07 NI-63 4.19E+09 2.59E+08 1.45E+08 NO DATA NO DATA NO ' DATA 1.29E+07 NI-65 4.20E-01 4.76E-02 2.16E-02 NO DATA NO DATA NO DATA 3.62E+00 CU-64 NO DATA' 2.04E+04 9.45E+03 NO DATA 3.45E+04 NO DATA 4.19E+05 g ZN-65 6.64E+03 2.28E+09 1.05E+09 NO DATA 1.10E+09 NO DATA 1.92E+09 g ZN-69 2.32E-12 4.18E-12 3.11E-13 NO DATA 1.74E-12 NO DATA 3.41E-10 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA G'R- 84 NO DATA NO DATA NO DATA NO DATA NO DATA E

g BR-85 NO DATA NO DATA RB-86 NO. DATA 2.65E+09 1.31E+09 NO DATA NO DATA NO DATA 6.79E+07 RB-88 NO DATA 2.25E-45 1.23E-45 NO DATA NO DATA NO DATA 2.19E-45 RB-89 NO DATA 4.09E-53 2.82E-53 NO DATA NO DATA NO DATA 1.39E-53 SR-89 2.64E+10 NO DATA 7.56E+08 NO DATA NO DATA NO DATA 5.42E+08 W SR-90 2.55E+11 NO DATA 6.50E+10 NO DATA NO DATA No DATA 3.19E+09 f SR-91 5.65E+05 NO DATA 2.05E+04 NO DATA NO DATA NO DATA 6.69E+05 i, SR-92 9.83E+00 NO DATA 3.65E-01 NO DATA NO DATA NO DATA 1.06E+02 '.

Y-90 8.19E+01 NO DATA 2.19E+00 NO DATA NO DATA NO DATA 1.13E+05 Y-91m 7.29E-20 NO DATA 2.48E-21 NO DATA NO DATA NO DATA 2.43E-16 Y-91 8.78E+03 NO DATA 2.34E+02 NO DATA NO DATA NO DATA 6.29E+05 g Y-92 6.40E-05 NO DATA 1.80E-06 NO DATA NO DATA NO DATA 1.22E+00 2.02E+03 g

Y-93 2.55E-01 NO DATA 6.95E-03 NO DATA NO DATA NO DATA ZR-95 8.16E+02 1.99E+02 1.41E+02 NO DATA 2.14E+02 NO DATA 9.90E+04 ZR-97 4.85E-01 8.33E-02 3.80E-02 NO DATA 8.40E-02 NO DATA 5.31E+03 g NB-95 7.12E+04 2.93E+04 1.69E+04 NO DATA 2.10E+04 NO DATA 2.47E+07 g MO-99 NO DATA 2.48E+07 4.84E+06 NO DATA 3.71E+07 NO DATA 8.18E+06 TC-99m 3.26E+00 6.73E+00 8.67E+01 7.24E+01 3.52E+00 1.96E+03 TC-101 RU-103 3.26E-60 1.04E+03 4.11E-60 NO DATA 4.06E-59 3.47E+02 NO DATA NO DATA NO DATA 4.88E-59 2.16E+03 2.24E-60_

No DATA 6.98E-58 1.26E+04

- ml RU-105 9.60E-04 NO DATA 3.23E-04 NO DATA 7.06E-03 NO DATA 3.82E-01 RU-106 2.28E+04 NO DATA 2.84E+03 NO DATA 2.69E+04 NO DATA 1.73E+05 AG-110m 4.62E+07 3.37E+07 2.23E+07 NO DATA 4.83E+07 NO DATA 1.75E+09 TE-125m 1.80E+07 6.02E+06 2.43E+06 6.06E+06 NO DATA NO DATA 8.58E+06 TE-127m 5.04E+07 1.67E+07 6.10E+06 1.46E+07 1.24E+08 NO DATA 2.03E+07 TE-127 7.57E+02 2.54E+02 1.63E+02 6.16E+02 1.85E+03 NO DATA 1.59E+04 g TE-129m , 6. 68E+07 2.29E+07 1.03E+07 2.57E+07 1.67E+08 NO DATA 3.99E+07 g TE-129 3.25E-10 1.12E-10 7.59E-11 2.73E-10 8.10E-10 NO DATA 2.60E-08 TE-131m 4.04E405 1.63E+05 1.34E+05 3.30E+05 1.12E+06 NO DATA 2.74E+06 TE-131 4.19E-33 1.55E-33 1.18E-33 3.74E-33 1.07E-32 NO DATA 1.69E-31 I,

1 CLINTON-1 3-83 Rev.17-12/98 I

1

I CPS -ODCM TABLE 3.5-21 (continued)

Iw GOAT MILK PATHWAY FACTORS - R".y (INFANT)

(m* mrem /yr per pCi/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISCYrOPE 2.54E+06 1.26E+06 1.17E+06 1.85E+06 7.86E+06 NO DATA 4.65E+06 ITE-132 I-130 4.22E+06 9.28E+06 3.73E+06 1.04E+09 1.02E+07 NO DATA 1.99E+06 I-131 3.25E+09 3.83E+09 1.69E+09 1.26E+12 4.4BE+09 NO DATA 1.37E+08 I-132 1.73E+00 3.50E+00 1.25E+00 1.64E+02 3.91E+00 NO DATA 2.84E+00 4.34E+07 6.32E+07 1.85E+07 1.15E+10 7.43E+07 1.07E+07 II-133 I-134 1.97E-11 4.04E-11 1.44E-11 9.42E-10 4.52E-11 NO DATA NO DATA 4.18E-11 l

I-135 1.36E+05 2.70E+05 9.85E+04 2.42E+07 3.01E+05 NO DATA 9.77E+04 f

l 1.09E+11 2.04E+11 2.06E410 NO DATA 5.25E+10 2.15E+10 5.54E+08 ICS-134 CS-136 5.'92E+09 1.74E+10 6.50E+09 NO DATA 6.94E+09 1.42E+09 2.64E+08 )

CS-137 1.54E+11 1.80E+11 -1.28E+10 NO DATA 4.84E+10 1.96E+10 5.63E+08 )

CS-138 2.42E-22 3.93E-22 1.90E-22 NO DATA 1.96E-22 3.06E-23 6.28E-22 E BA-139 5.14E-08 3.41E-11 1.49E-09 NO DATA 2.05E-11 2.07E-11 3.26E-06 E BA-140 2.87E+07 2.87E+04 1.48E+06 NO DATA 6.82E+03 1.76E+04 7.06E+06 BA-141 4.97E-46 3.40E-49 1.57E-47 NO DATA 2.05E-49 2.07E-49 6.07E-45

_ BA-142 2.76E-80 2.30E-83 1.36E-81 NO DATA 1.32E-83 1.39E-83 1.14E-79 l LA-140 4.83E+00 1.91E+00 4.90E-01 NO DATA NO DATA NO DATA 2.24E+04 '

5IA-142 2.07E-11 7.60E-12 1.82E-12 NO DATA NO DATA NO DATA 1.29E-06 CE-141 5.20E+03 3.17E+03 3.73E+02 NO DATA 9.78E+02 NO DATA 1.64E+06 CE-143 4.75E+01 3.15E+04 3.60E+00 NO DATA 9.18E+00 NO DATA 1.84E+05 2.79E+05 1.14E+05 1.56E+04 4.61E+04 ICE-144 PR-143 1.78E+02 6.66E+01 8.83E+00 NO DATA NO DATA 2.47E+01 NO DATA NO DATA 1.60E+07 9.40E+04 PR-144 7.51E-54 2.90E-54 3.78E-55 NO DATA 1.05E-54 NO DATA 1.35E-49 l 147 1.06E+02 1.08E+02 6.65E+00 NO DATA 4.18E+01 NO DATA 6.88E+04 I'187 JNP-239 7.27E+03 4.37E+00 5.06E+03 3.91E-01 1.75E+03 2.21E-01 NO DATA NO DATA NO DATA 7.80E-01 NO DATA NO DATA 2.97E+05 1.13E+04 l

Iomrem/yr per6 pCi/m 001.87 x 10 I

I I

I I'

CLINTON-1

=

3-84 Rev.17-12/98

i CPS-ODCM TABLE 3.5-22 GOAT MILK PATHWAY FACTORS - Rh (CHILD) l (m* mrem /yr per Ci/sec) /

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ORGAN:

ISOTOPE H-3 NO DATA 3.20E+03* 3.20E+03* 3.20E+03* 3.20E+03* 3.20E+03* 3.20E+03*

C-14 1.65E+06* 3.29E+05* 3.29E+05* 3.29E+05* 3.29E+05* 3.29E+05* 3.29E+05*

NA-24 1.07E+06** 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.07E+06 l P-32 9.32E+10 4.36E+09 3.59E+09 NO DATA NO DATA NO DATA 2.58E+09 3 CR-51 NO DATA NO DATA 1 22E+04 6.77E+03 1.85E+03 1.24Et04 6.47E+05 MN-54 NO DATA 2.51E+06 6.70E+05 NO DATA 7.05E+05 NO DATA 2.11E+06 MN-56 NO DATA 1.53E-03 3.45E-04 NO DATA 1.85E-03 NO DATA 1.21E-01 l W

FE-55 1.45E+06 7.65E+05 2.38E+05 NO DATA NO DATA 4.35E+05 1.42E+05 FE-59 1.55E+06 2.52E+06 1.25E+06 NO DATA NO DATA 7.29E+05 2.62E+06 CO-58 NO DATA 1.46E+06 4.46E+06 NO DATA NO DATA NO DATA 8.49E+06 CO-60 NO DATA 5.16E+06 1.52E+07 NO DATA NO DATA ' NO DATA 2.86E+07 NI-63 3.55E+09 1.90E+08' 1.21E+08 NO DATA NO DATA NO DATA' 1.28E+07 NI-65 1.99E-01 1.87E-02 1.09E-02 NO DATA NO DATA NO DATA 2.29E+00 CU-64 NO DATA' 8.23E+03 4.97E+03 NO DATA 1.99E+04 NO DATA 3.86E+05 3 ZN-65 4.96E+08 1.32E+09 8.22E+08 NO DATA 8.33E+08 NO DATA 2.32E+08 gl ZN-69 1.09E-12 1.58E-12 1.46E-13 NO DATA 9.56E-13 NO DATA 9.94E-11 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA l BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 3 RB-86 NO DATA 1.05E+09 6.47E+08 NO DATA NO DATA NO DATA 6.77E+07 RB-88 NO DATA 8.59E-46 5.97E-46 NO DATA NO DATA NO DATA 4.21E-47 RB-89 NO DATA 1.67E-53 1.49E-53 NO DATA NO DATA NO DATA 1.46E-55 5.37E+08 E

W SR-89 1.39E+10 NO DATA 3.96E+08 NO DATA NO DATA NO DATA SR-90 2.35E+11 NO DATA 5.95E+10 NO DATA NO DATA NC DATA 3.16E+09 SR-91 2.71E+05 NO DATA 1.02E+04 NO DATA NO DATA NO DATA 5.99E+05 SR-92 4.61E+00 NO DATA 1.85E-01 NO DATA NO DATA NO DATA 8.74E+01 1 Y-90 3.86E+01 NO DATA 1.03E+00 NO DATA NO DATA NO DATA 1.10E+05 Y-91m 3.44E-20 NO DATA 1.2SE-21 .NO DATA NO DATA NO DATA 6.73E-17 Y-91 4.67E+03 NO DATA 1.25E+02 NO DATA NO DATA. NO DATA 6.22E+05 E Y-92 3.02E-05 NO DATA 8.64E-07 NO DATA NO DATA NO DATA 8.73E-01 g Y-93 1.20E-01 NO DATA 3.29E-03 NO DATA NO DATA NO DATA 1.79E+03 ZR-95 4.5BE+02 1.01E+02 8.97E+01 NO DATA 1.44E+02 NO DATA 1.05E+05 ZR-97 2.23E-01 3.31E-02 1.95E-02 NO DATA 4.76E-02 NO DATA 5.02E+03 g NB.95 3.81E+04 1.48E+04 1.06E+04 NO DATA 1.39E+04 NO DATA 2.75E+07 E !

MO-99 NO DATA 9.74E+06 2.41E+06 NO DATA 2.08E+07 NO DATA 8.05E+06 TC-99m 1.58E+00 3.10E+00 5.13E401 NO DATA 4.50E+01 1.57E+00 1.76E+03 TC-101 1.54E-60 1.61E-60 2.04E-59 NO DATA 2.74E-59 8.50E-61 5.11E-60 E 5

RU-103 5.10E+02 NO DATA 1.96E+02 NO DATA 1.28E+03 NO DATA 1.32E+04 RU-105 4.53E-04 NO DATA 1.65E-04 NO DATA 3.99E-03 NO DATA 2.96E-01 RU-106 1.11E+04 NO DATA 1.38E+03 NO DATA 1.49E+04 NO DATA 1.72E+05 AG-110m 2.50E+07 1.69E+07 1.35E+07 NO DATA 3.15E+07 NO DATA 2.01E+09 TE-125m 8.84E+06 2.39E+06 1.18E+06 2.48E+06 NO DATA NO DATA 8.53E+06 TE-127m 2.49E+07 6.71E+06 2.96E+06 5.96E+0G 7.10E+07 NO DATA 2.02E+07 TE-127 3.57Et02 9.61E+01 7.65E+01 2.47E+02 1.01E+03 NO DATA 1.39E+04 g TE-129m -3.24E+07 9.06E+06 5.03E+06 1.05E+07 9.52E+07 NO DATA 3.96E+07 g TE-129 1.53E-10 4.28E-11 3.64E-11 1.09E-10 4.49E-10 NO DATA 9.55E-09 TE-131m 1.91E+05 6.60E+04 7.02E+04 1.36E+05 6.39E+05 NO DATA 2.68E+06 TE-131 1.96E-33 5.97E-34 5.83E-34 1.50E-33 5.92E-33 NO DATA 1.03E-32 CLINTON-1 3-85 Rev.17-12/98 I

I

l 1

l l

PS-ODCM TABLE 3.5-22 (continued)

GOAT MILK PATHWAY FACTORS - R".y (CHILD)

(m* mrem /yr per pCi/se'c)

>RGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI SOTOPE

'E-132 1.23E+06 5.45E+05 6.59E+05 7.94E+05 5.06E+06 NO DATA 5.49E+06

-130 2.06E+06 4.17E+06 2.15E+06 4.59E+08 6.23E+06 NO DATA 1.95E+06

-131 1.56E+09 1.57E+09 8.94E+08 5.20E+11 2.58E+09 NO DATA 1.40E+08

-132 8.32E-01 1.52E+00 7.03E-01 7.09E+01 2.34E+00 NO DATA 1.80E+00

' 133 2.06E+07 2.55E+07 9.64E+06 4.73E+09 4.25E+07 NO DATA 1.03E+07

-134 9.51E-12 1.77E-11 8.13E-12 4.06E-10 2.70E-11 NO DATA 1.17E-11

.-135 6.53E+04 1.17E+05 5.56E+04 1.04E+07 1.80E+05 NO DATA 8.95E+04

S-134 6.76E+10 1.11E+11 2.34E+10 NO DATA 3.44E+10 1.23E+10 5.98E+08

S-136 3.03E+09 8.33E+09 5.39E+09 NO DATA- 4.44E+09 6.62E+08 2.93E+08

S-137 9.65E+10 9.23E+10 1.36E+10 NO DATA 3.01E+10 1.08E+10 5.78E+08 lS-138 1.15E-22 1.59E-22 1.10E-22 NO DATA 1.12E-22 1.21E-23 '7.34E-23 A-139 2.42E-08 1.29E-11 7.01E-10 NO DATA 1.13E-11 7.59E-12 L 40E-06 A-140 1.40E+07 1.22E+04 8.15E+05 NO DATA 3.98E+03 7.29E+03 7.07E+06 A-141 2.34E-46 1.31E-49 7.62E-40 NO DATA 1.13E-49 7.70E-49 1.33E-46 A-142 1.31E-80 9.44E-84 7.32E-82 NO DATA 7.64E-84 5.55E-84 1.73E-82 A-140 2.32E+00 8.12E-01 2.53E-01 NO DATA NO DATA NO DATA 2.26E+04 A-142 9.85E-12 3.14E-12 9.83E-13 NO DATA NO DATA NO DATA 6.22E-07 lE-141 2.62E+03 1.31E+03 1.94E+02 NO DATA 5.73E+02 NO DATA 1.63E+06

E-143 2.24E+01' 1.22E+04 1.76E+00 No DATA 5.10E+00 NO DATA 1.78E+05

E-14 4 1.94E+05 6.10E+04 1.04E+04 NO DATA 3.38E+04 NO DATA 1.59E+07

'R-143 8.61E+01 2.58E+01 4.27E+00 NO DATA 1.40E+01 NO DATA 9.29E+04

'R-144 3.53E-54 1.09E-54 1.78E-55 NO DATA 5.78E-55 NO DATA 2.366-51 w147 5.33E+01 4.32E+01 3.34E+00 NO DATA 2.37E+01 NO DATA 6.84E+04

,-107 3.46E+03 2.05E+03 9.20E+02 NO DATA NO DATA NO DATA 2.88E+05

'P-239 2.07E+00 1.49E-01 1.04E-01 NO DATA 4.29E-01 NO DATA 1.10E+04

' mrem /yr per pCi/m

'*1.07 x 10' ,

SINTCM-1 3-86 Rev.17-12/98

Ces-ODCM TABLE 3.5-23 GOAT MILK PATHWAY FACTORS - R*.y (TEEN)

(m* mrem /yr per pCi) E E l, LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ORGAN: BONE ISOTOPE NO DATA 2.02E+03* 2.02E+03* 2.02E+03* 2.02E+03* 2.02E+03* 2.02E+03*

H-3 1.34E+05* 1.34E+05* 1.34E+05*

6.70E+05* 1.34E+05* 1.34E+05* 1.34E+05*

C-14 NA-24 5.15E+05** 5.15E+05 5.15E+05 5.15E+05 5.15E+05 5.15E+05 5.15E+05 g, P-32 3.78E+10 2.34E+09 1.47E+09 NO DATA NO DATA NO DATA 3.18E+09 g NO DATA No DATA 5.94E+03 3.30E+03 1.30E+03 8.48E+03 9.98E+05 CR-51 3.44E+06 MN-54 MN-56 NO DATA NO DATA 1.68E+06 8.77E-04 3.32E+05 1.56E NO DATA NO DATA 5.00E+05 1.11E-03 NO DATA NO DATA 5.77E-02 l {j 5.79E+05 4.11E+05 9.57E+04 NO DATA NO DATA 2.60E+05 1.78E+05 5 l FE-55 3.73E+06 FE-59 6.75E+05 1.58E+06 6.08E+05 NO DATA NO DATA 4.97E+05 NO DATA 9.51E+05 2.19E+06 NO DATA NO DATA NO DATA 1.31E+07 CO-58 NO DATA 3.32E+06 7.47E+06 NO DATA' HO DATA NO DATA 4.32E+07 CO-60 1.42E+09 1.00E+08 4.81E+07 NO DATA NO DATA NO DATA 1.60E+07 {

NI-63 NI-65 8.09E-02 1.03E-02 4.71E-03 NO DATA NO DATA NO DATA 5.61E-01 !

CU-64 NO DATA 4.63E+03 2.20E+03 NO DATA 1.18E+04 NO DATA 3.63E+05 g ZN-65 2.52E+08 8.76E+08 4.09E+08 NO DATA 5.61E+08 NO DATA 3.71E+08 1.56E-12 g'

ZN-69 4.44E-13 ,8.46E-13 5.92E-14 NO DATA 5.53E-13 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA No DATA GR-83 BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA g BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA g NO DATA 5.66E+08 2.66E+08 NO DATA NO DATA NO DATA 8.38E+07 RB-86 RB-88 NO DATA 4.66E-46 2.48E-46 NO DATA NO DATA NO DATA 3.99E-53 RB-89 NO DATA 9.52E-54 6.73E-54 NO DATA NO DATA NO DATA 1.46E-62 6.65E+08 l

W SR-89 5.59E+09 NO DATA 1.60E+08 NO DATA NO DATA NO DATA SR-90 1.38E+11 NO DATA 3.40E+10 NO DATA NO DATA NO DATA 3.87E+09 f 4.40E+03 NO DATA NO DATA NO DATA 5.01E+05 \

SR-91 1.11E+05 NO DATA SR-92 1.89E+00 NO DATA 8.05E-02 NO DATA NO DATA No DATA 4.81E+01 1.29E+05 l

su Y-90 1.56E+01 NO DATA 4.21E-01 NO DATA NO DATA NO DATA Y-91m 1.41E-20 NO DATA 5.37E-22 NO DATA NO DATA NO DATA 6.64E-19 Y-91 1.89E+03 NO DATA 5.07E+01 NO DATA NO DATA NO DATA 7.75E+05 Y-92 1.23E-05 NO DATA 3.57E-07 NO DATA NO DATA NO DATA 3.39E-01 Y-93 4.86E-02 NO DATA 1.33E-03 NO DATA NO DATA NO DATA 1.49E+03 ZR-95 1.98E+02 6.24E+01 4.29E+01 NO DATA 9.17E+01 NO DATA 1.44E+05 '

ZR-97 9.43E-02 1.87E-02 8.60E-03 NO DATA 2.83E-02 NO DATA 5.05E+03 NB-95 1.69E+04 9.37E+03 5.16E+03 NO DATA 9.08E+03 NO DATA 4.01E+07 MO-99 NO DATA 5.33E+06 1.02E+06 NO DATA 1.22E+07 NO DATA 9.55E+06 TC-99m 6.87E-01 1.92E+00 2.48E+01 NO DATA 2.86E+01 1.06E+00 1.26E+03 TC-101 6.26E-61 8.91E-61 8.75E-60 NO DATA 1.61E-59 5.43E-61 1.52E-67 l RU-103 2.17E+02 NO DATA 9.27E+01 NO DATA 7.64E+02 NO DATA 1.81E+04 3 RU-105 1.86E-04 NO DATA 7.21E-05 NO DATA 2.35E-03 NO DATA 1.50E-01

_RU-106 4.47E+03 NO DATA 5.63E+02 NO DATA 8.62E+03 NO DATA 2.14E+05 AG-110m 1.15E+07 1.09E+07 6.62E+06 NO DATA 2.08E+07 NO DATA 3.06E+09 1.29E+06 4.80E+05 1.00E+06 NO DATA NO DATA 1.06E+07 W TE-125m 3.59E+06 TE-127m 1.01E+07 3.57E+06 1. 2 0E+ 06 2.39E+06 4.08E+07 NO DATA 2.51E+07 TE-127 1.48E+02 5.14Et01 3.18E+01 1.02E+02 5.87E+02 NO DATA 1.14E+04 g TE-129m 1.32E+07 4.89E+06 2.08E+06 4.25E+06 5.51E+07 NO DATA 4.94E+07 g TE-129 6. 22 E-11 2.32E-11 1.51E-11 4.44E-11 2.61E-10 NO DATA 3.40E-10 TE-131m 7.86E+04 3.77E+04 3.14E+04 5.67E+04 3.93E+05 NO DATA 3.02E+06 TE-131 8.04E-34 3.31E-34 2.51E-34 6.19E-34 3.51E-33 NO DATA 6.60E-35 I

Il '

CLINTON-1 3-87 Rev.17-12/98 I J

CPS-ODCM TABLE 3.5-23 (continued)

C GOAT MILK PATHWAY FACTORS - R.g (TEEN)

(m* mrem /yr per pCi/sec)

ORGAN BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE TE-132 5.13E+05 3.25E+05 3.06E+05 3.43E+05 3.12E+06 NO DATA 1.03E+07 I-130 8.82E+05 2.55E+06 1.02E+06 2.08E+08 3.93E+06 NO DATA 1.96E+06 I-131 6.44E+08 9.01E+08 4.84E+08 2.63E+11 1.55E+09 NO DATA 1.78E+08 I-132 3.52E-01 9.20E-01 3.30E-01 3.10E+01 1.45E+00 NO DATA 4.01E-01 I-133 8.48E+06 1.44E+07 4.39E+06 2.01E+09 2.52E+07 NO DATA 1.09E+07 I-134 4.03E-12 1.07E-11 3.84E-12 1.78E-10 1.68E-11 NO DATA 1.41E-13 I-135 2.75E+04 7.08E+04 2.62E+04 4.56E+06 1.12E+05 NO DATA 7.85E+04 lCS-134 2.94E+10 6.91E+10 3.21E+10 NO DATA 2.20E+10 8.39E+09 8.60E+08 5 CS-136 1.34E+09 5.27E+09 3.54E+09 NO DATA 2.87E+09 4.52E+08' 4.24E+08 CS-137 .4.01E+10 5.33E+10 1.86E+10 NO DATA 1.82E+10 7.05E+09 7.59Et08 CS-138 4.73E-23 9.08E-23 4.54E-23 NO DATA .6.70E-23 7.80E-24 4.12E-26 BA-139 9.84E-09 6.92E-12 2.87E-10 NO DATA 6.53E-12 4.77E-12 8.78E-08 BA-140 5.82E+06 7.13E+03 3.75E+05 NO DATA. 2.42E+03 4.80E+03 8.98E+06 BA-141 9.53E-47 7.11E-50 3.18E-48 NO DATA .6.60E-50 4.87E-50 2.03E-52 BA-142 5.44E-81 5.44E-84 3.35E-82 NO DATA 4. 60E-84 3.62E-84 1.67E-92 LA-140 9.67E-01 4.75E-01 1.26E-01 NO DATA NO DATA NO DATA 2.73E+04 LA-142 4.08E-12 1.81E-12 4.51E-13 NO DATA NO DATA NO DATA 5.52E-08 CE-141 1.,07E+03 7.12E+02 8.17E+01 NO DATA 3.35E+02 NO DATA 2.04E+06 CE-143 9.14E+00 6.65E+03 7.43E-01 NO DATA 2.98E+00 NO DATA 2.00E+05 CE-144 7.86E+04 3.25E+04 4.23E+03 NO DATA 1.94E+04 NO DATA 1.98E+07 PR-143 3.47E+01 1.39E+01 1.73E+00 NO DATA 8.06E+00 NO DATA 1.14E+05 7 -144 1.42E-54 5.81E-55 7.19E-56 NO DATA 3.33E-55 NO DATA 1.56E-57 J-147 2.17E+01 2.36E+01 1.41E+00 NO DATA 1.38E+01 NO DATA 8.50E+04 ad-187 1.43E+03 1.16E+03 4.08E+02 NO DATA NO DATA NO DATA 3.15E+05 JNP-239 8.38E-01 7.90E-02 4.39E-02 NO DATA 2.48E-01 NO DATA 1.27E+04

mrcm/yr per pCi/m 5

- 5.15 x 10 i

i I

I CLINTON-1 3-88 Rev.17-12/98

CPS-ODCM TABLE 3.5-24 I GOAT MILK PATHWAY FACTORS - Rh { ADULT) ,

(m* mrem /yr per pCi/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 1.55E+03* 1.55E+03* 1.55E+03* 1.55E+03* 1.55E+03* 1.55E+03*

C-14 3.63E+05* 7.26E+04* 7.26E+04* 7.26E+04* 7.26E+04* 7.26E+04* 7.26E+04*

NA-24 2.95E+05** 2.95E+05 2.95E+05 2.95E+05 2.95E+05 2.95E+05 2.95E+05 l P-32 2.05E+10 1.27E+09 7.91E+08 NO DATA NO DATA NO DATA 2.30E+09 5 CR-51 NO DATA NO DATA 3.43E+03 2.05E+03 7.56E+02 4.55E+03 8.63E+05 MN-54 NO DATA '1.01E+06 1.92E+05 NO DATA 2.99E+05 NO DATA 3.08E+06 MN-56 NO DATA 4.96E-04 8.79E-05 NO DATA 6.29E-04 NO DATA 1.58E-02 FE-55 3.27E+05 2.26E+05 5.27E+04 NO DATA NO DATA 1.26E+05 1.30E+05 FE-59 3.85E+05 9.06E+05 3.47E+05 NO DATA NO DATA 2.53E+05 3.02E+06 CO-58 NO DATA 5.62E+05 1.26E+06 NO DATA NO DATA NO DATA 1.14E+07 g CO-60 NO DATA 1.96E+06 4.33E+06 NO DATA NO DATA NO DATA 3.69E+07 1.16E+07 g

NI-63 8.05E+08 5.58E+07 2.70E+07 NO DATA NO DATA NO DATA NI-65 4.43E-02 5.76E-03 2.63E-03 NO DATA NO DATA NO DATA 1.46E-01 CU-64 NO DATA 2.62E+03 1.23E+03 NO DATA 6.62E+03 NO DATA 2.24E+05 g ZN-65 1.64E+08 5.22E+08 2.36E+08 NO DATA 3.49E+08 NO DATA 3.29E+08 g ZN-69 2.41E-13 4.61E-13 3.21E-14 NO DATA 3.00E-13 NO DATA 6.93E-14 GR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-84 BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA l'

5 RB-86 NO DATA 3.10E+08 1.45E+08 NO DATA NO DATA NO DATA 6.12E+07 RB-88 NO DATA 2.57E-46 1.36E-46 NO DATA NO DATA NO DATA 3.55E-57 RB-89 NO DATA 5.37E-54 3.78E-54 NO DATA NO DATA NO DATA 3.12E-67 SR-89 3.04E+09 NO DATA 8.73E+07 NO DATA NO DATA NO DATA 4.88E+08 SR-90 9.78E+10 NO DATA 2.40E+10 NO DATA NO DATA NO DATA 2.83E+09 .

3 SR-91 6.01E+04 NO DATA 2.43E+03 NO DATA NO DATA NO DATA 2.86E+05 g SR-92 1.03E+00 NO DATA '4.45E-02 NO DATA NO DATA NO DATA 2.04E+01 Y-90 8.48E+00 NO DATA 2.28E-01. NO DATA NO DATA NO DATA 9.00E+04 E Y-91m 7.69E-21 PO DATA 2.98E-22 NO DATA NO DATA NO DATA 2.26E-20 Y-91 1.03E+03 NO DATA 2.75E+01 NO DATA NO DATA NO DATA 5.66E+05 g Y-92 6.68E-06 NO DATA 1.95E-07 NO DATA NO DATA NO DATA 1.17E-01 E1 Y-93 2.65E-02 NO DATA 7.32E-04 NO DATA NO DATA NO DATA 8.41E+02 ZR-95 1.13E+02 3.63E+01 2.46E+01 NO DATA 5.69E+01 NO DATA 1.15E+05 ZR-97 5.17E-02 1.04E-02 4.77E-03 NO DATA 1.58E-02 NO DATA 3.23E+03 l NB-95 9.90E+03 5.51E+03 2.96E+03 NO DATA 5.45E+03 NO DATA 3.34E+07 E HO-99 NO DATA 2.96E+06 5.63E+05 NO DATA 6.71E+06 NO DATA 6.86E+06 TC-99m 3.95E-01 1.12E+00 1.42E+01 NO DATA 1.70E+01 5.47E-01 6.61E+02 TC-101 3.43E-61 4.94E-61 4.84E-60 NO DATA 8.89E-60 2.52E-61 1.48E-72 RU-103 1.22E+02 NO DATA 5.24E+01 NO DATA 4.64E+02 NO DATA 1.42E+04 W RU-105 1.02E-04 NO DATA 4.02E-05 NO DATA 1.32E-03 NO DATA 6.23E-02 RU-106 2.44E+03 NO DATA 3.09E+02 NO DATA 4.72E+03 NO DATA 1.58E+05 AG-110m 6.96E+06 6.44E+06 3.82E+06 NO DATA 1.27E+07 NO DATA 2.63E+09 TE-125m 1.95E+06 7.07E+05 2.61E+05 5.87E+05 7.94E+06 NO DATA 7.79E+06 TE-127m 5.46EF06 1.95E+06 6.66E+05 1.40E+06 2.22E+07 NO DATA 2.83E+07 TE-127 7.82E+01 2.81E+01 1.69E+01 5.80E+01 3.19E+02 NO DATA 6.17E+03 i TE-129m 7.21E+06 2.69E+06 1.14E+06 2.40E+06 3.01E+07 NO DATA 3.63E+07 TE-129 3.83E-11 1.27E-11 8.23E-12 2.59E-11 1.42E-10 NO DATA 2.55E-11 TE-131m 4.33E+04 2.12E+04 1.76E+04 3.35E+04 2.14E+05 NO DATA 2.10E+06 TE-131 4.37E-34 1.83E-34 1.30E-34 3.60E-34 1.92E-33 NO DATA 6.19E-35 I

CLINTON-1 3-89 Rev.17-12/98 I

I

CPS-ODCM TABLE 3.5-24 (continued)

GOAT MILK PATHWAY FACTORS - R".g (ADULT)

(m* mrem /yr per pCi/sec)

ORGAN BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE ~

TE-132 2.87E+05 1.86E+05 1.74E+05 2.05E+05 1.79E+06 NO DATA 8.79E+06 I-130 5.00E+05 1.47E+06 5.82E+05 *1.25E+08 2.30E+06 NO DATA 1.27E+06 I-131 3.54E+0B 5.06E+0B 2.90E+08 1.66E+11 8.68E+08 NO DATA 1.34E+08 I-132 1.98E-01 5.29E-01 1.85E-01 1.85E+01 8.43E-01 NO DATA 9.93E-02 I-133 4.62E+06 8.03E+06 2.45E+06 1.18E+09 1.40E+07 NO DATA 7.22E+06 I-134 2.27E+12 6.16E-12 2.20E-12 1.07E-10 9.80E-12 NO DATA .5.37E-15 I-135 1.55E+04 4.06E+04 1.50E+04 2.68E+06 6.51E+04 NO DATA 4.59E+04 CS-134 , 1.69E+10 4.03E+10 3.29E+10 NO DATA 1.30E+10 4.32E+09 7.04E+08 CS-136 7.88E+08 3.11E+09 2.24E+09 NO DATA 1.73E+09 2.37E+08 3.53E+08 CS-137 2.21E+10 3.03E+10 1.98E+10 NO DATA 1.02E+10 3.41E+09 5.84E+08 CS-138 2.61E-23 5.15E-23 2.55E-23 NO DATA 3.78E-23 3.73E-24 2.20E-28 BA-139 5.32E-09 3.79E-12 1.56E-10 NO DATA 3.54E-12 2.15E-12 9.44E-09 BA-140 3.23E+06 4.05E+03 2.11E+05 NO DATA 1.38E+03 2.32E+03 6.65E+06 BA-141 5.18E-47 3.92E-50 1.75E-48 NO DATA 3.64E-50 2.22E-50 2.44E-56

BA-142 3.00E-81 3.09E-84 1.89E-82 NO DATA 2.61E-84 1.75E-84 4.23E-99 LA-140 5..iCM-01 2.72E-01 7.19E-02 NO DATA NO DATA NO DATA 2.00E+04 LA-142 2.27E-12 1.03E-12 2.57E-13 NO DATA NO DATA NO DATA 7.52E-09 CE-141 5.80E+02 3.92E+02 4.45E+01 NO DATA 1.82E+02 NO DATA 1.50E+06 CE.143 5.00E+00 3.70E+03 4.09E-01 NO DATA 1.63E+00 NO DATA 1.38E+05 CE-144 4.29E+04 1.79E+04 2.30E+03 NO DATA 1.06E+04 NO DATA 1.45E+07-PR-143 1.89E+01 7.56E+00 9.35E-01 NO DATA 4.37E+00 NO DATA 8.26E+04 7.71E-55 3.20E-55 3.92E-56 NO DATA 1.80E-55 NO DATA 1.11E-61

-147 1.13E+01 1.30E+01 7.79E-01 NO DATA 7.64E+00 NO DATA 6.25E+04 1pR-144 187 7.78E+02 6.50E+02 2.27E+02 NO DATA NO DATA NO DATA 2.13E+05 jNP-239 4'39E-01

. 4.32E-02 2.38E-02 NO DATA 1.35E-01 NO DATA 8.86E+03

mrem /yr per5 Ci/m

- 2.95 x 10 l

1 I

i I

l j

CLINTON-1 3-90 Rev.17-12/98

1 CPS-ODCM TABLE 3.5-25 g

" ]f MEAT PATHWAY FACTORS - R".y (CHILD)

(m* mrem /yr per pCi/sec) ,

)

ORGAN:_ BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI gl g

ISOTOPE H-3 NO DATA 2.33E+02* 2.33E+02* 2.33E+02* 2.33E+02* 2.33E+02* 2.33E+02*

C-14 5.29E+05* 1.06E+05* 1.06E+05* 1.06E+05* 1.06E+05* 1.06E+05* 1.06E+05*

NA-24 1.84E-03** 1.84E-03 1.84E-03 1.84E-03 1.84E-03 1.84E-03 1.84E-03 l P-32 7.43E+09 3.47E+08 2.86E+09 NO DATA NO DATA NO DATA 2.05E+08 3 CR-51 NO DATA NO DATA 8.78E+03 4.88E+03 1.33E+03 8.90E+03 4.66E+05 HN-54 NO DATA 8.03E+06 2.14E+06 NO DATA 2.25E+06 NO DATA 6.74E+06 MN-56 NO DATA 1.56E-53 3.52E-54 NO DATA 1.89E-53 NO DATA 2.26E 51 4.58E+08 2.43E+08 7.52E+07 NO DATA NO DATA 1.37E+08 4.50E+07 w FE-55 FE-59 3.76E+08 6.09E+08 3.03E+08 NO DATA NO DATA 1.76E+08 6.34E+08 CO-50 NO DATA 1.64E+07 5.03E+07 No DATA NO DATA NO DATA 9.58E+07 CO-60 NO DATA 6.93E+07 2.04E+08 NO DATA NO DATA NO DATA 3.84E+08 NI-63 2.91E+10 1.56E+09 9.90E+08 NO DATA NO DATA NO DATA 1.05E+08 NI-65 3.55E-52 3.34E-53 1.925-53 NO DATA NO DATA- NO DATA 4.10E-51 CU-64 No DATA 2.77E-07 1.67E-07 NO DATA 6.69E-07 NO DATA 1.30E-05 3 ZN-65 3.75E+08 1.00E+09 6.22E+08 No DATA 6.30E+08 NO DATA 1.76E+08 g ZN-69 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 NO DATA 0.00E+00 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA l BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 3 RB-86 NO DATA 5.76E+08 3.54E+08 NO DATA 'NO DATA NO DATA 3.71E+07' RB-88 NO DATA 0.00E+00 0.00E+00 NO DATA NO DATA No DATA 0.00E+00 '

RB-89 NO DATA 0.00E+00 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 4.80E+08 ,NO DATA 1.37E+07 NO DATA NO DATA NO DATA 1.86E+07 m '

SR-89 SR-90 1.04E+10 NO DATA 2.64E+09 NO DATA NO DATA NO DATA 1.40E+08 f, SR 2.26E-10 NO DATA 8.53E-12 NO DATA NO DATA NO DATA 4.99E-10 s?

NO DATA 3.80E-48 s SR-92 2.00E-49 NO' DATA 8.04E-51 NO DATA NO DATA Y-90 1.73E+02 NO DATA 4.62E+00 NO DATA NO DATA NO DATA 4.91E+05 '

Y-91m 0.00E+00 NO DATA 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 Y-91 1.80E+06 NO DATA 4.81E+04 NO DATA NO DATA NO DATA 2.40E+08 gi Y-92 2.37E-39 NO DATA 6.78E-41 NO DATA NO DATA NO DATA 6.84E-35 g Y-93 6.98E-12 NO DATA 1.92E-13 NO DATA NO DATA NO DATA 1.04E-07 ZR-95 2.67E+06 5.87E+05 5.22E+05 NO DATA 8.40E+05 NO DATA 6.12E408 ZR-97 3.16E-05 4.57E-06 2.69E-06 NO DATA 6.55E-06 NO DATA 6.92E-01 l NB-95 3.10E+06 1.21E+06 8.61E+05 NO DATA- 1.13E+06 NO DATA 2.23E+09 E MO-99 NO DATA 1.14E+05 2.83E+04 NO DATA 2.44E+05 NO DATA 9.45E+04 TC-99m 6.01E-21 1.18E-20 1.95E-19 NO DATA 1.71E-19 5.98E-21 6.71E-18 TC-101 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 4.01E+09 l3 5

RU-103 1.55E+08 No DATA 5.96E+07 HO DATA 3.90E+08 NO DATA RU-105 8.48E-28 NO DATA 3.0BE-28 NO DATA 7.45E-27 NO DATA 5.54E-25 RU-106 4.43E+09 NO DATA 5.53E+08 HO DATA 5.99E+09 NO DATA 6.90E+10 AG-110m 8.41E+06 5.68E+06 4.54E+06 NO DATA 1.06E+07 NO DATA 6.75E+08 ,

TE-125m 5.69E+08 1.54E+08 7.58E+07 1.60E+0B NO DATA NO DATA 5.49E+08 TE-127m 1.77E+09 4.78E+08 2.11E+08 4.24E+08 5.06E+09 NO DATA 1.44E+09 TE-127 3.34E-10 9.01E-11 7.17E-11 2.31E-10 9.51E-10 NO DATA 1.31E-08 3 TE-129m 1.79E+09 4.99E+08 2.77E+08 5.76E+08 5.25E+09 NO DATA 2.18E+09 g TE-129 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 TE-131m 6.97E+02 2.41E+02 2.57E+02 4.96E+02 2.33E+03 NO DATA 9.78E+03 TE-131 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 I

1 i

l CLINTON-1 3-91 Rev.17-12/98 I

I

CPS-ODCM TABLE 3.5-25 (continued)

MEAT PATHWAY FACTORS - R" y (CHILD) 5 (m* mrem /yr per pCi/sec)

)

ORGAN:- BONE LIVER T.DODY THYROID KIDNEY , LUNG GI-LLI ISOTOPE TE-132 2.13E+06 9.43E+05 1.14E+06 1.37E+06 8.76E+06 NO DATA 9.50E+06 I-130 2.91E-06 5.89E-06 3.03E-06 6.49E-04 8.80E-06 NO DATA 2.75E-06 I-131 1.65E+07 1.66E+07 9.46E+06 5.50E+09 2.73E+07 NO DATA 1.48E+06 I-132 1.05E-58 1.93E-58 8.86E-59 8.93E-57 2.95E-58 NO DATA 2.27E-58 I-133 5.75E-01 7.10E-01 2.69E-01 1.32E+02 1.18E+00 NO DATA 2.86E-01 I-134 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 No DATA 0.00E+00 I-135 6.86E-17 1.23E-16 5.83E-17 1.09E-14 1.89E-16 NO DATA 9.38E-17 CS-134 9.20E+08 1.51E+09 3.18E+08 NO DATA 4.68E+08 1.68E+08 8.14E+06 i CS-136 1.62E+07 4.45E+07 2.88E+07 NO DATA 2.37E+07 3.53E+06 1.56E+06 LS-137 1.33E+09 1.27E+09 1.88E+08 NO DATA 4.15E+08 1.49E+08 7.90E+06 CJ-138 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 BA-139' O.00E+00 0.00E+00 0.00E+00 NO' DATA 0.00E+00 0.00E+00 0.00E+00 BA-140 4.38E+07 3.84E+04 2.56E+06 NO DATA 1.25E+04 2.29E+04 2.22E+07 BA-141 0.00Et00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00

, BA-142 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 LA-140 5.56E-02 1.94E-02 6.05E-03 NO DATA NO DATA NO DATA 5.41E+02 LA-142 6.18E-92 1.97E-92 6.17E-93 NO DATA NO DATA NO DATA 3.91E-87 CE-141 2.22E+04 1.11E+04 1.64E+03 NO DATA 4.85E+03 NO DATA 1.38E+07 CE-143 3.20E-02 1.74E+01 2.51E-03 NO DATA 7.28E-03 NO DATA 2.54E+02

' CE-144 2.31E+06 7.24E+05 1.23E+05 NO DATA 4.01E+05 NO DATA 1.89E+08 PR-143 3.34E+04 1.00E+04 1.66E+03 NO DATA 5.43E+03 NO DATA 3.60E+07 PR-144 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 NO DATA 0.00E+00 i -147 1.17E+04 9.47E+03 7.33E+02 NO DATA 5.20E+03 NO DATA 1.50E+07 3 187 3.21E-02 1.90E-02 8.53E-03 NO DATA NO DATA NO DATA 2.67E+00 JNP-239 4.23E-01 3.04E-02 2.14E 02 NO DATA 8.79E-02 NO DATA 2.25E+03

mrem /yr per

- 1.84 x 10-'pCi/m l

I CLINTON-1 3-92 Rev.17-12/98

F CPS-ODCM TABLE 3.5-26 MEAT PATHWAY FACTORS - R".y (TEEN)

(m* mrem /yr per pCi) 3 ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI

'fSCfrOPE 3 H-3 NO DATA 1.93E+02* 1.93E+02* 1.93E+02* 1.93E+02* 1.93E+02* 1.93E+02*

C-14 2.81E+05* 5.62E+04* 5.62E+04* S.62E+04* 5. 62 E+ 04

5.62E+04* 5.62E+04*

NA-24 1.16E-03** 1.16E-03 1.16E-03 1.16E-03 1.16E-03 1.16E-03 1.16E-03 l P-32 3.95E+09 2.45E+08 1.53E+08 NO DATA NO DATA NO DATA 3.32E+08 M CR-51 NO DATA No DATA 5.65E+03 3.14E+03 1.24E+03 8.07E+03 9.50E+05 l MN-54 NO DATA 7.02E+06 1.39E+06 NO DATA 2.09E+06 NO DATA 1.44E+07 l MN-56 NO DATA 1.17E-53 2.09E-54 NO DATA 1.48E-53 NO DATA 7.72E-52 j FE-55 2.38E+08 1.69E+08 3.94E+07 NO DATA NO DATA 1.07E+08 7.31E+07 '

FE-59 2.12E+08 4.95E+08 1.91E+0B NO DATA NO DATA 1.56E+08 1.17E+09 CO-58 NO DATA 1.41E+07 3.25E+07 NO DATA NO DATA NO DATA 1.94E+08 CO-60 NO DATA 5.84E+07 1.32E+08 - NO DATA NO DATA NO DATA 7.61E+08 NI-63 1.52E+10 1.07E+09 5.15E+08 NO. DATA NO DATA NO~ DATA 1.71E+08 NI-65 1.90E-52 2.435-53 1.11E-53 NO DATA NO DATA NO DATA 1.32E-51 CU-64 NO DATA 2.06E-07 9.68E-08 NO DATA 5.21E-07 NO DATA 1.60E-05 l ZN-35 2.50E+08 8.69E+08 4.05E+08 NO DATA 5.56E+08 NO DATA 3.68E+08 3 ZN-69 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 NO DATA 0.00E+00 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA GR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 5 RB-86

NO DATA 4.05E+08 1.90E+08 NO DATA NO DATA NO DATA 6.00E+07 R&BB NO DATA 0.00E+00 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 RB-89 NO DATA 0.00E+00 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 SR-89 2.54E+08 NO DATA 7.27E+06 NO DATA NO DATA NO DATA 3.02E407 SR-90 8.04E+09 NO DATA 1.99E+09 NO DATA NO DATA NO DATA 2.26E+08 NO DATA SR-91 1.20E-10 NO DATA 4.78E-12 NO DATA NO DATA 5.45E-10 SR-92 1.08E-49 NO DATA 4.59E-51 NO DATA NO DATA NO DATA 2.74E-48 Y-90 9.11E+01 NO DATA 2.45E+00 NO DATA NO DATA NO DATA 7.51E+05 Y-91m 0.00E+00 NO DATA 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 Y-91 9.55E+05 NO DATA 2.56E+04 NO DATA NO DATA NO DATA 3.91E+08 l Y-92 1.26E-39 NO DATA 3.64E-41 NO DATA NO DATA NO DATA 3.45E-35 g Y-93 3.70E-12 NO DATA 1.01E-13 NO DATA NO DATA NO DATA 1.13E-07 ER-95 1.50E+06 4.74E+05 3.25E+05 NO DATA 6.93E+05 NO DATA 1.09E+09 ZR-97 1.70E-05 3.36E-06 1.55E-06 NO DATA 5.10E-06 NO DATA 9.11E-01 ND-95 1.79E+06 9.94E+05 5.47E+05 NO DATA 9.64E+05 NO DATA 4.25E+09 E MO-99 NO DATA 8.20E+04 1.56E+04 NO DATA 1.88E+05 NO DATA 1.47E+05 TC-99m 3.42E-21 9.54E-21 1.24E-19 NO DATA 1.42E-19 5.29E-21 6.26E-18 TC-101 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00C+00 0.00E+00 RU-103 8.57E+07 NO DATA 3.66E+07 NO DATA 3.02E+08 NO DATA 7.16E+09 RU-105 4.56E-28 NO DATA 1.77E-28 NO DATA 5.75E-27 NO DATA 3.68E-25 RU-106 2.36E+09 NO DATA 2.97E+08 NO DATA 4.54E+09 NO DATA 1.13E+11 AG-110m 5.04E+06 4.77E+06 2.90E+06 NO DATA 9.10E+06 NO DATA 1.34E+09 TE-125m 3.03E+08 1.09E+08 4.06E+07 8.47E+07 NO DATA NO DATA 8.95E+08 TE-127m 9.40E+08 3.33E+08 1.12E+08 2.24E+08 3.81E+09 NO DATA 2.34E+09 TE-127 1.78E-10 6.30E-11 3.82E-11 1.23E-10 7.20E-10 NO DATA 1.37E-08 l TE-129m 9.49E+08 3.52E+08 1.50E+08 3.06E+0B 3.97E+09 NO DATA 3.56E+09 g TE-129 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 TE-131m 3.73E402 1.79E+02 1.49E+02 2.69E+02 1.87E+03 NO DATA 1.44E+04 TE-131 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 I

CLINTON-1 3-93 Rev.17-12/98 I

I

CPS-ODCM s

TABLE 3.5-26 (continued)

MEAT PATHWAY FACTORS - R" y (TEEN)

[} (m' mrem /yr per pCi/sec) 1 ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE TE-132 1.17E+06 7.38E+05 6.95E+05 7.78E+05 7.08E+06 NO DATA 2.34E+07 I-130 1.63E-06 4.71E-06 1.88E-06 3.84E-04 7.25E-06 NO DATA 3.62E-06 I-131 8.89E+06 1.24E+07 6.69E+06 3.63E+09 2.14E+07 NO DATA 2.46E+06 I-132. 5.78E-59 1.51E-58 5.42E-59 5.09E-57 2.38E-58 NO DATA 6.58E-59 I-133 3.09E-01 5.25E-01 1.60E-01 7.32E+01 9.20E+01 NO DATA 3.97E-01 I-134 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 I-135 3.79E-17 9.75E-17 3.61E-17 6.27E-15 1.54E-16 NO DATA 1.08E-16 CS-134 5.22E+08 1.23E+09 5.70E+08 NO DATA 3.91E+08 1.49E+08 1.53E+07 tCS-136 9.36E+06 3.68E+07 2.47E+07 NO DATA 2.01E+07 3.16E+06 2.96E+06 CS-137 7.24E+08 9.63E+08 3.35E+08 NO DATA 3.28E+08 1.27E+08 1.37E+07 CS-138 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 BA-139 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 BA-140 2.37E+07 2.91E+04 1.53E+06 NO DATA 9.86E+03 1.96E+04 3.66E+07 BA-141 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00

'BA-142 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 LA-140. 3.03E-02 1.49E-02 3.97E-03 NO DATA NO DATA NO DATA 8.56E+02 LA-142 3.37E-92 1.49E-92 3.72E-93 NO DATA NO DATA NO DATA 4.55E-88 CE-141 1.17E+04 7.83E+03 9.00E+02 NO DATA 3.69E+03 NO DATA 2.24E+07 CE.143 1.70E-02 1.24E+01 1.38E-03 NO DATA 5.55E-03 NO DATA 3.72E+02 CE-144 1.23E+06 5.10E+05 6.62E+04 NO DATA 3.04E+05 NO DATA 3.10E+08 PR-143 1.77E+04 7.06E+03 8.80E+02 NO DATA 4.10E+03 NO DATA 5.82E+07 pR-144 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 NO DATA 0.00E+00

-147 6.22E+03 6.76E+03 4.05E+02 NO DATA 3.97E+03 NO DATA 2.44E+07

-187 1.74E-02 1.42E-02 4.96E-03 NO DATA NO DATA NO DATA 3.83E+00 jNP-239 2.25E-01 2.12E-02 1.18E-02 NO DATA 6.67E-02 NO DATA 3.42E+03 3

mrem /yr per

- l.16 x 10-'pCi/m f

CLINTON-1 3-94 Rev.17-12/98

CPS-ODCM TABLE 3o5-27 MEAT PATHWAY FACTORS - R".y (ADULT)

'(m* mrem /yr per pCi/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI l ISOTOPE E

NO DATA 3.24E+02* 3.24E+02* 3.24E+02* 3.24E+02* 3.24E+02* 3.24E+02*

H-3 6.66E+04*

3.33E+05* 6.66E+04* 6.66Et04* 6.66E+04* 6.66E+04* 6.66E+04*

C-14 NA-24 1. 4 5E-03 *

1.45E-03 1.45E-03 1.45E-03 1.45E-03 1.45E-03 1.45E-03 l, NO DATA NO DATA 5.23E+08 5 P-32 4.65E+09 2.89E+08 1.80E+08 NO DATA i CR-51 NO DATA NO DATA 7.05E+03 4.21E+03 1.55E+03 9.35E+03 1.77E+06 i MN-54 NO DATA 9.19E+06 1.75E+06 NO DATA 2.73E+06 NO DATA 2.81E+07 g l MN-56 NO DATA 1.45E-53 2.57E-54 NO DATA 1.84E-53 NO DATA 1.13E+08 4.62E-52 1.17E+08 gf FE-55 2.94E+08 2.03E+08 4.74E+07 NO DATA NO DATA FE-59 2.66E+08 6.24E+08 2.39E+08 NO DATA NO DATA 1.74E+08 2.08E+09 CO-58 NO DATA 1.83E+07 4.09E+07 NO DATA NO DATA NO DATA 3.70E+08 3' CO-60 No DATA 7.51E+07 1.31E+09 1.66E+0B 6.32E+08 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 1.41E+09 2.73E+08 gI .

NI-63 'l.89E+10 NI-65 2.275-52 2.94E-53 1.34E-53 NO DATA NO DATA NO DATA 7.46E-52 CU-64 NO DATA 2.52E-07 1.18E-07 NO DATA 6.36E-07 HO DATA NO DATA 2.15E-05 7.13E+08 ll g (

ZN-65 3.56E+08 1.13E+09 5.12E+08 NO DATA 7.57E+08 ZN-69 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 NO DATA 0.00E+00 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA ER-83 NO DATA BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA up BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA RD-86 NO DATA 4.87E+08 2.27E+08 NO DATA NO DATA NO DATA 9.61E+07 RB-88 NO DATA 0.00E+00 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 g R9-89 NO DATA 0.00E+00 0.00E+00 NO DATA NO DATA NO DATA NO DATA 0.00E+00 4.83E+07 g

SR-89 3.01E+08 NO DATA 8.64E+06 NO DATA NO DATA SR-90 1.24E+10 NO DATA 3.05E+09 NO DATA NO DATA NO DATA 3.59E+08 r SR-91 1.43E-10 NO DATA 5.79E-12 NO DATA NO DATA NO DATA 6.83E-10 '

E<

SR-92 1.28E-49 NO DATA 5.54E-51 NO DATA NO DATA NO DATA NO DATA 2.54E-48 1.15E+06 5

Y-90 1.09E+02 NO DATA 2.92E+00 NO DATA NO DATA Y-91m 0.00E+00 NO DATA 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 Y-91 1.13E+06 NO DATA 3.03E+04 NO DATA NO DATA NO DATA 6.23E+08 2.61E-35 l

g Y-92 1.49E-39 NO DATA 4.36E-41 NO DATA NO DATA NO DATA Y-93 4.40E-12 NO DATA 1.21E-13 NO DATA NO DATA NO DATA 1.39E-07 ZR-@S 1.87E+06 6.00E+05 4.06E+05 NO DATA 9.41E+05 NO DATA 1.90E+09 ZR-97 2.03E-05 4.10E-06 1.88E-06 NO DATA 6.17E-06 NO DATA 1.27E+00 l NB-95 2.30E+06 1.28E+06 6.86E+05 NO DATA 1.26E+06 NO DATA 7.75E+09 W MO-99 NO DATA 9.91E+04 1.89E+04 NO DATA 2.24E+05 NO DATA 2.30E+05 TC-99m 4.32E-21 1.22E-20 1.56E-19 NO DATA 1.86E-19 5.99E-21 7.23E-18' TC-101 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 RU-103 1.05E+08 NO DATA 4.53E+07 NO DATA 4.02E+08 NO DATA 1.23E+10 RU-105 5.42E-28 NO DATA 2.14E-28 NO DATA 7.00E-27 NO DATA 3.32E-25 RU-106 2.81E+09 NO DATA 3.55E+08 NO DATA 5.42E+09 NO DATA 1.82E+11 AG-110m 6.67E+06 6.17E+06 3.67E+06 NO DATA 1.21E+07 NO DATA 2.52E+09 TE-125m 3.59E+08 1.30E+08 4.81E+07 1.08E+08 1.46E+09 NO DATA 1.43E+09 TE-127m 1.12E+09 3.99E+08 1.36E+08 2.85E+08 4.54E+09 NO DATA 3.75E+09 TE-127 2.09E-10 7.52E-11 4.53E-11 1.55E-10 8.53E-10 NO DATA 1.65E-08 g TE-129m 1.13E+09 4.22E+08 1.79E+08 3.89E+08 4.73E+09 NO DATA 5.70E+09 g TE-129 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 TE-131m 4.50E+02 2.20E+02 1.83E+02 3.48E+02 2.23E+03 NO DATA 2.18E+04 TE-131 0.0]E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 I

3-95 Rev.17-12/98 I

CLINTON-1 I

S-ODCM TABLE 3.5-27 (continued)

MEAT PATHWAY FACTORS - R",y (ADULT)

(m* mrem /yr per pCOsec)

[;AN j BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI DrrOPE

-133 1.42E+06 9.21E+05 8.64E+05 1.02E+06 8.87E+06 NO DATA 4.36E+07 130 2.03E-06 5.98E-06 2.36E-06 5.07E-04 9.33E-06 NO DATA 5.15E-06 131 1.07E+07 1.54E+07 8.80E+06 5.03E+09 2.63E+07 NO DATA 4.05E+06 133 7.13E-59 1.91E-58 6.67E-59 6.67E-57 3.04E-58 NO DATA 3.58E-59 133 3.70E-01 6.43E-01. 1.96E-01 9.45E+01 1.12E+00 No DATA 5.78E-01 134 0.00E+00 0.00E+00 0.00Et00 0.00E+00 0.00E+00 NO DATA 0.00E+00 135 4.65E-17 1.22E-16 4.49E-17 8.03E-15 1.95E-16 NO DATA 1.38E-16

-134 6.53E+08 1.55E+09 1.27E+09 NO DATA 5.03E+08 1.67E+08 2.72E+07

-136 1.20E+07 4.75E+07 3.42E+07 NO DATA 2.65E+07 3.63E+06 5.40E+06

-137 8.69E+08 1.19E+09 7.78E+08 NO DATA 4.03E+08 1.34E+08 2.30E+07

-138 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00

-139 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00

-140 2.88E+07 3.62E+04 1.89E+06 NO DATA 1.23E+04 2.07E+04 5.94E+07

-141 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00

-142 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00

-140 3.68E-02 1.85E-02 4.90E-13 NO DATA NO DATA NO DATA 1.36E+03

-142 4.07E-92 1.85E-92 4.61E-93 NO DATA NO DATA NO DATA 1.35E-88

-141 1.39E+04 9.43E+03 1.07E+03 NO DATA 4.38E+03 NO DATA 3.61E+07

-143 3.03E-02 1.50E+01 1.66E-03 NO DATA 6.61E-03 NO DATA 5.61E+02

-144 1.46E+06 6.10E+05 7.83E+04 NO DATA 3.62E+05 NO DATA ,4.97E+08

-143 2.09E+04 8.40E+03 1.04E+03 NO DATA 4.85E+03 NO DATA 9.17E+07

-144 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 NO DATA 0.00E+00

-147 7.04E+03 8.14E+03 4.87E+02 NO DATA 4.762+03 NO DATA 3.91E+07 187 2.06E-02 1.72E-02 6.02E-03 NO DATA NO DATA NO DATA 5.64E+00

-239 2.57E-01 2.53E-02 1.39E-02 NO DATA 7.88E-02 NO DATA 5.18E+03 trem/yr per pCi/m'

1. 4 5 x 10-*

$NTON-1 3-96 Rev.17-12/98 1

TABLE 3.5-28 VEGETATION PATHWAY FACTORS - Rh (CHILD) ,. ,

(m* mrem /yr per pCi/sec)

J ORGAN:

ISOTOPE H-3 BONE NO DATA LIVER 4.01E+03*

T. BODY 4.01E+03*

THYROID 4.01E+03*

KIDNEY 4.01E+03*

LUNG 4.01E+03*

GI-LLI 4.01E+03*

I C-14 3.51E+06* 7.01E+05* 7.01E+05* 7.01E+05* 7.01E+05* 7.01E+05* 7.01E+05*

NA-24 3.75E+05** 3.75E+05 3.75E+05 3.75E+05 3.75E+05 3.75E+05 3.75E+05 P-32 3.37E+09 1.57E+08 1.30E+08 NO DATA NO DATA NO DATA 9.30E+07 CR-51 NO DATA .NO DATA 1.17E+05 6.49E+04 1.77E+04 1.18E+05 6.20E+06 HN-54 NO DATA 6.64E+08 1.77E+00 NO DATA 1.86E+08 NO DATA 5.58E+08 HN-56 NO DATA 1.87E+01 4.22E+00 NO DATA 2.26E+01 NO DATA 2.71E+03 FE-55 8.02E+08 4.25E+08 1.32E+08 NO DATA NO DATA 2.40E+08 7.88E+07 FE-59 3.98E+08 6.43E+08 3.21E+08 NO DATA NO DATA 1.87E+08 6.70E+08 CO-58 HO DATA 6.44E+07 1.97E+08 NO DATA NO DATA- NO DATA 3.76E+08 Co-60 NO DATA 3.79E+08 1.12E+09 NO DATA NO DATA NO DATA 2.10E+09 NI-63 3.95E+10 2.11E+09 1.34PF09 NO DATA NO DATA NO DATA 1.42E+08 NI-65 1.05E+02 9.89E+00 5.77E+00 NO DATA NO DATA NO DATA 1.21E+03 CU-64 NO DATA 1.09E+04 6.59E+03 NO DATA 2.64E+04 NO DATA 5.12E+05 ZN-65 8.11E+08 2.16E+09 1.34E+09 NO DATA 1.36E+09 NO DATA 3.79E+08 ZN-69 9.29E-06 1.34E-05 1.24E-06 NO DATA 8.14E-06 NO DATA 8.46E-04 BR-83 NO DATA NO DATA 5.40E+00 NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA 3.92E-11 NO DATA NO DATA NO DATA NO DATA DR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA RB-86 NO DATA 4.53E+08 2.79E+08 NO DATA NO DATA NO DATA 2.91E+07 RB-88 NO DATA 4.38E-22 3.04E-22 NO DATA NO DATA NO DATA 2.15E-23 RB-89 NO DATA 4.69E-26 4.17 E-26 NO DATA NO DATA NO DATA 4.09E-28 SR-89 3.59E+10 NO DATA 1.03E+09 NO DATA NO DATA NO DATA 1.39E+09 SR-90 l'.24E+12 NO DATA 3.14E+11 NO DATA NO DATA NO DATA 1.67E+10 f SR-91 5.21E+05 NO DATA 1.97E+04 NO DATA NO DATA NO DATA 1.15E+06 s SR-92 7.29E+02 NO DATA 2.92E+01 NO DATA NO DATA NO DATA 1.38E+04 Y-90 2.31E+04 NO DATA 6.18E+02 NO DATA NO DATA NO DATA - 6.58E+07 Y-91m 9.24E-09 NO DATA 3.36E-10 NO DATA NO DATA NO DATA 1.81E-05 Y-91 1.86E+07 NO DATA 4.97E+05 NO DATA NO DATA NO DATA 2.48E+09 l Y-92 1.58E+00 NO DATA 4.52E-02 NO DATA NO DATA NO DATA 4.57E+04 3 Y-93 2.92E+02 NO DATA 8.01E+00 NO DATA NO DATA NO DATA 4.35E+06

.. ZR-95 3.86E+06 8.49E+05 7.56E+05 NO DATA 1.22E+06 NO DATA 8.86E+08 ZR-97 5.66E+02 8.18E+01 4.83E+01 NO DATA 1.17E+02 NO DATA 1.24E+07

, NB-95 4.10E+05 1.60E+05 1.14E+05 NO DATA 1.50E+05 NO DATA 2.95E+08 p MO-99 NO DATA 7.67E+06 1.90E+06 NO DATA 1.64E+07 NO DATA 6.35E+06

,,.j TC-99m 4.70E+00 9.21E+00 1.53E+02 NO DATA 1.34E+02 4.68E+00 5.24E+03

.o TC-101 1.48E-30 1.54E-30 1.96E-29 NO DATA 2.63E-29 8.16E-31 4.91E-30 l

'] RU-103 RU-105 1.54E+07 9.16E+01 NO DATA NO DATA 5.90E406 3.32E+01 NO DATA NO DATA 3.86E607 8.05E+02 NO DATA NO DATA 3.97E+08 5.90E+04 l

l

^

s RU-106 7.45E+08 NO DATA 9.30E+07 NO DATA 1.01E+09 NO DATA 1.16E+10 (

AG-110m 3.21E+07 2.17E+07 1.73E+07 NO DATA 4.04E+07 NO DATA 2.58E+09 - ;

, TE-125m 3.51E+08 9.52E+07 4.68E+07 9.86E+07 NO DATA NO DATA 3.39E+08 l TE-127m 1.32E+09 3.56E+08 1.57E+08 3.16E+08 3.77E+09 NO DATA 1.07E+09 l TE-127 9.84E+03 2.65E+03 2.11E+03 6.81Et03 2.80E+04 NO DATA 3.84E+05 l TE-129m 8.43E+08 2.35E+08 1.31E+08 2.72E+08 2.47E+09 NO DATA 1.03E+09 l TE-129 1.32E-03 3.68E-04 3.13E-04 9.42E-04 3.86E-03 NO DATA 8.21E-02 .

TE-131m 1.54E+06 5.33E+05 5.67E405 1.10E+06 5.16E+06 NO DATA 2.16E+07 TE-131 2.59E-15 7.89E-16 7.71E-16 1.98E-15 7.83E-15 NO DATA 1.36E-14 ,

I Rev.17-12/98 I

CLINTON-1 3-97 I

I CPS-ODCM TABLE 3.5-28 (continued)

VEGETATION PATHWAY FACTORS - R".n (CHILD)

(m* mrem /yr per pCi/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE 7.00E+06 3.10E+06 3.74E+06 4.51E+06 3.12E+07 ITE-132 I-130 6.10E+05 1.23E+06 6.35E+05 1.36E+08 2.88E+07 NO DATA 1.84E+06' NO DATA 5.77E+05 I-131 1.43E+08 1.44E+08 8.16E+07 4.75E+1G 2.36E+08 NO DATA 1.28E+07 I-132 9.20E+01 1.69E+02 7.77E+01 7.84E+03 2.59E+02 NO DATA 1.99E+02 I ~I-133 I-134 3.53E+06 1.50E-04 4.16E+06 2.79E-04 1.65E+06 1.28E-04 8.11E+08 6.41E-03 7.27E+06 4.26E-04 NO DATA NO DATA 1.76E+06 1.85E-04 I-135 6.28E+04 1.13E+05 5.34E+04 1.00E+07 1.73E+05 NO DATA 8.61E+04 1.60E+10 2.63E+10 5.55E+09 NO DATA 8.15E+09 2.92E+09 1.42E+08 ICS-134 CS-136 CS-137 8.23E+07 2.39E+10 2.26E+08 2.29E+10 1.46E+08 3.38E+09 NO DATA 1.20E+08 1.80E+07 7.95E+06 NO DATA 7.46E+09 2.68E+09 1.43E+08 CS-138 6. 44 E-11 8.95E-11 5.68E-11 NO DATA 6.30E-11 6.78E-12 4.12E-11 BA-139 4.97E-02 2.65E-05 1.44E-03 NO DATA 2.32E-05 ~1.56E-05 2.87E+00 BA-140 2.77E+08 2.42E+05 1.62E+07 NO DATA 7.89E+04 1.45E+05 1.40E+08 BA-141 2.40E-21 1.14E-24 6.64E-23 NO DATA 9.88E-25 6.71E-24 1.16E-21 9.70E-39 6.98E-42 5.42E-40 NO DATA 5.65E-42 4.11E-42 1.27E-40 LA-140 1.13E+03' IBA-142 IA-142 3.24E+03 3.39E-04 1.08E-04 3.53E+02 3.38E-05 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 3.16E+07 2.14E+01 CE-141 6.56E+05 3.27E+05 4.85E+04 NO DATA 1.43E+05 NO DATA 4.08E+08 CE-143 '

1.71E+03 9.29E+05 1.35E+02 NO DATA 3.90E+02 NO DATA 1.36E+07 ICE-144 PR-143 1.27E+08 1.45E+05 3.99E+07 4.37E+04 6.79E+06 7.22E+03 NO DATA 2.21E+07 NO DATA 1.04E+10

NO DATA 2.36E+04 NO DATA 1.57E+08

'R-144 5.64E-76 1.74E-26 2.84E-27 NO DATA 9.22E-27 NO DATA 3.75E-23

>-147 7.16E+04 5.80E+04 4.49E+03 NO DATA 3.18E+04 NO DATA 9.18E+07 I .d-1E'7 6.44E+04 3.81E+04 1.71E+04 NO DATA NO DATA NO DATA 5.36E+06 JNP-OS 2.56E+03 1.84E+02 1.29E+02 NO DATA 5.31E+02 NO DATA 1.36E+07 g

g _* mrem /yr per pC1/m' 5

- 3.75'x 10 I

I I

I Y

I CLINTUJ-l ' 3-98 Rev.17-12/98 i

l TABLE 3.5-29 VEGETATION PATHWAY FACTORS - Rh (TEEN)

(m2 mrem /yr per pC1)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI l ISOTOPE W H-3 NO DATA 2.59E+03* 2.59E+03* 2.59E+03* 2.59E+03* 2.59E+03* 2.59E+03*

C-14 1.45E+06* 2.91E+05* 2.91E+05* 2.91E+05* 2.91E+05* 2.91E+05* 2.91E+05*

NA-24 2.40E+05** 2.40E+05 2.40E+05 2.40E+05 2.40E+05 2.40E+05 2.40E+05 P-32 1.61E+09 9.97E+07 6.24E+07 NO DATA NO DATA NO DATA 1.35E+0F CR-51 NO DATA NO DATA 6.12E+04 3.40E+04 1.34E+04 8.74E+04 1.03E+07 MN-54 NO DATA 4.54E+08 9.01E+07 NO DATA 1.36E+08 NO DATA 9.32E+08 MN-56 NO DATA 1.43E+01 2.54E+00 NO DATA 1.81E+01 NO DATA 9.41E+02 FE-55 3.26E+08 2.31E+08 5.39E+07 NO DATA NO DATA '1.46E+08 1.00E+08 FE-59 1.79E+08 4.18E+08 1.61E+08 NO DATA NO DATA 1.32E+08 9.88E+08 CO-58 NO DATA 4.36E+07 1.01E+08 NO DATA NO DATA NO DATA 6.02E+08 CO-60 NO DATA 2.49E+08 5.60E+08 NO DATA NO DATA NO DATA 3.24E+09 NI-63 1.61E+10 l'14E+09

. 5.46E+08 NO DATA NO DATA NO DATA 1.81E+08 NI-65 5.73E+01 7.32E+00 3.34E+00 dO DATA NO DATA NO DATA 3.97E+02 CU-64 NO DATA 8.28E+03 3.90E+03 NO DATA 2.10E+04 NO DATA 6.42E+05 ZN-65 4.23E+08 1.47E+09 6.86E+08 NO DATA 9.41E+08 NO DATA 6.23E+08 ZN-69 5.04E-06 9.60E-06 6.72E-07 NO DATA 6.28E-06 NO DATA 1.77E-05 BR-83 NO DATA NO DATA 2.93E+00 NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA 2.31E-11 NO DATA NO DATA NO DATA NO DATA BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA RB-86 NO DATA 2.72E+08 1.28E+08 NO DATA NO DATA NO DATA 4.02E+07 RB-88 NO DATA 3.17E-22 1.69E-22 NO DATA NO DATA NO DATA 2.72E-29 ~

RB-89 NO DATA 3.56E-26 2.52E-26 NO DATA NO DATA NO DATA 5.45E-35 SR-89 1.51E+10 NO DATA 4.32E+08 NO DATA NO DATA NO. DATA 1.80E+09 SR-90 7.50E+11 NO DATA 1.85E+11 NO DATA NO DATA NO DATA 2.11E+10 .

SR-91 2.82E+05 NO DATA 1.12E+04 NO DATA NO DATA NO DATA 1.28E+06 SR-92 4.00E+02 NO DATA 1.70E+01 NO DATA NO DATA NO DATA 1.02E+04 Y-90 1.25E+04 NO DATA 3.37E+02 NO DATA NO DATA NO DATA 1.03E+08 NO DATA 2.38E-07 Y-91m Y-91 Y-92 5.04E-09 7.84E+06 8.60E-01 NO DATA NO DATA NO DATA 1.93E-10 2.10E+05 2.49E-02 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 3.21E+09 2.36E+04

)3 Y-93 1.58E+02 NO DATA 4.34E+00 NO DATA NO DATA NO DATA 4.83E+06 ZR-95 1.73E+06 5. 4 tie + 05 3.75E+05 NO DATA 8.02E+05 NO DATA 1.26E+09 ZR-97 3.10E+02 6.14E+01 2.83E+01 NO DATA 9.31E+01 NO DATA 1.66E+07 NB-95 1.92E+05 1.07E+05 5.86E+04 NO DATA 1.03E+05 NO DATA 4.56E+08 HO-99 NO DATA 5.64E+06 1.08E+06 NO DATA 1.29E+07 NO DATA 1.01E+07 TC-99m 2.73E+00 7.61E+00 9.86E+01 NO DATA 1.13E+02 4.23E+00 5.00E+03 TC-101 8.02E-31 1.14E-30 1.12E-29 NO DATA 2.06E-29 6.95E-31 1.95E-37 i RU-103 6.81E+06 NO DATA 2.91E+06 NO DATA 2.40E+07 NO DATA 5.69E+08 l

~

RU-105 4.97E+01 NO DATA 1.93E+01 NO DATA 6.27E+02 NO DATA 4.01E+04 l RU-106 3.09E+08 NO DATA 3.89E+07 NO DATA 5.95E+08 NO DATA 1.48E+10 l AG-110m 1.51E+07 1.43E+07 8.72E+06 NO DATA 2.72E+07 NO DATA 4.03E+09 TE-125m 1.49E+08 5.35E+07 1.99E+07 4.15E+07 NO DATA NO DATA 4.38E+08 TE-127m 5.52E+08 1.96E+08 6.57E+07 1.31E+08 2.24E+09 NO DATA 1.38E+09 j TE-127 5.4M+03 1.92E+03 1.16E+03 3.73E+03 2.19E+04 NO DATA 4.17E+05 I

TE-129m 3.60E+08 1.34E+08 5.70E+07 1.16E+08 1.51E+09 NO DATA 1.35E+09 TE-129 7.13E-04 2.66E-04 1.73E-04 5.09E-04 2.99E-03 NO DATA 3.90E-03 TE-131m 8.44E+05 4.05E+05 3.38E+05 6.09E+05 4.22E+06 NO DATA 3.25E+07 TE-131 1.41E-15 5.80E-16 4.39E-16 1.08E-15 6.15E-15 NO DATA 1.15E-16 Il i l

I Il l CLINTON-1 3-99 Rev.17-12/98 l

L I

>S-ODCM TABLE 3.5-29 (continued) '

VEGETATION PATHWAY FACTORS - R*,y (TEEN)

(m* mrem /yr per pCi/sec) g BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI OTOPE

-132 3.91E+06 2.48E+06 2.33E+06 2.61E+06 2.37E+07 NO DATA 7.84E+07 130 3.50E+05 1.01E+06 4.05E+05 8.26E+07 1.56E+06 NO DATA 7.79E+05 131 7.66E+07 1.07E+08 5.76E+07 3.13E+10- 1.85E+08 NO DATA 2.12E+07 132 5.19E+01 1.36E+02 4.87E+01 4.58E+03 2.14E+02 NO DATA 5.91E+01

,133 1.93E+06 3.28E+06 1.00E+06 4.58E+08 5.75E+06 NO DATA 2.48E+06 134 8.44E-05 2.24E-04 8.03E-05 3.73E-03 3.53E-04 NO DATA 2.95E-06 135 3.53E+04 9.09E+04 3.37E+04 5.85E+06 1.44E+05 NO DATA 1.01E+05 l-134 7.10E+09 1.67E+10 7 75E+09

. NO DATA 5.31E+09 2.03E+09 2.08E+08 ,i l-136 4.37E+07 1.72E+08 1.16E+08 NO DATA 9.37E+07 1.48E+07 1.38E+07 l-137 1.01E+10 1.35E+10 4.70E+09 NO DATA 4.59E+09 1.78E+09 1.92E+08 l-138 3.54E-11 6.80E-11 3.40E-11 NO DATA 5.02E-11 5.84E-12 3.08E-14 L-139 " 2.70E-02 1.90E-05 7.86E-04 NO DATA 1.79E-05 1.31E-05 2.41E-01 6-140 1.38E+08 1.69E+05 8.89E+06 NO DATA 5.73E+04 1.14E+05 2.13E+08 L-141 1.11E-21 8.27E-25 3.70E-23 NO DATA 7.67E-25 5.66E-25 2.36E-27 s L-142 5.35E-39 5.35E-42 3.29E-40 NO DATA 4.53E-42 3.56E-42 1.64E-50 y L-140 1.80E+03 8.86E+02 2.36E+02 NO DATA NO DATA NO DATA 5.09E+07 -

L-14 2 1.88E-04 8.35E-05 2.08E-05 NO DATA NO DATA NO DATA 2.54E+00

-141 2.83E+05 1.89E+05 2.17E+04 NO DATA 8.90E+04 NO DATA 5.41E+08

-143 9.33E+02 6.79E+05 7.58E+01 NO DATA 3.04E+02 NO DATA 2.04E+07 l-144 5.29E+07 2.19E+C7 2.84E+06 NO DATA 1.31E+07 NO DATA 1.33E+10

t-143 7.00E+04 2.79E+04 3.48E+03 NO DATA 1.62E+04 NO DATA 2.30E+08 t-144 3.04E-26 1.24E-26 1.54E-27 NO DATA 7.14E-27 NO DATA 3.35E-29

-147 3.62E+04 3.94E+04 2.36E+03 NO DATA 2.31E+04 NO DATA' 1.42E+08 187 3.53E+04 2.88E+04 1.01E+04 NO DATA NO DATA NO DATA 7.79E+06

>-239 1.39E+03 1.31E+02 7.26E+01 NO DATA 4.10E+02 NO DATA 2.10E+07 em/yr per 5 pCi/n' 2.40 x 10

>INTON-1 3-100 Rev.17-12/98

CPS-ODC14 TABLE 3 S-30 VEGETATION PATIDfAY FACTORS - Rh (ADULT) .

(m* mrem /yr per Ci/Sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE g

H-3 NO DATA 2.26E+03* 2.26E+03* 2.26E+03* 2.26E+03* 2.26E+03* 2.26E+03*

C-14 8.97E+05* 1.79E+05* 1.79E+05* 1.79E+05* 1.79E+05* 1.79E+05* 1.79E+05*

NA-24 2.71E+05** 2.71E+05 2.71E+05 2.71E+05 2.71E+05 2.71E+05 2.71E+05 8.70E+07 5.41E+07 NO DATA NO DATA NO DATA 1.57E+08 W P-32 1.40E+09

/CR NO DATA HO DATA 4.60E+04 2.75E+04 1.01E+04 6.11E+04 1.16E+07 MN-54 NO DATA 3.13E+08 5.96E+07 NO DATA 9.30E+07 NO DATA 9.58E+08 g MN-56 NO DATA 1.59E+01 2.82E+00 NO DATA 2.01E+01 NO DATA 5.06E+02 8.33E+07 g

FE-55 2.10E+08 1.45E+08 3.38E+07 NO DATA NO DATA 8.10E+07 FE-59 1.26E+08 2.96E+08 1.13E+0B NO DATA NO DATA 8.27E+07 9.86E+08 CO-58 NO DATA 3.08E+07 6.90E+07 NO DATA NO DATA NO DATA 6.24E+08 g CO-60 NO DATA _ 1. 67E+08 3.69E+08 NO DATA NO DATA NO DATA 3.14E+09 g NI-63 1.04E+10 7.21E+08 3.49E+08 NO DATA NO DATA NO DATA 1.50E+08 NI-65 6.18E+01 8.03E+00 3.66E+00 NO DATA NO DATA NO DATA 2.04E+02 CU-64 NO DATA 9.16E+03 4.30E+03 NO DATA 2.31E+04 NO DATA 7.81E+05 l ZN-65 3.18E+08 1.01E+09 4.57E+08 NO DATA 6.76E+08 NO DATA 6.36E+08 E ZN-69 5.39E-06 1.03E-05 7.17E-07 NO DATA 6.69E-06 NO DATA 1.55E-06

-- BR-83 NO DATA NO DATA 3.13E+00 NO DATA NO DATA NO DATA 4.50E+00 BR-84 NO DATA NO DATA 2.54E-11 NO DATA NO DATA NO DATA 1.99E-16 NO DATA NO DATA NO DATA =

BR-85 NO DATA NO DATA NO DATA NO DATA RB-86 NO DATA 2.19E+08 1.02E+08 NO DATA NO. DATA NO DATA 4.33E+07 RB-88 NO DATA 3.43E-22 1.82E-22 NO DATA NO DATA NO DATA 4.74E-33 E RB-89 NO DATA 3.96E-26 2.79E-26 NO DATA NO DATA NO DATA NO DATA 2.30E-39 1.60E+09 g

SR-89 9.95E+09 NO DATA 2.86E+08 NO DATA NO DATA SR-90 6.04E+11 NO DATA 1.48E+11 NO DATA NO DATA NO DATA 1.75E+10 , ,

SR-91 3.02E+05 NO DATA 1.22E+04 NO DATA NO DATA NO DATA 1.44E+06 \

SR-92 4.28E+02 NO DATA 1.85E+01 NO DATA NO DATA NO DATA 8.48E+03 Y-90 1.33E+04 NO DATA 3.56E+02 NO DATA NO DATA NO DATA 1.41E+08 Y-91m 5.42E-09 NO DATA 2.10E-10 NO DATA NO DATA NO DATA 1.59E-08 Y-91 5.12E+06 NO DATA 1.37E+05 NO DATA NO DATA NO DATA 2.82E+09 l Y-92 9.13E-01 NO DATA 2.67E-02 NO DATA NO DATA NO DATA 1.60E+04 3 Y-93 1.69E+02 NO DATA 4.65E+00 NO DATA NO DATA NO DATA 5.35E+06 ZR 1.18E+06 3.79E+05 2.56E+05 NO DATA 5.94E+05 NO DATA 1.20E+0d ZR-97 3.36E+02 6.78E+01 3.10E+01 NO DATA 1.02E+02 NO DATA 2.10E+07 NB-95 1.42E+05 7.91E+04 4.25E+04 NO DATA 7.82E+04 NO DATA 4.80E+08 HO-99 NO DATA 6.12E+06 1.16E+06 NO DATA 1.39E+07 NO DATA 1.42E+07 TC-99m 3.09E+00 8.73E+00 1.11E+02 NO DATA 1.33E+02 4.28E+00 5.16E+03 g TC-101 8.62E-31 1.24E-30 1.22E-29 NO DATA 2.24E-29 6.35E-31 3.73E-42 5.57E+08 g

RU-103 4.77E+06 NO DATA 2.06E+06 NO DATA 1.82E+07 NO DATA RU-105 5.36E+01 NO DATA 2.12E+01 NO DATA 6.93E+02 NO DATA 3.28E+04 RU-106 1.93E+08 NO DATA 2.44E+07 NO DATA 3.73E+08 NO DATA 1.25E+10 AG-110m 1.05E+07 9.75E+06 5.79E+06 NO DATA 1.92E+07 NO DATA 3.98E+09 TE-125m 9.67E+07 3.51E+07 '1.30E+07 2.91E+07 3.93E+08 NO DATA 3.86E+08 TE-127m 3.49E+08 1.2SE+08 4.26E+07 8.93E+07 1.42E+09 NO DATA 1.17E+09 TE-127 5.65E403 2.03E+03 1.22E+03 4.19E+03 2.30E+04 NO DATA 4.46E+05 l TE-129m 2.51E+08 9.35E+07 3.97E+07 8.61E+07 1.05E+09 NO DATA 1.26E+09 3 TE-129 7.61E-04 2.86E-04 1.85E-04 5.84E-04 3.20E-03 NO DATA 5.75E-04 TE-131m 9.12E+05 4.46E+05 3.72E+05 7.06E+05 4.52E+06 NO DATA 4.43E+07 TE-131 1.51E-15 6.32E-16 4.78E-16 1.24E-15 6.63E-15 NO DATA 2.14E-16 I

l CLINTON-1 3-101 Rev.17-12/98 I

i

)

CPS-ODCM TABLE 3.5-30 (continued)

VEGETATION PATHWAY FACTORS - R" y (ADULT)

(m* mrem /yr per pCi/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE 75-132 4.31E+06 2.79E+06 2.62E+06 3.08E+06 2.68E+07 NO DATA 1.32E+08 I-130 3.91E+05 1.1$E+06 4.55E+05 9.77E+07 1.80E+06 NO DATA 9.93E+05 I-131 8.07E+07 1.15E+08 6.62E+07 3.78E+10 1.98E+08 NO DATA 3.05E+07 5.77E+01 1.54E+02 5.40E+01 5.40E+03 2.46E+02 NO DATA 2.90E+01 2.09E+06 3.63E+06 II-132 I-133 I-134 9.33E-05 2.53E-04 1.11E+06 5.34E+08 9.06E-05 4.39E-03 6.34E+06 NO DATA 4.03E-04 NO DATA 3.26E+06 2.12E-07 I-135 3.91E+04 1.02E+05 3.77E+04 6.75E+06 1.64E+05 NO DATA 1.16E+05 j 4.67E+09 1.11E+10 9.08E+09 NO DATA 3.59E+09 1.19E+09 1.94E+08 i I 'CS-134 CS-136 CS-137 4.26E+07 6.36E+09 1.68E+08 8.70E+09 1.21E+08 NO DATA 9.35E+07 1.28E+07 1.91E+07 5.70E+09 HO DATA 2.95E+09 9.82E+08 1.68E+08 CS-138 3.84E-11 7.58E 3.75E-11 NO DATA 5.57E-11 5.50E-12 3.23E-16 BA-139 2.86E-02 2.04E-05 8.38E-04 NO DATA 1.91E-05 1.16E-05 5.07E-02 IBA-140 1.29E+08 1.62E+05 8.43E+06 NO DATA 5.50E+04 9.26E+04 2.65E+08 BA-141 1.18E-21 0.90E-25 3.9BE-23 NO DATA 8.28E-25 5.05E-25 5.55E-31 BA-142 5.79E-39' 5.96E-42 3.64E-40 NO DATA 5.03E-42 3.37E-42 8.16E-57 1.98E+03 9.95E+02 2.63E+02 NO DATA NO DATA NO DATA 7.31E+07 ILA-140 LA-142 2.04E-04 9.25E-05 2.31E-05 NO DATA NO DATA NO DATA 6.76E-01 CE-141 1.97E+05 1.33E+05 1.51E+04 NO DATA 6.19E+04 NO DATA 5.09E+08 9.98E+02 7.38E+05 8.17E+01 NO DATA 3.25E+02 NO DATA 2.76E+07 ICE-143 CE-144 3.28E+07 1.37E+07 1.76E+06 NO DATA 8.14E+06 NO DATA 1.11E+10 PR-143 6.26E+04 2.51E+04~ 3.10E+03 NO DATA 1.45E+04 NO DATA 2.74E+08 PR-144 3.2SE-26 1.35E-26 1.65E-27 NO DATA 7.61E-27 NO DATA 4.68E-33 5-147 3.33E+04 3.85E+04 2.31E+03 NO DATA 2.25E+04 NO DATA 1.85E+08

-187 3.80E+04 3.18E+04 1.11E+04 NO DATA NO DATA NO DATA 1.40E+07 i

,jNP-239 1.43E+03 1.40E+02 7.74E+01 NO DATA 4.38E+02 NO DATA 2.88E+07

mrem /yr per pCi/m

02.71 x 10 I

I I

I G I

I T

CLINTON-1 3-102 Rev.17-12/98

CPS-ODC14 TABLE 3.5-31 GROUND PLANE PATHWAY FACTORS - R"i '

(m* mrem /yr per pCi/sec)

TOTAL TOTAL TOTAL ISOTOPE BODY SKIN ISOTOPE BODY SKIN ISOTOPE BODY SKIN H-3 0.00E+00 0.00E+00 Y-91 1.07E+06 1.21E+06 CS-136 1.51E+08 1.71E+08 C-14 0.00E+00 0.00E+00 Y-92 1.80E+05 2.14E+05 CS-137 1.30E+10- 1.52E+10 NA-24 1.20E+07* 1.39E+07 Y-93 1.83E+05 2.50E+05 CS-138 3.59E+05 4.10E+05 l P-32 0.00E+00 0.00E+00 ZR-95 2.45E+08 2.85E+08 BA-139 1.06E+05 1.19E+05 W CR-51 4.65E+06 5.50E+06 ZR-97 2.96E+06 3.44E+06 BA-140 2.05E+07 2.35E+07 HN-54 1.38E+09 1.62E+09 NB-95 1.37E+08 1.61E+0B BA-141 4.17E+04 4.75E+04 MN-56 9.03E+05 1.07E+06 MO-99 3.99E+06 4.62E+06 BA-142 4.49E+04 5.11E+04 FE-55 0.00E+00 0.00E+00 TC-99m 1.84E+05 2.11E+05 IA-140 1.92E+07 2.18E+07 FE-59 2.73E+08 3.20E+08 TC-101 2.03E+04 2.26E+04 IA-142 7.60E+05 9.12E+05 CO-58 3.60E+08 4.45E+08 RU-103 1.08E+08 1.26E+08 CE-141 1.37E+07 1.54E+07 CO-60 2.32E+10. 2.73E+10 RU-105 6.36E+05 .7.21E+05 CE-143 2.31E+06 2.63E+06 NI-63 0.00E+00 0.00E+00 RU-106 4.22E+08 5.06E+08 CE-144 6.96E+07 8.05E+07 NI-65 2.97E+05 3.45E+05 AG-110m 3.44E+09 4.01E+09 PR-143 0.00E+00 0.00E+00 CU-64 6.05E+05 6.86E+05 TE-125m 1.56E+06 2.13E+06 PR-144 1.84E+03 2.11E+03 ZN-65 7.48E+08 8.60E+08 TE-127m 9.16E+04 1.08E+05 ND-147 8.39E+06 1.01E+07 lI 3 '

ZN-69 0.00E+00 0.00E+00 TE-127 2.99E+03 3.29E+03 W-187 2.35E+06 2.73E+06 BR-83 4.87E+03 7.07E+03 TE-129m 1.98E+07 2.31E+07 NP-239 1.71E+06 1.98E+06 BR-84 2.03E+05 2.36E+05 TE-129 2.64E+04 3.12E+04 BR-85 0.00E+00 0.00E+00 TE-131m 8.02E+06 9.46E+06 RB-86 8.98E+06 1.03E+07 TE-131 2.92E+04 3.45E+04 RB-88 3.31E+04 3.78E+04 TE-132 4.24E+06 4.99E+06 RB-89 1.23E+05 1.48E+05 I-130 5.50E+06 6.68E+06 SR-89 2.16E+04 2.50E+04 I-131 1.72E+07 2.09E+07 SR-90 NO DATA NO DATA I-132 1.25E+06 1.47E+06 ,

SR-91 2.14E+06 2.51E+06 I-133 2.45E+06 2.98E+06 .f SR-92 7.77E+05 8.64E+05 I-134 4.46E+05 5.30E+05 Y-90 4.50E+03 5.31E+03 I-135 2.53E+06 2.95E+06 Y-91m 1.00E+05 1.16E+05 CS-l'34 6.87E+09 8.01E+09 *1.20 x 10 I

I I

I 1 I

I I

CLINTON-1 3-103 Rev.17-12/98 I

I CPS-ODCM COMPLIANCE WITH 40CFR190 Is 4.0 4.1 Total Dose - Operation and Surveillance Requirements OPERATION REQUIREMENT I The annual (calendar year) dose or dose commitment to any MEMBER OF THE PUBLIC due to releases of radioactivity and to radiation from uranium fuel cycle sources shall be limited to less than or equal to 25 mrem to the total body or any organ, except the thyroid, which shall be limited to less than or equal to 75 mrem. This requirement is applicable at all times.

REMEDIAL REQUIREMENT:

I a. With the calculated doses from the release of radioactive materials in liquid or gaseous effluents exceeding twice the limits of Sections 2.4.1(a),

I 2. 4. l (b) , 3. 5. l (a) , 3.5.1(b), 3.5.2(a), and 3.5.2 (b) , calculations shall be made including direct radiation contributions from the reactor unit and from outside storage tanks to determine whether I the above limits of Section 4.1 have been exceeded.

If such is the case, prepare and submit to the Regional Administrator of the Regional Office of the

. NRC within 30 days a Special Report that defines the s

, corrective action to be taken to reduce subsequent s/ releases to prevent recurrence of exceeding the I above limits and includes the schedule for-achieving conformance with the above limits. This Special Report, as defined in 10CFR20 Part 2203(4), shall include the following information:

1. A determination of which uranium fuel cycle facilities or operations, in addition to CPS, I contribute to the annual dose to the maximum exposed individual. Etel cycle facilities located beyond the 5-mile radius from CPS need not be considered in this determination.

2. A determination of the maximum exposed I individual.

I-I t' .

CLINTON-1 4-1 Rev.17-12/98 1

CPS-ODCM

3. A determination of the total annual dose to the '

maximum exposed individual from all existing pathways and sources of radioactivity and '

radiation (including direct radiation from N-16, the plant and storage facilities) using methodologies described in this manual. The g

\

Ng direct radiation dose may be either calculated or measured.

5

4. It shall-describe the levels of radiation and concentrations of radioactive material involved, and the cause of the exposure levels or concentrations.

If the estimated dose (s) exceeds the above ,

limits, and if the release condition resulting in violation of 40CFR Part 190 has not already been corrected, the Special Report shall include a request for a variance in accordance g with the provisions of 40CFR Part 190. 3 Submittal of the report is considered a timely request, and a variance is granted until staff action on the request is complete.

4.1.1 SURVEILLANCE REQUIREMENTS Cumulative do.se contributions from li~ quid and gaseous I effluents shall be determined in accordance with Sections 2.4.1.1, 3.5.1.1, and 3.5.2.1, and in accordance with the methodology and parameters described or specified in this .

manual. l 4.1.2 Cumulative dose contributions from direct radiation from the reactor and from radwaste storage tanks shall be j determined in accordance with the methodology and a!

parameters described or specified in this manual. This g requirement is-applicable only under conditions set forth in the Remedial Requirement specified above (Section 4.1).

The total body and organ doses resulting from liquid effluents will be summed with the doses resulting from gaseous effluents (including non-noble gases) and the doses to the maximum exposed individual from other operations of the uranium fuel cycle. The g, effluent doses will be based upon releases from CPS during the El previous three quarters and from the quart.er in which the Section 4.1 OPERATION REQUIREMENT-was exceeded. ;

i I'

I' CLINTON-1 4-2 Rev.17-12/98 I

CPS-ODCM 5.0 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM

, The primary requirements for the Clinton Power Station i

' Radiological Environmental Monitoring Program (:REHP) are set forth in Table 5.1-1 and shown by location in Figures 5.0-1, 5.0-2, 5.0-3 and 5.0-4.

4M In addition to the required sampling program,.. CPS will

$b perform supplemental periodic and long term sampling and analyses in order to better monitor enviro'nmental exposure pathways. These samples will not be listed in this manual.

5.1 Monitoring Program - Operation and Surveillance Requirements OPERATION REQUIREMENT The Radiological Environmental Monitoring Program shall be conducted as specified in Table 5.1-1. This requirement applies at all times.

REMEDIAL REQUIREMENT:

a. With the radiological environmental monitoring program not being conducted as specified in Table 5.1-1 prepare and submit to the Commission, in the j Annual Radiological Environmental Operating Report req'uired by Technical Specification 5.6.2, a description of the reasons for not conducting the program as required and the plans for preventing a recurrence.

f CLINTON-1 5-1 Rev.17-12/98

CPS-ODCM l

b. With the level of radioactivity as the result of plant effluents in an, environmental sampling medium at a specified location exceeding the report levels ] '

of Table 5.1-2 when averaged over any calendar '

quarter prepare and submit to the Regional Administrator of the Regional Office of the NRC l !

within 30 days a Special Report that identifies the 5 cause (s) for exceeding the limit (s) and defines the corrective actions to be taken to reduce radioactive 3 ef,fluents so that the potential annual dose' to a 3 MEMBER OF THE PUBLIC is less than the calendar year limits of Section 2.4.1, 3.5.1, and 3.5.2. When a more than one of the radionuclides in Table 5.1-2 g are detected in the sampling medium, this report shall be submitted if:

concentration (1) + concentration (2) + >1.0 reporting level (1) reporting level (2)

When radionuclides other than those in Table 5.1-2 are detected and the result of plant effluents, this report shall be submitted if the potential annual dose

to a MEMBER OF THE PUBLIC is equal to or greater than the calendar year limits of Section 2.4.1, 3.5.1, and 3.5.2. This report is not g required if the measured level of radioactivity was g not the result of plant effluents; however, in such an event, the condition shall be reported and described in the Annual Radiological Environmental Operating Report.

c. With milk or fresh leafy vegetation samples E unavailable from one or more of the sample locations W ,

required by Table 5.1-1, identify locations for obtaining replacement samples and add them to the radiological environmental monitoring program within 30 days. The specific locations from which samples were unavailable may then be deleted from the monitoring program. Pursuant to Technical '

MWgl Specification 5.5.1, identify the cause of the

~The methodology and parameters used to estimate the potential .'

annual dose to a MEMBER OF THE PUBLIC shall be indicated in this report.

I I; .

CLINTON-1 5-2 Rev.17-12/98

CPS-ODCM I' unavailability of samples and identify the new location (s) for obtaining replacement samples in the next annual Radiological Environmental Operating Report and also include in the report a revised I;/ figure (s) and table for this manual reflecting the new location (s) .

SURVEILLANCE REQUIREMENTS 5.1.1 The radiological environmental monitoring samples shall I be collected pursuant to Table 5.1-1 from the specific

, locations given in Table 5.1-1 and Figures 5.0-1, 5.0-2, 5.0-3, and 5.0-4 and shall be analyzed pursuant to the I requirements of Table 5.1-1 and the detection capabilities required by Table 5.1-3.

I I

I>

il lI l

I I

e CLINTON-1 5-3 Rev.17-12/98

W_

y 8 Y l 9 C r /

N e 2 E

U IS Q S t

r a

1 m

EY u q

R F L v

m A e e D N R s

NA o AF d E O P

Y a

m m

)

s m

T a e G l

_ i Y (

m M C

N n E o U i M

A Q E

t a -

M R R t 6765588388338873 G DF s . . . . . . . . . . . .

O N 0000022222321001 R AN m P

~

GI O

l y o r

M G NT r f N IC e .

I LE t E R r

_ O PL ML a C

N M_

T I AO u A N SC Q T O S I

1 M : D

- ,l a 1 L s sae A s w ncr 5 T

n o oia N S o d l i g E N i n l L

E M O t a

a f

o tol; alaY 5 M

B N I g torr A O ET t sreA T R VA se n s onD E 6 5 2342345678 1 453 I IC rei a 3 2224444444 336 V TO gonr feen D - - - - - - - - - -

N AL nmouseed o t gU O e L L L LLLLLLLLL L L LL gmeB O C E T i C C CCCCCCCCCC C CCC NE rrhatc n h L EL ooteaa i htE A SP t imrl p rcanI T C

I EM RA iow nw re reiS M

G PS otros ,

e O E m ofoy nnre L RD h dl nioh R O N etst s I

D FA O

nirngu iweeno i

ec tt O T NNE E E NES E E E SSS W S W W WWW N

M_ _

A S t tmiu nnef C N N E E S S S SWNW N N W -

R RE ureudn aoso E EL oemrri S BP rhitot MM UA tsscn) 0ioneo 1 M

NS 4 edirc (

D ~

N M Y O A E I W L T H P A T

AM A I

D M-P S A R

E RR T M U /O C M C S D E D O N R 'O O P T X A I

- D N S

P C

E 1

I L

C W

! l llll ll ll llj ll ,ll

ll lli i 8

Y 9 C /

N 2 E 1 U S -

Q IS 7 E Y 1 R

FA L v e

DN R NA AF E O P )

Y s T e l

i m

Y (

C N n E o M U i Q t A E a R R t 6585361163551543 G DF s . . . . . . . . . . . . . .

O N 4444444444444444 R AN m P O o G GI r N NT f I IC

) R LE E d O PL C e T ML N u I AO A n N SC T O S I

t M D gi n )l o L sa C

(

A nc )

T

oims

' N S i gk e 1 E N to l 5

- M O al8i ; -

m15 .

N O

R ET VA I

to sro met 5

ot0i E 6789345678010112 I IC fe .s 7777555555668855 E V TO D - - - - - - - - - - - - - - -

L N AL ot65 O B E T e e C L LLLLLLLLLLLLLLL mAT L NE EL gmeoh n

iht htt CCCCCCCCCCCCCCCC n A SP rc sm u C EM aneo u I RA reilr m G PS e if O E tnrm L RD uio e R r O N o t7 g O I FA ec.n T NNE E E E E E WWW W W D O nne3a C NES S SSS SWN W N A S aos( r E N N E E S S S W W NN m R RE S r EL BP MM )

UA 2 NS (

n r

D N

Y O a AE I W T H LP A T I AM A D)d P S A e R u E

RR T in 1 U /O C -

S E t N O D Rno O P N T X A I

E D (c N I

. L 1 C

8 Y 9 C /

N 2 E S 1 UI Q S E *

. RY .

FA L v e

D.N R

NA _

AF E O P )

Y s T e .

l i

m -

Y (

C N ~ n E o U i M Q t A E a R R G

O DF t

s d.

. 4.16 591 R N 3 22 312 P AN m O o G GI r N NT f I

IC

) R LE E d O PL C e T ML N u I AO A n N SC T i O S I

t M s n D n n yi o L o b C

(

A i rds _

T

ana N S tlaasea E N tian '

1 O e -

- M sc ,v 5 1 N I eh ,sr

. O ET epcsl e 5 R VA hsuros .

E 75511944 I IC 37641476 E V TO t n seo thon s D - - - - - - -

L N AL fisncto O L LLLLLLL B E T C CCCCCCCC A NE o decaes sti T L EL eer ,aa A SP .

C EM ccanset I RA na altica oers G PS lpstn l )

O E a eae2o l _

L RD berld r R o O N r I FA e beuirt tpson O

T E t W -

D O o NNNE nWWN A S honoe t ti p r 1 c C E o W _

E R RE S c -

EL (

BP S MM )

UA 3 NS ( _

"N Y O -

AE I W T H L P A T I AM D)d P A S Ae R u E R R O T in M U/ Ct C S D O D N R En o O

O P T X A D (c I

- N S E -

I P . L C 1 C ll

s !l !l C 2 L C I

. E P N PR A A X P S .

T aa I N O O O rd R /D S N ti B D

- ic O O U R (

ci uo R R E ld N S ai E AP tn M TA ee P s L H W a E A n Y d

b a S SN a AU MM P

aho1 m gcslt3 p PB vif raeoh l LE eg s olcces e ER S

rhaa ae S ucta a s S

, m nuot3m O E gscp E dlri p f AF R E C etol NN NC asoSl r N A T

O gcm me E N E OT lt nIe o DR D I

R eeosTs m E O rauf R vdf E SP olnr e i f 5 AR L ucio latnBr ME O nutm nh Oo l PS G dly I a t DnedUm

/u o LE C lthh iN c EN A eeae QahfDc a T L T lifAl gero t LA A C C vdv C CC C i OT E e iv L LL ahrYs o CI B L O lani O vee e n N L

- D ngc' 1 - - D esn AV V E 8 E 32 E s TE Dn i 5 rtt t : I I

/utn a o O R 5 5 Qahi g N O .

- .let e S N 1 7 y

M -

E 1 ,

N ~

T (

lrmcoC oeoopo CS A C OA L o D D aqrlen LM n I I duelrt LP M t

_ S S ii eai EL O i T T nrfctn CI N n A A gertiu TN I u M N C

N C

deioo qonu bunss IG O

NA T

O e

d E E ye R )

N I f f nwws dteia FD N r r R G M o m

o m

uletm s y k hp E

Q P 2 000 t l l U R

. s . . s iy s e E O 2 t 977 t f, ar N G a a m C R M t i

t i

op.

rl Y A M

o o e n n

( acaG P 1 R M (

m i

(

m bnhnr yaaao a

r 3

1 a

d i lnls t i l l ly g y s i a c T e e oses c n i Y s s ci#ib u a o P

~)

W R e

)

as;se t

i o

nfmlr

_)

oa o e mla t

G fa t l

a S

l d y i s

i s

n e

C O E FA A N ND A

L_ .v qoca od wi a

m w

e n a LF Y R J 1 u aps mi naio p e i S E Q

7 r oogc l k s I

- tst e l t S U E y e l

eio fi:tr ,

r N L r t p. iv : C J 5' lei li Y 8 y cttey I

l r M J

l i IIll

C 3 2 L .

E I

N T

C aW ST A

(

cA o I AX N

D O P M.

u R E nR B / S r t O O U f B RR

' i a O nRN E c R u S e E AP eN#E d M TA

)

P H L W _

E A _

Y S E 11 SN M

E

c. AU N ss MM E aa dt11l1 PB

(

mm S ih85o LE M_

d( S pp re. cs ER o

9 F wpu E n s C ll ee (

c S e

cl 63aa 0tm S

O R s t O T o E tem ip AF du n C iaikol N A t op T D r e rR ws t O o nte s l m ,n e DR E

I M_

e a r O a nt sr oR ,

s(

p) 9ar f SP AR L m )m te l

) r .so ME O

)

ra ed3 m PS G em vi f LE I C

a m

asmoa ltir EN T A eal c LA L T CC - 8 C C nneeo OT A LL L O ttsxn CI E B

- - 0/

D - at AV N V

L 99 E 1 D watmr TE E 01 1 E inopo I I

nd ll O R 5 5 d e N O .

- i S N 1 n

M -

E 1 N

~ 1C T (

o CS A C mm OA L o D op D LM n I LP M t S no S I

EL O i T ts CI N n hi T A t A TN I u N pe N IG T e C

E e C O NA O

R d

)

M rs E ia N I f

om f FD N r dp r R G o Sl o E m e m Q P 06 U R _

. . s 1 s E O 41 t o 6 t N G a v a C R e Y A t

i r t i M M o o n n qtmG

(

m i

l uroa ainm rttm

(

m i

M-e tiha l T M

eul e Y s

)

rmyi s P l . s )

O E ya o

. n aCo t FA lop AN R ymi ND e spc A M

.v io L Y R F

ssa S E in I Q ta el S U E y N fs C 9 oi Y 8 rs

_

.M_ _

l

- 3 E C X P W A

.c .b

(

P S cA N -

D G n o T D O S O r r E / D i o ti R O U (

n u n B RR E k

i n d uO R e N AP S

n g d E MT

)

A P

LH EW A Y

l1 bDt

dtt1 1 *

o yraN ihh S aoS SN N cs iko .

fna AU o aa Cne saes 0a flm MM .

ct a m eyp c iptiim lkn mu h nm mp PB acep il c l LE o ol nnfn n ne tgri roal ele tie ER gure efs S t

o,oc ele d O r *f nwmi p l "l f AF R o r a .

dso So .ir N A l o LtCa tf c ko DR D m a e ll b oa em E I l kri ewe ft l SP O o a no aa i y1 AR L c

a c e.oo ftr W S

E atc po feh ln S E to ME PS O

G t o rnp N C fr a E C or LE I i n u W T e o ni SE C o t O csf ts E T b2 EN A n r CLb R tu O T L T lal ep1 oi R e LA o iki s OT A n l nec dp nn o CI E B e t lt bio tp u AV N L c ood ye r TE V E e nrr hu c I I s i s3 em p e O R S s i O Pdn

- N .

a t o e ,s N 1 r ook s f ds S M

y wwi

E enn rsg

'gt ea N 1

t cp12C t T (

oe3 - o oi Q CS A C Srw mr1wm epfo u OA L o tea C C pf n CC a LM n aat L O LL C r LP M tme ooaeo t t

- - O i r 1 D srnks hd t EL O i of 4 E ima i ei 71 D e CI N n s D2 E r TN u nos t e lp t l IG I

T e i p ru e ,dsry e eaa lt y O O d s 2p o iis kn NA R )

0l tmsoa et N I s0i ho dm . FD N u e enip f R G pms rts l r E pi wh w e o Q P lla D il h m U R I sy eo D E O ier N ese w T S e n ve e w I S C G

P

d. T Y A i A Ir l A

t N - l M h C . N i E C n q t m ig p i c c c I E qtG S

f ainoor r

urosresoao- nlm1 W

e f ura e o rttts gscp3 l r aim r m t ih o s y r u u o 1 l o rtm T e u lp tia v s r m y iba eemls a p a ia 2 1 m eu Y i l P c t ya l .

certtttn o . s rmi e a t. eieea c 3 6* t l s OE n a yao t

aa

rod wy l a . nt FA B i aCn n t t ao u o loaa t ymlnC hooei fhs e i lp AN i n spydo afrns d o yi ND l n sc A '

d ( ios sseg pm n i ' LF YR i m ttto (

s a E n i isa o1hhhn t *m s eee m S Q g l i n I U

e e mim atrw e l e d S E s da

) f o

e ea mt oc sh s

)

N C

r f e e Y o r r

, l

4 3 a

I N d.

(

W A N

E X

P W

M G sS cA o D T / S O O E he nE i

l k

S T

I O

od ri em t R OU i B R R n O u S E f N le in e R N A P nt e

f d) E M P

L H A

T W

r E A o Y m .

s

y b w b a n d dis rw1 SN uT eehenooina ei AU rh a etinss m cts MM v i r i r w m ,e e t 3 p rha PB es y

neea a l e aep m LE

. s el pnle ER gdns1ocos txl S

$ a ro tec S iie O R p

m es5ise af E os AF A ae nanhtr S C ntf N D l tst mtaio E T air DR I e e o ep iv o m O lno E O ra alain R gm SP L r

e r8celnsm .g v AR O q

te h i aod ME G h k f wl lro PS I u

i acmor na foIhti tik u epn w LE EN C r ld mfehn ig .os T A L T e 1ci3 us tt er LA A m mthn C C OT E B e mltaihi a L O ne CI N L n r a ar le g 5 n - ta AV V E M t e t ne k r h i 7 D im TE I metaieekm B E a I R i

p d sngat smal la O O 5

s r N N 1 et r s e S M - "

c ro e, a

E 1 '

h ,

N e T (

c opaS S CS A C k tane e OA L o e hsim m LM n d etmi D i LP M t a ruam I S a n

EL O i n rlo T CI N n t A n TN I u n i ,e s tn u IG T e u m ah N a O O d a C l emrl soey E l NA R )

l N I y

l n f y FD N tow r R G a hnh o E s l e m Q P y n 2 U R p . s E O a a 1 t N G r t a C R Y A t t i M M o o f n maaG sG t onna (

ea h

e niam m i

mm tmlm im T haya l e aa a lls n Y n ysii s ni P n ss us O E

)

u a

aa trst o ao lt FA M l

o eeomp lo yp A N l toii ND a hnmc

. i c A F n e o

L R rpn Y E d a S ata n I Q u tshn a S U E s itl d muy l e y N er I s C sew-

.;h 1 i

s*

Y e3 n1 S_

f

l, : llllllllj l I l

@ l 4 C E P b a ( A X S N bIF rni avs teh

(

ci ol M n G /

c IN N P o

t S i

E O U D O R R S

E

(

O D

er nk t n T sta i u O I S

en n e N AP d u d M TA e )

P H d L

) EW A Y

da1 dics1 pdka1 SN ir inrp W rimt AU S ses s aes S es s MM caa cvpca W vt( aa PB

(

S hsm p h ip i m aa9 m LE c a S aciep S ln.cp ER o E rnl E (

E et3ol 9

n C goe E C grin ,e s el c o C n ne S

O t T et T ei (

n T tamt AF R r O . o O tcse O A o R R ayaua t nirf N D if n r rcc r R wdlor DR I '

l

) fs eophh o i elo E O l nis m SP L la a f, -

) dn l AR um ee posf ao tom MC O G

n dtoci PS I lr ih al LE cs a b3 re1tk EN C C

ep nba e 8ii T A de C tlsi C L T L C O c L C u ,s m e L C cl. on LA OT A d p O t ia e 6,n g E B 1

0 5

D E

bi -

ye p s 9 1 D E

g i

o r

1 1

6 D osm E nti1n a

CI AV TE N

V I

L E y l t '

l5i I li l a 3 e -m O R 5 an )

n .

s3a N O N

n t ) 0l S 1 3

1 t s

M -

E 1 N

ass T (

CS A C rea OA L o o I

D D I

emm ip D LM n S S I LP M t nal S EL O i T T one T CI N n A A tn A TN I u N N ui N IG T e C

E C san C O O d E el E NA R )

als N I f f sye f FD N r r o a r R G o o nis o E m m afo m Q P 3

5 0 s . s l

t ,n 1 s

U E

R O

t 4 t h 4 N

I a a eo t G t t yr a C R i i t Y A -

o o i M n n o n

( ( oG m m na (

m i i m '

l l em i l

e e da e T

s s i s Y

) ) bi ) P ls eo O E po t FA AN O

op S ri ND e A t

tc i LF R

~ oa Y E nn S Q U sa I

. l S U E

-' y ' N ,

s C i Y M s'

'lll! 'j.

C 4 L .

E A X I

N c.

(

I P -

T O'

cNG o

N D O S

O F

o nt E /

U o S O d i R RE n T I

P u O S P r deN A o M TA d

)

P H u L W c E A t Y s

s g p lo c lv k S sC

dp b a c 1 LSN arrofheeia uaN ily n l OAU S moec atgnm rso sa yas CMM N E p u d a t r t e dp vs cnw sa APB N N N C lnitwdutsl e e yCn a k htaasm TLE E T idcio) ca tr p IER

,E O gn l eton d g ,e t o s .

oo rweeol OS R if uwgarafe N O edsir o o nn es SAF R iv focnbf t dtitfo *N A seaofwa r iu .enhof DR D lnfenb( o3 es I n n r bsa

s ao E O sa wtde SP L oDuhenaudd .g hh a AR O t/ainegc i e a iip c ME G p Q lg t a r ,e h l f vcsrh PS I C C C h ef To eh o LE C L L L C eiaeoe aae hf idp EN A

- - - O rfvsfsasfr i blrur T L T 1 1 1 D f etftn e sS eirci A 1 1 1 E omr s d n a eqitn T A 8 7 5 ria ie - t il nugsc I E B m lg tas, nt ia i V N L eke e c w'. f dtfp E V I

E d hi oC era

. s rr dol R 5 5 s me m O .

- ae N 1 l tk M -

sN i A CS E 1 eo ow t OA N an nat LM T A

(

C D st t LP oh ie i EL L o I

S nl sr m CI n T y e TN M t cf IG O i A d o N n N ho O u C u er f NA I T e E r i

c N O d n ki h FD R )

f g er a R I r dr r E N o g i v Q G m ag e U 0 0 0 r o na s E P

. . . s nt t3 N R 7 9 7 t w ui C O a i ao Y G t n ln R i g l o yi A n n M aG a

sD oG

(

na e na m

i am pW m l lm ya ai em e s rt da i

T s ii t ,t Y

)

ss bi P o ls

. o fL eo O E t

o o po t FA tg p ha op A N i

e ,n ri N D R c* tc A F e l i L R

.v aM oa Y a ne nn S E

- n dn . a I Q d a l S UE

/ I ur y N se ,d s C

.i{4 1 3

i s* Y 9

8 1 o i r

'i)Ij llj1 Ijl

{ l l

1 3 8 1

Y -

9 C I /

N' 2 E 1 d

U IS n 7 Q a E S 1 RY

v F L A i c

e DN p~ R NA o t

AF o~

E O i s )

P s Y a e T l m i m

a (

m -

G n

g o M

A n i Y i t R .C w a 5 .

G N o t O E r s 2 R U g .

P Q g m 1 G

E o N DF R n r i f _

N I r

) R AN u E d O O d C h

e T GI N t I NT y A n N IC l n T i O LE ho S .

t M PL ts I n ML na D o L AO oe C

(

A T

SC Ms N

1 E

n 3

- M S oo g 1 1 N N

. O O it t e n 5 5 R I ash i

I l 4 E V ET tet p E 1 L N VA eel m D 1

~

B E IC h gi n a O -

A TO temi s C L T L AL T f v d C A NE of . nil 3tnk C EL I

SP a9awi.

G he( t mde O EM cl st L RA a minfm )

O PS edkdeir l I E a l o o D RD fo0) a r A FA N or3sv*f b- rOR t n

R O e 5l eene r o p TC o S l r 1i pi C RE pa E EL m tt S

( .

BP mln tco aiw6sen E MM smo .ar S UA .ir8 eis S NS 1 sg1ldi s

Y t A 'E c)

W ud H L P ) de T

A M N-e d rn ou PA S I O u Pi t

E R R S it Tn dn oo 1 U /O E n oc -

S G F( N O D N No O P

XA I (c c T

N E . I 4 L C

~

lI!ll

CPS-ODCM TABLE 5.1-1 (Continued)

RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM TABLE NOTATIONS

Refer to NUREG-0133, " Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants," October 1978, and to Radiological Assessment Branch Technical Position, g Revision 1, November 1979. Deviations are permitted from the E required sampling schedule if specimens are unobtainable due to hazardous conditions,' seasonal unavailability, malfunction of automatic sampling equipment and other legitimate reasons. If specimens are unobtainable due to sampling equipment malfunction, every effort shall be made to complete corrective action prior to the end of the next sampling period. All h.

deviations from the sampling. schedule shall be documented in the =

Annual Radiological Environmental Operating Report' pursuant to Technical Specification 5.6.2. It is recognized that, at times, 3 it may not be possible or practicable to continue to obtain M.

samples of the medin of choice at the most desired location or time. In these instances suitable alternative media and g locations'may be chosen for the particular pathway in question and appropriate substitutions made within 30 days in the 5

5 i radiological environmental monitoring program given in the ODCM.

Pursuant to Technical Specification 5.5.1, identify the cause of the unavailability of samples for that pathway and identify the new location (s) for obtaining replacement samples in the next ,

annual Radiological Environmental Operating Report and also h, include in the report a revised figure (s) and table for the ODCM E reflecting the new location (s).

"One or more instruments, such as a pressurized ion chamber, for measuring and recording dose rate continuously may be used in place of, or in addition to, integrating dosimeters. For the g purposes of this table, a thermoluminescent dosimeter (TLD) is g considered to be one phosphor; two or more phosphors in a packet are considered as two or more dosimeters. Film badges shall not be used as dosimeters for measuring direct radiation. The 40, {

stations is not an absolute number. The number of direct i radiation monitoring stations may be reduced.according to l geographical limitations; e.g., at an ocean site, some sectors l

will be over water so that the number of dosimeters may be 1 reduced accordingly. The frequency of analysis or readout for !

TLD systems will depend upon the characteristics of the specific system used and should be selected to obtain optimum dose h'

B information with minimal fading.

I l

1i I

l, CLINTON-1 5-14 Rev.17-12/98 l

CPS-ODCM TABLE 5.1-1 (Continued)

RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM TABLE NOTATIONS (Continued)

"The purpose of this sample is to obtain background information.

If it is not practical to establish control locations in accordance with the distance and wind direction criteria, other I sites that provide valid background data may be substituted.

d Airborne particulate sample filters shall be analyzed for gross beta radioactivity 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months or more after sampling to allow for radon and thoron daughter decay. If gross beta activity in air I particulate samples is greater than ten times the yearly mean of control samples, gamma isotopic analysis shall be performed on the ind'ividual samples.

E ' Gamma isotopic analysis means the identification and quantification of gamma-emitting radionuclides that may be attributable to the effluents from the facility.

'The " upstream sample" shall be taken at a distance beyond gg . significant influence of the discharge. The " downstream" sample shall.be taken in an area beyond but near the mixing zone.

" Upstream" samples in an estuary must be taken far enough upstream to be beyond the plant influence.

~

'A composite sample is one in which the quantity (aliquot) of liquid sampled is proportional to the quantity of flowing liquid I (or time) and in which the method of sampling employed results in a specimen that is representative of the liquid flow. In this program composite sample aliquots.shall be collected at time I intervals that are very short (e.g., hourly) relative to the compositing period (e.g., monthly) in order to assure obtaining a representative sample.

h Groundwater samples shall be taken when this source is tapped for drinking or irrigation purposes in areas where the hydraulic gradient or recharge properties are suitable for contamination.

'The dose shall be calculated for the maximum organ and age group, using the methodology and parameters in Section 2.4.2.

9 i

I 2

CLINTON-1 5-15 Rev.17-12/98 h '

I CPS-ODCM TABLE 5.1-1 (Continued)

RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM TABLE NOTATIONS (Continued) 8If harvest occurs more than.once a year, sampling shall be

-performed during each discrete harvest. If harvest occurs g continuously, sampling shall be monthly. Attention shall be paid 5 to including samples of tuberous and root food products.

"The dose shall be calculated for the maximum organ and age group, using the methodology and parameters in Section 3.5.4.

I I

I i

E I

I I

1 t

g CLINTON-1 5-16 Rev.17-12/98

l i

, 8 S) s 9 Tt t /

Ce s 2 Uw i 1 D 0 0 0 x -

O , 0 0 0 e 7 Rg 1 0 0 1 Pk , , y .

/ 1 2 a v Di w e S OC h R E Op t L F( a P p M

A r S e t

L a A )

w T 1 g N K E L /i 3 0 0 0 6 7 0 n

M I i C 3 k N

O Mp( n .

R i d I r e V d s N u E o n e N )

f b

I t e I y S w 0 0 0 0 0 0 0 a N H 0 0 0 0 0 0 0 m O S g, 0 0 0 0 0 0 0 I e 1 T I F /k 0 0 0 0 0 1 2 u /

A 3 1 3 1 2 l i R i a C 2

T C p

v p 1 N

. E ( 1 0 5 C 4 2 N 1 7

E O f 1 L C E t o -

r w B A

T Y

T I

T )_

A 3 Lm/ P a

l e

u 5

V U R a I C i I C F v w T C

A T

R (p A 9 C

0 4

a O . ,

I P S 0 0 0 s s

-a D E 1 2 i . t A ES d s w R NA se i RG O i s x .

R hu e r _

O BR T e F R O e y t

- S L

I A .b sy h a

w h

g u

E ea t a V lp m a d E

L G )

m1 a/

si p

r e

d n

a n N R1 *

C t I E/ * *

rp a t T Ti * * *

e w n t R AC Wp 0 0 0 0 0 0 0 2 0 0 0 t0 g r e

O 0 0 0 0 0 0 0 3 5 0 a0 P (

0 0 4 0 3 3 4 2 w0 n a p

E , , ,

, i R 0 1 1 g0 k

~ 2 n3 n r i i o kf r f S 5

, 0 n 'o d l

1 4 i q I S

Y 4 9 8,0 9

5 b 1 3 3 a 4 7 1

re du l

o n

a t

o N

O T

_ L 5 5 5 6 6 N 3 1 1 L ra f T N A 3 - - - - - - 1 - - - ov I

I N

g A - n e o o n r -

H M F C C Z Z I C C B s s a F

a L

C ll

M _

8 _

) 9 v

T r /7 'sM _

N d E 0 0 7 M g, 5 8 1 I

D /k E i 1 1 v

e M

S C p R

(

S)

Tt Ce Uw D

S I

O Rg Pk

/

0 0 0 6 6 8 M S Di Y

L OC Op d

M_

A F( ed N se A us u

E L K

)

l e

be M'_

P ) L /i 1 5 8 0 5 1 1 6 1 yb M D I C ay A L Mp ma S L

(

1 m O L /1 A N ) i/

T O N I t Ci pC 3

E M

T C

e w

0 p M 1 N E H 0 0 0 0 0 0 05 '

. O T S g, 3 5 R E I 3 6 3 6 01 5 1 1 3 I D F /k 1 2 1 2 '

E V N F i fo f l L

B E O C o 5 p e A R T

( eu T O ul F

I M E la av M S

I L T v E A a I R L)# a T

I E Um C / ,s L W I i st O

I L TC Rp 1 7 5 6 ts si B 0 0 0 ix A A( 0 P

A P

S 0 0 0 0 xe e y W C EA ya N

RG aw N

O OR wh I

T B

RO ht ta M'_

C I . ap E A p T r re E

D R1 E/

)

et ta aw W-Ti 4 0 5 0 5 0 0 5 1 5 8 0 5 w g 0 1 3 1 3 3 1 1 1 6 1 AC Wp

.(

0 2

gn ni ik W_

kn ._

ni a '

ir M

S I

t e 0, rd d U_ _

C '

S b 6 o '

D Y , 4 7 0 0 on O O L s 4 9 8 5 5 5 1 3 3 4 4 n T A s 5 5 5 6 9 9 3 1 1 1 1 f N S

P N

A o 3 r -

n e o n r b -

- - 1 - -

s s a a

- - fI I*

I L M_

C G H M F C Z Z N I C C B L ** C iI(Ill! lI(l f

CPS-ODCM L TABLE 5.1-3 (Continued) ,

i DETECTION FOR ENVIRONMENTAL SAMPLE ANALYSISa ,b I

TABLE NOTATIONS

This list.does not mean that.only these nuclides are to be considered. Other peaks that are. identifiable, together with those of.the above nuclides, shall also be analyzed and reported in the Annual Radiological Environmental Operating Report pursuant to Technical Specification 5.6.2. I

'E j Required detection capabilities.for thermoluminescent dosimeters used for environmental measurements shall be in accordance with

.the recommendations of Regulatory Guide 4.13, Rev. 1, July 1977.

'The LLD is defined, for purposes of these specifications,.as the smallest concentration of radioactive material in a sample that will yield a net count, above system background, that will be

~

detected with 95% probability with only 5% probability of falsely 1 concluding that a blank observation represents a "real" signal.

l i

For a particular measurement system, which may include radiochemical separation:

LLD

4. 66s3/ (E

V

2.22

Y

exp(-AAt) ]

Where:

LLD is the "a priori' lower limit of detection as defined above, as picocuries per unit mass or volume, se is the standard deviation of the background counting rate or ofLthe counting rate of a blank sample as appropriate, as counts per minute, E if.the counting efficiency, as counts per disintegration, V is the sample' size in units of mass or volume,

'2.22 is the number of disintegrations per minute per picocurie, Y is the fractional radiochemical yield, when applicable, A is the' radioactive decay constant for the particular radionuclide ' (sec") , and CLINTON-1 5-19 Rev.17-12/98

=

CPS-ODCM l At for environmental samples is the elapsed time between sample collection, or end of the sample collection period, and time of counting (sec) . &

Typical values of E,-V, Y, and At should b'e used in the calculation.

It should be recognized that the LLD is defined as an.a_ priori (before the fact) limit representing the capability of a ll u

measurement system and not as an a posteriori (after the fact) limit for a particular measurement. Analyses shall be' performed g in such a manner that the stated LLDs will be achieved under 3 routine-conditions. Occasionally background fluctuations, unavoidable small sample sizes, the presence of interfering g nuclides, or other uncontrollable circumstances may render these g LLDs unachievable. In such cases,. the contributing factors shall be identified and described in the Annual Radiological '

Environmental Operating Report pursuant to Technical Specification 5.6.2.

I I

i I

I I

3, I

CLINTON-1 5-20 Rev.17-12/98

I -

CPS-ODCM 5.2 Land Use Census - Operation and Surveillance Requirements OPERATION REQUIREMENT l 1

E A land use census shall be conducted and shall identify within a distance of 8 km (5 miles) the location in each I of the 16 meteorological sectors of the nearest milk animal,.the nearest residence and the nearest garden

of greater than 50 m2 (500 ft2) producing broad leaf 0 vegetati:.a. For elevated or mixed-mode releases as i 8@l defined in Regulatory Guide 1.111, Revision 1, July 1977, the land use census shall also identify within a distance l of 5 km (3 miles) the location in each of the 16 I meteorological sectors of,all milk animals and all gardens of greater than 50 m2 producing broad leaf !

vegetation. This requirement applies at all times.

I REMEDIAL REQUIREMENT:

I a. With a land use census identifying a location (s) that yields a calculated dose or dose commitment greater than the values currently being calculated in Section 3.5.2.1, identify the new location (s) in I the next annual Radiological Environmental Operating Report, pursuant to Technical Specification 5.6.2.

b. With a land-use census identifying a location (s) that' yields a calculated dose or dose commitment (via the same exposure pathway) 20 percent greater I than at a location from which samples are currently being obtained in accordance with Section 5.1, add the new location (s) to the radiological I environmental monitoring program within 30 days.

The sampling location (s), excluding the control station location, having the lowest calculated dose I or dose commitment (s), via the same exposure

Broad leaf vegetation sampling of at least three different kinds of vegetation may be performed at the site boundary in each of two different direction sectors with the highest predicted D/Os in lieu of the garden census. Specifications for broad leaf vegetation sampling in Table 5.1-1.4c shall be followed, including analysis of control samples.

1 -

g CLINTON-1 5-21 Rev.17-12/98

CPS-ODCM pathway, may be deleted from this monitoring program

'after October 31 of the' year in which this land use i

f- )

census was conducted. Pursuant to Technical l Specification 5.5.1, identify the new location (s) in the next Radioactive Effluent' Release Report and also include

~

g in the report a revised figure (s) and table for this W manual reflecting the new location (s).

SURVEILLANCE REQUIREMENTS 5.2.1 The land use census shall be conducted during the growing g season at least once per 12 months using that information g that will provide the best results, such as by a door-to-door survey, aerial survey, or by consulting local agriculture authorities. The results of the land use

--census shall be included in the annual Radiological Environmental Operating Report pursuant to Technical Specification 5.6.2.

5.3- Interlaboratory Comparison Program All analyses for CPS Radiological Environmental Monitoring Program are performed by Teledyne Brown Engineering Environmental Services Midwest Laboratories (Teledyne) located in Northbrook, Illinois.

Teledyne has participated in interlaboratory comparison (cross-check) programs since the formulation of its quality control program in December 1971. These programs have been operated by agencies which supply environmental-type samples (e.g., milk or water) g containing concentrations of radionuclides known to the y issuing laboratory but not to the participant laboratories. The purpose of such a program is to a provide an independent check on the laboratory's g analytical procedures and to alert it to any possible problems.

Participant laboratories. measure the c'oncentrations of I specified radionuclides and report them to the issuing .

laboratory. Several months later, the issuing laboratory reports the known values to the participant laboratories and specifies the range the results should fall within.

Results consistently higher or lower than the known l values and results outside the specific ranges indicate a 3 need to check the instruments or procedures used.

I I

~

I

__ se m 1,_12,ee g

CPS-ODCM If the results of a determination in the cross-check program are outside the control limits specified, CPS will require TIML to investigate the cause of the problem and take steps to correct it. The results of this I- investigation and corrective action shall be included in the Annual Radiological Environmental Operating Report. l Operation and Surveillance Requirements for the Interlaboratory Comparison Program are prescribed in I 5.3.1 Section 5.3.1 (which follows). ,

Interlaboratory Comparison Program - Operation and Surveillance Requirements I OPERATION REQUIREMENT l

I Analyses shall be performed on all radioactive materials, supplied as part of an Interlaboratory Comparison Program that has been approved by the Commission, that correspond I to samples required by Table 5.1-1. This requirement applies at all times.

REMEDIAL REQUIREMENT:

a. With analyses not being performed as required above, report the corrective actions taken to prevent a I' recurrence to the Commission in the Annual Radiological Environmental Operating Report pursuant to Technical Specification 5.6.2.

l SURVEILLANCE REQUIREMENTS 5.3.1.1 The Interlaboratory Comparison Program is described in I Section 5.3. A summary of the results obtained as part of the above required Interlaboratory Comparison Program I shall be included in the Annual Radiological Environmental Operating Report pursuant to Technical Specification 5.6.2.

I -

I I -

i CLINTON-1 5-23 Rev.17-12/98

l CPS-ODCM

,1euRm s.e-1 g

REMP LOCATIONS WITHIN 1 MILS OF CPS I

L I,

,s N "

i ie g g 6A M 2 N 5 I15I 29

_xv 2, l){

0 24 "5?" J

f I

O Ei k " l E\1

=

4 k ,)

I!

)f, l I

g I

~

CLINTON-1 5-24 Rev.17-12/98 1

CPS-ODCM FIGURE 5.0-2 REMP LOCATIONS 1-2 MILES FROM CPS

(

N 63*

4

\

ILL RT 54 F *l l CLI 3

% % "NTONJ*

i

_, j,

-[

U w

C T.T NTON- 1 5-25 Rev.17-12/98

CPS-ODCM FIGURE 5.0-3 REMP LOCATIONS 2-5 MILES FROM CPS [

E N

t l 77 ) l 32 Sie e >3 h 3

.e . j M I

dir / '

g

""M i

53*

DO / '8 ,

g 8 45 19 g

/ 54

/ > . .

42 pg e

s.

- 44 <=

t_, g, 00 )

60 g7 8 f gg *45' WELDON 56*

57 h

~

N - g Il

(

j I

CLINTON-1 5-26 Rev.17-12/98

g.. ..

CPS-ODCM FIGURE 5.0-4 REMP LOCATIONS GREATER THAN 5 MILES FROM CPS b

mb %

4 MORTON N W

(

INGT h ' #ANTOt .

. 1

? : I(

,CM INCi[LN Ct.INTON g

E3 \ ^URBANA p y tme

p '-

CHAMPAIGN D

zg

+

D

/ w.

OECATUR

+ nl .\

)

SPR CEIELD g i

,s f

4 .a s ID mg X yg 05

~

l CLINTON-1 S-27 Rev.17-12/98 i.

CPS-ODCM 6.0 BASES FOR OPERATION AND SURVEILLANCE REQUIREMENTS 6.1 General Operation and Surveillance Requirements The requirements of Sections 1.2 and 1.3 provide general E requirements applicable to each of the Operation E Requirements and Surveillance Requirements specified within Sections 2.0 through 5.0. g

. g 1.2.1 This requirement is provided to emphasize when !

each Operation Requirement is applicable and when the j associated REMEDIAL REQUIREMENT should be met.

1.2.2 This'. requirement defines those conditions ~

necessary to constitute compliance with the terms of an

. individual Operation Requirement and associated REMEDIAL ,

. REQUIREMENT. )

.1.3.1 This requirement provides that surveillance activities, necessary to ensure the Operation Requirements are met, will be performed during the conditions for which the Operation Requirements are applicable. Some surveillance activities may be required to be performed without regard to the applicable conditions specified in the associated Operation Requirement.

1.3.2 The provisions of this requirement provide allowable tolerances for performing surveillance activities beyond those specified in the nominal surveillance' interval. The~se tolerances are necessary to E provide operational flexibility because of scheduling and 3 performance considerations. The phgase "at least" associated with a surveillance frequency does not negate g this allowable tolerance; instead, it permits the more g frequent performance of surveillance activities.

The tolerance values, taken either individually or ;

consecutively over three test intervals, are sufficiently restrictive to ensure that the reliability associated with the iarveillance activity is not significantly degraded beyond that obtained from the nominal specified ,

1 interval.

I 1

1

\

I CLINTON-1 6-1 Rev.17-12/98

CPS-ODCM

., 1.3.3 The provisions of this requirement set forth the criteria for determination of compliance with the OPERABILITY requirements of the Operation Requirements.

Under these criteria, equipment, systems, or components are assumed to be OPERABLE if the associated surveillance activities have been satisfactorily performed within the specified time interval. Nothing in this provision is to be construed as defining equipment, systems or components l

OPERABLE, when such items are found or known to be inoperable although still meeting the Surveillance I Requirements.

1.3.4 This requirement ensures that surveillance I activities associated with a Operation Requirement have been' performed within the specified time interval prior to entry into a specified system operating mode. The I intent.of this provision is to ensure that surveillance activities have been satisfactorily demonstrated on a current basis as required to meet the OPERABILITY requirements of the Operation Requirement.

Under the terms of this requirement, for example, during initial plant startup or following extended plant outage, i the applicable surveillance activities must be performed within the stated surveillance interval prior to placing or returning the system or equipment into OPERABLE status.

6.2 Monitoring Instrumentation Section 2.7: Radioactive Liquid Effluent Monitoring Instrumentation The radioactive liquid effluent instrumentation is provided to monitor and control, as applicable, the g releases of radioactive materials in liquid effluents y during actual or potential releases of liquid effluents.

l The alarm / trip setpoints for these instruments shall be g calculated and adjusted in accordance with the l methodology and parameters in this manual to ensure that j the alarm / trip will occur prior to exceeding the limits of 10CFR Part 20. The OPERABILITY and use of this instrumentation is consistent with the requirements of l

General Design Criteria 60, 63 and 64 of Appendix A to 10CER Part 50.

CLINTON-1 6-2 Rev.17-12/98

CPS-ODCM Section 3.9.1: Offgas Radiation Monitoring Instrumentation The OPERABILITY of the radiation monitoring instrumentation ensures that; (1) the radiation levels are continually measured in the areas served by the individual channels; (2) the alarm or automatic action is initiated when the radiation level trip setpoint is E exceeded; and (3) sufficient information is available on 3 selected plant parameters to monitor and assess these variables following an accident. This capability is g consistent with 10CFR Part 50, Appendix A, General Design g Criteria 19, 60, 61, 63 and 64.

Section 3.9.2: Radioactive Gaseous Effluent Monitoring Instrumentation The radioactive gaseous effluent' instrumentation is provided.to monitor and control, as applicable, the release of radioactive materials in gaseous effluents during actual or potential releases of gaseous effluents. g The alarm / trip setpoints for these instruments shall be 3 calculated and adjusted in accordance with the methodology and parameters in this manual to ensure that 3 the alarm / trip will occur prior to exceeding the limits E of 10CFR Part 20. The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63 and 64 of Appendix A to i 10CFR Part 50. The sensitivity of any noble gas activity J monitors used to show compliance with the gaseous effluent release requirements of Section 3.5.1 shall be such that concentrations as low as 1 x 10-' Ci/ml are measurable.

6.3 Radioactive Effluents l 6.3.1 -Liquid Effluents

-Section 2.3.1: Liquid Effluent Concentration This requirement is provided to ensure that the concentration of radioactive materials released in liquid waste' effluents to UNRESTRICTED AREAS will be less than p\h ten times the concentration levels specified in 10CFR Part 20, Appendix B, Table 2, Column 2. This limitation provides additional assurance that the levels of radioactive materials in bodies of water in UNRESTRICTED g AREAS will result in. exposures within (1) the Section W II. A design objectives of Appendix I, 10CFR Part 50, to a MEMBER OF

~

I CLINTON-1 6-3 Rev.17-12/98

CPS-ODCH l

)

'THE PUBLIC and (2) the limits of 10CFR Part 20.1301 to the population. The concentration limit for dissolved or 5gq entrained noble gases is based upon the assumption that Xe-135 is the controlling radioisotope and its ECL in air (submersion) was converted to an equivalent concentration in water using the methods described in International Commission on Radiological Protection (ICRP) Publication

2. ,

I This requirement applies to the release of radioactive materials in liquid effluents from the site.

1 The required detection capabilities for radioactive I materials in liquid waste samples are tabulated in terms of the lower limits of detection (LLDs). Detailed discussion of the LLD, and other detection limits can be found in Currie,.L. A., " Lower Limit of Detection:

Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements,"

NUREG/CR-4007 (September 1984), and in the HASL Procedures Manual, RASL-300 (revised annually).

ydk Section 2.4.1: 10CFR50, Appendix I Dose Limits This requirement is provided to implement the requirements of Sections II.A, III.A and IV.A of Appendix I, 10CFR Part 50. The Limiting Condition for Operation implements the guides set forth in Section II.A of Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in liquid effluents to UNRESTRICTED. AREAS will be kept "as low as I is reasonably achievable." Also, for fresh water sites with drinking water supplies that can be potentially l affected by plant operations, there is reasonable l assurance that the operation of the facility will not result in radionuclide concentrations in the finished drinking water that are in excess of the requirements of I 40CFR Part 141. The dose calculation methodology and parameters in this manual implement the requirements in ,

Section III.A of Appendix I .that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The equations specified in this-manual for calculating the doses due to the actual release rates'of radioactive materials in liquid effluents are consistent with the

) C T.T NTON- 1 6-4 Rev.17-12/98

l CPS-ODCM metho.dology provided in Regulatory Guide 1.109, i

" Calculation of' Annual Doses to Man from Routine Releases I of Reactor Effluents for the Purpose of Evaluating Compliance with 10CFR Part 50, Appendix I," Revision 1,

( )

October 1977,and Regulatory Guide 1.113, " Estimating i Aquatic Dispersion of Effluents from Accidental and i Routine Reactor. Releases for the Purpose of Implementing Appendix I," April 1977.

This requirement applies to the. release of radioactive materials in liquid effluents from the one reactor unit 3 on the site. g; Section 2.5.1: Liquid Radwaste Treatment System d i

The OPERABILITY of the liquid radwaste treatment system ensures that this system will.be available for use ;

whenever liquid effluents' require treatment prior to . !

release to the environment. The requirements that the j appropriate portions of this system be used when ;

specified, provides assurance that the releases of radioactive materials in liquid effluents will be kept Ei 5 l "as low as is reasonably achievable." This specification )

implements the requirements of 10CFR Part 50.36a, General g j Design Criterion 60 of Appendix A to 10CFR Part 50 and gl the design objective given in Section II.D of appendix I I to 10CFR Part 50. The specified limits governing the use l of appropriate portions of the liquid radwaste treatment )

system were specified as a suitable fraction of the dose design objectives set forth.in Section II.A of Appendix I, 10CFR Part 50, for liquid effluents.

This requirement applies to the release of radioactive materials in liquid effluents from the one reactor unit g on the site. 3 I

6.3.2 Gaseous Effluents aj g1 Section 3.4.1: 10CFR20 Release Rate Limits This requirement is provided to ensure that the dose at any time at and beyond the SITE BOUNDARY from gaseous effluents from all units on the site will be within the .

annual dose limits of 10CFR Part 20 to UNRESTRICTED ll The annual dose limits are the doses associated AREAS. W with the concentrations of 10CFR Part 20, Appendix B, ;

Table 2, Column 1. These limits provide' reasonable assurance that radioactive; material discharged in gaseous E'

3 .

effluents will not result in the exposure of a MEMBER OF l

~

f I,

CLINTON-1 6-5 Rev.17-12/98 l _

l I CPS-ODCM l

THE PUBLIC in-an UNRESTRICTED AREA, either within or l outside the SITE BOUNDARY, to annual average I concentrations exceeding the limits specified in Appendix )

I B, Table 2 of 10CFR Part 20. For MEMBERS OF THE PUBLIC who may at times be within the SITE BOUNDARY, the occupancy of that MEMBER OF THE PUBLIC will usually be j

l I

I sufficiently low to compensate for any increase in the atmospheric diffusion factor above that for the SITE BOUNDARY. Examples of such MEMBERS OF THE PUBLIC, with

)

I the appropriate occupancy factors, shall be given in this manual. Doses for huch MEMBERS OF THE PUBLIC'are provided in the Radioactive Effluent Release Report. The specified release rate limits restrict, at all times, the

. corresponding gamma and beta dose rates above background to a MEMBER OF THE PUBLIC, at or beyond the SITE BOUNDARY, to less than or equal to 500 mrem / year to the whole body or to less than or equal to 3000 mrem / year to the skin. These release rate limits also restrict, at all times, the corresponding thyroid dose rate above I background to a child via the inhalation pathway to less than or equal to 1500 mrem / year.

I I This requirement applies to the release of radioactive materials in gaseous effluents from the one reactor unit on the site.

i The required detection capabilities for radioactive l materials in gaseous waste samples are tabulated in terms ;

of the lower limits of detection (LLDs) . Detailed I discussion of the LLD, and other detection limits can be found in Currie, L. A., " Lower Limit of Detection:

Definition and Elaboration of'a Proposed Position for I Radiological Effluent and Environmental Measurements,"

NUREG/CR-4007 (September 1984), and in the HASL Proce,ures d Manual, HASL-300 (revised annually).

Section 3.5.1: Noble Gas Dose This requirement is provided to implement the I 7.quirements of Sections II.B, III.A and IV.A of Appendix I, 10CFR Part 50. The Limiting Condition for Operation implements the guides set forth in Section II.B of I Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure I that the releases of radioactive material in gaseous effluents to UNRESTRICTED AREAS will be kept "as low as

-is. reasonably achievable." The Surveillance Requirements implement the requirements in Section III.A of Appendix I I CI.T NTON- 1 6-6 Rev.17-12/98

CPS-ODCM that conformance with the guides of Appendix I be shown by calculational procedures based on models and data such that the actual exposure of a MEMBER OF THE PUBLIC r through appropriate pathways is unlikely to be substantially underestimated. The dose calculation methodology and parameters established'in this manual for calculating the doses due to the actual release rates for radioactive noble gases in gaseous effluents are g consistent with the methodology provided in Regulatory 3 Guide 1.109, " Calculation of Annual Doses to Man from Routine Releases of. Reactor Effluents for the Purpose of a Evaluating Compliance with 10CFR Part 50, Appendix I," g Revision 1, October 1977 and Regulatory' Guide l'.111,

" Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water Cooled Reactors" Revision 1, July 1977.

p\Mdp l This requirement applies to the release of radioactive l materials in gaseous effluents from the site. W Section 3.5.2: Iodine-131, Iodine-133, Tritium, and Radionuclides in Particulate Form This requirement is provided to implement the a requirements of Sections II.C, III.A and IV.A of Appendix g I, 10CFR Part 50. The Limiting Conditions for Operation are the guides set forth in Section II.C of Appendix I.

The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in gaseous effluents to E UNRESTRICTED AREAS will be kept "as low as is reasonably 3 achievable." The calculational methods specified in the Surveillance Requirements implement the requirements in 3 Section III.A of Appendix I that conformance with the 3 guides of Appendix I be shown by calculational procedures based on models and data, such that the actual

exposure.

of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The calculational methodology and parameters for calculating the doses due to the actual release rates of the subject materials are consistent with the methodology provided in Regulatory Guide 1.109, " Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the E Purpose of Evaluating Compliance with 10CFR Part 50, 5 Appendix I," Revision 1, October 1977 and Regulatory I

l I I

CLINTON-1 6-7 Rev.17-12/98

I CPS-ODCM g Guide 1.111, " Methods for Estimating Atmospheric K Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water Cooled Reactors" Revision 1, July 1977. These equations also provide for determining the actual doses based upon the real time atmospheric conditions. The release rate specifications for iodine-131, tritium, and radionuclides in particulate form with I half lives greater than 8 days are dependent upon the existing radionuclide pathways to man in the areas at and beyond the SITE BOUNDARY. The pathways that were examined in the development of these calculations were:

(1) individual inhalation of airborne radionuclides, (2) deposition of radionuclides onto green leafy vegetation I with subsequent consumption by man, (3) deposition onto grassy areas where milk animals and meat producing animals graze with consumption of the milk and meat by man, and (4) deposition on the ground with subsequent 1 I exposure'of man.

I This requirement applies to the release of radioactive materials in gaseous effluents from one reactor unit on the site.

i Sections 3.6 and 3.7: Gaseous Radwaste (Ofp as) Treatment and Ventilation Exhaust Treatment System l The OPERABILITY of the WASTE GAS HOLDUP SYSTEM and the VENTILATION EXHAUST TREATMENT SYSTEM ensures that the systems will be available for use whenever gaseous I effluents require treatment prior to release to the environment. The requirement that the appropriate portions of these systems be used, when specified,

~

I provides reasonable assurance that the releases of radioactive materials in gaseous effluents will be kept "as low as reasonably achievable." This requirement implements the requirements of 10CFR Part 50.36a, General I Design Criterion 60 c,f Appendix A to 10CFR Part .50 and the design objectives given in Section II.D of Appendix I to 10CFR Part 50. The specified limits governing the use I of appropriate portions of the systems were specified as a suitable fraction of the dose design objectives set forth in Section II.B and II.C of Appendix I, 10CFR Part I 50, for gaseous effluents.

This requirement applies to the release of radioactive materials in gaseous effluents from the one reactor. unit on the site.

I -

I ~ r7 menu 1 6-8 Rev.17-12/98

p

' CPS-ODCM 6.3.3 Total Dose '

Section 4.1: Total Dose j This requirement is provided.co meet the dose limitations ,

of 40CFR Part 190 that have baen incorporated into pl94l -

10CFR20.1301. The requirement vquires the preparation and submittal of a Special Report whenever the calculated doses from plant generated radioactive effluents and direct radiation exceed 25 mrem to the total body or any organ,-except the thyroid, which shall be limited to less than or equal to 75 mrem. For sites containing up to 4 g reactors, it is highly unlikely that the resultant dose a to a MEMBER OF THE PUBLIC will exceed the dose limits of 40CFR Part 190 if the individual reactors remain within g{

twice the dose design objectives of Appendix I, and if 3 direct radiation doses from the reactor units and outside l storage tanks,are kept small. The Special Report will 3 describe a course of action that should result in the limitation of the annual dose to a MEMBER OF THE PUBLIC 5)l '

to within the 40CFR Part 190 limits. For the purposes of i the Special Report, it may be assumed that the dose commitment to the MEMBER OF THE PUBLIC from other uranium ,

fuel cycles sources is negligible, with the exception !

that dose contributions'from other nuclear fuel cycle facilities at the same site or within a radius of 8 km must be considered. If the dose to any MEMBER OF THE PUBLIC is estimated to exceed the requirements of 40CFR l Part 190, the Special Report with a request for a- E variance (provided the release conditions resulting in violation of 40CFR Part 190 have not already been E corrected) , in accordance with the provisions of 40CFR 3 Part 190.11 and 10CFR Part 20.2203, is considered to be a timely request and fulfills the requirements of 40CFR g Part 190 until NRC staff action is completed. The g variance only relates to the limits of 40CFR Part 190, and does not apply in any way to the other requirements

'for dose limitation of 10CFR Part 20, as addressed in Sections 2.3 and 3.4. An individual is not considered a MEMBER OF THE PUBLIC during any period in which he/she is engaged in carrying out any operation that is part of the nuclear fuel cycle.

I I

~

I I

- m __ g

CPS-ODCM 6.4 Radiological Environmental Monitoring Section 5.1: Monitoring Program The' radiological environmental monitoring program required by this requirement provides representative I measurements of radiation and of radioactive materials in those exposure pathways and for those radionuclides that lead to the highest potential radiation exposures of j MEMBERS OF THE PUBLIC resulting from the station I

operation. This monitoring program implementsSection IV.B.2 of Appendix I to 10CFR Part 50 and thereby' supplements the radiological effluent monitoring program I

I by verifying that the measurable concentrations of j radioactive materials and levels of radiation are not I higher than expected on the basis of the effluent I

measurements and the modeling of the environmental i exposure, pathways. Guidance for this monitoring program l is provided by the Radiological Assessment Branch ,

I Technical Position on Environmental Monitoring, Revision 1, November 1979. The initially specified monitoring program will be effective for at least the first three Following this period, I years of commercial operation.

. program changes may be initiated based on operational experience.

I The required detection capabilities for environmental sample analyses are tabulated in terms of the lower limits of detection (LLDs) . The LLDs required by Table I -

5.1-3 are' considered optimum for routine environmental measurements in industrial laboratories. It should be recognized that the LLD is defined as an a, priori (before i

I the fact) limit representing the capability of a measurement system and not as an a_ posteriori (after the fact) limit for a particular measurement.

Detailed discussion of the LLD, and other detection limits, can be found in Currie, L. A., " Lower Limit of Detection: Definition and Elaboration of a Proposed I Position for Radiological Effluent and Environmental Measurements," NUREG/CR-4007 (September 1984), and in the HASL Procedures Manual, HASL-300 (revised annually).

I .

Section 5.2: Land Use Census I This requirement is provided to ensure that changes.in the use of areas at and beyond the SITE BOUNDARY are identified and that modifications to the radiological.

environmental monitoring program are made if required by s

I CLINTON-1 6-10 Rev.17-12/98

l CPS-ODCM .

the results of this census. The land use census.shall be l performed'using the best information available (e.g., a door-to-door survey, from aerial surveys, questionnaire, or from consulting with local agricultural authorities).

(3E (

This census satisfies the requirements of Section IV.B.3 3 of Appendix I to 10CFR Part 50. Restricting the census g to gardens of greater than 50 m* provides assurance that significant exposure pathways via leafy vegetables will be identified and monitored since a garden of this, size is the minimum required to produce the quantity (26-kg/ year) of leafy vegetables assumed in Regulatory Guide 1.109 for consumption by a child. To determine this minimum garden size, the following assumptions were made:

(1) 20% of the garden was used for growing broad leaf vegetation (i.e., similar to lettuce and cabbage) and (2) E a vegetation yield of 2 kg/m*. E)

Section 5.3.1: Interlaboratory Comparison Program The requirement for participation in an Interlaboratory Comparison Program is provided to ensure that independent checks on the precision and accuracy of the measurements !

g of radioactive material in environmental sample matrices are performed as part of the quality assurance program {

\gik for environmental monitoring in order to demonstrate that !

the results are valid for the purposes of Section IV.B.2 l of Appendix I to 10CFR Part 50. 1 Il I I'

I l l

l i

l I

~

CLINTON-1 6-11 Rev.17-12/98

l I CPS-ODCM 7.0 REPORTING REQUIREMENTS 7.1 Annual Radiological Environmental Operating Report I Routine Radiological Environmental Operating Reports covering the operation of the unit during the previous I calendar year shall be submitted prior to May 1 of each year pursuant to Technical Specification 5.6.2.

The Annual Radiological Environmental Operating Reports I shall include the following information:

I 1. Summaries, interpretations, and an analysis of trends of the results of the radiological environmental surveillance activities for the report period, including a comparison with preoperational studies, with operational controls as appropriate, and with previous environmental surveillance reports, and an assessment of the observed impacts of the plant operation on the environment.

2. The results of land use censuses required by Section 5.2.

3. Results of analysis of all radiological environmental samples and of all environmental I'-

radiation measurements taken during the period pursuant to the locations specified in the Tables and Figures in this manual, as well as summarized 1 and tabulated results of these analyses and i measurements in the format of the table in the 1 Radiological Assessment Branch Technical Position, I Revision 1, November 1979. In the event that some individual results are not available for inclusion with the report, the report shall be submitted l

I ,

noting and explaining the reasons for the missing results. The missing data shall be submitted as soon as possible in a supplementary report.

4. A summary description of the radiological environmental monitoring program.

5. At least two legible maps covering all sample locations keyed to a table giving distances and directions from the HVAC stack.

One map shall cover stations near the site boundary and a second map.shall include the more distant stations.

Is

I CLINTON-1 7-1 Rev.17-12/98

f CPS-ODCM

6. The results of licensee participation in the Interlaboratory Comparison Program, required by ',

Section 5.3.1.

7. Discussion of all deviations from the sampling li W

schedule of Table 5.1-1.

8. Discussion of all analysis in which the LLD required g by Table 5.1-3 was not achievable. g 7.2 Radioactive Effluent Release Report Routine Radioactive Effluent Release 5teports covering the operation of the unit during the previous 12 months of operation shall- be submitted by May 1 of each year pursuant to Technical Specification 5.6.3.

The Radioactive Effluent' Release Report shall include the E following information: E

1. A summary of the quantities of radioactive liquid 3 and gaseous effluents and solid waste released from g the unit as outlined in Regulatory Guide 1.21,

" Measuring, Evaluating, and Reporting Radioactivity a in Solid Wastes and Releases of Radioactive g Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants, Revision 1, June 1974, with data summarized on a quarterly basis following the format of Appendix B thereof. For solid wastes, the format for Table 3 in Appendix B shall be supplemented with 3 additional categories: g class of solid wastes (as defined by 10CFR Part 61), 3 type of container (e.g., LSA, Type A, Type B, Large Quantity), and SOLIDIFICATION agent or absorbent (e.g., cement, urea formaldehyde) .

2. The following information for each class of solid waste (as defined by 10CFR Part 61) shipped.offsite during the report period:

a. Total container volume,

b. Total curie quantity (specify whether determined by measurement or estimate),

c. Principal radionuclides (specify whether determined by measurement or estimate),

d. Source of waste and processing employed (e.g.,

dewatered spent resin, compacted dry waste, evaporator bo'ttoms).

CLINTON-1 7-2 Rev.17-12/98

3 CPS-ODCM

, 3. A' list and description of unplanned releases from the site to UNRESTRICTED AREAS of radioactive materials in gaseous and liquid effluents made during the reporting period.

4. A listing of new locations for dose calculations and/or environmental monitoring identified by the land use census pursuant to Section 5.2.

1

5. Changes to'the ODCM pursuant to Technical 1 Specification 5.5.1.

6. Major changes to radioactive liquid, gaseous, and I solid waste treatment systems . The discussion of each change shall contain:"

A summary of the evaluation that led to the I a.

determination that the change could be made in accordance with 10CFR Part 50.59.

b. Sufficient detailed information to totally support the reason for the change without benefit of additional or supplemental I information;

c. A detailed description of the equipment, I' components and processes involved and the interfaces with other plant systems;

d. An evaluation of the change, wh'ich shows the predicted releases of radioactive materials in liquid and gaseous effluents and/or quantity of solid waste that differ from those previously I predicted in the license application and amendments thereto; I ~ Licensees may choose to submit the information called for in

,this requirement as part of its annual USAR update.

I Changes described by this requirement shall become effective upon review by the FRG.

1 CLINTON-1 7-3 Rev.17-12/90

m ,

CPS-ODCM

e. An evaluation of the change, which shows the !

expected minimum exposures to a HEMBER OF THE l PUBLIC in the UNRESTRICTED AREA and to the i j general population that differ from those previously estimated in the license application and amendments thereto; g 3 ]

f. A comparison of the predicted releases of radioactive materiale, in liquid and gaseous effluents and in solid waste, to the actual releases for the period prior to when the changes are to be made;

g. An estimate of the exposure to plant operating personnel as a result of the change; and

h. Documentation of the fact that the change was reviewed and found acceptable by the FRG.

7. An annual summary of hourly meteorolocjical data 3 collected over the previous year. _This annual g summary may be either in the form of an hour-by-hour listing on magnetic' tape of wind speed, wind direction, atmospheric stability, and precipitation f (if measured), or in the form of joint frequency i distributions of wind speed, wind direction, and {

atmospheric stability.

8. An assessment of the radiation doses due to the radioactive liquid and gaseous effluents released from the unit or station during the previous E calendar year. Beta and gamma air dose due to the release of noble gas in gaseous effluents is, 3

calculated at the CPS site boundary in each of the 16 geographical directions surrounding CPS. Dose due to the release of radioactive iodines and particulates in gaseous effluents is calculated at the critical receptor location in each of the 16 g geographical sectors surrounding CPS to a distance 3 of 5 miles. Dose summaries based on these calculations are provided in the Radioactive Effluent Release Report.

d. An a:ssessment of the radiation doses from radioactive liquid and gaseous effluents to MEMBERS l E

dV 7.HE PUBLIC due to their activities inside the SITE BOUNDARY (Figures 2.1-1 and 3.1-1) during the report period. g Note: W All assumptions used in making the following assessments, i.e., specific activity, exposure time and location, g shall be included in these reports. Annual average g meteorological conditions or meteorological conditions concurrent with the time of release of radioactive materials in gaseous effluents, as determined by sampling frequency and measurements, may be used for determining the gaseous pathway doses. The assessment of radiation doses shall be performed in accordance with the methodology and parameters in this manual.

I CLINTON-1 7-4 Rev.17-12/98

CPS-ODCM

10. An assessment of radiation doses to the likely most exposed MEMBER OF THE PUBLIC from reactor releases and other nearby uranium fuel cycle sources,_

including doses from primary effluent pathways and direct radiation, for the previous calendar year to show conformance with 40CFR Part 190, Environmental Radiation Protection Standards for Nuclear Power

( Operation.

Acceptable methods for calculating the dose contribution

( -from liquid and gaseous effluents are given in Regulatory Guide 1.109, Rev. 1, October 1977.

0

(

9 1 .

f CLINTON-1 7-5 Rev.17-12/98

CPS-ODCM 8.0 ADJUSTMENT OF THE CPS ODCM METHODOLOGY .

Consistent with the NRC Commissioners' opinion on 10CFR50 ('

Appendix I dated April 30, 1975, CPS will use environmental monitoring data to improve dose g calculational models and to request CPS ODCM changes on g the basis of such operating experience data. Such adjustments are recognized as being especially important for the radioiodine-milk pathway where conservative regulatory guide assumptions have been made. By using environmental monitoring data, uncertainties as.sociated .

with plume behavior, radioiodine chemical form, deposition and retention of forages, and milk consumption '

patterns may be circumvented or. reduced.,

I I

Ii 1 CLINTON-1 8-1 Rev.17-12/98

CPS-ODCM 9.0 ATMOSPHERIC TRANSPORT AND DISPERSION MODEL 9.1. Introduction The atmospheric transport and dispersion model used by Illinois Power Company is a straight-line, sector-I averaged Gaussian model designed to estimate ave, rage relative concentrations at various receptor points.

w The model was developed in accordance 'ith routine l, .

. release analysis procedures specified by Regulatory

. Guide 1.111 (Revision 1 July 1977), Section C.1.c

'" Constant Mean Wind Direction Models".

l. All meteorological and dose calculations prescribed in this manual are based on meteorological data concurrent with the time-of release or the annual average values.

I Near-real time meteorological data processing is

<[ described in Section 9.2.

9.2 Concurrent Meteorological Data Processing Meteorological datia is acquired and processed through a model which utilizes bi-level hourly meteorological tower data or single level joint frequency data to perform the required analysis. Three distinct release uodes are treated: elevated, ground and mixed.' A set I

of four output arrays are generated for each dose receptor location as:follows:

P y Relative undecayed, undepleted plume concentration (X/0)

Relative decayed and depleted radioiodine and l particulate concentration (D2DPXQ) [8 day decay]

kg\ '

Relative decayed noble gas concentration (DlXQ)

W [2.26 day decay]

Relative particulate and radioiodine deposition J (D/Q) .,

CLINTON-1 9-1 pey,17-12/98

CPS-ODCM l Since the Regulatory Guide 1.111 depletion and l L

deposition curves are defined only within the range i encompassing 100 to 200,000 meters, analysis results are not considered valid outside this range. The [g !

following sections describe the calculations performed l , by the transport and dispersion model for a one hour E time interval.

9.2.1 Determination"of Pasquill Stability Class ~

I The Pasquill Stab'ility Class is determined by categorizing the temperature gradient, AT, into one of

'several ranges between -0.900 and 0.900 'C/ meter according to,the following equation: g 3

AT = (Tu - Tn) / (Hu - Hn) , 'C/ meter (1) where .

! Tu = Meteorological (met) tower upper level E l temperature, *C g To = Meteorological tower lower level temperature, 'C Hu = Meteorological tower upper level instrumentation height.

I

= 60 meters ,

Hn = Meteorological tbwer level instrumentation height

= 10 meters AT is then classified according to the following scheme: -

=

Pasquill Stability Defining Condition I'

A (Extremely Unstable) -0.900 < AT $ -0.019 g B -0.019 < AT $ -0.017 3 C -0.017 < AT $ -0.015

, D (Neutral) -0.015 < AT < -0.005 E -0.005 < AT $ 0.01 6-F .

0.015 < AT <~ 0.040 G (Extremely Stable) 0.040 < AT < 0.900 Invalid AT $ -0.900 or AT > 0.900 I

I I

cLIwrON-1 9-2 Rev.17-12/98

CPS-ObCM' i 9.2.2 Calculation of Stack Height Wind Speed lt The wind spe'ed at the release point (HVAC Exhaust Stack

, or Standby Gas Treatment System Exhaust Stack) height, STACWS, is calculated using the expressions:

L STACWS = WSPu (STACKH/Hu)', meter /sec (2) 91 .

1 i

'where !

. W'SPu = Upper met tower level wind speed, meter /sec l WSPs =' Lower met tower level-wind speed, meter /sec 1 STACKH =. Physical release point, stack height P =. Wind power law exponent, 0.25 for stabilities A, B, C; 0.33 for: stability D; 0.5 for stabilities E, )

l F, G, dimensionless '

All other parsm.eters are as defined for equation (1).

9.2.3 Determination of Release Mode'and the Entrainment

! Coefficient The mode of release can be elevated,. ground or mixed; f the latter being a combination of the first two. The '

mode of release, as well as an entrainment coefficient, TCORR, are determined from the stack height, STACH',

building height, BLDGHT, stack exit velocity, EXITV, and wind speed at the stack height, STACWS.

s l

l For effluents exhausted from release points that are i higher than twice the height of adjacent solid I structures, i

g) [ STACKH > 2 (BLDGHT), TCORR = 0.0 (3) ithe' release is considered completely. elevated and;the entrainment coefficient is zero. For effluents released from points less than the height of adjacent solid structures, a ground-level release is assumed ggi STACKH < BLDGHT, TCORR = 1.0 (4) cand the entrainment coefficient is-unity. For effluents: released from points or vents at the level of, Lor above, adjacent solid structures, but lower than elevated' release points,

.CLINTON-1 9-3 Rev.17-12/90

1 i

CPS-ODCM 1ll 2(BLDGHT) > STACIGI > BLDGHT (5) the release is treated as elevated, ground or mixed according to the following relationships:

((

ELEVATED: TCORR = 0.00 if EXITV >5(STACWS) l6) lh GROUND: TCORR = 1.0 if EXITV < STACWS (7)

MIXED: T' CORR = 0.30-0.06(EXITV/STACWS) if (8) 5(STACWS) > EXITV > 1.5 (STACWS) s' TCORR = 2.58-1.58(EXITV/STACWS) if (9)

1. 5 (STACWS) > EXITV > (STACWS)

In the mixed mode, the release is considered to occur as an elevated release 100 (1-TCORR) percent of the g time and as a ground release .1.00 (TCORR) percent of the g time. Each of these cases are then evaluated separately and the concentration X/Q calculated according to the fraction of.the time each release occurs.

9.2.4 Calculation of Vertical Standard Deviation The vertical plume. spread (vertical standard deviation), o, is a function of the distance from the ilu release point to the reception point for a given Pasquill stability class. The numerical value of c, is obtained by linear inperpolation of the values in the E following table which are taken from Regulatory Guide 3 1.145: -

N.

g 0: Values u Distance Stability Class (meters) g A B C D E F G g N

h 200 500 31 120 21 55 15 34 10 19 6

13 4

8 3

5 g 1000 530 124 ' 64 32 21 13 0 .

5 2000 1000 340 120 52 34 20 13

3000 1000 800 170 68 44 25 16 g 6000 1000 1000 300 110 71 35 23 1000 1000 450 147 85 45 20 5

l 10000_

30000 1000 1000 1000 275 130 65 40 g 50000 1000 1000 1000 350 155 75 50 g 80000 1000 1000 1000 460 180 85 55 l -

h The values in this table are limited by the " mixing height lid"

')g which is specified at 1000m.

l CLINTON-1 9-4 Rev.17-12/98

1 I CPS-ODCM 9.2.5 Calculation of the Building Wake Correction For ground-based and mixed-mode releases, an adjustment I is made in the calculation of X/O that takes into consideration initial mixing of the effluent plume within the building wake. This adjustment is an I additional factor added in quadrature to the vertical plume spread equation (10) :

' E, = [a,* + 0.5 (BLDGHT) */x) (10) with the requirement that I, is restricted to values l 3 l Z, < (3)h (o ) . (11) 9.2.6 l Calculation of Momentum Plume Rise For elevated or mixed-mode releases o'nly, the amount of I plume rise due to the initial vertical momentum of the exhausted effluent, AH, is calculated. For Pasquill stability classes A,B,C and D, AH is calculated per I section 9.2.6.1; for classes E,F and G, section 9.2.6.2 is used.

9.2.6.1 AH For Pasquill Class A,B,C and D j l i AH is calculated using both equations (12) and (13) and the minimum value is selected for use.

I l I i I !

I -

g

~

I. .

4 CLINTON-1 9-5 Rev.17-12/98

CPS-ODCM

)$V l All t =

1. 4 4 (STACD) (EXITV/STACNS) 8 (12)

(X/STACD)I'#-DOWNWASH, '.neter q( l AH 2 = 3.0 (STACD) (EXITV/STACWS), meter (13) where STACD = Internal release point stack diameter

= 3.77 meters (ilVAC Exhaust Stack)

=,0.44 meters (SGTS Exhaust Stack)

EXITV = Stack exit velocity, meter /second X = Distance to specified receptor, meter All other parameters are as defined previously.

9.2.6.2 AH For Pasquill Class E,F and G AH is determined by selecting the minimum value calculated by equations (12) and (13) above and equations (14) and (15) below:

10 l AH 3 = 4. 0 [ (0. 5 (EXITV) (STACD) ) */S] , meter (14) gd { AH 4 = 1. 5 [ ( 0. 5 (EXITV) (STACD) ) */STACWS ] * (S) ~*,

meter (15) =

where S= Restoring acceleration per unit vertical displacement for adiabatic motion, sec-*

d.ph = 9.8

T./ (273+Te) i T. = 0.025 (E stability - default value)

T. = 0.05 (F stability - default value)

T. = 0.075 (G stability - de' fault value) i Where Te = Ambient air temperature (*C) [If temperature is missing, the default value will be l used]

All other parameters are as defined in section 9.2.6.1.

9.2.7 Calculation of the Effective Plume Height f The effective plume height, H, is determined using I section 9.2.6 results for the momentum plume rise, AH, and the terrain height, TERAIN:

I H = STACKH + AH - TERAIN, meter (16) I I'

l CLINTON-1 9-6 Rev.17-12/98

CPS-ODCM where

, TERAIN = Difference between the plant base height above mean sea level (MSL) and the receptor point height above MSL, meter >0.0.

9.2.8 Determination of Affected Sectors The wind direction for the hour determined which sector will be.affected. Sectors are 22.5* arcs and are classified according to the following scheme:

Sector Compass Wind Direction (WD)

Number Direction 1 N 0.0* < WD < 11.25' or 348.75* 2 WD < 360.00*

2 NNE 11.25* 2 WD 2 33.75*

3 NE 33.75* 2 WD < 56.25' 4 ENE 56.25* 2 WD < 78.75*

5 E 78.75* 2 WD < 101.25*

6 ESE 101.25* 2 WD < 123.75*

7 SE 123.75* 2 WD < 146.25*

8 SSE 146.25* I WD < 168.75*

9 S 168.75* 2 WD < 191.25*

10 SSW 191.25* 2 WD < 213.75*

11 SW 213.75* 2 WD < 236.25' 12 WSW 236.25* 2 WD < 258.75*

13 W 258.75* 2 WD < 281.25*

14 WNW ~

.281'.25* 2 WD < 303.75*

15 NW 303.75* 2 WD < 326.25*

16 NNW 326.25*3WD<348.75*

For elevated releases, the wind speed at the upper met tower level is used; ground releases use the speed of the wind at the lower met tower level. The wind gy )gji. direction is the same at both levels. During periods of calm wind, the wind speed is set at 0.5 .

meters /second the anemometer threshold value and assigned the direction measured for the hour.

e 9

i . .

CLINTON-1 9-7 Rev.17-12/98

CPS-OD'CH 9.2.9 Calculation of Depletion and Deposition Factors The depletion, DPF, and depositi is DPSF, factors are taken from the tables below which have been derived from curves found in Regulatory Guide 1.111. Both the DPF and DPSF values depend on the effective plume height, H, the stability class, S,.and the distance, X ,-

to the receptor.

The Regulatory Guide 1.111 curves represent plumes that are 100, 60, 30, and 0 (ground-level) meters above the ground. For plume heights and receptor distances other E than those listed, the factors are interpolated from E the tables. The model assumes that, after full plume rise is achieved, the plume cannot get higher from the 3 ground. The derivation of these curves assumed no 3 change in terrain height with downwind distance. Since topography does change with distance, as does the .g vertical distance between the plume centerline and the g ground, use more than one depletion or deposition value as the plume travels away from the plantwith distance.

DPF-DEFLETION FACTORS FROM F1 CURES 2 THROUCH 5 OF RECULATORY CUIDE 1.111

\% Helgid of Release PasqulE Stabatty 200 500 1,000 2,000 Distance (meten) 3,000 6,000 30,000 30,000 50,000 30,000 g (m) c1==

fY Cround AE 0.970 0.936 0300 RS60 0.832 8 710 0.714 0.590 0.517 0.440

\ 30 A.B.C. 0390 &964 8335 4 900 0.875 0228 S.793 0.630 e.590 0.478 30 D 1.000 0.9:5 &960 u20 e300 asse este 0.707 0.650 es93 30 E.F,G 1.000 1.000 1.000 1.000 1.000 1A00 E970 0.792 0.664 4.54 60 A,R,C 1.000 1985 4.967 E942 E923 0273 0339 E700 S.617 0.500 60 D 1.000 1.000 1.000 M70 E950 0310 SJ70 1767 E707 E646 60 F,F.C 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.977 100 A,B,C 1.000 1.000 8378 E950 1932 0.885 e.350 E725 0.628 0.500 100 D 1.000 1.000 1.000 E909 83E2 0.9M 8310 0.alr7 0.746 0.685 100 E,F,G 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.006 1.000 1.000 DPSF. DEPOSITION FACTORS FROM FIGURES 6 THROUCH 9 OF REGUIATORY CUIDE t.111 (m)*

Height of FaequiE Dhan-a (meters) n.a a= (en) Stabaity 200 500 1,000 2,000 3,000 6,000 30,000 30,000 50,000 30,000 W cin.

Cround AB 1.25FA SE 5 5.4F 5 3.2F 5 2.6E-5 1.5F 5 9.9FA 4.5FA 3FA 2FA 30 A,R C. 1.1 FA SF 5 (2 E-5 2.4 E-5 I.8E-5 1.lF 5 BFA 4.3FA 4FA 3.5FA 30 D 15FA 4.1F 4 48E.5 3F 5 2.4E-5 1.3E 5 SFA 3.4 FA 2.3FA 1.6FA 30 E,F.C 1.0E-11 IE-10 IF 9 IF 8 IE 7 2FA 6.3 FA E8FA 5.3FA 3FA 60 A,B,C 1.8F 5 4.4E-5 3.3F 5 2.4F 5 1.8E-5 1.1 E-5 S.2FA SFA 4.2 FA 3.5FA 60 D 2.BF 7 iSFA 1.6F 5 2 E.5 1.8E-5 1.3 E-5 8.9FA 3.6FA 2.5FA 1.7FA 60 F,F,0 1E-14 IF 13 IF 12 1F 11 1F 10 1L9 1F 8 1.6E-3 2 E-7 6.SE-7 100 A,B,C 4.0FA 2.6F 5 3.3 E.5 2.4E-5 1.7F 5 1.1E-5 8.1 FA SFA 4.5FA 3.7FA 200 D A.0E-3 2.6F 7 2.5FA 9FA 1.lF 5 I E-5 7.5F 4 39FA 2.8FA 1.9FA 100 E.F.C 1.0E-15 1.0E-1 IE-18 IE.15 1E-15 I E-15 IE-15 IE-15 1E-15 IE-15 '

5

The notation used in tids table is the mantissa and the exponent. For example I.254 means 1.25:10d.

l l

i l

n 1

l CLINTON-1 9-8 Re v .17- 12 / 9 ti l l

t - - - - i

CPS-ODCM e 9.2.10 Gronnd Level X/Q, D2DPXQ, D1XQ, D/O Analysis 9.2.10.1 Undecayed, Undepleted Plume Relative Concentration, X/O The atmospheric concentration of effluent at ground level, normalized by the source term Q, is given by the following equation:

4 X/Q = 2.032 (TCORR) /WSPt (X)1 ban, sec/m3 (20) where

=

76 n The lesser of the two values obtained by equations (10) and (11), meter b

2.032 = The constant (2/x) divided by the width in radians of a 22.5' sector (i.e., x/8, dimensionless

.X = Distance between release point to receptor, meter 9.2.10.2 Decayed, Depleted Radioiodine and Particulate Relative '

Concentration, D2DPXQ The decayed, depleted radioiodine concentration, ,

D2DPXQ, is calculated in accordance with the following equation:

g{ D2DPXQ = DPF(DC2)X/Q, sec/m' (21) where ,

DPF = The depletion factor calculated per section 9.2.9, dimensionless DC2 = The radioiodine 8 day decay factor, dimensionless

=

exp(-0. 693 (X) /ty(WSPt) ]

.= exp[-0.693 (X) / (8 day) (24 hr/ day) (3600 sec/hr) (WSPo) )

CLINTON-1 9-9 Rev.17-12/98

1 CPS-ODCM

= exp [-1. 00E-06 (X/WS P ,) )

9.2.10.3 Decayed Noble Gas Plume Relative Concentration, D1XQ The decayed noble gas plume relative concentration, D1XQ, is calculated in accordence with the following equation:

N DlXQ = DC1 (X/Q), sec/m' f (22) where DCI = The noble gas decay factor, dimensionless

= exp [-0. 693 (X) /ty(WSPg.) ]

= exp .[-0.U93(X)/ (2.26 day) (24 hr/ day)'

I !

(3600 sec/hr) (WSPs,)] l

= exp [-3.55E-06 (X/W3P ,)t ) IlI 1

9.2.10.4 Radiciodine and Particulate Relative Deposition, D/Q The relative deposition for radioiodines and '

particulates, D/Q is calculated in accordance with the following equation:

D/O = [DPSF(DC2) (TCORR) ) /.[ (2x/16)X], m*

9 (23) where DPSP = The deposition facto.r calculated per section 9.2.9., m-*

t 9.2.11 Elevated X/Q, D2DPXQ, D1XQ, D/O Analysis 9.2.11.1 Undecayed, Undepleted Plume Relative Concentration, X/O The atmospheric concentration of effluent at el'evated level, normalized by the source term Q, is given by the following equation:

3 X/Q = [2.03} (1-TCORR) exp [-0.5 (H/o ) 2]

z ] / [STACWS (X) o z),

sec/m (24) where all parameters are as previously defined.

~

I f

I

' ~

g CLINTON-1 9-10 Rev.17-12/98

CPS-ODCM 9.2.11.2 Decayed, Depleted Radioiodine and Particulate Relative Concentration, D2DPXQ The calculation of D2DPXQ for elevated releases follows section 9.2.10.2 methodology with the exception that the WSPt value used in the calculation of DC2 in equation (21) is replaced by the STACWS value and the equation (24) X/O is used.

D2DPXQ = DPF(DC2)X/Q, sec/m3 (25) where DPF = The depletion factor calculated per section 9.2.9, dimensionless DC2 = The radiciodine 8 day decay factor, dimensionless

= exp[-0.693 (X) /th(STACWS) ]

= exp[-0.693(X)/(8 day) (24 hr/ day) (3600 sec/hr)

( STACWS)]

= exp[-1.00E-06 (X/ STACWS) J 9.2.11.3 Decayed Noble Gas Plume Relative Concentration, D1XQ N

Q The calculation of D1XQ for elevated releases follows section 9.2.10.3 methodology by substituting the equation (24) X/Q value into equation (22) and STACWS for WSPc in the calculatilon of DC1.

DlXQ = DCl (X/Q) , sec/m ,_(2 6)

~

where DC1 = The noble gas decay factor, dimensionless

= exp [-0. 693 (X) /t y(STACWS)]

= exp [-0,693(X)/(2.26 day) (24 hr/ day)

(3600 sec/hr) ( STACWS) ]

= exp [-3.55E-06 (X/STACWS) ]

9.2.11.4 Rad'ioiodine and Particulate Relative Deposition, D/Q The calculation of D/Q for elevated releases follows section 9.2.10.4 methodology by substituting (1-TCORR) for the TCORR term in equation (23) and STACWS for WSP t

.in the calculation of DC2. -

D/Q = [DPSF(1-TCORR) ]./ [ (2 x/16) X] , m~

(27) where DPSF = The deposition factor calculated per sdction 9.2.9, m l

CLINTON-1 9-11 Rev.17-12/98

CPS-ODCM E

Table 9.2-1 GASEOUS EFFLUENT RELEASE POINT CHARACTERISTICS (

_ _ _ , _ / I R00F n.s7s v MACHNE SHOP BUU.c i ROOFEL78W j

_f 170'0* > 2067 y_

l

" " " " CONTROL ROOM.

x-sarsvExt N AnUn.uouno rs 1

! lopcom1NMENTCONC.EL 9277 E

' cournotocoNo I l-,.

R00F EL8477 l

l i

' ~ ~ ~

p t

~

nn l\

a 6 9 6-V g N / ROOF EL7907 OLP.)

Vll/ g i

, / /

f g roo .uo

a. 00 , _____

./a= EL7 o " E l E 5 5 5 E~5 &- q; , g ma.cEx.n.ne.uu fy - .m ,oa u.r.

(AT EL7197) g

~ , - - L --_ '/ g HVAC Exhaust SGTS Exhaust Stack Stack Release Point Height (m) 61 61 Building Height (m) 58 58 Release Point Geometry Duct Pipe Release Point Area (m*) 11.15 0.15 j Release Point Diameter (m) 3.77*' O.44 l Annual Average Flow Rate "(m'/sec,) 111.71 1.89 Vertical Exit Velocity (m/sec) 10.02 12.49

Ef fective 2 (A/x) diameter CLINTON-1 9-12 Rev.17-12/98 ,

i

)

ML20206E628

Text

The maximum acceptable release rate of all Ch3 noble gases in release path j, pCi/sec F3

Navigation menu

Search